Table of Contents

As filed with the Securities and Exchange Commission on November 5, 2014

Registration No. 333-

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM S-3

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

OMNICARE, INC.

SEE TABLE OF SUBSIDIARY GUARANTOR REGISTRANTS IDENTIFIED BELOW

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   31-1001351
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

 

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

(513) 719-2600

(Address, including zip code, and telephone number, including area code, of each registrant’s principal executive offices)

 

 

Alexander M. Kayne, Esq.

Senior Vice President, Secretary and General Counsel

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

(513) 719-2600

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Copies to:

Michelle B. Rutta, Esq.

White & Case LLP

1155 Avenue of the Americas

New York, New York 10036

(212) 819-8200

 

 

Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this Registration Statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.     ¨

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.     x

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.     ¨

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.     ¨

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.     x


Table of Contents

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.     ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer   x    Accelerated filer   ¨
Non-accelerated filer   ¨   (Do not check if a smaller reporting company)    Smaller reporting company   ¨

CALCULATION OF REGISTRATION FEE

 

Title of Each Class of Securities to be

Registered

 

Amount to be registered/Proposed maximum offering price per unit/

Proposed maximum aggregate offering price (1)

 

Amount of

registration fee (2)

Debt Securities        
Guarantees of Debt Securities (3)        
Common Stock, $1.00 par value        
Preferred Stock, no par value per share        
Warrants        

 

(1) An indeterminate amount of securities is being registered as may from time to time be issued at indeterminate prices. Separate consideration may or may not be received for securities that are issuable upon conversion of, or in exchange for, or upon exercise of, convertible or exchangeable securities.
(2) In accordance with Rules 456(b) and 457(r), the registrant is deferring payment of the registration fee.
(3) Guarantees of the payment of principal and interest on the Debt Securities may be provided by the subsidiaries of the registrant named below under “Additional Subsidiary Guarantor Registrants.” No separate consideration will be received for such guarantees and, pursuant to Rule 457(n) of the Securities Act of 1933, no separate registration fee is payable for such guarantees.


Table of Contents

ADDITIONAL SUBSIDIARY GUARANTOR REGISTRANTS

 

Exact Name of Registrant as Specified in its Charter*    State or Other
Jurisdiction of
Incorporation or
Organization
     I.R.S.
Employer
Identification
Number
 

Advanced Care Scripts, Inc.

     FL         43-2080503   

AMC-New York, Inc.

     DE         36-4091917   

AMC-Tennessee, Inc.

     DE         62-1696813   

APS Acquisition LLC

     DE         61-1401116   

ASCO Healthcare of New England, Limited Partnership

     MD         23-2763886   

ASCO Healthcare of New England, LLC

     MD         23-2762311   

ASCO Healthcare, LLC

     MD         52-0816305   

Badger Acquisition LLC

     DE         52-2119866   

Badger Acquisition of Kentucky LLC

     DE         52-2119911   

Badger Acquisition of Minnesota LLC

     DE         52-2119871   

Badger Acquisition of Ohio LLC

     DE         52-2119875   

Best Care LTC Acquisition Company LLC

     DE         20-8401946   

BPNY Acquisition Corp.

     DE         31-1563804   

Campo’s Medical Pharmacy, Inc.

     LA         72-1039948   

Capitol Home Infusion, Inc.

     VA         54-1744833   

Care Pharmaceutical Services, LP

     DE         31-1399042   

Care4 LP

     DE         22-3245022   

CCRx Holdings, LLC

     DE         20-2032406   

CCRx of North Carolina Holdings, LLC

     DE         20-5864517   

CCRx of North Carolina, LLC

     DE         20-5964894   

CHP Acquisition Corp.

     DE         31-1483612   

CIP Acquisition Corp.

     DE         31-1486402   

Compass Health Services, LLC

     WV         55-0730048   


Table of Contents

CompScript, LLC

     FL         65-0506539   

Continuing Care Rx, LLC

     PA         23-2952534   

CP Acquisition Corp.

     OK         61-1317566   

CP Services LLC

     DE         20-5858893   

D&R Pharmaceutical Services, LLC

     KY         61-0955886   

Delco Apothecary, Inc.

     PA         23-2350209   

Enloe Drugs LLC

     DE         31-1362346   

Evergreen Pharmaceutical of California, Inc.

     CA         61-1321151   

Evergreen Pharmaceutical, LLC

     WA         91-0883397   

HMIS, Inc.

     DE         36-4124072   

Home Care Pharmacy, LLC

     DE         31-1255845   

Home Pharmacy Services, LLC

     MO         37-0978331   

Hytree Pharmacy, Inc.

     OH         34-1090853   

Institutional Health Care Services, LLC

     NJ         22-2750964   

Interlock Pharmacy Systems, LLC

     MO         43-0951332   

JHC Acquisition LLC

     DE         31-1494762   

Langsam Health Services, LLC

     DE         73-1391198   

LCPS Acquisition LLC

     DE         61-1347084   

Lobos Acquisition, LLC

     DE         86-1068024   

Lo-Med Prescription Services, LLC

     OH         34-1396063   

Main Street Pharmacy L.L.C.

     MD         52-1925761   

Managed Healthcare, Inc.

     DE         31-1450845   

Management & Network Services, Inc.

     OH         34-1819691   

Med World Acquisition Corp.

     DE         61-1322120   

Medical Arts Health Care, Inc.

     GA         58-1640672   

MHHP Acquisition Company LLC

     DE         20-0619598   

NCS Healthcare of Illinois, LLC

     IL         37-1354510   


Table of Contents

NCS Healthcare of Indiana LLC

     DE         34-1958652   

NCS Healthcare of Indiana, Inc.

     IN         35-1954599   

NCS Healthcare of Iowa, LLC

     OH         31-1509013   

NCS Healthcare of Kansas, LLC

     OH         34-1839712   

NCS Healthcare of Kentucky, Inc.

     OH         31-1521217   

NCS Healthcare of Montana, Inc.

     OH         34-1851710   

NCS Healthcare of New Hampshire, Inc.

     NH         02-0468190   

NCS Healthcare of New Mexico, Inc.

     OH         34-1866493   

NCS Healthcare of Ohio, LLC

     OH         31-1257307   

NCS Healthcare of South Carolina, Inc.

     OH         31-1508225   

NCS Healthcare of Tennessee, Inc.

     OH         34-1866494   

NCS Healthcare of Washington, Inc.

     OH         34-1844193   

NCS Healthcare of Wisconsin, LLC

     OH         34-1866497   

NCS Healthcare, LLC

     DE         34-1816187   

NCS Services, Inc.

     OH         34-1837567   

NeighborCare Holdings, Inc.

     DE         23-2555703   

NeighborCare of Indiana, LLC

     IN         95-4482026   

NeighborCare of Virginia, LLC

     VA         95-4480544   

NeighborCare Pharmacies, LLC

     MD         52-1465507   

NeighborCare Pharmacy Services, Inc.

     DE         23-2963282   

NeighborCare Repackaging, Inc.

     MD         20-1128397   

NeighborCare Services Corporation

     DE         23-2585556   

NeighborCare, Inc.

     PA         06-1132947   

NIV Acquisition LLC

     DE         31-1501415   

North Shore Pharmacy Services, LLC

     DE         31-1428484   

OCR-RA Acquisition, LLC

     DE         31-1442830   

Omnicare Distribution Center LLC

     DE         61-1389057   


Table of Contents

Omnicare ESC LLC

     DE         20-5859052   

Omnicare Headquarters LLC

     DE         76-0720510   

Omnicare Holding Company

     DE         31-1262386   

Omnicare Indiana Partnership Holding Company, LLC

     DE         16-1653107   

Omnicare Management Company

     DE         31-1256520   

Omnicare of Nevada LLC

     DE         20-0888517   

Omnicare of New York, LLC

     DE         95-4450977   

Omnicare Pharmacies of Pennsylvania East, LLC

     DE         61-1347894   

Omnicare Pharmacies of Pennsylvania West, LLC

     PA         25-1213193   

Omnicare Pharmacies of the Great Plains Holding Company

     DE         61-1386242   

Omnicare Pharmacy and Supply Services, LLC

     SD         41-1730324   

Omnicare Pharmacy of Florida, LP

     DE         76-0716528   

Omnicare Pharmacy of Maine LLC

     DE         61-1339662   

Omnicare Pharmacy of Nebraska LLC

     DE         61-1386244   

Omnicare Pharmacy of North Carolina, LLC

     DE         76-0716543   

Omnicare Pharmacy of Pueblo, LLC

     DE         76-0716546   

Omnicare Pharmacy of Tennessee LLC

     DE         61-1347088   

Omnicare Pharmacy of Texas 1, LP

     DE         76-0716554   

Omnicare Pharmacy of Texas 2, LP

     DE         11-3657397   

Omnicare Pharmacy of the Midwest, LLC

     DE         31-1374275   

Omnicare Property Management, LLC

     DE         27-1403681   

Omnicare Purchasing Company General Partner, Inc.

     DE         61-1401040   

Omnicare Purchasing Company Limited Partner, Inc.

     DE         61-1401038   

Omnicare Purchasing Company LP

     DE         61-1401039   

Pharmacy Associates of Glens Falls, Inc.

     NY         14-1554120   

Pharmacy Consultants, LLC

     SC         57-0640737   

Pharmacy Holding #1, LLC

     DE         76-0716538   


Table of Contents

Pharmacy Holding #2, LLC

     DE         76-0716536   

Pharmasource Healthcare, Inc.

     GA         58-2066823   

Pharmed Holdings, Inc.

     DE         36-4060882   

PMRP Acquisition Company, LLC

     DE         26-3418908   

PP Acquisition Company, LLC

     DE         20-2394950   

PRN Pharmaceutical Services, LP

     DE         35-1855784   

Professional Pharmacy Services, Inc.

     MD         23-2847488   

PSI Arkansas Acquisition, LLC

     DE         20-5810731   

Roeschen’s Healthcare, LLC

     WI         39-1084787   

RXC Acquisition Company

     DE         20-3113620   

Shore Pharmaceutical Providers, Inc.

     DE         31-1425144   

Specialized Pharmacy Services, LLC

     MI         38-2143132   

Sterling Healthcare Services, Inc.

     DE         36-4031863   

Suburban Medical Services, LLC

     PA         23-2014806   

Superior Care Pharmacy, Inc.

     DE         31-1543728   

TCPI Acquisition Corp.

     DE         31-1508476   

Three Forks Apothecary LLC

     KY         61-0995656   

UC Acquisition Corp.

     DE         31-1414594   

Uni-Care Health Services of Maine, Inc.

     NH         02-0468192   

Value Health Care Services, LLC

     DE         31-1485530   

VAPS Acquisition Company, LLC

     DE         20-4849023   

Vital Care Infusions, Inc.

     NY         61-1336267   

Weber Medical Systems LLC

     DE         31-1409572   

Westhaven Services Co., LLC

     OH         34-1151322   

Williamson Drug Company, Incorporated

     VA         54-0590067   

ZS Acquisition Company, LLC

     DE         20-4763592   

 


Table of Contents
* The address for each of the additional registrants is c/o Omnicare, Inc., 900 Omnicare Center, 201 E. Fourth Street, Cincinnati, Ohio 45202, telephone: (513) 719-2600. The name, address, including zip code, of the agent for service for each of the additional registrants is Alexander M. Kayne, Senior Vice President, Secretary and General Counsel of Omnicare, Inc., 900 Omnicare Center, 201 E. Fourth Street, Cincinnati, Ohio 45202, telephone: (513) 719-2600.


Table of Contents

OMNICARE, INC.

Debt Securities

Guarantees of Debt Securities

Common Stock

Preferred Stock

Warrants

We may offer from time to time

    debt securities, which may be senior or subordinated and which may be convertible into shares of our common stock or other debt securities,
    guarantees, if any, of our obligations under any debt securities, which may be given by one or more of our subsidiaries,
    shares of our common stock, par value $1.00 per share,
    shares of our preferred stock, no par value, or
    warrants to purchase any of the other securities that may be sold under this prospectus.

We will provide specific terms of any offering in supplements to this prospectus. The securities may be offered separately or together in any combination and as separate series. You should read this prospectus and any prospectus supplement, as well as the documents incorporated or deemed to be incorporated by reference in this prospectus, carefully before you invest.

Our common stock is listed on the New York Stock Exchange under the symbol “OCR.”

The mailing address of our principal executive office is 900 Omnicare Center, 201 E. Fourth Street, Cincinnati, Ohio 45202. Our telephone number is (513) 719-2600.

Investing in these securities involves risks. You should carefully review the information under the heading “ Risk Factors ” on page 2 regarding information included and incorporated by reference in this prospectus and the applicable prospectus supplement.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

We may sell these securities on a continuous or delayed basis directly, through agents, dealers or underwriters as designated from time to time, or through a combination of these methods. We reserve the sole right to accept, and together with any agents, dealers and underwriters reserve the right to reject, in whole or in part, any proposed purchase of securities to be made directly or through agents, dealers or underwriters. If any agents, dealers or underwriters are involved in the sale of any securities, the relevant prospectus supplement will set forth any applicable commissions or discounts. The price to the public and our net proceeds from the sale of such securities also will be set forth in the relevant prospectus supplement.

The date of this prospectus is November 5, 2014.


Table of Contents

TABLE OF CONTENTS

 

ABOUT THIS PROSPECTUS

     1   

FORWARD-LOOKING STATEMENTS

     1   

RISK FACTORS

     2   

OUR COMPANY

     3   

RATIO OF EARNINGS TO FIXED CHARGES

     4   

USE OF PROCEEDS

     4   

DESCRIPTION OF DEBT SECURITIES AND GUARANTEES OF DEBT SECURITIES

     4   

DESCRIPTION OF CAPITAL STOCK

     8   

DESCRIPTION OF WARRANTS

     12   

PLAN OF DISTRIBUTION

     14   

LEGAL MATTERS

     15   

EXPERTS

     16   

WHERE YOU CAN FIND MORE INFORMATION

     16   

DOCUMENTS INCORPORATED BY REFERENCE INTO THIS PROSPECTUS

     16   


Table of Contents

ABOUT THIS PROSPECTUS

This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the “SEC”) as a “well-known seasoned issuer” as defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”) utilizing a “shelf” registration process. Under this shelf process, we may sell, at any time and from time to time, the securities described in this prospectus. For further information about our business and the securities, you should refer to the registration statement and its exhibits. The exhibits to our registration statement contain the full text of certain contracts and other important documents we have summarized in this prospectus. Since these summaries may not contain all the information you may find important in deciding whether to purchase the securities we offer, you should review the full text of these documents. The registration statement and the exhibits can be obtained from the SEC as indicated under the heading “Where You Can Find More Information.”

This prospectus provides you with a general description of the securities we may offer. Each time we sell securities, we will provide a prospectus supplement that will contain specific information about the terms of that offering. The prospectus supplement may also add, update or change information contained in this prospectus. You should read both the prospectus and any prospectus supplement together with the additional information described under the heading “Where You Can Find More Information.”

We have not authorized any person to give any information or to make any representation in connection with this offering other than those contained or incorporated by reference in this prospectus, and, if given or made, the information or representation must not be relied upon as having been authorized by us. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy by anyone in any jurisdiction in which the offer or solicitation is not authorized, or in which the person is not qualified to do so or to any person to whom it is unlawful to make the offer or solicitation. Neither the delivery of this prospectus nor any sale under this prospectus shall, under any circumstances, create any implication that there has been no change in our affairs since the date of this prospectus, that the information contained in this prospectus is correct as of any time subsequent to its date, or that any information incorporated by reference in this prospectus is correct as of any time subsequent to its date.

Unless otherwise stated or the context requires otherwise, references to “Omnicare,” “we,” “us”, “our” and the “Company” refer to Omnicare, Inc. and its consolidated subsidiaries.

FORWARD-LOOKING STATEMENTS

In addition to historical information, this report contains certain statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements regarding the intent, belief or current expectations regarding the matters discussed or incorporated by reference in this document (including statements as to “beliefs,” “expectations,” “anticipations,” “intentions” or similar words) and all statements which are not statements of historical fact. Such forward-looking statements, together with other statements that are not historical, are based on management’s current expectations and involve known and unknown risks, uncertainties, contingencies and other factors that could cause results, performance or achievements to differ materially from those stated.

The most significant of these risks and uncertainties are described in the Company’s Form 10-K, Form 10-Q and Form 8-K reports filed with the SEC and include, but are not limited to: overall economic, financial, political and business conditions; trends in the long-term healthcare and pharmaceutical industries; our ability to attract new clients and service contracts and retain existing clients and service contracts; our ability to identify, finance and consummate acquisitions on favorable terms or at all; trends for the continued growth of our businesses; changes in drug pricing; delays and reductions in reimbursement by the government and other payors to

 

1


Table of Contents

Omnicare and our customers; the overall financial condition of our customers and our ability to assess and react to such financial condition; the ability and willingness of our vendors and business partners to continue to provide products and services to Omnicare; the successful integration of acquired companies and realization of contemplated synergies; the continued availability of suitable acquisition candidates; the ability to attract and retain skilled management; competition for qualified staff in the healthcare industry; variations in demand for our products and services; variations in costs or expenses; our ability to implement productivity, consolidation and cost reduction efforts and to realize anticipated benefits; the potential impact of legislation, government regulations, and other government action and/or executive orders, including those relating to Medicare Part D, its implementing regulations and any subregulatory guidance; reimbursement and drug pricing policies and changes in the interpretation and application of such policies, including changes in calculation of average wholesale price; discontinuation of reporting average wholesale price and/or implementation of new pricing benchmarks; legislative and regulatory changes impacting long-term care pharmacies or specialty pharmacies; government budgetary pressures and changes, including federal and state budget shortfalls; efforts by payors to control costs; changes to or termination of our contracts with pharmaceutical benefit managers, Medicare Part D Plan sponsors and/or commercial health insurers or changes in the proportion of our business covered by specific contracts; the outcome of pending and future legal or contractual disputes; potential liability for losses not covered by, or in excess of, insurance; the impact of executive separations; the impact of benefit plan terminations; the impact of differences in actuarial assumptions and estimates as compared to eventual outcomes; events or circumstances that could result in an impairment of assets, including but not limited to, goodwill and identifiable intangible assets; our ability to successfully complete planned divestitures; market conditions; the outcome of audit, compliance, administrative, regulatory, or investigatory reviews; volatility in the market for our stock and in the financial markets generally; timing of conversions of our convertible debt securities; access to adequate capital and financing on acceptable terms; changes in our credit ratings given by rating agencies; changes in tax laws and regulations; changes in accounting rules and standards; the impacts of potential cybersecurity risks and/or incidents; costs to comply with our Corporate Integrity Agreement; and unexpected costs and interruptions from the implementation of our new information technology system. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements could differ materially from those expressed in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

Except as otherwise required by law, the Company does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

RISK FACTORS

Investing in our securities involves risks. You should carefully consider the risks described under “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2013, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, and the other documents incorporated by reference in this prospectus (which risk factors are incorporated by reference herein), as well as the other information contained or incorporated by reference in this prospectus or in any prospectus supplement hereto before making a decision to invest in our securities. See “Where You Can Find More Information” below.

These risks are not the only ones facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business operations. Any of these risks could materially and adversely affect our business, financial condition or results of operations. In such cases, you may lose all or part of your investment.

 

2


Table of Contents

OUR COMPANY

We are a leading healthcare services company that specializes in the management of complex pharmaceutical care. We operate two primary businesses, Long-Term Care Group (“LTC”) and Specialty Care Group (“SCG”), each serving different customer populations but sharing a common objective of advancing health outcomes at the lowest possible cost. Through LTC, we are the nation’s largest provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, chronic care facilities and other settings. Through SCG, we provide specialty pharmacy and commercialization services for the biopharmaceutical industry. We leverage our specialized clinical capabilities and innovative technology solutions across both of these primary businesses as key components of the value that management believes we provide to our customers. We service customers in both of these businesses across the United States.

Long-Term Care

Through LTC, we operate the largest institutional pharmacy business in the United States as measured in both revenues and the number of customers served. Due to the size and scope of LTC, we believe we have unique cost advantages, especially pertaining to the sourcing of pharmaceuticals. The scale of our operations has also provided us with the opportunity to make investments in proprietary automation technology to reduce our dispensing costs while improving the accuracy and consistency of our service delivery. LTC’s customers consist of skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other healthcare service providers. In light of a customer mix that is heavily concentrated in the senior market, we have a high level of insight into geriatric pharmaceutical care.

In addition to pharmaceutical distribution, we believe we provide value to our customers through our extensive clinical services, our customer-facing technology offerings and the speed at which we transition residents of our customers’ facilities to lower-cost generic pharmaceuticals. With respect to our clinical services, we provide pharmacy consulting, including monthly patient drug therapy evaluations, assist in compliance with state and federal regulations and provide proprietary clinical and health management programs (utilizing outcomes-based algorithm technology). LTC also provides a suite of technology solutions based largely on our Omniview ® web-based platform that is intended to improve the efficiency of our customers’ operations through such tools as the electronic ordering of prescription refills, proof-of-delivery tracking, and real-time validation of Medicare Part D coverage, among others. LTC also provides a number of other products and services, including intravenous medications and nutrition products (infusion therapy products and services), respiratory therapy services, and clinical care planning. We also provide pharmaceutical case management services for retirees, employees and dependents who have drug benefits under corporate-sponsored healthcare programs.

Specialty Care Group

SCG operates across a broad spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Our SCG services are largely centered on the specialty pharmaceutical market and revolve around four platforms: brand support services, supply chain solutions, patient support services and specialty pharmacy. By integrating these services across SCG’s platforms, we are able to provide our manufacturer clients a customized end-to-end solution for all of their needs. Our brand support services, supply chain solutions and patient support services are integrated, fee-for-service platforms which focus on helping the drug manufacturer to market, distribute and obtain reimbursement for their products. In our specialty pharmacy platform, we dispense specialized pharmaceuticals that are high cost, have complex reimbursement and supply chain challenges, have limited patient populations and are not available through normal retail channels. These specialized drugs deal primarily with specific categories of drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology and growth hormones.

 

3


Table of Contents

Corporate Information

Our principal executive office is located at 900 Omnicare Center, 201 E. Fourth Street, Cincinnati, Ohio 45202, and our telephone number is (513) 719-2600. Our corporate website address is www.omnicare.com. Information contained on our website is not a part of, or incorporated by reference in, this prospectus.

RATIO OF EARNINGS TO FIXED CHARGES

Set forth below is information concerning our ratio of earnings to fixed charges.

 

     Nine Months
Ended September 30,
   Year Ended December 31,  
     2014    2013     2012     2011     2010     2009  

Ratio of Earnings to Fixed Charges (1)

   4.1x      2.2     2.8     2.4     1.1     2.3

 

  (1) Our ratio of earnings to fixed charges has been computed by adding income from continuing operations before income taxes and fixed charges to derive adjusted income from continuing operations, and dividing adjusted income from continuing operations by fixed charges. Fixed charges consist of interest expense on debt (including the amortization of debt expense) and one-third (the proportion deemed representative of the interest portion) of rent expense.

USE OF PROCEEDS

Unless we indicate otherwise in an accompanying prospectus supplement, we intend to use the net proceeds from the sale of the securities offered by this prospectus for general corporate purposes, which may include, but not be limited to, repayment or reduction of indebtedness, working capital, capital expenditures, acquisitions, and repurchases and redemptions of securities.

DESCRIPTION OF DEBT SECURITIES AND

GUARANTEES OF DEBT SECURITIES

We may issue debt securities either separately or together with, or upon the conversion of or in exchange for, other securities. We may issue senior debt securities and/or subordinated debt securities. The subordinated debt securities of any series may be our senior subordinated obligations, subordinated obligations, junior subordinated obligations or may have such other ranking as will be described in the relevant prospectus supplement. We may issue any of these types of debt securities in one or more series. Our senior debt securities may be issued from time to time under a senior debt securities indenture. Our subordinated debt securities may be issued from time to time under a subordinated debt securities indenture. The form of indenture relating to our senior debt securities and the executed indenture related to our subordinated debt securities have been filed as exhibits to the registration statement of which this prospectus is a part.

The applicable prospectus supplement and the form of indenture relating to any particular debt securities offered will describe the specific terms of that series. When evaluating an offering of our debt securities, you also should refer to all provisions of the applicable indenture and the debt securities. When we refer to “Omnicare,” “we,” “us” or “our” in this section or when we otherwise refer to ourselves in this section, we mean Omnicare, Inc., excluding, unless otherwise expressly stated or the context requires, our subsidiaries.

This section summarizes selected terms of the debt securities that we may offer. If any particular terms of the debt securities described in a prospectus supplement differ from any of the terms described in this prospectus, then the terms described in the applicable prospectus supplement will supersede the terms described in this prospectus.

 

4


Table of Contents

General

We can issue an unlimited amount of debt securities under the indentures. However, certain of our existing or future debt agreements may limit the amount of debt securities we may issue. We can issue debt securities from time to time and in one or more series as determined by us. In addition, we can issue debt securities of any series with terms that differ from the terms of debt securities of any other series, and the terms of particular debt securities within any series may differ from each other, all without the consent of the holders of previously issued series of debt securities.

A prospectus supplement relating to the series of debt securities being offered will describe the specific terms of that series of debt securities, including, where applicable, the following:

 

    the title and series designation of the series of debt securities and whether the debt securities of the series will be senior debt securities or subordinated debt securities;

 

    any limit on the aggregate principal amount of debt securities of the series;

 

    the price or prices at which the debt securities of the series will be issued;

 

    whether the debt securities will be guaranteed and the terms of any such guarantees;

 

    the date or dates on which the principal amount and premium, if any, are payable;

 

    the interest rate or rates or the method for calculating the interest rate, which may be fixed or variable, at which the debt securities of the series will bear interest, if any, the date or dates from which interest will accrue and the interest payment date on which interest will be payable, subject to our right, if any, to defer or extend an interest payment date and the duration of that deferral or extension;

 

    the date or dates on which interest, if any, will be payable and the record dates for payment of interest;

 

    the place or places where the principal and premium, if any, and interest, if any, will be payable and where the debt securities of the series can be surrendered for transfer, conversion or exchange;

 

    our right, if any, to redeem the debt securities and the terms and conditions upon which the debt securities of the series may be redeemed, in whole or in part;

 

    any mandatory or optional sinking fund or analogous provisions;

 

    if the debt securities of the series will be secured, any provisions relating to the security provided;

 

    whether the debt securities of the series are convertible or exchangeable into other debt or equity securities, and, if so, the terms and conditions upon which such conversion or exchange will be effected;

 

    whether any portion of the principal amount of the debt securities of the series will be payable upon declaration or acceleration of the maturity thereof pursuant to an event of default;

 

    provisions relating to the modification, supplement or waiver of any provisions of the indenture relating to the debt securities of the series both with and without the consent of holders of the debt securities of such series;

 

    whether the debt securities of the series, in whole or any specified part, will be defeasible pursuant to the indenture and the manner in which any election by us to defease the debt securities of the series will be evidenced;

 

    the events of default pertaining to the debt securities of the series;

 

    covenants pertaining to the debt securities of the series;

 

    if other than U.S. dollars, the currency or currencies, including composite currencies, of payment of principal of, premium, if any, and interest, if any, on the debt securities of the series;

 

5


Table of Contents
    whether the debt securities of the series may be satisfied and discharged and, if so, the terms and conditions for such satisfaction and discharge;

 

    any terms applicable to debt securities of any series issued at an issue price below their stated principal amount, including the issue price thereof and the rate or rates at which the original issue discount will accrue;

 

    whether the debt securities of the series are to be issued or delivered (whether at the time of original issuance or at the time of exchange of a temporary security of such series or otherwise), or any installment of principal or any premium or interest is to be payable only, upon receipt of certificates or other documents or satisfaction of other conditions in addition to those specified in the indenture;

 

    whether the debt securities of the series are to be issued in fully registered form without coupons or are to be issued in the form of one or more global securities in temporary global form or permanent global form;

 

    whether the debt securities of the series are to be issued in registered or bearer form, the terms and conditions relating to the applicable form, including, but not limited to, tax compliance, registration and transfer procedures and, if in registered form, the denominations in which we will issue the registered securities if other than $1,000 or a multiple thereof and, if in bearer form, the denominations in which we will issue the bearer securities;

 

    any special United States federal income tax considerations applicable to the debt securities of the series;

 

    any addition to or change in the covenants set forth in the indenture that apply to the debt securities of the series; and

 

    any other terms of the debt securities of the series not inconsistent with the provisions of the indenture.

The prospectus supplement relating to any series of subordinated debt securities being offered also will describe the subordination provisions applicable to that series. In addition, the prospectus supplement relating to a series of subordinated debt securities will describe our rights, if any, to defer payments of interest on the subordinated debt securities by extending the interest payment period.

Debt securities may be issued at a discount below their principal amount or at a premium above their principal amount. In the event of an acceleration of the maturity of any original issue discount security, the amount payable to the holder upon acceleration will be determined in the manner described in the applicable prospectus supplement.

The above is not intended to be an exclusive list of the terms that may be applicable to any debt securities and we are not limited in any respect in our ability to issue debt securities with terms different from or in addition to those described above or elsewhere in this prospectus, provided that the terms are not inconsistent with the indenture. Any applicable prospectus supplement also will describe any special provisions for the payment of additional amounts with respect to the debt securities.

Subordination Provisions Relating to Subordinated Debt

Debt securities may be subject to contractual subordination provisions contained in the subordinated debt securities indenture. These subordination provisions may prohibit us from making payments on the subordinated debt securities in certain circumstances before a defined class of “senior indebtedness” is paid in full or during certain periods when a payment or other default exists with respect to certain senior indebtedness. If we issue subordinated debt securities, the applicable prospectus supplement relating to the subordinated debt securities will include a description of the subordination provisions and the definition of senior indebtedness that apply to the subordinated debt securities.

 

6


Table of Contents

If the trustee under the subordinated debt indenture or any holder of the series of subordinated debt securities receives any payment or distribution that is prohibited under the subordination provisions, then the trustee or the holders will have to repay that money to the holders of senior indebtedness.

Even if the subordination provisions prevent us from making any payment when due on the subordinated debt securities of any series, we will be in default on our obligations under that series if we do not make the payment when due. This means that the trustee under the subordinated debt indenture and the holders of that series can take action against us, but they will not receive any money until the claims of the holders of senior indebtedness have been fully satisfied.

Conversion and Exchange Rights

The debt securities of a series may be convertible into or exchangeable for certain of our other securities, if at all, according to the terms and conditions described in the applicable prospectus supplement. Such terms will include the conversion or exchange price and any adjustments thereto, the conversion or exchange period, provisions as to whether conversion or exchange will be mandatory, at our option or at the option of the holders of that series of debt securities, and provisions affecting conversion or exchange in the event of the redemption of that series of debt securities.

The Trustees under the Indentures

A trustee in its individual or any other capacity may become the owner or pledgee of debt securities and may otherwise deal with us or any of our affiliates with the same rights it would have if it were not a trustee. If, however, any trustee acquires any conflicting interest it must eliminate such conflict within 90 days, apply to the SEC for permission to continue to act as trustee or resign.

The holders of a majority in principal amount of the then outstanding debt securities of a series will have the right to direct the time, method and place of conducting any proceeding for exercising any remedy available to the trustee, subject to certain exceptions. The indenture provides that if an event of default occurs and is continuing, a trustee will be required, in the exercise of its power, to use the degree of care and skill of a prudent person in the conduct of its own affairs. Subject to such provisions, a trustee will be under no obligation to exercise any of its rights or powers under the indenture at the request of any holder of debt securities, unless such holder has offered to the trustee security and indemnity satisfactory to it against any loss, liability or expense.

Global Securities

The debt securities of a series may be issued in whole or in part in the form of one or more global securities that will be deposited with, or on behalf of, a depositary identified in the applicable prospectus supplement. Global securities will be issued in registered form and in either temporary or permanent form. Unless and until it is exchanged for the individual debt securities, a global security may not be transferred except as a whole by the depositary for such series to a nominee of such depositary or by a nominee of such depositary to such depositary or another nominee of such depositary or by such depositary or any such nominee to a successor depositary for such series or a nominee of such successor depositary. The specific terms of the depository arrangement will be described in the applicable prospectus supplement.

Subsidiary Guarantees

Debt securities may be guaranteed by certain of our domestic subsidiaries. The prospectus supplement will describe the terms of any guarantees, including, among other things, the method for determining the identity of the guarantors and the conditions under which guarantees will be added or released. Any guarantees will be joint and several obligations of the guarantors. The obligations of each guarantor under its guarantee will be limited as necessary to prevent that guarantee from constituting a fraudulent conveyance or fraudulent transfer under applicable law.

 

7


Table of Contents

Applicable Law

The debt securities and the indentures will be governed by and construed in accordance with the laws of the State of New York.

DESCRIPTION OF CAPITAL STOCK

Our authorized capital stock consists of 200,000,000 shares of common stock, par value $1.00 per share, and 1,000,000 shares of preferred stock, no par value per share.

Common Stock

This section summarizes the general terms of our common stock that we may offer. The prospectus supplement relating to the common stock offered will state the number of shares offered, the initial offering price and the market price, dividend information and any other relevant information. The summaries in this section and the prospectus supplement do not describe every aspect of our common stock. When evaluating an offering of our common stock, you should also refer to all of the provisions of our charter, our by-laws and the Delaware General Corporation Law (the “DGCL”). Our charter and by-laws are incorporated by reference as exhibits to the registration statement of which this prospectus is a part and are incorporated by reference herein.

Terms of the Common Stock

As of September 30, 2014, 97,883,851 shares of our common stock were outstanding. Our common stock has no preemptive rights and no redemption, sinking fund or conversion provisions. All shares of our common stock have one vote on any matter submitted to the vote of stockholders. Our common stock does not have cumulative voting rights. Upon our liquidation, the holders of our common stock are entitled to receive, on a pro rata basis, all assets then legally available for distribution after payment of debts and liabilities and preferences on preferred stock, if any. Holders of our common stock are entitled to receive dividends when and as declared by the board of directors out of funds legally available therefor (subject to the prior rights of preferred stock, if any). All outstanding shares of our common stock are fully paid and nonassessable.

Provisions with Possible Anti-takeover Effects

Certain provisions of our charter, by-laws and the DGCL may delay or prevent any transaction involving us that might result in a change of control.

Fair Price Provision.

With certain exceptions, in the event a person, corporation or other entity owns 10% or more of our stock entitled to vote, a majority of the outstanding shares of our capital stock not so owned is required to authorize (i) any merger or consolidation of us with or into such corporation, (ii) any sale, lease, exchange or other disposition of all or a substantial part of our assets to or with such person, corporation or other entity or (iii) issuances and transfers of our securities to such person, corporation or other entity for assets and/or securities with a value of at least $5 million or for cash.

Board of Directors.

Our board of directors, when evaluating any offer of another party to make a tender or exchange offer for our equity securities, merge or consolidate with us, or purchase or otherwise acquire all or substantially all of our assets, shall, in connection with the exercise of its judgment in determining what is in the best interests of us and our stockholders, give due consideration to all relevant factors, including the social and economic effects on our employees, customers, suppliers and other constituents and on the communities in which we operate or are located.

 

8


Table of Contents

Our charter also provides that directors may be removed without cause only by the holders of two-thirds of the shares of our capital stock then entitled to vote on the election of directors.

Amendments to the Charter.

The sections of our charter relating to the fair price and director removal provisions described above, as well as those relating to elimination of director liability, indemnification of directors and the ability of our board of directors to amend the by-laws, may only be repealed or amended with the approval of the holders of two-thirds of the outstanding shares of each class of our capital stock entitled to vote thereon as a class.

Business Combinations.

We are subject to Section 203 of the DGCL, which restricts a wide range of transactions (“business combinations”) between a corporation and an interested stockholder. An “interested stockholder” is, generally, any person who beneficially owns, directly or indirectly, 15% or more of the corporation’s outstanding voting stock. Business combinations are broadly defined to include (i) mergers or consolidations with, (ii) sales or other dispositions of more than 10% of the corporation’s assets to, (iii) certain transactions resulting in the issuance or transfer of any stock of the corporation or any subsidiary to, (iv) certain transactions resulting in an increase in the proportionate share of stock of the corporation or any subsidiary owned by, or (v) receipt of the benefit (other than proportionately as a stockholder) of any loans, advances or other financial benefits by an interested stockholder. Section 203 provides that an interested stockholder may not engage in a business combination with the corporation for a period of three years from the time of becoming an interested stockholder unless (a) the board of directors approved either the business combination or the transaction which resulted in the person becoming an interested stockholder prior to the time that person became an interested stockholder; (b) upon consummation of the transaction which resulted in the person becoming an interested stockholder, that person owned at least 85% of the corporation’s voting stock (excluding shares owned by persons who are directors and also officers and shares owned by certain employee stock plans); or (c) the business combination is approved by the board of directors and authorized by the affirmative vote of at least 66  2 3 % of the outstanding voting stock not owned by the interested stockholder.

Future Issuances of Preferred Stock.

We are not required to seek stockholder approval prior to designating any future series of preferred stock. Our board of directors could issue preferred stock in one or more transactions with terms that might make the acquisition of control of our company more difficult or costly.

Transfer Agent

The transfer agent for our common stock is BNY Mellon Shareowner Services, Jersey City, New Jersey.

Preferred Stock

This section summarizes the general terms of the preferred stock that we may offer. The prospectus supplement relating to a particular series of preferred stock will describe the specific terms of that series, which may be in addition to or different from the general terms summarized in this section. The summaries in this section and the prospectus supplement do not describe every aspect of the preferred stock. If any particular terms of a series of preferred stock described in a prospectus supplement differ from any of the terms described in this prospectus, then the terms described in the applicable prospectus supplement will be deemed to supersede the terms described in this prospectus. When evaluating an offering of our preferred stock, you also should refer to all of the provisions of our charter, the applicable certificate of designation for the offered series of preferred stock and the DGCL. The applicable certificate of designation will be filed as an exhibit to or incorporated by reference in the registration statement of which this prospectus is a part.

 

9


Table of Contents

General

Our board of directors is authorized to issue shares of preferred stock, in one or more series or classes, and to fix for each series voting powers and those preferences and relative, participating, optional or other special rights and those qualifications, limitations or restrictions as are permitted by the DGCL.

Our board of directors is authorized to determine the terms for each series of preferred stock, and a prospectus supplement will describe the terms of any series of preferred stock being offered thereby, including:

 

    the designation of the shares and the number of shares that constitute the series;

 

    the purchase price of the preferred stock;

 

    the dividend rate (or the method of calculation thereof), if any, on the shares of the series and the priority as to payment of dividends with respect to other classes or series of our capital stock;

 

    the dividend periods (or the method of calculation thereof);

 

    the voting rights of the shares;

 

    the liquidation preference and the priority as to payment of the liquidation preference with respect to other classes or series of our capital stock and any other rights of the shares of the series upon our liquidation or winding up;

 

    whether or not and on what terms the shares of the series will be subject to redemption or repurchase at our option;

 

    whether and on what terms the shares of the series will be convertible into or exchangeable for other securities;

 

    whether the shares of the series of preferred stock will be listed on a securities exchange;

 

    any special United States federal income tax considerations applicable to the series; and

 

    the other rights and privileges and any qualifications, limitations or restrictions of the rights or privileges of the series.

Dividends

Holders of shares of preferred stock will be entitled to receive, when and as declared by our board of directors, dividends payable at the dates and at the rates, if any, per share per annum as set forth in the applicable prospectus supplement.

Unless otherwise set forth in the applicable prospectus supplement, each series of preferred stock will rank junior as to dividends to any series of preferred stock that may be issued in the future that is expressly senior as to dividends to that preferred stock. If we should fail at any time to pay accrued dividends on any senior shares at the time the dividends are payable, we may not pay any dividend on the junior preferred stock or redeem or otherwise repurchase shares of junior preferred stock until the accumulated but unpaid dividends on the senior shares have been paid or set aside for payment in full by us.

Unless otherwise set forth in the applicable prospectus supplement, no dividends (other than in common stock or other capital stock ranking junior to the preferred stock of any series as to dividends and upon liquidation) may be declared or paid or set aside for payment, nor may any other distribution be declared or made upon the common stock, or any of our other capital stock ranking junior to or on a parity with the preferred stock of that series as to dividends, nor may any common stock or any of our other capital stock ranking junior to or on a parity with the preferred stock of that series as to dividends be redeemed, purchased or otherwise acquired for any consideration (or any monies be paid to or made available for a sinking fund for the redemption of any shares of any of that stock) by us (except by conversion into or exchange for other capital stock of ours ranking junior to

 

10


Table of Contents

the preferred stock of that series as to dividends) unless (i) if that series of preferred stock has a cumulative dividend, full cumulative dividends on the preferred stock of that series have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof set apart for all past dividend periods and the then current dividend period and (ii) if such series of preferred stock does not have a cumulative dividend, full dividends on the preferred stock of such series have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof set apart for payment for the then current dividend period. However, any monies deposited in any sinking fund with respect to any preferred stock in compliance with the provisions of the sinking fund may be applied to the purchase or redemption of that preferred stock in accordance with the terms of the sinking fund, regardless of whether at the time of the application full dividends, including cumulative dividends, upon shares of the preferred stock outstanding on the last dividend payment date have been paid or declared and set apart for payment. In addition, any junior or parity preferred stock or common stock may be converted into or exchanged for our stock ranking junior to the preferred stock as to dividends.

The amount of dividends payable for the initial dividend period or any period shorter than a full dividend period will be computed on the basis of a 360-day year of twelve 30-day months, unless otherwise set forth in the applicable prospectus supplement. Accrued but unpaid dividends will not bear interest, unless otherwise set forth in the applicable prospectus supplement.

Convertibility

No series of preferred stock will be convertible into, or exchangeable for, other securities or property except as set forth in the applicable prospectus supplement.

Redemption and Sinking Fund

No series of preferred stock will be redeemable or receive the benefit of a sinking fund except as set forth in the applicable prospectus supplement.

Liquidation Rights

Unless otherwise set forth in the applicable prospectus supplement, in the event of our liquidation, dissolution or winding up, the holders of shares of each series of preferred stock are entitled to receive out of our assets available for distribution to stockholders, before any distribution of assets is made to holders of (i) any other shares of preferred stock ranking junior to that series of preferred stock as to rights upon liquidation, dissolution or winding up and (ii) shares of common stock, liquidating distributions per share in the amount of the liquidation preference specified in the applicable prospectus supplement for that series of preferred stock plus any dividends accrued and accumulated but unpaid to the date of final distribution; but the holders of each series of preferred stock will not be entitled to receive the liquidating distribution of, plus such dividends on, those shares until the liquidation preference of any shares of our capital stock ranking senior to that series of preferred stock as to rights upon liquidation, dissolution or winding up have been paid (or a sum set aside therefor sufficient to provide for payment) in full. If upon our liquidation, dissolution or winding up, the amounts payable with respect to a series of preferred stock, and any other preferred stock ranking on a parity with such preferred stock as to any distribution are not paid in full, then the holders of such series of preferred stock and the other parity preferred stock will share ratably in any distribution of assets in proportion to the full respective preferential amount to which they are entitled. Unless otherwise specified in a prospectus supplement for a series of preferred stock, after payment of the full amount of the liquidating distribution to which they are entitled, the holders of shares of such series of preferred stock will not be entitled to any further participation in any distribution of our assets. Neither a consolidation nor merger of us with another corporation nor a sale of securities will be considered a liquidation, dissolution or winding up of us.

Voting Rights

The holders of each series or class of preferred stock we may issue will have no voting rights, except as required by law and as described below or in the applicable prospectus supplement. Our board of directors may,

 

11


Table of Contents

upon issuance of a series or class of preferred stock, grant voting rights to the holders of that series or class to elect additional board members if we fail to pay dividends in a timely fashion.

Without the affirmative vote of a majority of the shares of any class of preferred stock then outstanding, we may not:

 

    increase or decrease the aggregate number of authorized shares of that class;

 

    increase or decrease the par value of the shares of that class; or

 

    alter or change the powers, preferences or special rights of the shares of that class so as to affect them adversely.

If the amendment would adversely alter or change the powers, preferences or special rights of one or more series of a class of preferred stock, but not the entire class, then only the shares of the affected series will have the right to vote on the amendment.

Miscellaneous

The holders of our preferred stock will have no preemptive rights. All shares of preferred stock that we may offer will be fully paid and not liable to further calls or assessment by us. If we should redeem or otherwise reacquire shares of our preferred stock, then these shares will resume the status of authorized and unissued shares of preferred stock undesignated as to series, and will be available for subsequent issuance.

No Other Rights

The shares of a series of preferred stock will not have any preferences, voting powers or relative, participating, optional or other special rights except as set forth above or in the applicable prospectus supplement, our charter or the applicable certificate of designation or as otherwise required by law.

Outstanding Preferred Stock

As of September 30, 2014, there were no shares of preferred stock outstanding.

Transfer Agent and Registrar

The transfer agent and registrar designated for a particular series of preferred stock will be identified in the applicable prospectus supplement.

DESCRIPTION OF WARRANTS

We may issue, either separately or together with other securities, warrants for the purchase of any of the other types of securities that we may sell under this prospectus.

This section summarizes the general terms of the warrants that we may offer. The warrants will be issued under warrant agreements to be entered into between us and a bank or trust company, as warrant agent. A prospectus supplement will describe the specific terms of the particular series of warrants offered thereby, which may be in addition to or different from the general terms summarized in this section. The summaries in this section and the applicable prospectus supplement do not describe every aspect of the warrants. If any particular terms of a series of warrants described in a prospectus supplement differ from any of the terms described in this prospectus, then the terms described in the applicable prospectus supplement will be deemed to supersede the terms described in this prospectus. When evaluating an offering of our warrants, you also should refer to all the provisions of the applicable warrant agreement, the certificates representing the warrants and the specific descriptions in the applicable prospectus supplement. The applicable warrant agreement and warrant certificates will be filed as exhibits to or incorporated by reference in the registration statement.

 

12


Table of Contents

General

A prospectus supplement, as well as the related warrant agreement and warrant certificates, will describe the terms of the series of warrants being offered, including the following, where applicable:

 

    the principal amount or the number of securities, as the case may be, purchasable upon exercise of each warrant and the initial price at which the principal amount or number of securities, as the case may be, may be purchased upon such exercise;

 

    the designation and terms of the securities, if other than common stock, purchasable upon exercise thereof and of any securities, if other than common stock, with which the warrants are issued;

 

    the procedures and conditions relating to the exercise of the warrants;

 

    the date, if any, on and after which the warrants, and any securities with which the warrants are issued, will be separately transferable;

 

    the offering price of the warrants, if any;

 

    the date on which the right to exercise the warrants will commence and the date on which that right will expire;

 

    a discussion of any special United States federal income tax considerations applicable to the warrants;

 

    whether the warrants represented by the warrant certificates will be issued in registered or bearer form, and, if registered, where they may be transferred and registered;

 

    call provisions of the warrants, if any;

 

    antidilution provisions of the warrants, if any; and

 

    any other material terms of the warrants.

Exercise of Warrants

A warrant will entitle the holder to purchase that principal amount of or number of securities, as the case may be, at the exercise price set forth in, or to be determined as set forth in, the applicable prospectus supplement relating to that series of warrants. Unless otherwise specified in the applicable prospectus supplement, warrants may be exercised at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement at any time up to 5:00 p.m. Eastern Standard Time on the expiration date set forth in the applicable prospectus supplement. After 5:00 p.m. Eastern Standard Time on the expiration date, unexercised warrants will become void. Upon receipt of payment of the exercise price and the warrant certificate properly completed and duly executed, we will, as soon as practicable, issue the securities purchasable upon exercise of the warrant. If less than all of the warrants represented by the warrant certificate are exercised, a new warrant certificate will be issued for the remaining amount of warrants.

No Rights of Security Holder Prior to Exercise

Prior to the exercise of their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon the exercise of such warrants and will not be entitled to:

 

    in the case of warrants to purchase debt securities, payments of principal of, premium, if any, or interest, if any, on the debt securities purchasable upon exercise; or

 

    in the case of warrants to purchase equity securities, the right to vote or to receive dividend payments or similar distributions on the securities purchasable upon exercise.

Exchange of Warrant Certificates

Warrant certificates will be exchangeable for new warrant certificates of different denominations at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement.

 

13


Table of Contents

PLAN OF DISTRIBUTION

We may offer and sell the securities described in this prospectus from time to time. We may sell the securities to one or more underwriters for public offering and sale by them; or we may sell the securities to investors through agents or dealers; or we may use a combination of these methods. Any underwriter or agent involved in the offer and sale of the securities will be named in the applicable prospectus supplement. We also reserve the right to sell securities directly to investors in those jurisdictions where we are authorized to do so.

The distribution of securities may be effected from time to time in one or more transactions at a fixed price or prices, which may be changed, or from time to time at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. We also may, from time to time, authorize underwriters acting as our agents to offer and sell the securities upon the terms and conditions set forth in any prospectus supplement. In connection with the sale of the securities, underwriters may be deemed to have received compensation from us in the form of underwriting discounts or commissions and may also receive commissions from purchasers of the securities for whom they may act as agent. If we use underwriters in the sale of securities, we will execute an underwriting agreement with the underwriter at the time of sale.

If a dealer is utilized in the sale of the securities in respect of which this prospectus is delivered, we may sell the securities to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.

Any underwriter, dealer or agent that will participate in a distribution of securities will be identified in the applicable prospectus supplement or other offering materials.

Any underwriting compensation paid by us to underwriters or agents in connection with the offering of securities, and any discounts, concessions or commissions allowed by underwriters to participating dealers, will be set forth in the applicable prospectus supplement. Underwriters, dealers and agents participating in distribution of the securities may be deemed to be underwriters under the Securities Act, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions under the Securities Act. We may enter into agreements with underwriters, dealers and agents that entitle them to indemnification against and contribution toward certain civil liabilities, including liabilities under the Securities Act, and to reimbursement by us for certain expenses.

In connection with underwritten offerings of securities, underwriters may over-allot or effect transactions that stabilize, maintain or otherwise affect the market price of the offered securities at levels above those that might otherwise prevail in the open market, including by entering stabilizing bids, effecting syndicate covering transactions or imposing penalty bids, each of which is described below.

 

    A stabilizing bid means the placing of any bid, or the effecting of any purchase, for the purpose of pegging, fixing or maintaining the price of a security.

 

    A syndicate covering transaction means the placing of any bid on behalf of the underwriting syndicate or the effecting of any purchase to reduce a short position created in connection with the offering.

 

    A penalty bid means an arrangement that permits the managing underwriter to reclaim a selling concession from a syndicate member in connection with the offering when offered securities originally sold by the syndicate member are purchased in syndicate covering transactions.

These transactions may be effected on the New York Stock Exchange, in the over-the-counter market or otherwise. Underwriters are not required to engage in any of these activities, or to continue the activities if commenced.

If so indicated in the applicable prospectus supplement, we may authorize dealers acting as our agents to solicit offers by institutions to purchase securities from us or the dealers at the public offering price set forth in

 

14


Table of Contents

the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on the date or dates stated in the prospectus supplement. Each delayed delivery contract will be for an amount not less than, and the aggregate principal amount or offering price of the securities sold pursuant to delayed delivery contracts will not be less nor more than, the respective amounts stated in the prospectus supplement. Institutions with whom delayed delivery contracts, when authorized, may be entered into include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other institutions, but such contracts will in all cases be subject to approval by us.

In the event we sell securities directly to investors, no underwriters, agents or dealers would be involved. We may use electronic media, including the internet, to offer and sell securities directly.

The securities also may be offered and sold, if so indicated in the applicable prospectus supplement, in connection with a remarketing upon their purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more firms (“remarketing firms”), acting as principals for their own accounts or as agents for us. Any remarketing firm will be identified and the terms of its agreement, if any, with us and its compensation will be described in the applicable prospectus supplement. Remarketing firms may be deemed to be underwriters in connection with the securities remarketed thereby. We may enter into agreements with remarketing firms that entitle them to indemnification by us against certain liabilities, including liabilities under the Securities Act.

We may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. The applicable prospectus supplement will indicate, in connection with those derivatives, if such third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third parties in such sale transactions will be underwriters and will be identified in the applicable prospectus supplement (or a post-effective amendment).

The securities may or may not be listed on a national securities exchange or a foreign securities exchange. Securities offered may be a new issue of securities with no established trading market. Any underwriters to whom or agents through whom these securities are sold by us for public offering and sale may make a market in these securities, but such underwriters or agents will not be obligated to do so and may discontinue any market making at any time without notice. No assurance can be given as to the liquidity of, or the trading market for, any such securities.

One or more of the underwriters, dealers or agents, and/or one or more of their respective affiliates, may be a lender under our credit agreements and may provide other commercial banking, investment banking and other services to us and/or our subsidiaries and affiliates in the ordinary course of business.

LEGAL MATTERS

Legal matters with respect to the validity of the securities being offered hereby will be passed upon for us by White & Case LLP, New York, New York. Certain matters under Georgia law will be passed upon by Briskin, Cross & Sanford, LLC. Certain matters under Illinois law and Maryland law will be passed upon by Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C. Certain matters under Indiana law and Ohio law will be passed upon by Bingham Greenebaum Doll LLP. Certain matters under Kentucky law, South Carolina law, Virginia law and West Virginia law will be passed upon by Hancock, Daniel, Johnson & Nagle, P.C. Certain matters under Louisiana law will be passed upon by Taylor Porter Brooks & Phillips, L.L.P. Certain matters under Michigan law will be passed upon by Plunkett Cooney, P.C. Certain matters under Missouri law will be passed upon by Carmody MacDonald P.C. Certain matters under New Hampshire law will be passed upon by Shaheen & Gordon, P.A. Certain matters under New Jersey law and Pennsylvania law will be passed upon by Stradley Ronon Stevens & Young, LLP. Certain matters under Oklahoma law will be passed upon by McAfee &

 

15


Table of Contents

Taft, A Professional Corporation. Certain matters under South Dakota law will be passed upon by Davenport, Evans, Hurwitz & Smith, LLP. Certain matters under Washington law will be passed upon by Stoel Rives LLP. Certain matters under Wisconsin law will be passed upon by Davis  & Kuelthau, S.C.

EXPERTS

The financial statements incorporated in this prospectus by reference to Omnicare, Inc.’s Current Report on Form 8-K dated November 5, 2014 and the financial statement schedule and management’s assessment of the effectiveness of internal control over financial reporting (which is included in Management’s Report on Internal Control over Financial Reporting) incorporated in this prospectus by reference to the Annual Report on Form 10-K of Omnicare, Inc. for the year ended December 31, 2013 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.

WHERE YOU CAN FIND MORE INFORMATION

We file reports, proxy statements and other information with the SEC. You may read and copy any document we file at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov. Our filings are also available at the offices of the New York Stock Exchange, 20 Broad Street, New York, New York 10005. Information about us, including our SEC filings, is also available at our website at www.omnicare.com. However, the information on our website is not a part of, or incorporated by reference in, this prospectus or any prospectus supplement.

This prospectus constitutes part of a registration statement on Form S-3 that we filed with the SEC under the Securities Act. As permitted by the rules and regulations of the SEC, this prospectus omits some of the information, exhibits and undertakings included in the registration statement. You may read and copy the information omitted from this prospectus but contained in the registration statement, as well as the periodic reports and other information we file with the SEC, at the addresses and websites listed above.

DOCUMENTS INCORPORATED BY REFERENCE INTO THIS PROSPECTUS

We have elected to “incorporate by reference” certain information into this prospectus. By incorporating by reference, we can disclose important information to you by referring you to another document we have filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, except for information incorporated by reference that is superseded by information contained in any document we subsequently file with the SEC that is incorporated or deemed to be incorporated by reference in this prospectus. Likewise, any statement in this prospectus or any document which is incorporated or deemed to be incorporated by reference herein will be deemed to have been modified or superseded to the extent that any statement contained in any document that we subsequently file with the SEC that is incorporated or deemed to be incorporated by reference herein modifies or supersedes that statement. We are incorporating by reference the following documents that we have previously filed with the SEC (other than information in such documents that is deemed not to be filed):

 

  (a) Omnicare, Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 (filed February 19, 2014) (the financial statements and related audit report have been superseded by the financial statements and related audit report included in the Current Report on Form 8-K filed on November 5, 2014);

 

  (b) Omnicare, Inc.’s Quarterly Reports on Form 10-Q for the periods ended March 31, 2014 (filed April 23, 2014), June 30, 2014 (filed July 23, 2014) and September 30, 2014 (filed October 24, 2014);

 

16


Table of Contents
  (c) Omnicare Inc.’s Current Reports on Form 8-K filed February 28, 2014, March 25, 2014, April 16, 2014, May 22, 2014, May 27, 2014, July 2, 2014, October 31, 2014 and November 5, 2014; and

 

  (d) Omnicare, Inc.’s description of its common stock contained in the Registration Statement filed on Form 8-A pursuant to Section 12(b) of the Securities Exchange Act of 1934 including any amendment or report updating such description.

We also are incorporating by reference all future documents that we file with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934 prior to the termination of the offering of the securities made hereby (other than information in such documents that is deemed not to be filed).

We will provide without charge to each person, including any beneficial owner, to whom a copy of this prospectus has been delivered, on the written or oral request of that person, a copy of any or all of the documents referred to above which have been incorporated by reference in this prospectus other than exhibits to these documents, unless the exhibits are also specifically incorporated by reference herein. Requests for copies should be directed to 900 Omnicare Center, 201 E. Fourth Street, Cincinnati, Ohio 45202, Attention: Secretary; telephone number (513) 719-2600. The information relating to us contained in this prospectus does not purport to be complete and should be read together with the information contained in the documents incorporated or deemed to be incorporated by reference in this prospectus and the information included in the applicable prospectus supplement.

 

17


Table of Contents

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14. Other Expenses of Issuance and Distribution

The expenses relating to the issuance and distribution of the securities registered hereby will be borne by the registrant. Such expenses are estimated to be as follows:

 

SEC Registration Fee

   $ *   

Accounting fees and expenses

     100,000   

Legal fees and expenses

     300,000   

Printing and engraving expenses

     50,000   

Rating agencies’ fees

     200,000   

Trustee’s and registrar’s fees and expenses

     50,000   

Miscellaneous expenses

     25,000   

Total:

   $ 725,000   

 

 

* Deferred in reliance upon Rules 456(b) and 457(r).

Item 15. Indemnification of Directors and Officers

The following summaries are qualified in their entirety by reference to the complete text of any statutes referred to below and the organizational documents of Omnicare, Inc. and the subsidiary guarantors, as applicable.

Delaware

AMC-New York, Inc., AMC-Tennessee, Inc., BPNY Acquisition Corp., CHP Acquisition Corp., CIP Acquisition Corp., HMIS, Inc. Managed Healthcare, Inc., Med World Acquisition Corp., NeighborCare Holdings, Inc., NeighborCare Pharmacy Services, Inc., NeighborCare Services Corporation, Omnicare Holding Company, Omnicare Management Company, Omnicare Pharmacies of the Great Plains Holding Company, Omnicare Purchasing Company General Partner, Inc., Omnicare Purchasing Company Limited Partner, Inc., Pharmed Holdings, Inc. RXC Acquisition Company, Shore Pharmaceutical Providers, Inc., Sterling Healthcare Services, Inc., Superior Care Pharmacy, Inc., TCPI Acquisition Corp. and UC Acquisition Corp. are incorporated under the laws of Delaware.

Under Section 102 of Delaware General Corporation Law (the “DGCL”), a corporation may eliminate or limit the personal liability of its directors to the corporation or its stock holders for monetary damages for breach of fiduciary duty as a director, except where the director (i) breached his duty of loyalty to the corporation or its stockholders, (ii) failed to act in good faith or where the director engaged in intentional misconduct or a knowing violation of the law, (iii) authorized the payment of an unlawful dividend or an unlawful stock repurchase or redemption, or (iv) derived an improper personal benefit.

Under Section 145 of the DGCL, a corporation may indemnify a director, officer, employee or agent of the corporation (or a person who is or was serving at the request of the corporation as a director, officer, employee or

 

II-1


Table of Contents

agent of another corporation, partnership, joint venture, trust or other enterprise) against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. In the case of an action brought by or in the right of a corporation, the corporation may indemnify a director, officer, employee or agent of the corporation (or a person who is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise) against expenses (including attorneys’ fees) actually and reasonably incurred by him if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification may be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent a court finds that, in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses as the court shall deem proper.

The Restated Certificate of Incorporation of Omnicare, Inc. provides that a director of Omnicare, Inc. will not be liable to Omnicare, Inc. or its stockholders for monetary damages for breach of fiduciary duty as a director, to the full extent permitted by the DGCL, as amended or interpreted from time to time. In addition, the Restated Certificate of Incorporation of Omnicare, Inc. states that Omnicare, Inc. shall, to the full extent permitted by the DGCL, as amended or interpreted from time to time, indemnify all directors, officers and employees whom it may indemnify pursuant thereto and, in addition, Omnicare, Inc. may, to the extent permitted by the DGCL, indemnify agents of Omnicare, Inc. or other persons.

The company maintains a director and officer liability insurance policy for the benefit of its directors and certain officers covering certain liabilities that may be incurred in the performance of these duties, which may include liability or related losses under the Securities Act or the Securities Exchange Act of 1934, as amended.

The certificate of incorporation of AMC-New York, Inc., as amended, provides that except as prohibited by law, every director and officer of the registrant shall be entitled as of right to be indemnified by the registrant against all expenses and liability incurred by such person in connection with any actual or threatened claim, action, suit or proceeding, whether civil, criminal, administrative, investigative or other, or whether brought by or against such person or by or in the right of the registrant or otherwise, in which such person may be involved, as a party or otherwise, by reason of such person being or having been a director or officer of the registrant or a subsidiary of the registrant or by reason of the fact that such person is or was serving at the request of the registrant as a director, officer, employee, fiduciary or other representative of another corporation, partnership, joint venture, trust, employee benefit plan or other entity (such claim, action, suit or proceeding hereinafter being referred to as an “Action”); provided, however, that no such right to indemnification shall exist with respect to an Action brought by an indemnitee (as defined below) against the registrant (an “Indemnitee Action”) except as relating to the last sentence of this paragraph. Persons who are not directors or officers of the registrant may be similarly indemnified in respect of service to the registrant or a subsidiary of the registrant or to another such entity at the request of the registrant to the extent the board of directors of the registrant at any time designates any of such persons as entitled to the benefits of the indemnification article. Additionally, as used in the indemnification article, “indemnitee” includes each director and officer of the registrant and each other person designated by the board of directors of the registrant as entitled to the benefits of the indemnification article; “expenses” means all expenses actually and reasonably incurred, including fees and expenses of counsel selected by an indemnitee; and “liability” means all liability incurred, including the amounts of any judgments, excise taxes, fines or penalties and any amounts paid in settlement an indemnitee shall be entitled to be indemnified pursuant to the indemnification article against expenses incurred in connection with an indemnitee Action if (i) the Indemnitee Action instituted under the indemnification article and the indemnitee is successful in whole or in part in such Indemnitee Action, (ii) the indemnitee is successful in whole or in part in another Indemnitee Action for which expenses are claimed or (iii) the indemnification for expenses is included in a settlement of, or is awarded by a court in, such other Indemnitee Action.

 

II-2


Table of Contents

The bylaws of AMC-New York, Inc., as amended, and Superior Care Pharmacy, Inc. each state that the registrant shall indemnify its officers, directors, employees and agents to the extent permitted by the DGCL.

The certificates of incorporation of each of AMC-Tennessee, Inc., as amended, and HMIS, Inc. state that each registrant shall, to the fullest extent to which it is empowered to do so by the DGCL or any other applicable laws, as they may from time to time be in effect, indemnify any person who was or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he is or was a director or officer of the corporation, or is or was serving at the request of the corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise, against all expenses (including attorneys’ fees), judgments, fines and amounts incurred by him in connection with such action, suit or proceeding.

The bylaws of each of AMC-Tennessee, Inc., HMIS, Inc. and Superior Care Pharmacy, Inc. state that a director of the registrant shall not be personally liable to the registrant or its stockholders for monetary damages or breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the registrant or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the DGCL, or (iv) for any transaction from which the director derived an improper personal benefit. If the DGCL, or any other applicable law, is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the registrant shall be limited or limited to the fullest extent permitted by the DGCL, or any other applicable law, as so amended. Any repeal or modification of this indemnification by the stockholders of the registrant shall not adversely affect any right or protection of a director of the registrant existing at the time of such repeal or modification.

Additionally, each person who was or is made a party or is threatened to be made a party to or is involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a “proceeding”), by reason of the fact that he or she or a person of whom he or she is the legal representative is or was a director or officer, employee or agent of the registrant or is or was serving at the request of the registrant as a director, officer or employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent or in any other capacity while serving as a director, officer, employee or agent, shall be indemnified and held harmless by the registrant to the fullest extent authorized by the DGCL, or any other applicable law, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such\ amendment permits the registrant to provide broader indemnification rights than said law permitted the registrant to provide prior to such amendment). All expenses, liability and loss (including attorneys’ fees, judgments, fines, ERlSA excise taxes or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such person in connection therewith and such indemnification shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of his or her heirs, executors and administrators; provided, however, that except with respect to proceedings seeking to enforce rights to indemnification, the registrant shall indemnify any such person seeking indemnification in connection with a proceeding (or part thereat) initiated by such person only if such proceeding (or part thereof) was authorized by the board of directors of the registrant. Such rights of indemnification and the payment of expenses incurred in defending a proceeding in advance of its final disposition shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, provision of the certificate of incorporation, bylaw, agreement, vote of stockholders or disinterested directors or otherwise.

The certificates of incorporation of each of BPNY Acquisition Corp., CHP Acquisition Corp., CIP Acquisition Corp., Managed Healthcare, Inc., Med World Acquisition Corp., NeighborCare Pharmacy Services, Inc., Omnicare Pharmacies of the Great Plains Holding Company, Shore Pharmaceutical Providers, Inc., TCPI Acquisition Corp. and UC Acquisition Corp. state that a director of the registrant shall not be personally liable to the corporation or its stockholders for monetary damages or breach of fiduciary duty as a director except for

 

II-3


Table of Contents

liability (i) for any breach of the director’s duty of loyalty to the registrant or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the DGCL, or (iv) for any transaction from which the director derived any improper personal benefit.

The bylaws of each of BPNY Acquisition Corp., CHP Acquisition Corp., CIP Acquisition Corp., Managed Healthcare, Inc., Med World Acquisition Corp., Omnicare Holding Company, Omnicare Pharmacies of the Great Plains Holding Company, Omnicare Purchasing Company General Partner, Inc., Omnicare Purchasing Company Limited Partner, Inc., Shore Pharmaceutical Providers, Inc., Sterling Healthcare Services, Inc., TCPI Acquisition Corp. and UC Acquisition Corp. state that the registrant shall indemnify its officers, directors, employees and agents to the extent permitted by the DGCL.

The certificate of incorporation of Omnicare Holding Company, as amended, is silent with respect to exculpation of directors from monetary damages and indemnification by the registrant of its directors and officers.

The certificates of incorporation of each of Omnicare Purchasing Company General Partner, Inc. and Omnicare Purchasing Company Limited Partner, Inc. provide that the registrant shall indemnify its officers, directors, employees and agents to the extent permitted by the DGCL.

The certificates of incorporation of each of NeighborCare Holdings, Inc., NeighborCare Services Corporation, Pharmed Holdings, Inc. and Sterling Healthcare Services, Inc. provide that to the fullest extent permitted by the DGCL, as the same exists or may hereafter be amended, a director of the registrant shall not be liable to the registrant or its stockholders for breach of fiduciary duty as a director.

The bylaws of Pharmed Holdings, Inc. state that the registrant shall indemnify every person who was or is a party or is or was threatened to be made a party to any action, suit, or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she is or was a director or officer of the registrant or, while a director or officer of the registrant, is or was serving at the request of the registrant as a director, officer, employee, agent or trustee of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, against expenses (including counsel fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding, to the full extent permitted by applicable law. Expenses incurred by a person who is or was a director or officer of the registrant in appearing at, participating in or defending any such action, suit or proceeding shall be paid by the registrant at reasonable intervals in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of the director or officer to repay such amount if it shall ultimately be determined that he or she is not entitled to be indemnified by the registrant as authorized by such indemnification. If such a claim is not paid in full by the registrant within ninety days after a written claim has been received by the registrant, the claimant may at any time thereafter bring suit against the registrant to recover the unpaid amount of the claim and, if successful in whole or in part, the claimant shall be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where the required undertaking, if any is required, has been tendered to the registrant) that the claimant has not met the standards of conduct which make it permissible under the DGCL or other applicable law for the registrant to indemnify the claimant for the amount claimed, but the burden of proving such defense shall be on the registrant. Neither the failure of the registrant (including its board of directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct set forth in the DGCL or other applicable law, nor an actual determination by the registrant (including its board of directors, independent legal counsel, or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard of conduct.

 

II-4


Table of Contents

First, the bylaws of each of NeighborCare Holdings, Inc., NeighborCare Pharmacy Services, Inc. and NeighborCare Services Corporation state that the registrant shall indemnify, to the fullest extent now or hereafter permitted by law, any director or officer of the registrant who was or is a party or is threatened to be made a party to, or is involved in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (a “Proceeding”) by reason of the fact that such person, or a person of whom he or she is the legal representative, is or was a director or officer of the registrant, or is or was serving at the request of the registrant as a director, officer, partner, trustee, employee or agent of another corporation, partnership, joint venture, trust or other enterprise (including service with respect to employee benefit plans), whether the basis of such Proceeding is alleged action in an official capacity as a director, officer, partner, trustee, employee or agent or in any other capacity while serving as a director, officer, partner, trustee, employee or agent, against all expenses, liability and loss (including attorneys’ fees, judgments, fines, excise taxes or penalties and amounts paid or to be paid in settlement) actually and reasonably incurred or suffered by such person in connection therewith. Such indemnification shall continue as to a person who has ceased to be a director, officer, partner, trustee, employee or agent and shall inure to the benefit of such person’s heirs, executors and administrators; provided, however, that, except as relating to suits to enforce indemnification rights, the registrant shall indemnify any such person seeking indemnification in connection with a Proceeding initiated by such person only if such Proceeding was authorized by the board of directors.

Second, the bylaws of each of NeighborCare Holdings, Inc., NeighborCare Pharmacy Services, Inc. and NeighborCare Services Corporation state that expenses, including attorneys’ fees, incurred by a director or officer of the registrant in defending any Proceeding, shall be paid by the registrant, in advance of the final disposition of such Proceeding, upon receipt of an undertaking by or on behalf of the director or officer to repay such amount if it shall ultimately be determined that such officer or director is not entitled to be indemnified by the registrant, which undertaking may be secured or unsecured; in the discretion of the board of directors. If such a claim is not paid in full by the registrant within thirty (30) days after a written claim has been received by the registrant, the claimant may at any time thereafter bring suit against the registrant to recover the unpaid amount of the claim, and, if successful in whole or in part; the claimant shall be entitled to be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where the required undertaking, if any is required, has been rendered to the registrant) that the claimant has not met the standards of conduct which make it permissible under the DGCL to indemnify the claimant for the amount claimed, but the burden of proving such defense shall be on the registrant. Neither the failure of the registrant (including its board of directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because the claimant has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the registrant (including its board of directors, independent legal counsel, or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the claimant not met the applicable standard of conduct.

Third, the bylaws of each of NeighborCare Holdings, Inc., NeighborCare Pharmacy Services, Inc. and NeighborCare Services Corporation provide that such indemnification and advancement of expenses shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any law, the certificate of incorporation, the by-laws, any agreement, vote of stockholders or of disinterested directors or otherwise, both as to action in their official capacity and as to action in another capacity while holding such office. Without limiting the generality or effect of the foregoing, the registrant may enter into one or more agreements with any person which provide for indemnification greater or different than or in addition to the indemnification provided for in the by-laws.

Fourth, the indemnification provided for in the bylaws of each of NeighborCare Holdings, Inc., NeighborCare Pharmacy Services, Inc. and NeighborCare Services Corporation shall be deemed a contract between the registrant and each director or officer of the registrant, or individual who is or was serving at the request of the registrant as a director, officer, partner, trustee, employee or agent of another corporation,

 

II-5


Table of Contents

partnership, joint venture, trust or other enterprise, who serves in such capacity at any time while the indemnification provided for in the by-laws is in effect. No repeal, amendment, or other modification shall affect any rights or obligations then existing with respect to any state of facts then or therefore existing or any action, suit or proceeding theretofore or thereafter brought or threatened based in whole or in part upon any such state of facts. Should the indemnification provided for in the bylaws be invalidated or found unenforceable on any ground by any court of competent jurisdiction, then the registrant shall nevertheless indemnify each director, officer, employee or agent of the registrant against expenses (including attorneys’ fees), judgments, fines, excise taxes, penalties and amounts paid in settlement with respect to any action, suit, or proceeding, whether civil, criminal, administrative or investigative, to the fullest extent permitted by the by-laws that shall not have been invalidated or found unenforceable, or by any other applicable law.

Fourth, any portion of the indemnification provided for in the by-laws of NeighborCare Holdings, Inc., NeighborCare Pharmacy Services, Inc. and NeighborCare Services Corporation shall be invalidated or found unenforceable on any ground by any court of competent jurisdiction, then the registrant shall nevertheless indemnify each director, officer, employee or agent of the registrant against expenses (including attorneys’ fees), judgments, fines, excise taxes, penalties and amounts paid in settlement with respect to any action, suit, or proceeding, whether civil, criminal, administrative or investigative, to the fullest extent permitted by the by-laws that shall not have been invalidated or found unenforceable, or by any other applicable law.

Finally, the by-laws of each of NeighborCare Holdings, Inc., NeighborCare Pharmacy Services, Inc. and NeighborCare Services Corporation state that the registrant may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the registrant or individual serving at the request of the registrant as a director, officer, partner, trustee, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any such expense, liability or loss, whether or not the registrant would have the power to indemnify such person against such expense, liability or loss under the DGCL.

The certificate of incorporation of Omnicare Management Company is silent with respect to exculpation of directors from monetary damages and indemnification by the registrant of its directors and officers.

The bylaws of Omnicare Management Company state that the registrant shall indemnify its officers, directors, employees and agents to the extent permitted by the DGCL.

The certificate of incorporation of RXC Acquisition Company provides that the personal liability of the directors of the registrant is hereby eliminated to the fullest extent permitted by paragraph (7) of subsection (b) of DGCL Section 102. Any repeal or modification of this indemnification by the stockholders of the registrant shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification. Additionally, the registrant shall, to the fullest extent permitted by the provisions of DGCL Section 145, as the same may be amended and supplemented from time to time, indemnify any and all persons whom it shall have the power to indemnify under said section from and against any and all of the expenses, liabilities, or other matters referred to in or covered by said section, and the indemnification provided for herein shall not be deemed exclusive of any other rights to which those indemnified may be entitled under any by-law, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee, or agent and shall inure to the benefit of the heirs, executors, and administrators of such a person.

The bylaws of RXC Acquisition Company provide that the registrant shall indemnify, in the manner and to the full extent permitted by law, any person (or the estate of any person) who was or is a party to, or is threatened to be made a party to, any threatened, pending or completed action, suit or proceeding, whether or not by or in the right of the registrant, and whether civil, criminal, administrative, investigative or otherwise, by reason of the fact that such person is or was a director, officer, employee or agent of the registrant, or is or was serving at the

 

II-6


Table of Contents

request of the registrant as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise. Where required by law, the indemnification provided for herein shall be made only as authorized in the specific case upon a determination, in the manner provided by law, that indemnification of the director, officer, employee or agent is proper in the circumstances. The registrant may, to the full extent permitted by law, purchase and maintain insurance on behalf of any such person against any liability which may be asserted against such person. To the full extent permitted by law, the indemnification provided herein shall include expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement, and, in the manner provided by law, any such expenses may be paid by the registrant in advance of the final disposition of such action, suit or proceeding. The indemnification provided herein shall not be deemed to limit the right of the registrant to indemnify any other person for any such expenses to the full extent permitted by law, nor shall it be deemed exclusive of any other rights to which any person seeking indemnification from the registrant may be entitled under any agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office. Such indemnification shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such person.

APS Acquisition LLC, Badger Acquisition LLC, Badger Acquisition of Kentucky LLC, Badger Acquisition of Minnesota LLC, Badger Acquisition of Ohio LLC, Best Care LTC Acquisition Company LLC, CCRx Holdings, LLC, CCRx of North Carolina, LLC, CCRx of North Carolina Holdings, LLC, CP Services LLC, Enloe Drugs LLC, Home Care Pharmacy, LLC, JHC Acquisition LLC, Langsam Health Services, LLC, LCPS Acquisition LLC, Lobos Acquisition, LLC, MHHP Acquisition Company LLC, NCS Healthcare, LLC, NCS Healthcare of Indiana, LLC, NIV Acquisition LLC, North Shore Pharmacy Services, LLC, OCR-RA Acquisition, LLC, Omnicare Distribution Center LLC, Omnicare ESC LLC, Omnicare Headquarters LLC, Omnicare Indiana Partnership Holding Company, LLC, Omnicare of Nevada LLC, Omnicare of New York, LLC, Omnicare Pharmacies of Pennsylvania East, LLC, Omnicare Pharmacy of Maine LLC, Omnicare Pharmacy of Nebraska LLC, Omnicare Pharmacy of North Carolina, LLC, Omnicare Pharmacy of Pueblo, LLC, Omnicare Pharmacy of Tennessee LLC, Omnicare Pharmacy of the Midwest, LLC, Omnicare Property Management, LLC, Pharmacy Holding #1, LLC, Pharmacy Holding #2, LLC, PMRP Acquisition Company, LLC, PP Acquisition Company, LLC, PSI Arkansas Acquisition, LLC, Value Health Care Services, LLC, VAPS Acquisition Company, LLC, Weber Medical Systems LLC and ZS Acquisition Company, LLC are registered under the laws of Delaware.

Section 18-108 of the Delaware Limited Liability Company Act provides that, subject to any standards and restrictions, if any, set forth in a company’s limited liability company agreement, a limited liability company may indemnify and hold harmless any member or manager or other person from and against any and all claims and demands whatsoever.

The limited liability agreement of APS Acquisition LLC states that its member shall not have any liability for the obligations or liabilities of the registrant, except to the extent provided in the Delaware Limited Liability Company Act.

The limited liability company agreements of each of Badger Acquisition LLC, Badger Acquisition of Kentucky LLC, Badger Acquisition of Minnesota LLC, Badger Acquisition of Ohio LLC, Best Care LTC Acquisition Company LLC, CCRx Holdings, LLC, CCRx of North Carolina, LLC, CCRx of North Carolina Holdings, LLC, CP Services LLC, Home Care Pharmacy, LLC, Langsam Health Services, LLC, LCPS Acquisition LLC, Lobos Acquisition, LLC, NCS Healthcare, LLC, NCS Healthcare of Indiana, LLC, North Shore Pharmacy Services, LLC, OCR-RA Acquisition, LLC, Omnicare ESC LLC, Omnicare of New York, LLC, Omnicare Pharmacy of Tennessee LLC, Omnicare Pharmacy of the Midwest, LLC, Omnicare Property Management, LLC, PMRP Acquisition Company, LLC, PP Acquisition Company, LLC, PSI Arkansas Acquisition, LLC, Value Health Care Services, LLC, VAPS Acquisition Company, LLC and ZS Acquisition

 

II-7


Table of Contents

Company, LLC provide that neither any member nor any manager shall have any liability for the obligations or liabilities of the registrant except to the extent provided by the limited liability company agreement or in the Delaware Limited Liability Company Act. The registrant shall indemnify to the full extent permitted by law each manager, and the testator or intestate of any such manager, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such manager is or was a manager, officer, employee, appointee or designee of the registrant; provided that no indemnification or reimbursement shall be made to or on behalf of any such manager to the extent that a final judgment or other final adjudication binding upon such manager establishes that the acts or omissions of such manager resulted from the bad faith, fraud or criminal act of such manager. Expenses, including attorneys’ fees, incurred by any such manager in defending any such action, suit or proceeding shall be paid or reimbursed by the registrant promptly upon receipt by it of an undertaking of such manager to repay such expenses if it shall ultimately be determined that such manager is not entitled to be indemnified by the registrant. In case any such action, suit or proceeding shall be brought against any such manager, such manager shall notify the registrant of the commencement thereof, and the registrant shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof. Additionally, the indemnification and reimbursement of expenses provided by the limited liability agreement shall not be deemed exclusive of any other rights to which those seeking indemnification or reimbursement of expenses may be entitled under any other instrument or by reason of any other action or otherwise. However, such indemnification and reimbursement of expenses shall be available only to the extent that indemnification or reimbursement is unavailable to such manager under any applicable policy of insurance or otherwise.

The limited liability company agreements of each of Enloe Drugs LLC, JHC Acquisition LLC, MHHP Acquisition Company LLC, NIV Acquisition LLC, Omnicare Distribution Center LLC Omnicare Headquarters LLC, Omnicare Indiana Partnership Holding Company, LLC, Omnicare of Nevada LLC, Omnicare Pharmacies of Pennsylvania East, LLC, Omnicare Pharmacy of Maine LLC, Omnicare Pharmacy of Nebraska LLC, Omnicare Pharmacy of North Carolina, LLC Omnicare Pharmacy of Pueblo, LLC, Pharmacy Holding #1, LLC, Pharmacy Holding #2, LLC and Weber Medical Systems LLC state that the registrant shall, to the maximum extent provided by law, indemnify, defend and hold harmless each present or former member, board member or officer (each, an “Indemnitee”), to the extent of the registrant’s assets, from and against any liability, damage, cost, expense, loss, claim, judgment or amounts paid in settlement thereof (including reasonable attorneys’ fees and costs in settlement or defense thereof) incurred by reason of the fact that such Indemnitee is or was the member, a board member or an officer. Notwithstanding the foregoing, no Indemnitee shall be so indemnified, defended or held harmless for claims arising out of a breach by the Indemnitee of the limited liability company agreement or any acts or omissions by the Indemnitee that constitute fraud, willful misconduct or breach of fiduciary duty to the registrant or to the member. The registrant shall advance the expenses of defense if the Indemnitee undertakes in writing to repay the advanced funds to the registrant if the Indemnitee is finally determined by a court of competent jurisdiction not to be entitled to indemnification pursuant to the indemnification provided for in the limited liability company agreement.

Care Pharmaceutical Services, LP, Care4 LP, Omnicare Pharmacy of Florida, LP, Omnicare Pharmacy of Texas 1, LP, Omnicare Pharmacy of Texas 2, LP, Omnicare Purchasing Company LP and PRN Pharmaceutical Services, LP are registered under the laws of Delaware.

Section 17-108 of the Delaware Revised Uniform Limited Partnership Act provides that a limited partnership may, and shall have the power to, indemnify and hold harmless any partner or other person from and against any and all claims and demands whatsoever, subject to such standards and restrictions set forth in the partnership agreement.

The agreement of limited partnership of Care4 LP, as amended, states that its general partner shall not be liable, responsible or accountable in damages or otherwise to the registrant or the limited partner for any act or omission performed or omitted by it in good faith, provided that such act or omission does not constitute gross negligence or fraud and except in such case, the registrant shall indemnify the general partner and its directors,

 

II-8


Table of Contents

shareholders, successors and assigns against all loss or damage incurred by them and against expenses (including attorneys’ fees) incurred by them in connection with the defense or settlement of any threatened, pending or completed action or suit by the limited partner or third party. The satisfaction of any indemnification and any saving harmless shall be from and limited to the registrant’s assets, and the limited partner shall not have any personal liability on account thereof.

The limited partnership agreements of each of Care Pharmaceutical Services, LP, Omnicare Pharmacy of Florida, LP, Omnicare Pharmacy of Texas 1, LP, Omnicare Pharmacy of Texas 2, LP, Omnicare Purchasing Company LP and PRN Pharmaceutical Services, LP provide that the liability of its general partner arising from carrying on the business affairs or operations of the registrant or for the debts of the registrant is unrestricted. The liability of its limited partner with regard to the registrant the limited partner makes, or agrees to make, to the registrant. The limited partner cannot be assessed to make any additional capital contribution to the registrant above that which it agrees to make to the registrant. If additional capital contributions to the registrant are required and are made by a general partner, it shall not entitle the general partner to a greater share of the profits or cash distributions of the registrant than otherwise is provided for by the limited partnership agreement. Additionally, nothing in each of the limited partnership agreements shall prevent or act against a partner lending money to the registrant on a promissory note or similar evidence of indebtedness, for a reasonable rate of interest. Any partner lending money to the registrant shall have the same rights regarding the loan as would any person or entity making the loan who was not a partner of the registrant.

California

Evergreen Pharmaceutical of California, Inc. is incorporated under the laws of California.

Section 317 of the California Corporations Code authorizes a corporation to indemnify any person who was or is a party or is threatened to be made a party to any proceeding (other than an action by or in the right of the corporation to procure a judgment in its favor) by reason of the fact that the person is or was a director, officer, employee or other agent of the corporation, against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred in connection with the proceeding, if that person acted in good faith and in a manner reasonably believed by such person to be in the best interests of the corporation and, in the case of a criminal proceeding, had no reasonable cause to believe the conduct of the person was unlawful.

Section 317 of the California Corporations Code also provides that a corporation may, subject to certain limitations and conditions, indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or other agent of the corporation, against expenses actually and reasonably incurred by that person in connection with the defense or settlement of the action if the person acted in good faith, in a manner the person believed to be in the best interests of the corporation and its shareholders.

To the extent that a director, officer, employee or other agent of the corporation is successful on the merits in defense of any proceeding referred to above or in defense of any claim, issue or matter therein, the corporation shall indemnify such agent against expenses actually and reasonably incurred by that person in connection therewith.

Section 204(a)(10) of the California Corporations Code permits a corporation’s articles of incorporation to limit a director’s personal liability for monetary damages in an action brought by or in the right of the corporation for breach of a director’s duties to the corporation or its shareholders except with respect to the following items: (i) acts or omissions that involve intentional misconduct or a knowing and culpable violation of law, (ii) acts or omissions that a director believes to be contrary to the best interests of the corporation or its shareholders or that involve the absence of good faith on the part of the director, (iii) any transaction from which a director derived an improper personal benefit, (iv) acts or omissions that show a reckless disregard for the

 

II-9


Table of Contents

director’s duty to the corporation or its shareholders in circumstances in which the director was aware, or should have been aware, in the ordinary course of performing a director’s duties, of a risk of serious injury to the corporation or its shareholders, (v) acts or omissions that constitute an unexcused pattern of inattention that amounts to an abdication of the director’s duty to the corporation or its shareholders, (vi) contracts or transactions between the corporation and a director, or between the corporation and any corporation, firm or association in which a director has a material financial interest, outside the scope of Section 310 of the California Corporations Code or (vii) authorizing improper distributions, loans and guarantees under Section 316 of the California Corporations Code.

Article V of the Articles of Incorporation of Evergreen Pharmaceutical of California, Inc., as amended, provide that the liability of the directors of the Corporation for monetary damages shall be eliminated to the fullest extent permissible under California law.

The bylaws of Evergreen Pharmaceutical of California, Inc., as amended, are silent as to the indemnification of directors and the limits of directors’ liability to Evergreen Pharmaceutical of California, Inc. and its shareholders.

Florida

Advanced Care Scripts, Inc. is incorporated under the laws of Florida.

Section 850 of the Florida Business Corporation Act (the “Florida Statute”) provides that a Florida corporation may indemnify any person who was or is a party to any proceeding (other than an action by, or in the right of, the corporation), by reason of the fact that he or she is or was a director, officer, employee, or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise against liability incurred in connection with such proceeding, including any appeal thereof, if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. Section 850 further provides that a corporation similarly may indemnify any such person serving in any such capacity who was or is a party to any proceeding by or in the right of the corporation to procure a judgment in its favor, against expenses and amounts paid in settlement not exceeding, in the judgment of the board of directors, the estimated expense of litigating the proceeding to conclusion, actually and reasonably incurred in connection with the defense or settlement of such proceeding, including any appeal thereof. Such indemnification shall be authorized if such person acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation, except that no indemnification shall be made in respect of any claim, issue, or matter as to which such person shall have been adjudged to be liable unless, and only to the extent that, the court in which such proceeding was brought, or any other court of competent jurisdiction, shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper. Where a director, officer, employee, or agent of a corporation is successful on the merits or otherwise in defense of any proceeding referred to above, the corporation must indemnify him or her against expenses actually and reasonably incurred.

However, a Florida corporation is not permitted to indemnify any director, officer, employee, or agent if a judgment or other final adjudication establishes that his or her actions, or omissions to act, were material to the cause of action so adjudicated and constitute: (a) a violation of the criminal law, unless the director, officer, employee, or agent had reasonable cause to believe his or her conduct was lawful or had no reasonable cause to believe his or her conduct was unlawful; (b) a transaction from which the director, officer, employee, or agent derived an improper personal benefit; (c) in the case of a director, a circumstance under which the liability provisions of Section 834 of the Florida Statute are applicable; or (d) willful misconduct or a conscious disregard for the best interests of the corporation in a proceeding by or in the right of the corporation to procure a judgment in its favor or in a proceeding by or in the right of a shareholder.

 

II-10


Table of Contents

Section 850 further authorizes a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee, or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise against any liability asserted against such person and incurred by him or her in any such capacity or arising out of his or her status as such, whether or not the corporation would have the power to indemnify the person against such liability under the Florida Statute.

The articles of incorporation, as amended, of Advanced Care Scripts, Inc. eliminate the personal liability of its directors to the fullest extent permitted by the Florida Statute. Any repeal or modification of the articles by its stockholders shall not adversely affect any right or protection of its directors existing at the time of such repeal of modification. The articles of incorporation also provide that the registrant shall indemnify, to the fullest extent permitted by the provisions of the Florida Statute, any and all persons whom it shall have the power to indemnify under said section from and against any and all of the expenses, liabilities or other matters referred to in or covered by said section. The indemnification is not deemed exclusive of any other rights to which those indemnified may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.

The bylaws, as amended, of Advanced Care Scripts, Inc. state that the registrant shall indemnify and advance expenses to any person who was or is a party to any proceeding or threatened proceeding by reason of the fact that he is or was a director, officer, employee, or agent of the corporation or is or was serving at the request of the corporation; subject in each instance to satisfaction of all applicable requirements under the Florida Statute.

Compscript, LLC is registered under the laws of Florida.

Section 608.4229 of the Florida LLC Statute provides that, subject to such standards and restrictions, if any, as are set forth in its articles of organization or operating agreement, and except with respect to certain criminal or improper acts and unlawful distributions, a limited liability company may, but is not required to, indemnify and hold harmless any member or manager or other person from and against any and all claims and demands whatsoever.

The limited liability company agreement of Compscript, LLC provides that the registrant shall indemnify the member, to the full extent permitted by law and the testator or intestate of any such member, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such member is or was a manager, officer, employee, appointee or designee of the registrant; provided that no indemnification or reimbursement shall be made to or on behalf of any such member to the extent that a final judgment or other final adjudication binding upon such member establishes that the acts or omissions of such member resulted from the bad faith, fraud or criminal act of such member. In addition, expenses, including attorneys’ fees, incurred by any such member in defending any such action, suit or proceeding shall be paid or reimbursed by the registrant promptly upon receipt by it of an undertaking of such member to repay such expenses if it shall ultimately be determined that such member is not entitled to be indemnified by the registrant. In case any such action, suit or proceeding shall be brought against any such member, such member shall notify the registrant of the commencement thereof, and the registrant shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof.

The limited liability company agreement of Compscript, LLC also states that any such indemnification and reimbursement of expenses shall not be deemed exclusive of any other rights to which those seeking indemnification or reimbursement of expenses may be entitled under any other instrument or by reason of any other action or otherwise. However, any such indemnification and reimbursement of expenses shall be available only to the extent that indemnification or reimbursement is unavailable to such member under any applicable policy of insurance or otherwise.

 

II-11


Table of Contents

Georgia

Medical Arts Health Care, Inc. and Pharmasource Healthcare, Inc. are incorporated under the laws of Georgia.

Under O.C.G.A. §14-2-850, et seq. of the Georgia Business Corporation Code (“GBCC”), a Georgia corporation may indemnify an individual who is a party to a proceeding because he or she is or was a director of the corporation against the obligation to pay a judgment, settlement, penalty, fine or reasonable expenses (which includes counsel fees) incurred with respect to such proceeding, if such individual (A) conducted himself or herself in good faith and (B) reasonably believed (i) while acting in his or her official capacity, that his or her conduct was in the best interests of the corporation, or (ii) while acting any other capacity, that his or her conduct was at least not opposed to the best interests of the corporation, or (C) with respect to any criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful. A corporation must indemnify a director who was wholly successful, on the merits or otherwise, in the defense of any such proceeding against reasonable expenses incurred by the director in connection with the proceeding. The termination of the proceeding by judgment, order, settlement or conviction or upon the entry of a plea of nolo contendere is not, of itself, determinative that the person did not meet the standard of conduct set forth in O.C.G.A. § 14-2-851(a).

A Georgia corporation may not indemnify a director under the GBCC in connection with a proceeding by or in the right of the corporation, except for reasonable expenses incurred by such director in connection with the proceeding, provided it is determined that such director met the relevant standard of conduct. A corporation may not indemnify a director in connection with any proceeding with respect to conduct for which such director was found liable on the basis that he or she received an improper personal benefit, whether or not such director was acting in his or her official capacity as a director of the corporation.

Additionally, a Georgia corporation may, before final disposition of a proceeding, advance funds to pay for or reimburse the reasonable expenses incurred by a director who is a party to a proceeding; provided, that such director delivers to the corporation (i) a written affirmation of his or her good faith belief that he or she met the relevant standard of conduct described in O.C.G.A. §14-2-851 or that the proceeding involves conduct for which such director’s liability has been properly eliminated by provision of the articles of incorporation, and (ii) a written undertaking by the director to repay any funds advanced if it is ultimately determined that such director was not entitled to such indemnification.

The GBCC allows a Georgia corporation to indemnify directors without regard to the above-referenced limitations, if authorized by the articles of incorporation or a bylaw, contract, or resolution duly adopted by a vote of the shareholders of the corporation by a majority of votes entitled to be cast, excluding shares owned or voted under the control of the director or directors who do not qualify as a disinterested director with respect to any proceeding to which such indemnification is being sought; provided, that such director delivers to the corporation the abovementioned written affirmation and written undertaking. Notwithstanding the foregoing, the corporation may not indemnify a director for any liability incurred in a proceeding in which the director is found liable to the corporation or is subjected to injunctive relief in favor of the corporation for, among other things: (1) Any appropriation, in violation of the director’s duties, of any business opportunity of the corporation; (2) Acts or omissions which involve intentional misconduct or a knowing violation of law; or (3) Any transaction from which he or she received an improper personal benefit.

Under the GBCC, a Georgia corporation may indemnify and advance expenses to an officer of the corporation to the same extent as a director or if not also a director, then to such further extent as otherwise provided by the articles of incorporation, the bylaws, a resolution of the board of directors or by contract; provided, however, if the officer is not also a director of the corporation, the corporation may not indemnify the officer for any liability arising out of conduct that constitutes, among other things, (1) Any appropriation, in violation of the officer’s duties, of any business opportunity of the corporation; (2) Acts or omissions which involve intentional misconduct or a knowing violation of law; or (3) Any transaction from which he or she

 

II-12


Table of Contents

received an improper personal benefit. The foregoing limitation will also apply to an officer who is also a director of the corporation if the sole basis on which he or she is a party to the proceeding is an act or omission by him or her in the official capacity as an officer of the corporation.

A Georgia corporation may also indemnify and advance expenses to an employee or agent of the corporation who is not a director to the extent that may be provided by the articles of incorporation, the bylaws, a resolution of the board of directors or by contract.

Under the GBCC, a Georgia corporation may purchase and maintain insurance on behalf of an individual who is a director, officer, employee or agent of the corporation against liability asserted against or incurred by such individual while acting in his or her official capacity or arising from his or her status as a director, officer, employee or agent of the corporation, notwithstanding whether a corporation would have the power to indemnity or advance expenses to such individual for the same liability.

The Bylaws of Medical Arts Health Care, Inc. provide that the company shall indemnify its officers and directors against all reasonable expenses incurred by them in defending claims or suits, irrespective of the time of occurrence of the claims or causes of action in such suits, made or brought against them as officers or directors of the corporation, and against all liability in such suits, except in such cases as involve gross negligence or willful misconduct in the performance of their duties. Such indemnification shall extend to the payments paid in cash settlement of such claims or actions and may apply to judgments in favor of the corporation or amounts paid in settlement to the corporation. Such indemnification shall also extend to the payment of counsel fees and expenses of such officers and directors in suits against them where successfully defended by them or where unsuccessfully defended, if there is no finding or judgment that the claim or action arose from the gross negligence or willful misconduct of such officers or directors. Such right of indemnification shall not be exclusive of any right to which such officer or director may be entitled as a matter of law and shall extend and apply to the estates of such deceased officers and directors.

The Bylaws of Pharmasource Healthcare, Inc. provide that it shall indemnify its officers and directors against all reasonable expenses incurred by them in defending claims or suits, irrespective of the time of occurrence of the claims or causes of action in such suits, made or brought against them as officers or directors of the corporation, and against all liability in such suits, except in such cases as involve gross negligence or willful misconduct in the performance of their duties. Such indemnification shall extend to the payments paid in cash settlement of such claims or actions and may apply to judgments in favor of the corporation or amounts paid in settlement to the corporation. Such indemnification shall also extend to the payment of counsel fees and expenses of such officers and directors in suits against them where successfully defended by them or where unsuccessfully defended, if there is no finding or judgment that the claim or action arose from the gross negligence or willful misconduct of such officers or directors. Such right of indemnification shall not be exclusive of any right to which such officer or director may be entitled as a matter of law and shall extend and apply to the estates of such deceased officers and directors.

Illinois

NCS Healthcare of Illinois, LLC is registered under the laws of Illinois.

Section 180/15-7 of the Illinois Limited Liability Company Act provides that a limited liability company shall reimburse a member or manager for payments made and indemnify a member or manager for liabilities incurred by the member or manager in the ordinary course of the business of the company or for the preservation of its business or property.

Illinois law, section 180/15-3 provides that the fiduciary duties a member owes to a member-managed company and its other members include the duty of loyalty and the duties referred to in subsections of that section 180/15-3. A member’s duty of loyalty to a member-managed company and its other members includes

 

II-13


Table of Contents

the following: (1) to account to the company and to hold as trustee for it any property, profit, or benefit derived by the member in the conduct or winding up of the company’s business or derived from a use by the member of the company’s property, including the appropriation of a company’s opportunity; (2) to act fairly when a member deals with the company in the conduct or winding up of the company’s business as or on behalf of a party having an interest adverse to the company; and (3) to refrain from competing with the company in the conduct of the company’s business before the dissolution of the company. A non-member-manager’s duty of care to a member-managed company and its other members in the conduct of and winding up of the company’s business is limited to refraining from engaging in grossly negligent or reckless conduct, intentional misconduct, or a knowing violation of law. A member shall discharge his or her duties to a member-managed company and its other members under the Illinois limited liability company act or under the operating agreement and exercise any rights consistent with the obligation of good faith and fair dealing.

Thus, an indemnity with respect to breach of obligations under Section 180/15-3 may not be enforceable by a member or member manager in certain circumstances.

The limited liability company agreement of NCS Healthcare of Illinois, LLC provides for the maximum amount of indemnification allowed by law, but only applies if the member has been a manager, officer, employee, appointee or designee of the company.

Indiana

NCS Healthcare of Indiana, Inc. is incorporated under the laws of Indiana.

Chapter 37 of the Indiana Corporation Law (“INCL”) states that a corporation may indemnify an individual made a party to a proceeding because the individual is or was a director against liability incurred in the proceeding if the individual’s conduct was in good faith, the individual reasonably believed, in the case of conduct in the individual’s official capacity with the corporation, that the individual’s conduct was in its best interests, and, in the case of any criminal proceeding, the individual either had reasonable cause to believe the individual’s conduct was lawful or had no reasonable cause to believe the individual’s conduct was unlawful. Unless limited by its articles of incorporation, a corporation must indemnify a director who was wholly successful, on the merits or otherwise, in the defense of any proceeding to which the director was a party because the director is or was a director of the corporation against reasonable expenses incurred by the director in connection with the proceeding. A corporation may pay for or reimburse the reasonable expenses incurred by a director who is a party to a proceeding in advance of final disposition of the proceeding if the director furnishes the corporation a written affirmation of the director’s good faith belief that the director has met the standard of conduct described in the INCL, the director furnishes the corporation a written undertaking, executed personally or on the director’s behalf, to repay the advance if it is ultimately determined that the director did not meet the standard of conduct and a determination is made that the facts then known to those making the determination would not preclude indemnification under the law. A corporation may not indemnify a director unless authorized in the specific case after a determination has been made that indemnification of the director is permissible in the circumstances because the director has met the standard of conduct set forth under the law. The determination shall be made by the board of directors by majority vote of a quorum consisting of directors not at the time parties to the proceeding, or by the other methods specified in Chapter 37 of the INCL.

A corporation may purchase and maintain insurance on behalf of an individual who is or was a director, officer, employee, or agent of the corporation, or who, while a director, officer, employee, or agent of the corporation, is or was serving at the request of the corporation as a director, officer, partner, member, manager, trustee, employee, or agent of another foreign or domestic corporation, partnership, limited liability company, joint venture, trust, employee benefit plan, or other enterprise, against liability asserted against or incurred by the individual in that capacity or arising from the individual’s status as a director, officer, member, manager, employee, or agent. The indemnification and advance for expenses provided for or authorized by the INCL does not exclude any other rights to indemnification and advance for expenses that a person may have under a corporation’s articles of incorporation, bylaws or certain other duly authorized agreements.

 

II-14


Table of Contents

The Bylaws of NCS Healthcare of Indiana, Inc. provide that the corporation shall, indemnify any director or officer to the fullest extent provided by, or permissible under, Chapter 37 of the Indiana Business Corporation Law, as the same may be amended from time to time; and the corporation is hereby specifically authorized to take any and all further action to effectuate any indemnification of any director or officer which any Indiana corporation may have power to take, by any vote of the shareholders, vote of disinterested directors, by an agreement, or otherwise. The Bylaws of the corporation shall be interpreted in all respects to expand such power to indemnify to the maximum extent permissible to any Indiana corporation with regard to the particular facts of each case, and not in any way to limit any statutory or other power to indemnify, or right of any individual to indemnification.

NeighborCare of Indiana, LLC is registered under the laws of Indiana.

Chapter 4, Section 4 of the Indiana Business Flexibility Act governing Indiana limited liability companies provides that a written operating agreement may provide for indemnification of a member or manager for judgments, settlements, penalties, fines, or expenses incurred in a proceeding to which a person is a party because the person is or was a member or manager.

The Operating Agreement of NeighborCare of Indiana, LLC provides that the company shall indemnify the member to the full extent permitted by the Indiana Business Flexibility Act and the testator or intestate of the member, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the member is or was a manager, officer, employee, appointee or designee of the company; provided that no indemnification or reimbursement shall be made to or on behalf of the member to the extent that a final judgment or other final adjudication binding upon the member establishes that its acts or omissions resulted from its bad faith, fraud or criminal act. Expenses, including attorneys’ fees, incurred by the member in defending any such action, suit or proceeding shall be paid or reimbursed by the company promptly upon receipt by it of an undertaking of the member to repay such expenses if it shall ultimately be determined that the member is not entitled to be indemnified by the company. In case any such action, suit or proceeding shall be brought against the member, the member shall notify the company of the commencement thereof, and the company shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof.

Kentucky

D&R Pharmaceutical Services, LLC and Three Forks Apothecary LLC are registered under the laws of Kentucky.

Section 275.180 of the Kentucky Revised Statutes provides that the written operating agreement of a limited liability company may (i) eliminate or limit the personal liability of a member or manager for monetary damages for breach of certain of such member’s or manager’s duties as described in Section 275.170 of the Kentucky Revised Statutes, and (ii) provide for the indemnification of a member or manager for judgments, settlements, penalties, fines, or expenses incurred in a proceeding to which a person is a party because the person is or was a member or manager.

Neither the Articles of Organization nor the Limited Liability Company Agreement of D&R Pharmaceutical Services, LLC specifies the extent to which the company may indemnify its officers or directors.

The Operating Agreement for Three Forks Apothecary LLC provides that each person who was or is a member, or agent of the company, or is or was serving at the request of the company as a director, officer, partner, trustee, manager, employee, or agent of another corporation, partnership, limited liability company, joint venture, trust, or other enterprise, may be indemnified by the company to the full extent permitted by Kentucky law against any liability or loss (including attorneys’ fees) such person reasonably incurs in such capacity or arising out of acting in such capacity.

 

II-15


Table of Contents

Louisiana

Campo’s Medical Pharmacy, Inc. is incorporated under the laws of Louisiana.

In general, §12.83 of the Louisiana Business Corporation Law (“LBCL”) allows corporations to indemnify their present and former directors and officers and those of affiliated corporations against expenses incurred in the defense of any lawsuit to which they are made parties by reason of being or having been such directors or officers if such person acted in good faith and in a manner reasonably believed to be in, or not opposed to, the best interests of the corporation, and with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. Under the LBCL, a termination of the action by judgment, settlement, conviction or plea of nolo contendere, will not, of itself, create a presumption that the person did not act in good faith. To the extent that such person is successful on the merits or otherwise in defense of any claim, issue or matter therein, he or she must be indemnified by the corporation. Expenses may be paid in advance of the final outcome if authorized by the board of directors without regard to whether or not a voting director is a party to the action, upon receipt of undertaking by such person to repay such amount advanced, if it is ultimately determined that he is entitled to indemnification.

If the action is by or in the right of the corporation, the indemnity is limited to expenses not exceeding, in the judgment of the board of directors, the estimated expense of litigating the action to conclusion. No indemnification can be made if a court of competent jurisdiction, after exhaustion of appeals, finds the director liable for willful or intentional misconduct, unless the court determines that, given the circumstances of the case, the director is fairly and reasonably entitled to indemnification for certain expenses.

The LBCL allows a corporation to procure or maintain insurance against liability on behalf of a director or any such person.

The Bylaws of Campo’s Medical Pharmacy, Inc., a Louisiana corporation, expressly provide that the corporation shall indemnify its officers and directors to the extent permitted by the Business Corporation law of Louisiana.

Maryland

NeighborCare Repackaging, Inc. and Professional Pharmacy Services, Inc. are incorporated under the laws of Maryland.

Maryland corporate law regarding the indemnity of officers and directors, primarily found in Corporations and Associations Section 2-418, permits a Maryland corporation to indemnify a director and advance expenses for indemnification for actions brought to enforce an indemnification or if the charter, bylaws, resolution of the board or agreement approved by the board so permit. Indemnification is not permitted under Courts and Judicial Proceedings Article 5-418 if (i) the act or omission of the director was material to the matter giving rise to the proceeding; and was committed in bad faith; or was the result of active and deliberate dishonesty; or (ii) the director actually received an improper personal benefit in money, property, or services; or (iii) in the case of any criminal proceeding, the director had reasonable cause to believe that the act or omission was unlawful.

Officers who are not directors have a slightly broader indemnity available to them. By board of director’s action, the corporate charter, bylaws, or board of director actions can broaden the indemnity and advance of expenses.

Maryland law requires a Maryland corporation (unless otherwise provided in its charter) to indemnify a director or officer who has been successful, on the merits or otherwise, in the defense of any proceeding to which he or she is made or threatened to be made a party by reason of his or her service in that capacity for judgments, penalties, fines, settlements and reasonable expenses actually incurred by them in connection with any proceeding to which they may be made or threatened to be made a party by reason of their service in those or other capacities unless subject to an exception such as listed above.

 

II-16


Table of Contents

Unless limited by the charter, a court may order indemnification if it determines that the director or officer is fairly and reasonably entitled to indemnification, even though the director or officer did not meet the prescribed standard of conduct or was adjudged liable on the basis that personal benefit was improperly received. However, indemnification for an adverse judgment in a suit by the corporation or in the right of the corporation, or for a judgment of liability on the basis that personal benefit was improperly received, is limited to expenses.

Maryland law permits a Maryland corporation to advance reasonable expenses to a director or officer upon receipt of (a) a written affirmation by the director or officer of his or her good faith belief that he or she has met the standard of conduct necessary for indemnification and (b) a written undertaking by him or her or on his or her behalf to repay the amount paid or reimbursed if it is ultimately determined that the standard of conduct was not met. Such advance is limited by section 5-418 of the Courts and Judicial Proceedings Article summarized above.

NeighborCare Repackaging, Inc. and Professional Pharmacy Services, Inc. have indemnity provisions for officers and directors in either their Articles of Incorporation or their Bylaws as presently in force to the maximum extent allowed by law.

ASCO Healthcare of New England, LLC, ASCO Healthcare, LLC, Main Street Pharmacy L.L.C. and NeighborCare Pharmacies, LLC are registered under the laws of Maryland.

The Maryland Limited Liability Company Act, Title 4A of the Corporations and Associations article, does not have limitations on indemnity of members of limited liability corporations or any provisions for indemnification. The articles of organization and operating agreements of a limited liability company will control with two exceptions: first, because members are generally authorized under Maryland law to bind the LLC in the ordinary course of its business, under principles of agency law, agents are generally not liable or can require reimbursement for their lawful actions by their principal; and second, general equitable principles against self-dealing and failure to act in good faith or with reasonable care may prelude indemnification even if permitted in the articles of organization and operating agreement.

The Operating Agreements of the ASCO Healthcare of New England, LLC, ASCO Healthcare, LLC, Main Street Pharmacy L.L.C. and NeighborCare Pharmacies, LLC permit indemnification to the fullest extent of Maryland law for a member, if the member is or was a manager, officer, employee, appointee or designee of the company, with exceptions for bad faith, fraud or criminal acts.

ASCO Healthcare of New England, Limited Partnership is registered under the laws of Maryland.

Title 10 of the Maryland Corporations and Associations article, which contains the Maryland Limited Partnership Act, has no restrictions on indemnity of partners or persons conducting business on behalf of the limited partnership. However, general partners are subject to the restrictions and liabilities of a partner in a (general) partnership. There are limitations on the ability to disclaim certain general partner duties such as the ability of a general partner to disclaim a duty of loyalty, limitations on the ability to disclaim a duty of care under certain sections of Title 10, and a limitation on the ability to disclaim the obligation of good faith and fair dealing, but standards may be prescribed to measure whether or not such duties or obligations have been met. There will be no indemnification if there is a breach of those duties. There may be indemnification under the law of expenses to benefit or preserve the limited partnership.

The Agreement of Limited Partnership of ASCO Healthcare of New England, Limited Partnership is silent as to indemnification of directors and officers.

 

II-17


Table of Contents

Michigan

Specialized Pharmacy Services, LLC is registered under the laws of Michigan.

Section 216 of the Michigan Limited Liability Company Act (the “MLLCA”) provides that, except as otherwise provided in an operating agreement, a limited liability company may indemnify, hold harmless, and defend a member, manager, or other person from and against any and all losses, expenses, claims, and demands sustained by that person, except that the company may not indemnify the person for liability in connection with the receipt of a financial benefit to which the person is not entitled, voting or assenting to a distribution in violation of the company’s operating agreement or the law, or a knowing violation of the law.

Section 216 further provides that, except as otherwise provided in an operating agreement, a limited liability company may purchase and maintain insurance on behalf of a member, manager, or other person against any liability or expense asserted against or incurred by that person, whether or not the company may indemnify that person under Section 216.

The Limited Liability Company Agreement of Specialized Pharmacy Services, LLC provides that the company shall indemnify and hold harmless the sole member (being NeighborCare, Inc., a Pennsylvania corporation), to the fullest extent permitted by the MLLCA; provided that no indemnification or reimbursement shall be made to the member to the extent that a final adjudication binding upon the member establishes that its acts or omissions resulted from its bad faith, fraud or criminal act. Any obligation to pay on behalf of or reimburse the member any expenses subject to indemnification is preconditioned upon the member undertaking the reimburse the company for such expenses if it shall ultimately be determined that the member is not entitled to be indemnified.

Missouri

Interlock Pharmacy Systems, LLC and Home Pharmacy Services, LLC are registered under the laws of Missouri.

The Missouri Limited Liability Company Act is silent as to indemnification.

The Limited Liability Company Agreement of Interlock Pharmacy Systems, LLC (formerly known as IP Acquisition Sub, LLC), a Missouri limited liability company (“Interlock”), provides that Interlock shall indemnify its sole member to the fullest extent permitted by the Missouri Limited Liability Company Act (RSMo. § 347.010, et seq. ) if the member is made or threatened to be made a party to any action by reason of the fact that the sole member is or was a manager, officer, employee, appointee or designee of Interlock.

The indemnification requirement is subject to claw back by Interlock if a final judgment establishes that the sole member’s acts or omissions were in bad faith, fraudulent or criminal. Interlock may advance the sole member’s expenses in defending any claims so long as the sole member agrees to reimburse Interlock if it is ultimately determined that the sole member is not entitled to indemnification by Interlock.

The sole member is obligated to notify Interlock of any litigation which may lead to indemnification, and Interlock shall be entitled to participate in such litigation.

The indemnification provided by Interlock’s Limited Liability Company Agreement is not exclusive of any other indemnification rights the sole member may have at law or by separate agreement, and is available only to the extent that indemnification is unavailable to the sole member under any applicable policy of insurance or otherwise.

The Limited Liability Company Declaration (the “Declaration”) of Home Pharmacy Services, LLC (formerly known as Home Pharmacy Merger Sub LLC), a Missouri limited liability company (“HPS”), provides

 

II-18


Table of Contents

that HPS shall indemnify, defend and hold harmless its present or former members, board members or officers (each, an “Indemnitee”) to the maximum extent provided by law, from and against any liability or expense incurred by reason of the fact that any such Indemnitee is or was a member, a board member or an officer of HPS.

No Indemnitee shall be indemnified for claims arising out of a breach of the Declaration by such Indemnitee or any acts or omissions by such Indemnitee that constitute fraud, willful misconduct or breach of fiduciary duty to HPS or to the member.

HPS shall advance an Indemnitee’s expenses in defending any claims so long as such Indemnitee agrees in writing to repay HPS if it is ultimately determined by a court that such Indemnitee is not entitled to indemnification by HPS.

New Hampshire

NCS Healthcare of New Hampshire, Inc. and Uni-Care Health Services of Maine, Inc. are incorporated under the laws of New Hampshire.

Section 293-A:8.51 of the New Hampshire Business Corporation Act (“NHBCA”) provides that a corporation may indemnify an individual made a party to a proceeding because he is or was a director against liability incurred in the proceeding if: (1) he conducted himself in good faith; and (2) he reasonably believed (i) in the case of conduct in his official capacity with the corporation, that his conduct was in its best interests; and (ii) in all other cases, that his conduct was at least not opposed to its best interests; and (3) in the case of any criminal proceeding, he had no reasonable cause to believe his conduct was unlawful. Under NHBCA Section 293-A:8.53, a New Hampshire corporation may pay for or reimburse the reasonable expenses incurred by a director who is a party to a proceeding in advance of the final disposition of the proceeding if: (1) the director furnishes the corporation a written affirmation of his good faith belief that he has met the standard of conduct described in the preceding sentence; and (2) the director furnishes the corporation an undertaking, executed personally or on his behalf, to repay the advance if it is ultimately determined that he did not meet the standard of conduct. Unless a corporation’s articles of incorporation provide otherwise, the corporation may indemnify and advance expenses to an officer, employee or agent of the corporation who is not a director to the same extent as to a director. A corporation may not indemnify a director (x) in connection with a proceeding by or in the right of the corporation in which the director was adjudged liable to the corporation; or (y) in connection with any other proceeding charging improper personal benefit to him, whether or not involving action in his official capacity, in which he was adjudged liable on the basis that personal benefit was improperly received by him. Unless limited by its articles of incorporation, a New Hampshire corporation must indemnify a director or officer who was wholly successful, on the merits or otherwise, in the defense of any proceeding to which he was a party because he is or was a director or officer of the corporation against reasonable expenses incurred by him in connection with the proceeding. A New Hampshire corporation may also purchase and maintain on behalf of a director or officer insurance against liabilities incurred in such capacities, whether or not the corporation would have the power to indemnify him against the same liability under NHBCA Sections 293-A:8.51 or 293-A:8.52.

The Bylaws of NCS Healthcare of New Hampshire, Inc. provide that the corporation shall, indemnify its officers and directors against all reasonable expense incurred by them in defending claims or suits, irrespective of the time of occurrence of the claims or causes of action in such suits, made or brought against them as officers or directors of the corporation, and against all liability in such suits, except in such cases as involve gross negligence or willful misconduct in the performance of their duties. Such indemnification shall extend to the payments of judgments against such officers and directors and to reimbursement of amounts paid in cash settlement of such claims or actions and may apply to judgments in favor of the corporation or amounts paid in settlement to the corporation. Such indemnification shall also extend to the payment of counsel fees and expenses of such officers and directors in suits against them where successfully defended by them or where unsuccessfully defended, if there is no finding or judgment that the claim or action arose from the gross negligence or willful

 

II-19


Table of Contents

misconduct of such officers or directors. Such right of indemnification shall not be exclusive of any right to which such officer or director may be entitled as a matter of law and shall extend and apply to the estates of such deceased officers and directors.

The Bylaws of Uni-Care Health Services of Maine, Inc. provide that the corporation shall, indemnify its officers and directors against all reasonable expense incurred by them in defending claims or suits, irrespective of the time of occurrence of the claims or causes of action in such suits, made or brought against them as officers or directors of the corporation, and against all liability in such suits, except in such cases as involve gross negligence or willful misconduct in the performance of their duties. Such indemnification shall extend to the payments of judgments against such officers and directors and to reimbursement of amounts paid in cash settlement of such claims or actions and may apply to judgments in favor of the corporation or amounts paid in settlement to the corporation. Such indemnification shall also extend to the payment of counsel fees and expenses of such officers and directors in suits against them where successfully defended by them or where unsuccessfully defended, if there is no finding or judgment that the claim or action arose from the gross negligence or willful misconduct of such officers or directors. Such right of indemnification shall not be exclusive of any right to which such officer or director may be entitled as a matter of law and shall extend and apply to the estates of such deceased officers and directors.

New Jersey

Institutional Health Care Services, LLC is registered under the laws of New Jersey.

Section 42:2C-38 of the Revised Uniform Limited Liability Company Act of New Jersey provides that a limited liability company shall indemnify a member, officer, employee or agent of the indemnifying company (a “company agent”) against expenses to the extent that the company agent is successful on the merits or otherwise in any proceeding brought against the company agent by reason of the company agent serving as a company agent or serving another enterprise at the request of the limited liability company. The operating agreement may alter or eliminate the indemnification for a member provided by Section 38.

The Operating Agreement of Institutional Health Care Services, LLC provides that it shall indemnify the member to the full extent permitted by law and the testator or intestate of the member, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the member is or was a manager, officer, employee, appointee or designee of the guarantor; provided that no indemnification or reimbursement shall be made to or on behalf of the member to the extent that a final judgment or other final adjudication binding on the member establishes that its acts or omissions resulted from its bad faith, fraud or criminal act.

New York

Pharmacy Associates of Glens Falls, Inc. and Vital Care Infusions, Inc. are incorporated under the laws of New York.

Reference is made to Sections 721 to 726 of the New York Business Corporation Law (“NYBCL”), which provide for indemnification of directors and officers, subject to certain limitations, for liabilities and expenses in connection with actions or proceedings involving them in such capacity. Pursuant to Section 721 of the NYBCL, no indemnification shall be made to or on behalf of a director or officer if a judgment or other final adjudication adverse to the director or officer establishes that his or her acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action so adjudicated, or that he or she personally gained in fact a financial profit or other advantage to which he or she was not legally entitled. Section 402(b) of the NYBCL permits a certificate of incorporation to set forth a provision limiting or eliminating the personal liability of directors to a corporation or its shareholders for damages for any breach of duty in such capacity, provided that no such provision shall eliminate or limit the liability of a director if a

 

II-20


Table of Contents

judgment or other final adjudication adverse to him or her establishes (i) that his or her acts or omissions were in bad faith or involved intentional misconduct or a knowing violation of law, or (ii) that he or she personally gained in fact a financial profit or other advantage to which he or she was not legally entitled or (iii) that his or her acts violated Section 719 of the NYBCL.

The certificates of incorporation of each of Pharmacy Associates of Glens Falls, Inc. and Vital Care Infusions, Inc., as amended, are silent as to indemnification of directors and officers.

The bylaws of each of Pharmacy Associates of Glens Falls, Inc., as amended, and Vital Care Infusions, Inc., are silent as to indemnification of directors and officers.

Ohio

Hytree Pharmacy, Inc., Management & Network Services, Inc., NCS Healthcare of Kentucky, Inc., NCS Healthcare of Montana, Inc., NCS Healthcare of New Mexico, Inc., NCS Healthcare of South Carolina, Inc., NCS Healthcare of Tennessee, Inc., NCS Healthcare of Washington, Inc., NCS Services, Inc. are incorporated under the laws of Ohio.

Pursuant to Section 1701.13(E) of the Ohio Revised Code, a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that he or she is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding (i) if such person acted in good faith and in a manner that person reasonably believed to be in or not opposed to the best interests of the corporation and (ii) with respect to any criminal action or proceeding, if he or she had no reasonable cause to believe such conduct was unlawful. In actions brought by or in the right of the corporation, a corporation may indemnify such person against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner that person reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification may be made in respect of (i) any claim, issue or matter as to which that person shall have been adjudged to be liable for negligence or misconduct in performance of his duty to the corporation unless, and only to the extent that, the court of common pleas or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnification for such expenses which the court of common pleas or such other court shall deem proper; or (ii) any action or suit in which the only liability asserted against a director is pursuant to section 1701.95 of the Ohio Revised Code. An Ohio corporation is required to indemnify a director or officer against expenses actually and reasonably incurred to the extent that the director or officer is successful in defending a lawsuit brought against him or her by reason of the fact that the director or officer is or was a director or officer of the corporation.

The indemnification provided for in Section 1701.13(E) of the Ohio Revised Code is not exclusive of any other rights of indemnification to which those seeking indemnification may be entitled, and a corporation may purchase and maintain insurance against liabilities asserted against any former or current director, officer, employee or agent of the corporation, or a person who is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, whether or not the power to indemnify is provided by the statute.

The Bylaws of Hytree Pharmacy, Inc. provide that the corporation shall indemnify its officers, directors, employees and agents to the extent permitted by the General Corporation Law of Ohio.

 

II-21


Table of Contents

The Bylaws of Management & Network Services, Inc., NCS Healthcare of Kentucky, Inc., NCS Healthcare of Montana, Inc., NCS Healthcare of New Mexico, Inc., NCS Healthcare of South Carolina, Inc., NCS Healthcare of Tennessee, Inc., NCS Healthcare of Washington, Inc., and NCS Services, Inc. provide that the corporation shall indemnify any director or officer to the fullest extent provided by, or permissible under, Section 1701.13 (E) of the Ohio Revised Code; and the corporation is specifically authorized to take any and all further action to effectuate any indemnification of any director or officer which any Ohio corporation may have power to take, by any vote of the shareholders, vote of disinterested directors, by any agreement, or otherwise. This Section of the Code of Regulations of the Corporation shall be interpreted in all respects to expand such power to indemnify to the maximum extent permissible to any Ohio corporation with regard to the particular facts of each case, and not in any way to limit any statutory or other power to indemnify, or right of any individual to indemnification.

Lo-Med Prescription Services, LLC, NCS Healthcare of Iowa, LLC, NCS Healthcare of Kansas, LLC, NCS Healthcare of Ohio, LLC, NCS Healthcare of Wisconsin, LLC and Westhaven Services Co., LLC are registered under the laws of Ohio.

Pursuant to Section 1705.32(A) of the Ohio Revised Code, a limited liability company may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the limited liability company) by reason of the fact that he or she is or was a manager, member, employee or agent of the limited liability company, or is or was serving at the request of the limited liability company as a manager, officer, employee or agent of another company, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding (i) if such person acted in good faith and in a manner that person reasonably believed to be in or not opposed to the best interests of the company and (ii) with respect to any criminal action or proceeding, if he or she had no reasonable cause to believe such conduct was unlawful. In actions brought by or in the right of the company, a limited liability company may indemnify such person against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner that person reasonably believed to be in or not opposed to the best interests of the company, except that no indemnification may be made in respect of any claim, issue or matter as to which that person shall have been adjudged to be liable for negligence or misconduct in performance of his duty to the company unless, and only to the extent that, the court of common pleas or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnification for such expenses which the court of common pleas or such other court shall deem proper. An Ohio limited liability company is required to indemnify a manager or officer against expenses actually and reasonably incurred to the extent that the manager or officer is successful in defending a lawsuit brought against him or her by reason of the fact that the manager or officer is or was a manager or officer of the company.

The statutory right of indemnification is not exclusive in Ohio, and a limited liability company may, among other things, grant rights to indemnification under the limited liability company’s operating agreement or other agreements. Ohio limited liability companies are also specifically authorized to procure insurance against any liability that may be asserted against managers and officers, whether or not the limited liability company would have the power to indemnify such persons.

The Operating Agreements of Lo-Med Prescription Services, LLC, NCS Healthcare of Iowa, LLC, NCS Healthcare of Kansas, LLC, NCS Healthcare of Ohio, LLC, and NCS Healthcare of Wisconsin, LLC provide that the company shall indemnify the member to the full extent permitted by law and the testator or intestate of the member, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the member is or was a manager, officer, employee, appointee or designee of the company; provided that no indemnification or reimbursement shall be made to or on

 

II-22


Table of Contents

behalf of the member to the extent that a final judgment or other final adjudication binding upon the member establishes that its acts or omissions resulted from its bad faith, fraud or criminal act. Expenses, including attorneys’ fees, incurred by the member in defending any such action, suit or proceeding shall be paid or reimbursed by the company promptly upon receipt by it of an undertaking of the member to repay such expenses if it shall ultimately be determined that the member is not entitled to be indemnified by the company. In case any such action, suit or proceeding shall be brought against the member, the member shall notify the company of the commencement thereof, and the company shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof.

The Operating Agreement of Westhaven Services Co., LLC provides that the company shall indemnify its officers, the member and their respective managers, officers, directors, employees, agents, appointees or designees (each, an “Indemnified Person”) to the full extent permitted by law and the testator or intestate of any of the foregoing, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the Indemnified Person is or was a manager, officer, employee, agent, appointee or designee of the company or the member; provided that no indemnification or reimbursement shall be made to or on behalf of the Indemnified Person to the extent that a final judgment or other final adjudication binding upon the Indemnified Person establishes that the Indemnified Person’s acts or omissions resulted from its bad faith, fraud or criminal act. Expenses, including attorneys’ fees, incurred by the Indemnified Person in defending any such action, suit or proceeding shall be paid or reimbursed by the company promptly upon receipt by it of an undertaking of the Indemnified Person to repay such expenses if it shall ultimately be determined that the Indemnified Person is not entitled to be indemnified by the company. In case any such action, suit or proceeding shall be brought against the Indemnified Person, the Indemnified Person shall notify the company of the commencement thereof, and the company shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof.

Oklahoma

CP Acquisition Corp. is incorporated under the laws of Oklahoma.

Section 1031 of the Oklahoma General Corporation Act (“OGCA”) allows a corporation to indemnify any persons who were or are parties or are threatened to be made parties to any threatened, pending, or completed action, suit or proceeding against (a) expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by them in connection with any such action, suit or proceeding brought by reason of such person being or having been a director, officer, employee or agent of the corporation, or of any other corporation, partnership, joint venture, trust or other enterprise at the corporation’s request, other than an action by or in the right of the corporation, provided that, to be entitled to indemnification, the individual must have acted in good faith and in a manner he reasonably believed to be in or not opposed to the corporation’s best interest, and with respect to any criminal action, the person seeking indemnification had no reasonable cause to believe that the conduct was unlawful, and (b) expenses, including attorneys’ fees, actually and reasonably incurred in connection with the defense or settlement of any action or suit by or in the right of the corporation brought by reason of the person seeking indemnification being or having been a director, officer, employee or agent of the corporation, or any other corporation, partnership, joint venture, trust or other enterprise at the corporation’s request, provided the actions were in good faith and were reasonably believed to be in or not opposed to the corporation’s best interest, except that no indemnification shall be made in respect of any claim, issue or matter as to which the individual shall have been adjudged liable to the corporation, unless and only to the extent that the court in which such action was decided has determined that the person is fairly and reasonably entitled to indemnity for such expenses which the court deems proper.

The Certificate of Incorporation of CP Acquisition Corp., an Oklahoma corporation (the “Corporation”), provides that a director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of the director’s fiduciary duty as a director, except for liability resulting from (i) any breach of the director’s duty of loyalty to the Corporation or its stockholders; (ii) acts or omissions not in

 

II-23


Table of Contents

good faith or that involve intentional misconduct or knowing violation of the law; (iii) the payment of unlawful dividends or any unlawful stock purchase or redemption under Section 1053 of the Oklahoma General Corporation Act; and (iv) any transaction from which the director derived an improper personal benefit.

The Bylaws of the Corporation provide that the Corporation shall indemnify and hold harmless each person that is or was a director or officer of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee, fiduciary, or agent of another corporation or of a partnership, joint venture, trust, or other enterprise, to the fullest extent not prohibited by the Oklahoma General Corporation Act, except for any claim based on an act or omission (i) involving intentional misconduct or a knowing violation of law or (ii) from which such person derived an improper personal pecuniary benefit. Such indemnification shall include all expenses, liability, loss (including attorneys’ fees), judgments, fines, and amounts paid in settlement. The right of indemnification is not exclusive of any other right to which such person may be entitled pursuant to any statute, provision of the certificate of incorporation, agreement, vote of stockholders or disinterest directors, or otherwise. In addition, persons not specifically covered by the aforementioned indemnification provisions of the Bylaws may be indemnified to the extent authorized by the Board of Directors of the Corporation.

Pennsylvania

NeighborCare, Inc. and Delco Apothecary, Inc. are incorporated under the laws of Pennsylvania.

Section 1741 of the Pennsylvania Business Corporation Law of 1988, as amended (the “Pennsylvania Statute”), provides that, unless otherwise restricted in its bylaws, a business corporation may indemnify its directors and officers (other than in an action by or in the right of the corporation) against expenses, judgments, fines and amounts paid in settlement reasonably incurred in such capacity provided the person acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful. Section 1742 of the Pennsylvania Statute provides that, unless otherwise restricted in its bylaws, a business corporation may indemnify its directors and officers in any action by or in the right of the corporation against expenses reasonably incurred in such capacity provided the person acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation. However, this power to indemnify does not exist in the case of actions against any person by or in the right of the corporation if the person otherwise entitled to indemnification shall have been adjudged to be liable to the corporation unless a court determines that despite the adjudication of liability but in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for expenses that the court deems proper. Pursuant to Section 1743 of the Pennsylvania Statute, a corporation is required to indemnify its directors and officers against reasonable expenses they may incur in defending actions against them in such capacities if they are successful on the merits or otherwise in the defense of such actions. Section 1746 of the Pennsylvania Statute provides that the foregoing provisions shall not be deemed exclusive of any other rights to which a person seeking indemnification may be entitled under, among other things, any bylaws provision, provided that no indemnification may be made in any case where the act or failure to act giving rise to the claim for indemnification is determined by a court to have constituted willful misconduct or recklessness. Section 1747 of the Pennsylvania Statute grants a corporation, unless otherwise restricted in its bylaws, the power to purchase and maintain insurance on behalf of its directors and officers against any liability asserted against them in such capacity, whether or not the corporation would have the power to indemnify them against such liability.

Section 8 of the Amended and Restated Articles of Incorporation of NeighborCare, Inc. provides the corporation shall indemnify to the fullest extent permitted by applicable law any person who was or is a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, external, administrative or investigative (a “Proceeding”), by reason of the fact that such person is or was a director or officer of the corporation, or is or was serving at the request of the corporation as a director or officer of another corporation or of a partnership, joint venture, trust or other enterprise or entity, whether or not for profit, whether domestic or foreign, including service with respect to an employee benefit

 

II-24


Table of Contents

plan, its participants or beneficiaries, against all liability, loss and expense (including attorneys’ fees and amounts paid in entitlement) actually and reasonably incurred by such person in connection with such Proceeding, whether or not the indemnified liability arises or arose from any Proceeding by or in the right of the corporation.

The bylaws of NeighborCare, Inc. provide that the guarantor shall, to the fullest extent permitted by applicable law, indemnify its directors and officers who were or are a party or are threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (whether or not such action, suit or proceeding arises or arose by or in the right of the guarantor or other entity) by reason of the fact that such director or officer is or was a director or officer of the guarantor or is or was serving at the request of the guarantor as a director, officer, employee, general partner, agent or fiduciary of another corporation, partnership, joint venture, trust or other enterprise (including service with respect to employee benefit plans), against expenses (including, but not limited to, attorneys’ fees and costs), judgments, fines (including excise taxes assessed on a person with respect to any employee benefit plan) and amounts paid in settlement actually and reasonably incurred by such director or officer in connection with such action, suit or proceedings, except as otherwise provided in the next sentence. No indemnification shall be provided with respect to expenses or the payment of profits arising from the purchase or sale of securities of the guarantor in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended; (b) if a final unappealable judgment or award establishes that such director or officer engaged in self-dealing, willful misconduct or recklessness; (c) for expenses or liabilities of any type whatsoever (including, but not limited to, judgments, fines, and amounts paid in settlement) which have been paid directly to such person by an insurance carrier under a policy of officers’ and directors’ liability insurance whose premiums are paid for by the guarantor or by an individual or entity other than such director or officer ; and (d) for amounts paid in settlement of any threatened, pending or completed action, suit or proceeding without the written consent of the guarantor, which written consent shall not be unreasonably withheld.

The Bylaws of Delco Apothecary, Inc. provide that the corporation shall, to the fullest extent permitted by applicable law, indemnify its directors and officers who were or are a party or are threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (whether or not such action, suit or proceeding arises or arose by or in the right of the corporation or other entity) by reason of the fact that such director or officer is or was a director or officer of the corporation or is or was serving at the request of the corporation as a director, officer, employee, general partner, agent or fiduciary of another corporation, partnership, joint venture, trust or other enterprise (including service with respect to employee benefit plans), against expenses (including, but not limited to, attorneys’ fees and costs), judgments, fines (including excise taxes assessed on a person with respect to any employee benefit plan) and amounts paid in settlement actually and reasonably incurred by such director or officer in connection with such action, suit or proceeding.

No indemnification shall be provided (a) with respect to expenses or the payment of profits arising from the purchase or sale of securities of the Corporation in violation of Section 16(b) of the Securities Exchange Act of 1934; (b) if a final unappealable judgment or award establishes that such director or officer engaged in self-dealing, willful misconduct or recklessness; (c) for expenses or liabilities of any type whatsoever (including, but not limited to, judgments, fines, and amounts paid in settlement) which have been paid directly to, or for the benefit of, such person by an insurance carrier under a policy of officers’ and directors’ liability insurance whose premiums are paid for by the corporation or by an individual or entity other than such director or officer; and (d) for amounts paid in settlement of any threatened, pending or completed action, suit or proceeding without the written consent of the corporation, which written consent shall not be unreasonably withheld.

Continuing Care Rx, LLC, Omnicare Pharmacies of Pennsylvania West, LLC and Suburban Medical Services, LLC are registered under the laws of Pennsylvania.

Section 8945 of the Pennsylvania Limited Liability Company Law of 1994 provides that a Pennsylvania limited liability company may and shall have the power to indemnify and hold harmless any member or manager

 

II-25


Table of Contents

or other person from and against any and all claims and demands whatsoever; provided, however, that a limited liability company may not indemnify a manager, member or other person for an act that is determined by a court to constitute willful misconduct or recklessness. Further, subsection (d) provides that a limited liability company may pay expenses incurred by a member, manager or other person in advance of disposition of any claim if such person makes an undertaking to repay the company if it is determined that such person is not entitled to indemnification. Finally, under subsection (f), a limited liability company must indemnify its members and managers for payments made, and personal liabilities reasonably incurred, in the ordinary and proper conduct of its business or for the preservation of its business or property.

The Limited Liability Company Agreement of Continuing Care Rx, LLC provides that the company shall indemnify its officers, the member and their respective managers, officers, directors, employees, agents, appointees or designees (each, an “Indemnified Person”) to the full extent permitted by law and the testator or intestate of any of the foregoing, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the Indemnified Person is or was a manager, officer, director, employee, agent, appointee or designee of the company or the member; provided that no indemnification or reimbursement shall be made to or on behalf of the Indemnified Person to the extent that a final judgment or other final adjudication binding upon the Indemnified Person establishes that the Indemnified Person’s actions or omissions resulted from such person’s bad faith, fraud or criminal act.

The Limited Liability Company Agreement of Omnicare Pharmacies of Pennsylvania West, LLC provides that the company shall indemnify the member to the full extent permitted by law and the testator or intestate of the member, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the member is or was a manager, officer, employee, appointee or designee of the company; provided that no indemnification or reimbursement shall be made to or on behalf of the member to the extent that a final judgment or other final adjudication binding upon the member establishes that its acts or omissions resulted from its bad faith, fraud or criminal act.

The Limited Liability Company Operating Agreement of Suburban Medical Services, LLC provides that the member, the officers and their respective managers, officers, directors, employees, agents, appointees and designees shall be indemnified by the company to the fullest extent permitted by the Pennsylvania Limited Liability Company Act and as may be otherwise permitted by applicable law.

South Carolina

Pharmacy Consultants, LLC is registered under the laws of South Carolina.

Section 33-44-403 of the South Carolina Uniform Limited Liability Company Act of 1996 discusses members’ and managers’ rights to payments and reimbursement. A limited liability company shall reimburse a member or manager for payments made and indemnify a member or manager for liabilities incurred by the member or manager in the ordinary course of the business of the company or for the preservation of its business or property. A limited liability company shall reimburse a member for an advance to the company beyond the amount of contribution the member agreed to make. A payment or advance made by a member that gives rise to an obligation of a limited liability company under the South Carolina statute constitutes a loan to the company upon which interest accrues from the date of the payment or advance. A member is not entitled to remuneration for services performed for a limited liability company, except for reasonable compensation for services rendered in winding up the business of the company.

The Limited Liability Company Agreement of Pharmacy Consultants, LLC provides that the company shall indemnify its officers, the member and their respective managers, officers, directors, employees, agents, appointees or designees (each, an “Indemnified Person”) to the full extent permitted by law and the testator or intestate of any of the foregoing, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the Indemnified Person is or was a

 

II-26


Table of Contents

manager, officer, director, employee, agent, appointee or designee of the company or the member; provided that no indemnification or reimbursement shall be made to or on behalf of the Indemnified Person to the extent that a final judgment or other final adjudication binding upon the Indemnified Person establishes that the Indemnified Person’s acts or omissions resulted from such person’s bad faith, fraud or criminal act. Additionally, expenses, including attorneys’ fees, incurred by the Indemnified Person in defending any such action, suit or proceeding shall be paid or reimbursed by the company promptly upon receipt by it of an undertaking of the Indemnified Person to repay such expenses if it shall ultimately be determined that the Indemnified Person is not entitled to be indemnified by the company. In case any such action, suit or proceeding shall be brought against the Indemnified Person, the Indemnified Person shall notify the company of the commencement thereof, and the company shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof.

Furthermore, the indemnification and reimbursement of expenses provided above shall not be deemed exclusive of any other rights to which those seeking indemnification or reimbursement of expenses may be entitled under any other instrument or by reason of any other action or otherwise. However, the indemnification and reimbursement of expenses so provided shall be available only to the extent that indemnification or reimbursement is unavailable to the Indemnified Person under any applicable policy of insurance or otherwise.

South Dakota

Omnicare Pharmacy and Supply Services, LLC is registered under the laws of South Dakota.

Section 47-34A-403(a) of the South Dakota Limited Liability Act provides that a limited liability company shall reimburse a member or a manager for payments made and indemnify a member or manager for liabilities incurred by the member or manager in the ordinary course of the business of the company or for the preservation of its business or property.

The Limited Liability Company Agreement of Omnicare Pharmacy and Supply Services, LLC provides that the company shall indemnify the member to the full extent permitted by law and the testator or intestate of the member, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the member is or was a manager, officer, employee, appointee or designee of the company; provided that no indemnification or reimbursement shall be made to or on behalf of the member to the extent that a final judgment or other final adjudication binding upon the member establishes that its acts or omissions resulted from its bad faith, fraud or criminal act. Expenses, including attorneys’ fees, incurred by the member in defending any such action, suit or proceeding shall be paid or reimbursed by the company promptly upon receipt by it of an undertaking of the member to repay such expenses if it shall ultimately be determined that the member is not entitled to be indemnified by the company. In case any such action, suit or proceeding shall be brought against the member, the member shall notify the company of the commencement thereof, and the company shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof.

Further, the indemnification and reimbursement of expenses provided above shall not be deemed exclusive of any other rights to which those seeking indemnification or reimbursement of expenses may be entitled under any other instrument or by reason of any other action or otherwise. However, the indemnification and reimbursement of expenses so provided shall be available only to the extent that indemnification or reimbursement is unavailable to the member under any applicable policy of insurance or otherwise.

Virginia

Capitol Home Infusion, Inc. and Williamson Drug Company, Incorporated are incorporated under the laws of Virginia.

Section 697 et seq. of the Virginia Stock Corporation Act (the “Virginia Statute”) provides that a Virginia corporation may indemnify an individual made a party to a proceeding because he is or was a director against

 

II-27


Table of Contents

liability incurred in the proceeding if: (a) the individual conducted himself in good faith; and (b) the individual believed: (i) in the case of conduct in his or her official capacity with the corporation, that his or her conduct was in its best interests; and (ii) in all other cases, that his or her conduct was at least not opposed to its best interests; and (iii) in the case of any criminal proceeding, he or she had no reasonable cause to believe his or her conduct was unlawful. A Virginia corporation is not permitted to indemnify a director under this section: (a) in connection with a proceeding by or in the right of the corporation in which the director was adjudged liable to the corporation; or (b) in connection with any other proceeding charging improper personal benefit to him or her, whether or not involving action in his or her official capacity, in which he or she was adjudged liable on the basis that personal benefit was improperly received by him or her. Indemnification permitted under the Virginia Statute in connection with a proceeding by or in the right of the corporation is limited to reasonable expenses incurred in connection with the proceeding by directors who meet the good faith and actual belief standards for indemnity described above. Unless limited by its articles of incorporation, a corporation must indemnify a director who entirely prevails in the defense of any proceeding to which he or she was a party because he or she is or was a director of the corporation against reasonable expenses incurred by him or her. With respect to a proceeding by or in the right of the corporation, the court may (i) order indemnification of the director to the extent of his or her reasonable expenses if it determines that, considering all the relevant circumstances, the director is entitled to indemnification even though he or she was adjudged liable to the corporation and (ii) also order the corporation to pay the director’s reasonable expenses incurred to obtain the order of indemnification. The Virginia Statute further authorizes a Virginia corporation to indemnify an officer, employee, or agent of the corporation to the same extent as to a director, and requires, unless limited by its articles of incorporation, indemnification of an officer who entirely prevails in the defense of any proceeding to which he was a party because he is or was an officer of the corporation against reasonable expenses incurred by him in connection with the proceeding.

In addition, Section 703 of the Virginia Statute authorizes a Virginia corporation to purchase and maintain insurance on behalf of an individual who is or was a director, officer, employee, or agent of the corporation, or who, while a director, officer, employee, or agent of the corporation, is or was serving at the request of the corporation as a director, officer, partner, trustee, employee, or agent of another foreign or domestic corporation, partnership, joint venture, trust, employee benefit plan, or other enterprise, against liability asserted against or incurred by him or her in that capacity or arising from his or her status as a director, officer, employee, or agent, whether or not the corporation would have power to indemnify him or her against the same liability under the Virginia Statute.

The Capitol Home Infusion, Inc. Bylaws provide that the corporation shall indemnify any person who was or is a party, including those who were, are, or are threatened to be made a named defendant or respondent, to any proceeding, including a proceeding by or in the right of the corporation to procure a judgment in its favor, by reason of the fact that he or she is or was a director, or officer, or employee or agent of the corporation, or is or was serving at the request of the corporation as a director, trustee, partner or officer of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, against any liability incurred by him or her in connection with such proceeding if (i) he or she believed, in the case of conduct in his or her official capacity, that his or her conduct was in the best interest of the corporation, and in all other cases that his or her conduct was at least not opposed to its best interests, and, in the case of any criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful, and (ii) he or she was not guilty of gross negligence or willful misconduct.

Notwithstanding the above provision, no indemnification shall be made in connection with any proceeding charging the applicant with improper benefit to himself or herself, whether or not involving action in his or her official capacity, in which he or she was adjudged liable on the basis that personal benefit was improperly received by him or her. To the extent that the applicant has been successful on the merits or otherwise in defense of any proceeding referred to in the indemnification section of the Bylaws, or in defense of any claim, issue or matter therein, he or she shall be indemnified against expenses actually incurred by him or her in connection therewith.

 

II-28


Table of Contents

Furthermore, all decisions with regard to indemnification shall be made by a majority vote of the Board of Directors, excluding the vote of any director who is the subject of such vote, and the right of indemnification shall not be exclusive of other rights to which any such Director or Officer may be entitled as a matter of law.

The Bylaws also provide that expenses covered by such indemnification shall include the cost of reasonable settlements (other than amounts paid to the corporation itself), made with a view to curtailing costs of litigation whenever the best interests of the corporation are served. In determining the reasonableness of any settlement, the judgment of the Board of Directors shall be final. Finally, the corporation shall have the power to purchase Directors and Officers liability insurance on behalf of any such person who is or was a Director or Officer of the corporation.

The Williamson Drug Company, Incorporated Bylaws provide that the corporation shall indemnify its officers, directors, employees and agents to the extent permitted by the Stock Corporation Act of Virginia.

NeighborCare of Virginia, LLC is registered under the laws of Virginia.

Section 13.1-1009 of the Virginia Limited Liability Company Act (“VALLCA”) permits a Virginia limited liability company, subject to the standards and restrictions set forth in its articles of organization or operating agreement, to indemnify and hold harmless any member, manager or other person from and against any and all claims and demands whatsoever, and to pay for or reimburse any member, manager or other person for reasonable expenses incurred by such a person who is party to a proceeding in advance of final disposition of the proceeding.

The Operating Agreement of NeighborCare of Virginia, LLC provides that the company shall indemnify to the full extent permitted by law each manager, and the testator or intestate of any such manager, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such manager is or was a manager, officer, employee, appointee or designee of the company; provided that no indemnification or reimbursement shall be made to or on behalf of any such manager to the extent that a final judgment or other final adjudication binding upon such manager establishes that the acts or omissions of such manager resulted from the bad faith, fraud or criminal act of such manager. Additionally, expenses, including attorneys’ fees, incurred by any such manager in defending any such action, suit or proceeding shall be paid or reimbursed by the company promptly upon receipt by it of an undertaking of such manager to repay such expenses if it shall ultimately be determined that such manager is not entitled to be indemnified by the company. In case any such action, suit or proceeding shall be brought against any such manager, such manager shall notify the company of the commencement thereof, and the company shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof.

Furthermore, the indemnification and reimbursement of expenses provided shall not be deemed exclusive of any other rights to which those seeking indemnification or reimbursement of expenses may be entitled under any other instrument or by reason of any other action or otherwise. However, the indemnification and reimbursement of expenses so provided shall be available only to the extent that indemnification or reimbursement is unavailable to such manager under any applicable policy of insurance or otherwise.

Washington

Evergreen Pharmaceutical, LLC is registered under the laws of Washington.

Section 25.15.040 of the Washington Limited Liability Company Act (the “WLLCA”) provides that a limited liability company agreement may contain provisions not inconsistent with law that: (a) eliminate or limit the personal liability of a member or manager to the limited liability company or its members for monetary damages for conduct as a member or manager, provided that such provisions shall not eliminate or limit the liability of a member or manager for acts or omissions that involve intentional misconduct or a knowing violation

 

II-29


Table of Contents

of law by a member or manager, for conduct of the member or manager violating Section 25.15.235 of the WLLCA (which restricts distributions when a company’s liabilities exceed its assets), or for any transaction from which the member or manager will personally receive a benefit in money, property or services to which the member or manager is not legally entitled; or (b) indemnify any member or manager from and against any judgments, settlements, penalties, fines or expenses incurred in a proceeding to which an individual is a party because he or she is, or was, a member or a manager, provided that no such indemnity shall indemnify a member or a manager from or on account of acts or omissions of the member or manager finally adjudged to be intentional misconduct or a knowing violation of law by the member or manager, conduct of the member or manager adjudged to be in violation of Section 25.15.235 of the WLLCA or any transaction with respect to which it was finally adjudged that such member or manager received a benefit in money, property or services to which such member or manager was not legally entitled.

The Limited Liability Company Agreement of Evergreen Pharmaceutical, LLC provides that the company shall indemnify and hold harmless the member to the fullest extent permitted by law.

West Virginia

Compass Health Services, LLC is registered under the laws of West Virginia.

Section 31B-4-403 of the West Virginia Uniform Limited Liability Company Act discusses members’ and managers’ rights to payments and reimbursement. A limited liability company shall reimburse a member or manager for payments made and indemnify a member or manager for liabilities incurred by the member or manager in the ordinary course of the business of the company or for the preservation of its business or property. A limited liability company shall reimburse a member for an advance to the company beyond the amount of contribution the member agreed to make. A payment or advance made by a member that gives rise to an obligation of a limited liability company under the West Virginia statute constitutes a loan to the company upon which interest accrues from the date of the payment or advance. A member is not entitled to remuneration for services performed for a limited liability company, except for reasonable compensation for services rendered in winding up the business of the company.

The limited liability company agreement of Compass Health Services, LLC provides that the company shall indemnify its member to the full extent permitted by law and the testator or intestate of the M\member, made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the member is or was a manager, officer, employee, appointee or designee of the company; provided that no indemnification or reimbursement shall be made to or on behalf of the member to the extent that a final judgment or other final adjudication binding upon the member establishes that its acts or omissions resulted from its bad faith, fraud or criminal act. Expenses, including attorneys’ fees, incurred by the member in defending any such action, suit or proceeding shall be paid or reimbursed by the company promptly upon receipt by it of an undertaking of the member to repay such expenses if it shall ultimately be determined that the member is not entitled to be indemnified by the company. In case any such action, suit or proceeding shall be brought against the member, the member shall notify the company of the commencement thereof, and the company shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof.

The limited liability company agreement specifies that the indemnification and reimbursement available as described above shall not be deemed exclusive of any other rights to which those seeking indemnification or reimbursement of expenses may be entitled under any other instrument or by reason of any other action or otherwise. However, the indemnification and reimbursement of expenses shall be available only to the extent that indemnification or reimbursement is unavailable to the member under any applicable policy of insurance or otherwise.

 

II-30


Table of Contents

Wisconsin

Roeschen’s Healthcare, LLC is registered under the laws of Wisconsin.

Section 183.0403 of the Wisconsin Limited Liability Company Act (the “WLLCA”), a Wisconsin limited liability company shall indemnify or allow reasonable expenses to and pay liabilities of each member and, if management of the limited liability company is vested in one or more managers, of each manager, incurred with respect to a proceeding if that member or manager was a party to the proceeding in the capacity of a member or manager. An operating agreement may alter or provide additional rights to indemnification of liabilities or allowance of expenses to members and managers. Under Section 183.0403(4) of the WLLCA, a Wisconsin limited liability company may not indemnify a member or manager for liabilities or permit a member or manager to retain any allowance for expenses unless it is determined by or on behalf of the limited liability company that the liabilities or expenses did not result from the member’s or manager’s breach or failure to perform a duty to the limited liability company as provided in Section 183.0402 of the WLLCA which provides that unless otherwise set forth in the operating agreement of the limited liability company, no member or manager shall act or fail to act in a manner that constitutes any of the following: (a) a willful failure to deal fairly with the limited liability company or its members in connection with a matter in which the member or manager has a material conflict of interest; (b) a violation of criminal law, unless the member or manager had reasonable cause to believe that the person’s conduct was lawful or no reasonable cause to believe that the conduct was unlawful; (c) a transaction from which the member or manager derived an improper personal profit; or (d) willful misconduct. Unless otherwise provided in the operating agreement, all of the following apply: (y) A member or manager who is a party to a proceeding because the person is a member or manager shall be conclusively presumed not to have breached or failed to perform a duty to the limited liability company to the extent that the member or manager has been successful on the merits or otherwise in the defense of the proceeding; and (z) In situations not described in the preceding subparagraph (y), the determination of whether a member or manager, who is a party to a proceeding because the person is a member or manager, has breached or failed to perform a duty to the limited liability company, or whether the liability or expenses resulted from the breach or failure, shall be made by the vote of the members, except that the vote of any member who is a party to the same or a related proceeding shall be excluded unless all members are parties.

The Limited Liability Company Agreement of Roeschen’s Healthcare, LLC dated June 9, 2006, at Section 17, requires the company to indemnify a member to the fullest extent permitted by law, when said member is made or threatened to be made a party to any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that the member is or was a manager, officer, employee, appointee or designee of the company, provided that no indemnification or reimbursement shall be made to or on behalf of the member to the extent that a final judgment or other final adjudication binding upon the member establishes that its acts or omissions resulted from its bad faith, fraud or criminal act. Expenses, including attorneys’ fees, incurred by the member in defending any such action, suit or proceeding shall be paid or reimbursed by the company promptly upon receipt by it of an undertaking of the member to repay such expenses if it shall ultimately be determined that the member is not entitled to be indemnified by the company. In case any such action, suit or proceeding shall be brought against the member, the member shall notify the company of the commencement thereof, and the company shall be entitled to participate therein and, to the extent that it shall wish, to assume the defense thereof. The indemnification and reimbursement of expenses provided in the company’s limited liability company agreement is not exclusive of any other rights to which those seeking indemnification or reimbursement of expenses may be entitled under any other instrument or by reason of any other action or otherwise. However, the indemnification and reimbursement of expenses so provided by said Section 17 shall be available only to the extent that indemnification or reimbursement is unavailable to the member under any applicable policy of insurance or otherwise.

 

II-31


Table of Contents

Item 16. Exhibits

 

Exhibit
No.

  

Description

1.1    Form of Underwriting Agreement.*
3.1    Restated Certificate of Incorporation of Omnicare, Inc. (as amended) (incorporated herein by reference from Exhibit 3.1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2002).
3.2    Fourth Amended and Restated By-Laws of Omnicare, Inc. (incorporated herein by reference from Exhibit 3.2 to our Current Report on Form 8-K filed February 22, 2011).
4.1    Form of Senior Debt Securities Indenture.
4.2    Subordinated Debt Securities Indenture, dated as of June 13, 2003 between Omnicare, Inc. and U.S. Bank National Association (as successor to SunTrust Bank), as trustee (incorporated herein by reference from Exhibit 4.2(a) to our Current Report on Form 8-K filed June 16, 2003).
4.3    Form of Senior Debt Securities (included in exhibit 4.1).
4.4    Form of Subordinated Debt Securities (included in exhibit 4.2).
4.5    Form of certificate of designation of preferred stock.*
4.6    Form of Warrant.*
5.1    Opinion of White & Case LLP.
5.2    Opinion of Briskin, Cross & Sanford, LLC.
5.3    Opinion of Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C.
5.4    Opinion of Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C.
5.5    Opinion of Bingham Greenebaum Doll LLP.
5.6    Opinion of Bingham Greenebaum Doll LLP.
5.7    Opinion of Hancock, Daniel, Johnson & Nagle, P.C.
5.8    Opinion of Hancock, Daniel, Johnson & Nagle, P.C.
5.9    Opinion of Hancock, Daniel, Johnson & Nagle, P.C.
5.10    Opinion of Hancock, Daniel, Johnson & Nagle, P.C.
5.11    Opinion of Taylor Porter Brooks & Phillips, L.L.P.
5.12    Opinion of Plunkett Cooney, P.C.
5.13    Opinion of Carmody MacDonald P.C.
5.14    Opinion of Shaheen & Gordon, P.A.
5.15    Opinion of Stradley Ronon Stevens & Young, LLP.
5.16    Opinion of Stradley Ronon Stevens & Young, LLP.
5.17    Opinion of McAfee & Taft, A Professional Corporation.
5.18    Opinion of Davenport, Evans, Hurwitz & Smith, LLP.
5.19    Opinion of Stoel Rives LLP.
5.20    Opinion of Davis & Kuelthau, S.C.
12.1    Statement of Computation of Ratio of Earnings to Fixed Charges for the five years ended December 31, 2013 (incorporated herein by reference from Exhibit 12 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2013).

 

II-32


Table of Contents
12.2    Statement of Computation of Ratio of Earnings to Fixed Charges for the nine months ended September 30, 2014 (incorporated herein by reference from Exhibit 12 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2014).
23.1    Consent of White & Case LLP (included in its opinion filed as Exhibit 5.1).
23.2    Consent of Briskin, Cross & Sanford, LLC (included in its opinion filed as Exhibit 5.2).
23.3    Consent of Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C. (included in its opinion filed as Exhibit 5.3).
23.4    Consent of Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C. (included in its opinion filed as Exhibit 5.4).
23.5    Consent of Bingham Greenebaum Doll LLP (included in its opinion filed as Exhibit 5.5).
23.6    Consent of Bingham Greenebaum Doll LLP (included in its opinion filed as Exhibit 5.6).
23.7    Consent of Hancock, Daniel, Johnson & Nagle, P.C. (included in its opinion filed as Exhibit 5.7).
23.8    Consent of Hancock, Daniel, Johnson & Nagle, P.C. (included in its opinion filed as Exhibit 5.8).
23.9    Consent of Hancock, Daniel, Johnson & Nagle, P.C. (included in its opinion filed as Exhibit 5.9).
23.10    Consent of Hancock, Daniel, Johnson & Nagle, P.C. (included in its opinion filed as Exhibit 5.10).
23.11    Consent of Taylor Porter Brooks & Phillips, LLP (included in its opinion filed as Exhibit 5.11).
23.12    Consent of Plunkett Cooney, P.C. (included in its opinion filed as Exhibit 5.12).
23.13    Consent of Carmody MacDonald P.C. (included in its opinion filed as Exhibit 5.13).
23.14    Consent of Shaheen & Gordon, P.A. (included in its opinion filed as Exhibit 5.14).
23.15    Consent of Stradley Ronon Stevens & Young, LLP (included in its opinion filed as Exhibit 5.15).
23.16    Consent of Stradley Ronon Stevens & Young, LLP (included in its opinion filed as Exhibit 5.16).
23.17    Consent of McAfee & Taft, A Professional Corporation (included in its opinion filed as Exhibit 5.17).
23.18    Consent of Davenport, Evans, Hurwitz & Smith, LLP (included in its opinion filed as Exhibit 5.18).
23.19    Consent of Stoel Rives LLP (included in its opinion filed as Exhibit 5.19).
23.20    Consent of Davis & Kuelthau, S.C. (included in its opinion filed as Exhibit 5.20).
23.21    Consent of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP).
24.1    Powers of Attorney (included on the signature pages hereto).
25.1    Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under the Senior Debt Securities Indenture and the Subordinated Debt Securities Indenture.

 

 

* To be filed, if necessary, with an amendment to the registration statement or as an exhibit to a document incorporated by reference herein.

 

II-33


Table of Contents

Item 17. Undertakings

 

  (a) Each of the undersigned registrants hereby undertakes:

 

  (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

  (i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

 

  (ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

 

  (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

provided, however , that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

 

  (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

  (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

  (4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

 

  A. Each prospectus filed by a Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

 

  B.

Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to

 

II-34


Table of Contents
  the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however , that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

 

  (5) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

 

  (i) Any preliminary prospectus or prospectus of an undersigned Registrant relating to the offering required to be filed pursuant to Rule 424;

 

  (ii) Any free writing prospectus relating to the offering prepared by or on behalf of an undersigned Registrant or used or referred to by an undersigned Registrant;

 

  (iii) The portion of any other free writing prospectus relating to the offering containing material information about an undersigned Registrant or its securities provided by or on behalf of an undersigned Registrant; and

 

  (iv) Any other communication that is an offer in the offering made by an undersigned Registrant to the purchaser.

 

  (b) That, for purposes of determining any liability under the Securities Act of 1933, each filing of Registrant’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

  (c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of each Registrant pursuant to the foregoing provisions, or otherwise, each Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by a Registrant of expenses incurred or paid by a director, officer or controlling person of a Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, that Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.

 

  (d) The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of section 310 of the Trust Indenture Act (“Act”) in accordance with the rules and regulations prescribed by the SEC under section 305(b)(2) of the Act.


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cincinnati, State of Ohio, on the 5 th day of November, 2014.

 

OMNICARE, INC.
By:  
  /s/    Robert O. Kraft
Name:         Robert O. Kraft
Title:   Senior Vice President and Chief Financial Officer

POWER OF ATTORNEY

We, the undersigned directors and officers of Omnicare, Inc., do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney-in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933; and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Nitin Sahney

(Nitin Sahney)

   President, Chief Executive Officer and Director (Principal Executive Officer)   November 5, 2014

/s/ Robert O. Kraft

(Robert O. Kraft)

   Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)   November 5, 2014

/s/ James D. Shelton

(James D. Shelton)

   Director   November 5, 2014

/s/ John L. Bernbach

(John L. Bernbach)

   Director   November 5, 2014

/s/ James G. Carlson

(James G. Carlson)

   Director   November 5, 2014

/s/ Mark A. Emmert, Ph.D.

(Mark A. Emmert, Ph.D.)

   Director   November 5, 2014

/s/ Steven J. Heyer

(Steven J. Heyer)

   Director   November 5, 2014


Table of Contents

/s/ Samuel R. Leno

(Samuel R. Leno)

   Director   November 5, 2014

/s/ Barry P. Schochet

(Barry P. Schochet)

   Director   November 5, 2014

/s/ Amy Wallman

(Amy Wallman)

   Director   November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, each of the companies listed below certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

ADVANCED CARE SCRIPTS, INC.

AMC-NEW YORK, INC.

AMC-TENNESSEE, INC.

BPNY ACQUISITION CORP.

CAMPO’S MEDICAL PHARMACY, INC.

CAPITOL HOME INFUSION, INC.

CHP ACQUISITION CORP.

CIP ACQUISITION CORP.

CP ACQUISITION CORP.

DELCO APOTHECARY, INC

EVERGREEN PHARMACEUTICAL OF CALIFORNIA, INC.

HMIS, INC.

HYTREE PHARMACY, INC.

MANAGED HEALTHCARE, INC.

MANAGEMENT & NETWORK SERVICES, INC.

MED WORLD ACQUISITION CORP.

MEDICAL ARTS HEALTH CARE, INC.

NCS HEALTHCARE OF INDIANA, INC.

NCS HEALTHCARE OF KENTUCKY, INC.

NCS HEALTHCARE OF MONTANA, INC.

NCS HEALTHCARE OF NEW HAMPSHIRE, INC.

NCS HEALTHCARE OF NEW MEXICO, INC.

NCS HEALTHCARE OF SOUTH CAROLINA, INC.

NCS HEALTHCARE OF TENNESSEE, INC.

NCS HEALTHCARE OF WASHINGTON, INC.

NCS SERVICES, INC.

NEIGHBORCARE HOLDINGS, INC.

NEIGHBORCARE PHARMACY SERVICES, INC.

NEIGHBORCARE REPACKAGING, INC.

NEIGHBORCARE SERVICES CORPORATION

NEIGHBORCARE, INC.

OMNICARE PHARMACIES OF THE GREAT PLAINS HOLDING COMPANY

OMNICARE PURCHASING COMPANY GENERAL PARTNER, INC.

OMNICARE PURCHASING COMPANY LIMITED PARTNER, INC.

PHARMACY ASSOCIATES OF GLENS FALLS, INC.

PHARMASOURCE HEALTHCARE, INC.

PHARMED HOLDINGS, INC

PROFESSIONAL PHARMACY SERVICES, INC.

RXC ACQUISITION COMPANY

SHORE PHARMACEUTICAL PROVIDERS, INC.

STERLING HEALTHCARE SERVICES, INC.

SUPERIOR CARE PHARMACY, INC.

TCPI ACQUISITION CORP.

UC ACQUISITION CORP.

UNI-CARE HEALTH SERVICES OF MAINE, INC.

VITAL CARE INFUSIONS, INC.

WILLIAMSON DRUG COMPANY, INCORPORATED

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer


Table of Contents

We, the undersigned directors and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Omnicare Holding Company and Omnicare Management Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE HOLDING COMPANY

OMNICARE MANAGEMENT COMPANY

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys– in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ David Hileman

David Hileman

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Robert Kraft

Robert Kraft

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, each of the companies listed below, certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

ASCO HEALTHCARE, LLC

CCRX HOLDINGS, LLC

COMPSCRIPT, LLC

CP SERVICES

D&R PHARMACEUTICAL SERVICES, LLC

EVERGREEN PHARMACEUTICAL, LLC

HOME CARE PHARMACY, LLC

INTERLOCK PHARMACY SYSTEMS, LLC

LANGSAM HEALTH SERVICES, LLC

LO-MED PRESCRIPTION SERVICES, LLC

NCS HEALTHCARE OF ILLINOIS, LLC

NCS HEALTHCARE OF IOWA, LLC

NCS HEALTHCARE OF KANSAS, LLC

NCS HEALTHCARE OF OHIO, LLC

NCS HEALTHCARE OF WISCONSIN, LLC

NORTH SHORE PHARMACY SERVICES, LLC

OCR-RA ACQUISITION, LLC

OMNICARE ESC LLC

OMNICARE OF NEW YORK, LLC

OMNICARE PHARMACIES OF PENNSYLVANIA WEST, LLC

OMNICARE PHARMACY AND SUPPLY SERVICES, LLC

OMNICARE PHARMACY OF THE MIDWEST, LLC

OMNICARE PROPERTY MANAGEMENT, LLC

PHARMACY CONSULTANTS, LLC

PMRP ACQUISITION COMPANY, LLC

ROESCHEN’S HEALTHCARE, LLC

SPECIALIZED PHARMACY SERVICES, LLC

VALUE HEALTH CARE SERVICES, LLC

WESTHAVEN SERVICES CO., LLC

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.


Table of Contents

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, ASCO Healthcare of New England, Limited Partnership certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

ASCO HEALTHCARE OF NEW ENGLAND, LIMITED PARTNERSHIP

By: ASCO HEALTHCARE OF NEW ENGLAND, LLC

its general partner

By: ASCO HEALTHCARE, LLC

its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, each of the companies listed below, certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

ASCO HEALTHCARE OF NEW ENGLAND, LLC

COMPASS HEALTH SERVICES, LLC

INSTITUTIONAL HEALTH CARE SERVICES, LLC

NEIGHBORCARE PHARMACIES, LLC

SUBURBAN MEDICAL SERVICES, LLC

By: ASCO HEALTHCARE, LLC

its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, each of the companies listed below, certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

APS ACQUISITION LLC

BEST CARE LTC ACQUISITION COMPANY LLC

ENLOE DRUGS LLC

LOBOS ACQUISITION, LLC

OMNICARE INDIANA PARTNERSHIP HOLDING COMPANY LLC

VAPS ACQUISITION COMPANY, LLC

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Badger Acquisition LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

BADGER ACQUISITION LLC

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Badger Acquisition of Kentucky LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

BADGER ACQUISITION OF KENTUCKY LLC

By: NEIGHBORCARE HOLDINGS, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Badger Acquisition of Minnesota LLC and Badger Acquisition of Ohio LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

BADGER ACQUISITION OF MINNESOTA LLC

BADGER ACQUISITION OF OHIO LLC

By: BADGER ACQUISITION, LLC

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, each of the companies listed below certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

HOME PHARMACY SERVICES, LLC

JHC ACQUISITION LLC

MHHP ACQUISITION COMPANY LLC

NIV ACQUISITION LLC

OMNICARE OF NEVADA LLC

OMNICARE PHARMACY OF MAINE LLC

WEBER MEDICAL SYSTEMS LLC

By: OMNICARE HOLDING COMPANY

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, NCS Healthcare, LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

NCS HEALTHCARE, LLC

By: OMNICARE HOLDING COMPANY

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ David Hileman

David Hileman

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Robert Kraft

Robert Kraft

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, each of Care Pharmaceutical Services, LP and PRN Pharmaceutical Services, LP has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cincinnati, State of Ohio, on the 5 th day of November 2014.

CARE PHARMACEUTICAL SERVICES, LP

PRN PHARMACEUTICAL SERVICES, LP

By: OMNICARE INDIANA PARTNERSHIP HOLDING COMPANY, LLC

its general partner

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of its general partner, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Care4 LP certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

CARE4, LP

By: INSTITUTIONAL HEALTH CARE SERVICES, LLC

its general partner

By: ASCO HEALTHCARE, LLC

its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, CCRX of North Carolina Holdings, LLC and Continuing Care Rx, LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

CCRX OF NORTH CAROLINA HOLDINGS, LLC

CONTINUING CARE RX, LLC

By: CCRX HOLDINGS, LLC

its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, CCRX of North Carolina, LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

CCRX OF NORTH CAROLINA, LLC

By: CCRX OF NORTH CAROLINA HOLDINGS, LLC

its sole member

By: CCRX HOLDINGS, LLC

its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, LCPS Acquisition LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

LCPS ACQUISITION LLC

By: LANGSAM HEALTH SERVICES, LLC

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Ankur Bhandari

Ankur Bhandari

  

President, Manager

  November 5, 2014

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Main Street Pharmacy, L.L.C. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

MAIN STREET PHARMACY, L.L.C.

By: PROFESSIONAL PHARMACY SERVICES, INC.

its managing member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the managing member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, NCS Healthcare of Indiana LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

NCS HEALTHCARE OF INDIANA LLC

By: NCS SERVICES, INC.

        NCS HEALTHCARE OF INDIANA, INC.

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, each of NeighborCare of Indiana, LLC and NeighborCare of Virginia, LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

NEIGHBORCARE OF INDIANA, LLC

NEIGHBORCARE OF VIRGINIA, LLC

By: OMNICARE OF NEW YORK, LLC

its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Omnicare Distribution Center LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE DISTRIBUTION CENTER LLC

By: OMNICARE MANAGEMENT COMPANY

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Omnicare Headquarters LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE HEADQUARTERS LLC

By: OMNICARE, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Omnicare Pharmacies of Pennsylvania East, LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE PHARMACIES OF PENNSYLVANIA EAST, LLC

By: OMNICARE PHARMACIES OF PENNSYLVANIA WEST, LLC

its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Omnicare Pharmacy of Florida, LP certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE PHARMACY OF FLORIDA, LP

By: PHARMACY HOLDING #2, LLC

its general partner

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers of the general partner, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Omnicare Pharmacy of Nebraska LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE PHARMACY OF NEBRASKA LLC

By: OMNICARE PHARMACIES OF THE GREAT PLAINS HOLDING COMPANY

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, each of Omnicare Pharmacy of North Carolina, LLC, Omnicare Pharmacy of Pueblo, LLC, Pharmacy Holding #1, LLC and Pharmacy Holding #2, LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE PHARMACY OF NORTH CAROLINA, LLC

OMNICARE PHARMACY OF PUEBLO, LLC

PHARMACY HOLDING #1, LLC

PHARMACY HOLDING #2, LLC

By: APS ACQUISITION LLC

its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

  

President, Manager

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Manager

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Manager

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Omnicare Pharmacy of Tennessee LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE PHARMACY OF TENNESSEE LLC

By: LCPS ACQUISITION, LLC

          its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

   President, Manager   November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

   Treasurer, Manager   November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

   Secretary, Manager   November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, each of Omnicare Pharmacy of Texas 1, LP and Omnicare Pharmacy of Texas 2, LP certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE PHARMACY OF TEXAS 1, LP

OMNICARE PHARMACY OF TEXAS 2, LP

By: PHARMACY HOLDING #2, LLC

        its general partner

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers of the general partner, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

   President, Manager   November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

   Treasurer, Manager   November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

   Secretary, Manager   November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Omnicare Purchasing Company LP certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

OMNICARE PURCHASING COMPANY LP

By: OMNICARE PURCHASING COMPANY GENERAL PARTNER, INC.

          its general partner

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the general partner, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Date

 

Title

/s/ David Hileman

David Hileman

  

President, Director

  November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

  

Treasurer, Director

  November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

  

Secretary, Director

  November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, PP Acquisition Company, LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

PP ACQUISITION COMPANY, LLC

By: ROESCHEN’S HEALTHCARE, LLC

        its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

        its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned managers and officers, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Date

 

Title

/s/ Elizabeth A. Haley

Elizabeth A. Haley

   President, Director   November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

   Treasurer, Director   November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

   Secretary, Director   November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, PSI Arkansas Acquisition, LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

PSI ARKANSAS ACQUISITION, LLC

By: CP ACQUISITION CORP.

          its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

   President, Director   November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

   Treasurer, Director   November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

   Secretary, Director   November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, Three Forks Apothecary, LLC. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

THREE FORKS APOTHECARY, LLC

By: NEIGHBORCARE, INC.

            its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

   President, Director   November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

   Treasurer, Director   November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

   Secretary, Director   November 5, 2014


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, ZS Acquisition Company, LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Cincinnati, State of Ohio, on the 5 th day of November 2014.

ZS ACQUISITION COMPANY, LLC

By: LO-MED PRESCRIPTION SERVICES, LLC

        its sole member

By: NEIGHBORCARE PHARMACY SERVICES, INC.

        its sole member

/s/ Ankur Bhandari            

Ankur Bhandari, Treasurer

We, the undersigned directors and officers of the sole member, do hereby severally constitute and appoint Robert O. Kraft and Alexander M. Kayne, and each of them severally, our true and lawful attorney– in-fact and agent, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorneys-in-fact and agents may deem necessary or advisable to enable said Company to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with the Registration Statement on Form S-3, including specifically, but without limitation, power and authority to sign for us or any of us, in our names in the capacities indicated below, any and all amendments (including pre- and post-effective amendments) hereto and any related registration statement and amendments thereto filed pursuant to Rule 462(b) promulgated under the Securities Act of 1933, and we do each hereby ratify and confirm all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Elizabeth A. Haley

Elizabeth A. Haley

   President, Director   November 5, 2014

/s/ Ankur Bhandari

Ankur Bhandari

   Treasurer, Director   November 5, 2014

/s/ Jonathan D. Kukulski

Jonathan D. Kukulski

   Secretary, Director   November 5, 2014


Table of Contents

EXHIBIT INDEX

 

Exhibit
No.

  

Description

  1.1    Form of Underwriting Agreement.*
  3.1    Restated Certificate of Incorporation of Omnicare, Inc. (as amended) (incorporated herein by reference from Exhibit 3.1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2002).
  3.2    Fourth Amended and Restated By-Laws of Omnicare, Inc. (incorporated herein by reference from Exhibit 3.2 to our Current Report on Form 8-K filed February 22, 2011).
  4.1    Form of Senior Debt Securities Indenture.
  4.2    Subordinated Debt Securities Indenture, dated as of June 13, 2003 between Omnicare, Inc. and U.S. Bank National Association (as successor to SunTrust Bank), as trustee (incorporated herein by reference from Exhibit 4.2(a) to our Current Report on Form 8-K filed June 16, 2003).
  4.3    Form of Senior Debt Securities (included in exhibit 4.1).
  4.4    Form of Subordinated Debt Securities (included in exhibit 4.2).
  4.5    Form of certificate of designation of preferred stock.*
  4.6    Form of Warrant.*
  5.1    Opinion of White & Case LLP.
  5.2    Opinion of Briskin, Cross & Sanford, LLC.
  5.3    Opinion of Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C.
  5.4    Opinion of Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C.
  5.5    Opinion of Bingham Greenebaum Doll LLP.
  5.6    Opinion of Bingham Greenebaum Doll LLP.
  5.7    Opinion of Hancock, Daniel, Johnson & Nagle, P.C.
  5.8    Opinion of Hancock, Daniel, Johnson & Nagle, P.C.
  5.9    Opinion of Hancock, Daniel, Johnson & Nagle, P.C.
  5.10    Opinion of Hancock, Daniel, Johnson & Nagle, P.C.
  5.11    Opinion of Taylor Porter Brooks & Phillips, L.L.P.
  5.12    Opinion of Plunkett Cooney, P.C.
  5.13    Opinion of Carmody MacDonald P.C.
  5.14    Opinion of Shaheen & Gordon, P.A.


Table of Contents

Exhibit
No.

  

Description

  5.15    Opinion of Stradley Ronon Stevens & Young, LLP.
  5.16    Opinion of Stradley Ronon Stevens & Young, LLP.
  5.17    Opinion of McAfee & Taft, A Professional Corporation.
  5.18    Opinion of Davenport, Evans, Hurwitz & Smith, LLP.
  5.19    Opinion of Stoel Rives LLP.
  5.20    Opinion of Davis & Kuelthau, S.C.
12.1    Statement of Computation of Ratio of Earnings to Fixed Charges for the five years ended December 31, 2013 (incorporated herein by reference from Exhibit 12 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2013).
12.2    Statement of Computation of Ratio of Earnings to Fixed Charges for the nine months ended September 30, 2014 (incorporated herein by reference from Exhibit 12 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2014).
23.1    Consent of White & Case LLP (included in its opinion filed as Exhibit 5.1).
23.2    Consent of Briskin, Cross & Sanford, LLC (included in its opinion filed as Exhibit 5.2).
23.3    Consent of Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C. (included in its opinion filed as Exhibit 5.3).
23.4    Consent of Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C. (included in its opinion filed as Exhibit 5.4).
23.5    Consent of Bingham Greenebaum Doll LLP (included in its opinion filed as Exhibit 5.5).
23.6    Consent of Bingham Greenebaum Doll LLP (included in its opinion filed as Exhibit 5.6).
23.7    Consent of Hancock, Daniel, Johnson & Nagle, P.C. (included in its opinion filed as Exhibit 5.7).
23.8    Consent of Hancock, Daniel, Johnson & Nagle, P.C. (included in its opinion filed as Exhibit 5.8).
23.9    Consent of Hancock, Daniel, Johnson & Nagle, P.C. (included in its opinion filed as Exhibit 5.9).
23.10    Consent of Hancock, Daniel, Johnson & Nagle, P.C. (included in its opinion filed as Exhibit 5.10).
23.11    Consent of Taylor Porter Brooks & Phillips, LLP (included in its opinion filed as Exhibit 5.11).
23.12    Consent of Plunkett Cooney, P.C. (included in its opinion filed as Exhibit 5.12).
23.13    Consent of Carmody MacDonald P.C. (included in its opinion filed as Exhibit 5.13).
23.14    Consent of Shaheen & Gordon, P.A. (included in its opinion filed as Exhibit 5.14).
23.15    Consent of Stradley Ronon Stevens & Young, LLP (included in its opinion filed as Exhibit 5.15).
23.16    Consent of Stradley Ronon Stevens & Young, LLP (included in its opinion filed as Exhibit 5.16).


Table of Contents

Exhibit
No.

  

Description

23.17    Consent of McAfee & Taft, A Professional Corporation (included in its opinion filed as Exhibit 5.17).
23.18    Consent of Davenport, Evans, Hurwitz & Smith, LLP (included in its opinion filed as Exhibit 5.18).
23.19    Consent of Stoel Rives LLP (included in its opinion filed as Exhibit 5.19).
23.20    Consent of Davis & Kuelthau, S.C. (included in its opinion filed as Exhibit 5.20).
23.21    Consent of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP).
24.1    Powers of Attorney (included on the signature pages hereto).
25.1    Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Trustee under the Senior Debt Securities Indenture and the Subordinated Debt Securities Indenture.

 

* To be filed, if necessary, with an amendment to the registration statement or as an exhibit to a document incorporated by reference herein.

Exhibit 4.1

 

 

 

OMNICARE, INC.

SENIOR DEBT SECURITIES

 

 

INDENTURE

Dated as of [                      ]

 

 

 

 

U.S. BANK NATIONAL ASSOCIATION

Trustee

 

 

 

 

 


CROSS-REFERENCE TABLE*

 

Trust Indenture Act Section

   Indenture
Section

310(a)(1)

   7.10

(a)(2)

   7.10

(a)(3)

   N.A.

(a)(4)

   N.A.

(a)(5)

   7.10

(b)

   7.10

(c)

   N.A.

311(a)

   7.11

(b)

   7.11

(c)

   N.A.

312(a)

   2.07

(b)

   13.03

(c)

   13.03

313(a)

   7.06

(b)(1)

   7.06

(b)(2)

   7.07

(c)

   7.06; 13.02

(d)

   7.06

314(a)

   4.03; 13.05

(b)

   N.A.

(c)(1)

   13.04

(c)(2)

   13.04

(c)(3)

   N.A.

(d)

   N.A.

(e)

   13.05

(f)

   N.A.

315(a)

   7.01

(b)

   7.05; 13.02

(c)

   7.01

(d)

   7.01

(e)

   6.11

316(a) (last sentence)

   2.11

(a)(1)(A)

   6.05

(a)(1)(B)

   6.04

(a)(2)

   N.A.

(b)

   6.07

(c)

   2.14

317(a)(1)

   6.08

(a)(2)

   6.09

(b)

   2.06

318(a)

   13.01

(b)

   N.A.

(c)

   13.01

N.A. means not applicable.

* This Cross Reference Table is not part of this Indenture.


Table of Contents

 

         Page  
Article I DEFINITIONS AND INCORPORATION BY REFERENCE      1   
Section 1.01  

Definitions.

     1   
Section 1.02  

Other Definitions.

     5   
Section 1.03  

Incorporation by Reference of Trust Indenture Act

     5   
Section 1.04  

Rules of Construction

     6   
Article II THE SECURITIES      6   
Section 2.01  

Form Generally

     6   
Section 2.02  

Securities in Global Form

     6   
Section 2.03  

Title and Terms

     7   
Section 2.04  

Execution, Authentication, Delivery and Dating

     9   
Section 2.05  

Registrar and Paying Agent

     11   
Section 2.06  

Paying Agent to Hold Money in Trust

     11   
Section 2.07  

Holder Lists

     11   
Section 2.08  

Registration, Registration of Transfer and Exchange

     11   
Section 2.09  

Replacement Securities

     13   
Section 2.10  

Outstanding Securities

     13   
Section 2.11  

Treasury Securities

     14   
Section 2.12  

Temporary Securities

     14   
Section 2.13  

Cancellation

     14   
Section 2.14  

Section 2.14 Payment of Interest

     14   
Section 2.15  

Persons Deemed Owners

     15   
Section 2.16  

Computation of Interest

     15   
Section 2.17  

CUSIP Numbers

     15   
Article III REDEMPTION AND PREPAYMENT      15   
Section 3.01  

Right to Redeem; Notices to Trustee

     15   
Section 3.02  

Selection of Securities to Be Redeemed

     16   
Section 3.03  

Notice of Redemption to Holders

     16   
Section 3.04  

Effect of Notice of Redemption

     17   
Section 3.05  

Deposit of Redemption Price

     17   
Section 3.06  

Securities Redeemed in Part

     17   
Article IV COVENANTS      17   
Section 4.01  

Payment of Securities

     17   
Section 4.02  

Maintenance of Office or Agency

     17   
Section 4.03  

Reports

     18   
Section 4.04  

Compliance Certificate

     18   
Article V SUCCESSORS      19   
Section 5.01  

Merger, Consolidation, or Sale of Assets

     19   
Section 5.02  

Successor Corporation Substituted

     19   
Article VI DEFAULTS AND REMEDIES      19   
Section 6.01  

Events of Default

     19   
Section 6.02  

Acceleration

     21   
Section 6.03  

Other Remedies

     21   
Section 6.04  

Waiver of Past Defaults

     21   
Section 6.05  

Control by Majority

     21   
Section 6.06  

Limitation on Suits

     21   


         Page  
Section 6.07  

Rights of Holders of Securities to Receive Payment and Convert

     22   
Section 6.08  

Collection Suit by Trustee

     22   
Section 6.09  

Trustee May File Proofs of Claim

     22   
Section 6.10  

Priorities

     23   
Section 6.11  

Undertaking for Costs

     23   
Article VII TRUSTEE      23   
Section 7.01  

Duties of Trustee

     23   
Section 7.02  

Rights of Trustee

     24   
Section 7.03  

Individual Rights of Trustee

     24   
Section 7.04  

Trustee’s Disclaimer

     25   
Section 7.05  

Notice of Defaults

     25   
Section 7.06  

Reports by Trustee to Holders of the Securities

     25   
Section 7.07  

Compensation and Indemnity

     25   
Section 7.08  

Replacement of Trustee

     26   
Section 7.09  

Successor Trustee by Merger, etc.

     27   
Section 7.10  

Eligibility; Disqualification

     27   
Section 7.11  

Preferential Collection of Claims Against Company

     27   
Article VIII LEGAL DEFEASANCE AND COVENANT DEFEASANCE      27   
Section 8.01  

Option to Effect Legal Defeasance or Covenant Defeasance

     27   
Section 8.02  

Legal Defeasance and Discharge

     27   
Section 8.03  

Covenant Defeasance

     28   
Section 8.04  

Conditions to Legal or Covenant Defeasance

     28   
Section 8.05  

Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions

     29   
Section 8.06  

Repayment to Company

     29   
Section 8.07  

Reinstatement

     29   
Article IX AMENDMENT, SUPPLEMENT AND WAIVER      30   
Section 9.01  

Without Consent of Holders of Securities

     30   
Section 9.02  

With Consent of Holders of Securities

     31   
Section 9.03  

Compliance with Trust Indenture Act

     32   
Section 9.04  

Revocation and Effect of Consents

     32   
Section 9.05  

Notation on or Exchange of Securities

     32   
Section 9.06  

Trustee to Sign Amendments, etc.

     32   
Section 9.07  

Section 9.07 Effect of Supplemental Indentures

     32   
Article X SINKING FUNDS      33   
Section 10.01  

Applicability of Article

     33   
Section 10.02  

Satisfaction of Sinking Fund Payments with Securities

     33   
Section 10.03  

Redemption of Securities for Sinking Fund

     33   
Article XI SECURITY GUARANTEES      33   
Section 11.01  

Applicability of this Article

     33   
Section 11.02  

Guarantee

     34   
Section 11.03  

Limitation on Guarantor Liability

     34   
Section 11.04  

Release of Guarantors

     35   
Article XII SATISFACTION AND DISCHARGE      35   
Section 12.01  

Satisfaction and Discharge

     35   


         Page  
Section 12.02  

Application of Trust Money

     35   
Article XIII MISCELLANEOUS      36   
Section 13.01  

Trust Indenture Act Controls

     36   
Section 13.02  

Notices

     36   
Section 13.03  

Communication by Holders of Securities with Other Holders of Securities

     37   
Section 13.04  

Certificate and Opinion as to Conditions Precedent

     37   
Section 13.05  

Statements Required in Certificate or Opinion

     37   
Section 13.06  

Rules by Trustee and Agents

     38   
Section 13.07  

No Personal Liability of Directors, Officers, Employees and Stockholders

     38   
Section 13.08  

Governing Law

     38   
Section 13.09  

No Adverse Interpretation of Other Agreements

     38   
Section 13.10  

Successors

     38   
Section 13.11  

Severability

     38   
Section 13.12  

Counterpart Originals

     38   
Section 13.13  

Table of Contents, Headings, etc.

     38   


INDENTURE dated as of [                      ] between Omnicare, Inc., a Delaware corporation (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).

The Company has duly authorized the execution and delivery of this Indenture (as defined herein) to provide for the issuance from time to time of its debentures, notes or other evidences of indebtedness (herein called the “Securities”) to be issued in one or more series as provided in this Indenture.

For and in consideration of the premises and purchase of the Securities by the Holders (as defined herein) thereof, it is mutually covenanted and agreed, for the equal and ratable benefit of the Holders of the Securities of each series thereof as follows:

ARTICLE I

DEFINITIONS AND INCORPORATION BY REFERENCE

Section 1.01 Definitions.

“Affiliate” of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For purposes of this definition, “control”, as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise; provided that beneficial ownership of 10% or more of the Voting Stock of a Person shall be deemed to be control. For purposes of this definition, the terms “controlling,” “controlled by” and “under common control with” have correlative meanings.

“Agent” means any Registrar, Paying Agent or co-registrar.

“Bankruptcy Law” means Title 11, U.S. Code or any similar federal or state law for the relief of debtors.

“Bearer Security” means any Security, including any interest coupons appertaining thereto, that does not provide for the identification of the Holder thereof.

“Board of Directors” means the board of directors of the Company (or any duly authorized committee thereof);

“Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification, and delivered to the Trustee.

“Business Day” means any day other than a Legal Holiday.

“Capital Lease Obligation” means, at the time any determination is to be made, the amount of the liability in respect of a capital lease that would at that time be required to be capitalized on a balance sheet in accordance with GAAP.

“Capital Stock” means:

(a) in the case of a corporation, corporate stock;

(b) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock;

(c) in the case of a partnership or limited liability company, partnership or membership interests (whether general or limited); and


(d) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person.

“Company” means Omnicare, Inc., and any and all successors thereto.

“Company Order” means a written order signed in the name of the Company by an Officer and delivered to the Trustee or, with respect to Sections 2.04, 2.08, 2.09, 2.12 and 9.05 any other employee of the Company named in an Officers’ Certificate delivered to the Trustee.

“Corporate Trust Office of the Trustee” shall be at the address of the Trustee specified in Section 13.02 hereof or such other address as to which the Trustee may give notice to the Company.

“Default” means any event that is, or with the passage of time or the giving of notice or both would be, an Event of Default.

“Depositary” means, with respect to the Securities issuable or issued in whole or in part in global form, the Person specified pursuant to Section 2.03(a) hereof as the Depositary with respect to the Securities, and any and all successors thereto appointed as depositary hereunder and having become such pursuant to the applicable provision of this Indenture.

“Discount Security” means any Security which provides for an amount less than the principal amount thereof to be due and payable upon a declaration of acceleration of the maturity thereof pursuant to Section 6.02 hereof.

“Domestic Subsidiary” means any Restricted Subsidiary organized under the laws of the United States or any state of the United States or the District of Columbia.

“Equity Interests” means Capital Stock and all warrants, options or other rights to acquire Capital Stock (but excluding any debt security that is convertible into, or exchangeable for, Capital Stock).

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

“GAAP” means generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession, which are in effect on the date of determination.

“Global Security” or “Global Securities” means any Security or Securities, as the case may be, in the form established pursuant to Section 2.02 evidencing all or a part of a series of Securities issued to the Depositary of such series or its nominee and registered in the name of such Depositary or nominee.

“Government Securities” means direct obligations of, or obligations guaranteed by, the United States of America, and the payment for which the United States pledges its full faith and credit.

“Guarantee” means a guarantee other than by endorsement of negotiable instruments for collection in the ordinary course of business, direct or indirect, in any manner including, without limitation, by way of a pledge of assets or through letters of credit or reimbursement agreements in respect thereof, of all or any part of any Indebtedness.

“Guarantor” means with respect to Securities of any series, any Domestic Subsidiary who has guaranteed the Company’s obligations under this Indenture and with respect to such series of Securities pursuant to Article 11 hereof; provided that upon the release and discharge of any Person from its Security Guarantee in accordance with this Indenture, such Person shall cease to be a Guarantor.


“Hedging Obligations” means, with respect to any specified Person, the obligations of such Person under (a) interest rate swap agreements, interest rate cap agreements and interest rate collar agreements and (b) other agreements or arrangements designed to protect such Person against fluctuations in interest rates or foreign exchange rates.

“Holder” means a Person in whose name a Security is registered. “Indebtedness” means, with respect to any specified Person, any indebtedness of such Person, whether or not contingent:

(a) in respect of borrowed money;

(b) evidenced by bonds, notes, debentures or similar instruments or letters of credit (or reimbursement agreements in respect thereof);

(c) in respect of banker’s acceptances;

(d) representing Capital Lease Obligations;

(e) representing the balance deferred and unpaid of the purchase price of any property; or

(f) representing any Hedging Obligations, if and to the extent any of the preceding items (other than letters of credit and Hedging Obligations) would appear as a liability upon a balance sheet of the specified Person prepared in accordance with GAAP. In addition, the term “Indebtedness” includes all Indebtedness of others secured by a Lien on any asset of the specified Person (whether or not such Indebtedness is assumed by the specified Person) and, to the extent not otherwise included, the Guarantee by the specified Person of any indebtedness of any other Person, in each case limited to the maximum amount of liability of the specified Person with respect to such Lien or Guarantee on the date in question. Notwithstanding anything in the foregoing to the contrary, Indebtedness shall not include trade payables or accrued expenses for property or services incurred in the ordinary course of business. The amount of any Indebtedness issued with original issue discount will be the accreted value of such Indebtedness.

“Indenture” means this Indenture, as amended or supplemented from time to time.

“Interest Payment Date,” when used with respect to any Security, means the Stated Maturity of an installment of interest on such Security.

“Legal Holiday” means a Saturday, a Sunday or a day on which banking institutions in the City of New York or at a place of payment are authorized by law, regulation or executive order to remain closed. If a payment date is a Legal Holiday at a place of payment, payment may be made at that place on the next succeeding day that is not a Legal Holiday, and no interest shall accrue on such payment for the intervening period.

“Lien” means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or other title retention agreement, any lease in the nature thereof, any option or other agreement to sell or give a security interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any jurisdiction.

“Obligations” means any principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities payable under the documentation governing any Indebtedness.


“Officer” means, with respect to any Person, the Chairman of the Board, the Chief Executive Officer, the President, the Chief Operating Officer, the Chief Financial Officer, the Treasurer, any Assistant Treasurer, the Controller, the Secretary or any Vice-President of such Person.

“Officers’ Certificate” means a certificate signed on behalf of the Company or, if applicable, a Guarantor, by two Officers of the Company, one of whom must be the principal executive officer, the principal financial officer, the treasurer or the principal accounting officer of the Company, that meets the requirements of Section 13.05 hereof.

“Opinion of Counsel” means, as to the Company or, if applicable, a Guarantor, an opinion from legal counsel who is reasonably acceptable to the Trustee, that meets the requirements of Section 13.05 hereof. The counsel may be an employee of or counsel to the Company, any Subsidiary of the Company or the Trustee.

“Person” means any individual, corporation, partnership, joint venture, association, joint-stock company, trust, unincorporated organization, limited liability company or government or other entity. “Redemption Date,” when used with respect to any Security to be redeemed, shall mean the date specified for redemption of such Security in accordance with the terms of such Security and this Indenture.

“Redemption Price,” when used with respect to any Security to be redeemed, means the price at which it is to be redeemed pursuant to this Indenture. “Registered Security” means any Security in the form (to the extent applicable thereto) established pursuant to Section 2.01 hereof which is registered on the books of the Registrar.

“Regular Record Date” for the interest payable on any Interest Payment Date on the Registered Securities of any series means the date specified for that purpose as contemplated by Section 2.03(a) hereof. “Representative” means the indenture trustee or other trustee, agent or representative for any Senior Debt.

“Responsible Officer,” when used with respect to the Trustee, means any officer within the Corporate Trust Administration of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because of his knowledge of and familiarity with the particular subject.

“Restricted Subsidiary” means any direct or indirect Subsidiary of the Company other than an Unrestricted Subsidiary.

“SEC” means the Securities and Exchange Commission.

“Securities Act” means the Securities Act of 1933, as amended.

“Security Guarantee” means, with respect to the Securities of any series, the Guarantee with respect to the Securities of such series by each Guarantor pursuant to Article 11 hereof and a supplemental indenture.

“Securities” has the meaning assigned to it in the preamble to this Indenture.

“Significant Subsidiary” means any Subsidiary that would be a “significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such Regulation is in effect on the date hereof.

“Special Record Date” for the payment of any Defaulted Interest on the Registered Securities of any issue means a date fixed by the Trustee pursuant to Section 2.14 hereof.


“Stated Maturity” means, with respect to any installment of interest or principal on any series of Indebtedness, the date on which the payment of interest or principal was scheduled to be paid in the original documentation governing such Indebtedness, and will not include any contingent obligations to repay, redeem or repurchase any such interest or principal prior to the date originally scheduled for the payment thereof.

“Subsidiary” means, (a) any corporation more than 50% of the outstanding securities having ordinary voting power of which shall at the time be owned or controlled, directly or indirectly, by the Company and/or by one or more of its Restricted Subsidiaries, or (b) any partnership, limited liability company, association, joint venture or similar business organization more than 50% of the ownership interests having ordinary voting power of which shall at the time be so owned or controlled.

“TIA” means the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) as in effect on the date on which this Indenture is qualified under the TIA.

“Trustee” means the party named as such above until a successor replaces it in accordance with the applicable provisions of this Indenture and thereafter means the successor serving hereunder.

“Unrestricted Subsidiary” means any Subsidiary of the Company that is designated by the Board of Directors as an Unrestricted Subsidiary pursuant to a Board Resolution, but only to the extent that such Subsidiary:

(a) has no Indebtedness other than Indebtedness that is without recourse to the Company or its Restricted Subsidiaries;

(b) is not party to any agreement, contract, arrangement or understanding with the Company or any Restricted Subsidiary unless the terms of any such agreement, contract, arrangement or understanding are not materially less favorable to the Company or such Restricted Subsidiary than those that might be obtained at the time from Persons who are not Affiliates of the Company;

(c) is a Person with respect to which neither the Company nor any of its Restricted Subsidiaries has any (a) continuing direct or indirect obligation to subscribe for additional Equity Interests or (b) direct or indirect obligation to maintain or preserve such Person’s financial condition or to cause such Person to achieve any specified levels of operating results; and

(d) has not guaranteed or otherwise directly or indirectly provided credit support for any Indebtedness of the Company or any of its Restricted Subsidiaries.

“Voting Stock” of any Person as of any date means the Capital Stock of such Person that is at the time entitled to vote in the election of the Board of Directors of such Person.

Section 1.02 Other Definitions.

 

Term

   Defined
in
Section
 

“Covenant Defeasance”

     8.03   

“Defaulted Interest”

     2.14   

“Event of Default”

     6.01   

“Legal Defeasance”

     8.02   

“Paying Agent”

     2.05   

“Registrar”

     2.05   


Section 1.03 Incorporation by Reference of Trust Indenture Act . Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the following meanings: “indenture securities” means the Securities; “indenture security Holder” means a Holder of a Security; “indenture to be qualified” means this Indenture; “indenture trustee” or “institutional trustee” means the Trustee; and “obligor” on the Securities and the Security Guarantees means the Company and the Guarantors, respectively, and any successor obligor upon the Securities and the Security Guarantees, respectively.

All other terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule under the TIA have the meanings so assigned to them.

Section 1.04 Rules of Construction . Unless the context otherwise requires:

(a) a term has the meaning assigned to it;

(b) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP;

(c) “or” is not exclusive;

(d) words in the singular include the plural, and in the plural include the singular;

(e) provisions apply to successive events and transactions; and

(f) references to sections of or rules under the Securities Act shall be deemed to include substitute, replacement of successor sections or rules adopted by the SEC from time to time.

ARTICLE II

THE SECURITIES

Section 2.01 Form Generally . The Securities of each series shall be substantially in the form of Exhibit A hereto or in such other form as shall be established by delivery to the Trustee of an Officers’ Certificate or in one or more indentures supplemental hereto, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture, and may have such letters, numbers or other marks of identification and such legends or endorsements placed thereon as may be required to comply with the rules of any securities exchange or as may, consistently herewith, be determined by the Officers executing such Securities as evidenced by their execution of the Securities.

The permanent Securities shall be printed, lithographed, engraved or cord processed or produced by any combination of these methods or may be produced in any other manner, provided that such method is permitted by the rules of any securities exchange on which such Securities may be listed, all as determined by the Officers executing such Securities as evidenced by their execution of such Securities.

Section 2.02 Securities in Global Form . If Securities of a series are issuable as a Global Security, as specified as contemplated by Section 2.03(a) hereof, then, notwithstanding clause (9) of Section 2.03(a) hereof and the provisions of Section 2.03(b) hereof, any such Global Security shall represent such of the outstanding Securities of such series as shall be specified therein and may provide that it shall represent the aggregate principal amount of outstanding Securities from time to time endorsed thereon or otherwise notated on the books and records of the Registrar and that the aggregate principal amount of outstanding Securities represented thereby may from time to time be reduced or increased, as appropriate, to reflect exchanges and redemptions. Each Global Security shall bear legends as set forth in


Exhibit A hereto. Any endorsement of a Global Security to reflect the aggregate principal amount of any increase or decrease in the amount of outstanding Securities represented thereby shall be made by the Trustee in such manner and upon instructions given by the Holder thereof as required by Section 2.08 hereof.

Global Securities may be issued in either registered or bearer form and in either temporary or permanent form. Permanent Global Securities will be issued in definitive form.

The provisions of the last sentence of Section 2.04 hereof shall apply to any Security represented by a Global Security if such Security was never issued and sold by the Company, and the Company delivers to the Trustee the Security in global form together with written instructions (which need not comply with Section 13.04 or 13.05 hereof and need not be accompanied by an Opinion of Counsel) with regard to the reduction in the principal amount of Securities represented thereby, together with the written statement contemplated by the last sentence of Section 2.04 hereof.

Notwithstanding the provisions of Sections 2.02 and 2.14 hereof, unless otherwise specified as contemplated by Section 2.03(a) hereof, payment of principal of and any interest on any Global Security shall be made to the person or persons specified therein.

None of the Company, the Guarantor, if any, the Trustee of such series of Securities, any Paying Agent or Registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of a Global Security or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests.

Section 2.03 Title and Terms .

(a) The aggregate principal amount of Securities which may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or more series. There shall be established and, subject to Section 2.04 hereof, set forth, or determined in the manner provided, in an Officers’ Certificate or established in one or more indentures supplemental hereto, prior to the issuances of Securities of any series, any or all of the following, as applicable:

(1) the title and series designation of the Securities of the series (which shall distinguish the Securities of the series from all other Securities);

(2) any limit upon the aggregate principal amount of the Securities of the series which may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of, transfer of, or in exchange for, or in lieu of, other Securities of the series pursuant to Sections 2.08, 2.09, 2.12, 3.06, 9.05 or 10.03 hereof and except for any Securities which, pursuant to Section 2.04 hereof, are deemed never to have been authenticated and delivered hereunder);

(3) the price or prices at which the Securities of the series will be issued;

(4) if the Securities of the series will be guaranteed and the terms of any such Security Guarantees;

(5) the date or dates on which the principal amount and premium, if any, of the Securities of the series is payable;


(6) the interest rate or rates or the method for calculating the interest rate, which may be fixed or variable, of the Securities of the series, the date or dates from which any such interest shall accrue and the Interest Payment Dates on which such interest shall be payable, subject to the right, if any, of the Company to defer or extend an Interest Payment Date and the duration of such deferral or extension;

(7) the place or places where, subject to the provisions of Section 4.02 hereof, the principal of, premium, if any, and interest on Securities of the series will be payable and where any Securities of the series may be surrendered for registration of transfer, Securities of the series may be surrendered for exchange and notices and demands to or upon the Company in respect of the Securities of the series and this Indenture may be served;

(8) the right, if any, to redeem the Securities of the series and the terms and conditions upon which Securities of the series may be redeemed, in whole or in part;

(9) any mandatory or optional sinking fund or analogous provisions;

(10) whether the Securities of the series will be secured and any provisions relating to the security provided;

(11) if and the terms and conditions upon which the Securities of the series may or must be converted into securities of the Company or exchanged for securities of the Company or another enterprise;

(12) if other than the principal amount thereof, the portion of the principal amount of any Securities of the series which shall be payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.02 hereof;

(13) whether the Securities of the series, in whole or any specified part, shall not be defeasible pursuant to Section 8.04 or 8.05 hereof or both such Sections and, if other than by an Officers’ Certificate, the manner in which any election by the Company to defease such Securities shall be evidenced;

(14) any addition to or change in the Events of Default which apply to any Securities of the series and any change in the right of the Trustee or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 6.02 hereof;

(15) if other than U.S. dollars, the currency or currencies in which payment of the principal of, premium, if any, and interest on the Securities of the series shall be payable and whether the Securities of the series may be satisfied and discharged other than as provided in Article 8 hereof;

(16) any terms applicable to Original Issue Discount, if any, (as that term is defined in the Internal Revenue Code of 1986 and the Regulations thereunder) including the rate or rates at which such Original Issue Discount, if any, shall accrue;


(17) if the Securities of the series may be issued or delivered (whether upon original issuance or upon exchange of a temporary Security of such series or otherwise), or any installment of principal of, or any premium or interest is payable, only upon receipt of certain certificates or other documents or satisfaction of other conditions in addition to those specified in this Indenture, the form and terms of such certificates, documents or conditions;

(18) whether the Securities of the series may be represented initially by a Security in temporary or permanent global form and, if so, the Depositary with respect to any such temporary or permanent Global Security, and if other than as provided in Section 2.08 or 2.12 hereof, as applicable, whether and the circumstances under which beneficial owners of interests in any such temporary or permanent Global Security may exchange such interests for Securities of such series and of like tenor of any authorized form and denomination;

(19) whether Securities of the series are to be issued as Registered Securities, Bearer Securities or both, the terms and conditions relating to the applicable form, including, but not limited to, tax compliance, registration and transfer procedures and, if in registered form, the denominations in which any Registered Securities of the series will be issuable if other than denominations of $1,000 and any integral multiple thereof and if in bearer form, the denominations in which any Bearer Securities will be issuable;

(20) any special United States federal income tax considerations applicable to the Securities of the series;

(21) any addition to or change in the covenants set forth in Article 4 which apply to Securities of the series; and

(22) any other terms of the Securities of the series (which terms shall not be inconsistent with the provisions of this Indenture, except as permitted by Section 9.01(i) hereof).

All Securities of any one series shall be substantially identical except as to denomination and the rate or rates of interest, if any, and Stated Maturity, the date from which interest, if any, shall accrue and except as may otherwise be provided in or pursuant to an Officers’ Certificate pursuant to this Section 2.03(a) or in any indenture supplemental hereto.

All Securities of any one series need not be issued at the same time and, unless otherwise provided, a series may be reopened for issuances of additional Securities of such series or for the establishment of additional terms with respect to the Securities of such series.

If any of the terms of the series are established by action taken pursuant to a Board Resolution, a copy of any appropriate record of such action shall be certified by the Secretary or an Assistant Secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officers’ Certificate setting forth the terms of the series.

(b) Unless otherwise provided as contemplated by Section 2.03(a) hereof with respect to any series of Securities, the Securities of such series shall be issuable in denominations of $1,000 or integral multiples thereof.

Section 2.04 Execution, Authentication, Delivery and Dating . Two Officers shall sign the Securities for the Company by manual or facsimile signature. If an Officer whose signature is on a Security no longer holds that office at the time a Security is authenticated, the Security shall nevertheless be valid.


A Security shall not be valid until authenticated by the manual signature of the Trustee . The signature shall be conclusive evidence that the Security has been authenticated under this Indenture.

At any time and from time to time after the execution and delivery of this Indenture (and subject to delivery of an Officers’ Certificate or a supplemental indenture as set forth in Section 2.03(a) hereof with respect to the initial issuance of Securities of any series), the Company may deliver Securities of any series executed by the Company to the Trustee for authentication, together with a Company Order for the authentication and delivery of such Securities; and the Trustee in accordance with such Company Order shall authenticate and deliver such Securities . If the forms or terms of the Securities of the series have been established in or pursuant to one or more Officers’ Certificates as permitted by Sections 2.01 and 2.03(a) hereof, in authenticating such Securities, and accepting the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive, and shall be fully protected in relying upon, an Opinion of Counsel stating:

(a) that the form or forms and terms of such Securities have been duly authorized by the Company and established in conformity with the provisions of this Indenture; and

(b) that such Securities when authenticated and delivered by the Trustee or its authenticating agent and issued by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute legal, valid and binding obligations of the Company, enforceable in accordance with their terms, subject to customary exceptions.

Notwithstanding the provisions of Section 2.03(a) hereof and of the preceding paragraph, if all Securities of a series are not to be originally issued at one time, it shall not be necessary to deliver the Officers’ Certificate otherwise required pursuant to Section 2.03(a) hereof and the Opinion of Counsel required by the preceding paragraph at or prior to the time of authentication of each Security of such series if such documents are delivered at or prior to the authentication upon original issuance of the first Security of such series to be issued.

Each Security shall be dated the date of its authentication.

No Security shall be entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Security a certificate of authentication substantially in the form provided for herein duly executed by the Trustee by manual signature of an authorized signatory, and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder. The Trustee’s certificate of authentication shall be in substantially the following form:

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.

 

[                                           ],

as Trustee

By:
Authorized Officer

Notwithstanding the foregoing, if any Security shall have been duly authenticated and delivered hereunder but never issued and sold by the Company, and the Company shall deliver such Security to the


Trustee for cancellation as provided in Section 2.13 hereof together with a written statement (which need not comply with Section 13.04 or 13.05 hereof and need not be accompanied by an Opinion of Counsel) stating that such Security has never been issued and sold by the Company, for all purposes of this Indenture such Security shall be deemed never to have been authenticated and delivered hereunder and shall never be entitled to the benefits of this Indenture.

Section 2.05 Registrar and Paying Agent . The Company shall maintain, with respect to each series of Securities, an office or agency where such Securities may be presented for registration of transfer or for exchange (“Registrar”) and an office or agency where Securities may be presented for payment (“Paying Agent”). The Registrar shall keep a register of the Securities and of their transfer and exchange . The Company may appoint one or more co-registrars and one or more additional paying agents. The term “Registrar” includes any co-registrar and the term “Paying Agent” includes any additional paying agent. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company shall notify the Trustee in writing of the name and address of any Agent not a party to this Indenture. If the Company fails to appoint or maintain another entity as Registrar or Paying Agent, the Trustee shall act as such. The Company or any of its Subsidiaries may act as Paying Agent or Registrar.

The Company initially appoints the Trustee to act as the Registrar and Paying Agent.

Section 2.06 Paying Agent to Hold Money in Trust . The Company shall require each Paying Agent other than the Trustee to agree in writing that the Paying Agent will hold in trust for the benefit of Holders of Securities of any series or the Trustee all money held by the Paying Agent for the payment of principal, premium, if any, or interest on such series of Securities, and will notify the Trustee of any default by the Company in making any such payment. While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee. The Company at any time may require a Paying Agent to pay all money held by it to the Trustee. Upon payment over to the Trustee, the Paying Agent (if other than the Company or a Subsidiary) shall have no further liability for the money. If the Company or a Subsidiary acts as Paying Agent, it shall segregate and hold in a separate trust fund for the benefit of the Holders all money held by it as Paying Agent. Upon any bankruptcy or reorganization proceedings relating to the Company, the Trustee shall serve as Paying Agent for the Securities.

Section 2.07 Holder Lists . The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of all Holders of each series of Securities and shall otherwise comply with TIA § 312(a). If the Trustee is not the Registrar, the Company shall furnish to the Trustee at least seven Business Days before each interest payment date and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of the Holders of such series of Securities and the Company shall otherwise comply with TIA § 312(a).

Section 2.08 Registration, Registration of Transfer and Exchange . Upon surrender for registration of transfer of any Securities of a series at an office or agency of the Company designated pursuant to Section 4.02 hereof for such purpose, the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the designated transferee or transferees, one or more new Securities of the same series of any authorized denominations, of a like aggregate principal amount. The Company shall not charge a service charge for any registration of transfer or exchange, but the Company may require payment of a sum sufficient to pay all taxes, assessments or other governmental charges that may be imposed in connection with the transfer or exchange of the Securities from the Holder requesting such transfer or exchange (other than any exchange of a temporary Security for a permanent Security not involving any change in ownership or any exchange pursuant to Section 2.12, 3.06, 9.05 or 10.3 hereof, not involving any transfer).


Notwithstanding any other provisions (other than the provisions set forth in the sixth and seventh paragraphs) of this Section 2.08, a Security in global form representing all or a portion of the Securities of a series may not be transferred except as a whole by the Depositary for such series to a nominee of such Depositary or by a nominee of such Depositary to such Depositary or another nominee of such Depositary or by such Depositary or any such nominee to a successor Depositary for such series or a nominee of such successor Depositary.

At the option of the Holder of Securities of any series, Securities of such series may be exchanged for other Securities of the same series of any authorized denomination or denominations of a like aggregate principal amount and tenor, upon surrender of the Securities to be exchanged at such office or agency. Whenever any Securities are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Securities which the Holder making the exchange is entitled to receive.

Unless otherwise specified as contemplated by Section 2.03(a) hereof, if the Securities of any series shall have been issued in the form of one or more Global Securities, such series of Securities in global form will be exchanged for Securities of such series in permanent form if (i) the Depositary for the Securities of such series notifies the Company that it is unwilling or unable to continue as Depositary for the Securities of such series and a successor Depositary for the Securities of such series is not appointed by the Company within 120 days after the Company receives such notice, (ii) the Company in its sole discretion determines that the Securities of such series shall no longer be represented by such Global Security or Securities or (iii) an Event of Default with respect to the Securities of such series shall have occurred and be continuing. In any such event the Company will execute, and the Trustee, upon receipt of a Company Order for the authentication and delivery of permanent Securities of such series, will authenticate and deliver Securities of such series in permanent form and in an aggregate principal amount equal to the principal amount of the Security or Securities in global form representing such series in exchange for such Security or Securities in global form.

Notwithstanding the foregoing, except as otherwise specified in the preceding paragraph or as contemplated by Section 2.03(a) hereof, any Global Security shall be exchangeable only as provided in this paragraph. If the beneficial owners of interests in a Global Security are entitled to exchange such interests for permanent Securities of such series and of like principal amount and tenor but of another authorized form and denomination, as specified as contemplated by Section 2.03(a) hereof, then without unnecessary delay but in any event not later than the earliest date on which such interests may be so exchanged, the Company shall deliver to the Trustee permanent Securities in aggregate principal amount equal to the principal amount of such Global Security, executed by the Company. On or after the earliest date on which such interests may be so exchanged, such Global Security shall be surrendered by the Depositary with respect thereto to the Trustee, as the Company’s agent for such purpose, to be exchanged, in whole or from time to time in part, for permanent Securities without charge and the Trustee shall authenticate and deliver, in exchange for each portion of such Global Security, an equal aggregate principal amount of permanent Securities of the same series of authorized denominations and of like tenor as the portion of such Global Security to be exchanged which shall be in the form of Securities, or any combination thereof, as shall be specified by the beneficial owner thereof; provided, however, that notwithstanding the last paragraph of this Section 2.08 hereof, no such exchanges may occur during a period beginning at the opening of business 15 days before any selection of Securities of that series to be redeemed and ending on the relevant Redemption Date. If a Registered Security is issued in exchange for any portion of a Global Security after the close of business at the office or agency where such exchange occurs on (i) any Regular Record Date and before the opening of business at such office or agency on the relevant Interest Payment Date, or (ii) any Special Record Date and before the opening of business at such office or agency on the related proposed date for payment of Defaulted Interest (as defined herein), interest or Defaulted Interest, as the case may be, will not be payable on such Interest Payment Date or proposed date for payment, as the case may be, in respect of such Security, but will be payable on such


Interest Payment Date or proposed date for payment, as the case may be, only to the Person to whom interest in respect of such portion of such Global Security is payable in accordance with the provisions of this Indenture.

Upon the exchange of a Security in global form for Securities in permanent form, such Security in global form shall be cancelled by the Trustee. All cancelled Securities held by the Trustee shall be destroyed by the Trustee and a certificate of their destruction delivered to the Company unless the Company directs, by Company Order, that the Trustee shall cancel Securities and deliver a certificate of destruction to the Company. Securities issued in exchange for a Security in global form pursuant to this Section 2.08 hereof shall be registered in such names and in such authorized denominations as the Depositary for such Security in global form, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee in writing. The Trustee shall deliver such Securities as instructed in writing by the Depositary.

All Securities issued upon any registration of transfer or exchange of Securities shall be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered upon such registration of transfer or exchange.

Every Security presented or surrendered for registration of transfer or for exchange shall be duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Registrar duly executed, by the Holder thereof or his attorney duly authorized in writing.

The Company shall not be required (i) to issue, register the transfer of or exchange any Securities of any series during a period beginning at the opening of 15 Business Days before any selection of Securities of such series to be redeemed and ending at the close of business on the day of the mailing of the relevant notice of redemption or (ii) to register the transfer of or exchange any Security of any series so selected for redemption, in whole or in part, except the unredeemed portion of any Security being redeemed in part.

Section 2.09 Replacement Securities . If (a) any mutilated Security is surrendered to the Trustee, or (b) the Company and the Trustee receive evidence to their satisfaction of the destruction, loss or theft of any Security, the Company shall issue and the Trustee, upon receipt of a Company Order, shall authenticate and deliver a replacement Security of like tenor and principal amount, bearing a number not contemporaneously outstanding, if the Trustee’s requirements are met. If required by the Trustee or the Company, an indemnity bond must be supplied by the Holder that is sufficient in the judgment of the Trustee and the Company to protect the Company, the Trustee, any Agent and any authenticating agent from any loss that any of them may suffer if a Security is replaced. The Company may charge for its expenses in replacing a Security.

Every replacement Security is an additional obligation of the Company and shall be entitled to all of the benefits of this Indenture equally and proportionately with all other Securities duly issued hereunder.

The provisions of this Section are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities or coupons.

Section 2.10 Outstanding Securities . The Securities of any series outstanding at any time are all the Securities of such series authenticated by the Trustee except for those canceled by it, those delivered to it for cancellation, those reductions in the interest in a Global Security effected by the Trustee in accordance with the provisions hereof, and those described in this Section as not outstanding. Except as set forth in Section 2.11 hereof, a Security does not cease to be outstanding because the Company or an Affiliate of the Company holds the Security. Subject to the foregoing, only Securities outstanding at the


time of such determination shall be considered in any such determination (including, without limitation, determinations pursuant to Articles 6 and 9 hereof). In addition, in determining whether the Holders of the requisite principal amount of outstanding Securities have given or concurred in any request, demand, authorization, direction, notice, consent or waiver hereunder, (i) the principal amount of a Discount Security that shall be deemed to be outstanding shall be the amount of the principal thereof that would be due and payable as of the date of such determination upon acceleration of the maturity thereof pursuant to Section 6.02 hereof and (ii) the principal amount of a Security denominated in a foreign currency or currencies shall be the dollar equivalent, as determined on the date of original issuance of such Security, of the principal amount (or, in the case of a Discount Security, the dollar equivalent on the date of original issuance of such Security of the amount determined as provided in (i) above) of such Security.

If a Security is replaced pursuant to Section 2.09 hereof, it ceases to be outstanding unless the Trustee receives proof satisfactory to it that the replaced Security is held by a bona fide purchaser.

If the principal amount of any Security is considered paid under Section 4.01 hereof, it ceases to be outstanding and interest on it ceases to accrue.

If the Paying Agent (other than the Company, a Subsidiary or an Affiliate of any thereof) holds, on a redemption date or maturity date, money sufficient to pay Securities payable on that date, then on and after that date such Securities shall be deemed to be no longer outstanding and shall cease to accrue interest.

Section 2.11 Treasury Securities . In determining whether the Holders of the required principal amount of Securities of any series have concurred in any direction, waiver or consent, Securities of such series owned by the Company, or by any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company, shall be considered as though not outstanding, except that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Securities of that series that the Trustee knows are so owned shall be so disregarded.

Section 2.12 Temporary Securities . Until certificates representing Securities of any series are ready for delivery, the Company may prepare and the Trustee, upon receipt of a Company Order, shall authenticate temporary Securities. Temporary Securities shall be substantially in the form of certificated Securities but may have variations that the Company considers appropriate for temporary Securities and as shall be reasonably acceptable to the Trustee. Without unreasonable delay, the Company shall prepare and the Trustee shall authenticate definitive Securities of the same series in exchange for temporary Securities. Holders of temporary Securities of any series shall be entitled to all of the benefits of this Indenture as permanent Securities of the same series.

Section 2.13 Cancellation . The Company at any time may deliver Securities to the Trustee for cancellation. The Registrar and Paying Agent shall forward to the Trustee any Securities surrendered to them for registration of transfer, exchange or payment. The Trustee and no one else shall cancel all Securities surrendered for registration of transfer, exchange, payment, replacement or cancellation and shall destroy canceled Securities (subject to the record retention requirement of the Exchange Act). Certification of the destruction of all canceled Securities shall be delivered to the Company. The Company may not issue new Securities to replace Securities that it has paid or that have been delivered to the Trustee for cancellation.

Section 2.14 Payment of Interest . Unless otherwise provided as contemplated by Section 2.03(a) hereof with respect to any series of Securities, interest on any Security which is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the person in whose name that Security (or one or more predecessor Securities) is registered at the close of business on the Regular Record Date for such interest.


If the Company defaults in a payment of interest on the Securities of any series which is payable (“Defaulted Interest”), it shall pay the Defaulted Interest in any lawful manner plus, to the extent lawful, interest payable on the Defaulted Interest, to the Persons who are Holders of the series on a subsequent Special Record Date, in each case at the rate provided in the Securities of that series and in Section 4.01 hereof. The Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each Securities of a series and the date of the proposed payment. The Company shall fix or cause to be fixed each such Special Record Date and payment date, provided that no such Special Record Date shall be less than 10 days prior to the related payment date for such Defaulted Interest. At least 15 days before the Special Record Date, the Company (or, upon the written request of the Company, the Trustee in the name and at the expense of the Company) shall mail or cause to be mailed to Holders of the series a notice that states the Special Record Date, the related payment date and the amount of such interest to be paid.

Subject to the foregoing provisions of this Section 2.14 and Section 2.08 hereof, each Security delivered under this Indenture upon registration of transfer of or in exchange for or in lieu of any other Security shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Security.

Section 2.15 Persons Deemed Owners . Prior to due presentment of a Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the person in whose name such Security is registered as the owner of such Security for the purpose of receiving payment of principal of and (except as otherwise specified as contemplated by Section 2.03(a) hereof and subject to Sections 2.08 and 2.14 hereof) interest on such Security and for all other purposes whatsoever, whether or not such Security be overdue, and neither the Company, the Trustee nor any agent of the Company or the Trustee shall be affected by notice to the contrary.

None of the Company, the Trustee, any Paying Agent or the Registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of a Security in global form or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests.

Section 2.16 Computation of Interest . Except as otherwise specified as contemplated by Section 2.03(a) hereof for Securities of any series, (i) interest on any Securities which bear interest at a fixed rate shall be computed on the basis of a 360-day year comprised of twelve 30-day months and (ii) interest on any Securities which bear interest at a variable rate shall be computed on the basis of the actual number of days in an interest period divided by 360.

Section 2.17 CUSIP Numbers . The Company, in issuing the Securities, may use “CUSIP” numbers (if then generally in use) and, if so, the Trustee shall use “CUSIP” numbers in notices of redemption as a convenience to Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities of a series or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Securities of such series, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company will promptly notify the Trustee of any change in the “CUSIP” numbers.

ARTICLE III

REDEMPTION AND PREPAYMENT

Section 3.01 Right to Redeem; Notices to Trustee . Securities of any series which are redeemable before their Stated Maturity shall be redeemable in accordance with their terms and (except as otherwise specified as contemplated by Section 2.03(a) hereof for Securities of any series) in accordance


with this Article 3. If the Company elects to redeem Securities of any series, it shall furnish to the Trustee, at least 35 days (or such shorter period as may be acceptable to the Trustee) but not more than 75 days before a redemption date, an Officers’ Certificate setting forth (i) the clause of this Indenture pursuant to which the redemption shall occur, (ii) the Redemption Date, (iii) the principal amount of Securities of such series to be redeemed, (iv) any other information necessary to identify the Securities of such series to be redeemed and (v) the Redemption Price.

Section 3.02 Selection of Securities to Be Redeemed . Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, if less than all of the Securities of a series are to be redeemed or purchased in an offer to purchase at any time, the Trustee will select the Securities to be redeemed or purchased among the Holders of the Securities of that Series in compliance with the requirements of the principal national securities exchange, if any, on which the Securities are listed or, if the Securities are not so listed, on a pro rata basis, by lot or in accordance with any other method the Trustee considers fair and appropriate. In the event of partial redemption by lot, the particular Securities to be redeemed shall be selected, unless otherwise provided herein, not less than 30 nor more than 60 days prior to the Redemption Date by the Trustee from the outstanding Securities not previously called for redemption.

The Trustee shall promptly notify the Company in writing of the Securities selected for redemption and, in the case of any Security selected for partial redemption, the principal amount thereof to be redeemed. Unless otherwise specified as contemplated by Section 2.03(a) hereof, Securities and portions of Securities selected will be in amounts of $1,000 or whole multiples of $1,000. Except as provided in the preceding sentence, provisions of this Indenture that apply to Securities called for redemption also apply to portions of Securities called for redemption.

Section 3.03 Notice of Redemption to Holders . Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, at least 30 days but not more than 60 days before a Redemption Date, the Company shall mail or cause to be mailed, by first class mail, a notice of redemption to each Holder whose Securities are to be redeemed at its registered address.

The notice shall identify the Securities to be redeemed and shall state:

(a) the Redemption Date;

(b) the Redemption Price;

(c) if less than all the outstanding Securities of any series are to be redeemed, the identification (and in the case of partial redemption, the principal amount) of the particular Security to be redeemed;

(d) that, after the Redemption Date upon surrender of such Security, a new Security or Securities in principal amount equal to the unredeemed portion shall be issued upon cancellation of the original Security;

(e) the name and address of the Paying Agent;

(f) that Securities called for redemption must be surrendered to the Paying Agent to collect the Redemption Price;

(g) that, unless the Company defaults in making such redemption payment, interest, if any, on Securities called for redemption ceases to accrue on and after the Redemption Date;

(h) the paragraph of the Securities and/or Section of this Indenture pursuant to which the Securities called for redemption are being redeemed;


(i) that the redemption is for a sinking fund, if such is the case; and

(j) that no representation is made as to the correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the Securities.

At the Company’s request, the Trustee shall give the notice of redemption in the Company’s name and at its expense; provided, however, that the Company shall have delivered to the Trustee, at least 5 Business Days prior to the date chosen for giving such notice to the Holders (or such shorter period as may be acceptable to the Trustee), an Officers’ Certificate requesting that the Trustee give such notice and setting forth the information to be stated in such notice as provided in the preceding paragraph.

Notwithstanding the foregoing, a redemption notice may be mailed more than 60 days prior to the Redemption Date if the notice is issued in connection with a defeasance of the Securities or satisfaction and discharge of this Indenture.

Section 3.04 Effect of Notice of Redemption . Once notice of redemption is mailed in accordance with Section 3.03 hereof, Securities called for redemption become irrevocably due and payable on the Redemption Date at the Redemption Price. A notice of redemption may not be conditional.

Section 3.05 Deposit of Redemption Price . Prior to 12:00 noon (Eastern Standard Time) on the Redemption Date, the Company shall deposit with the Trustee or with the Paying Agent money sufficient to pay the Redemption Price of and accrued interest on all Securities of a series to be redeemed on that date. The Trustee or the Paying Agent shall promptly return to the Company any money deposited with the Trustee or the Paying Agent by the Company in excess of the amounts necessary to pay the Redemption Price of, and accrued interest on, all Securities to be redeemed.

If the Company complies with the provisions of the preceding paragraph, on and after the Redemption Date, interest shall cease to accrue on the Securities or the portions of Securities called for redemption. If a Security is redeemed on or after a Regular Record Date but on or prior to the related Interest Payment Date, then any accrued and unpaid interest shall be paid to the Person in whose name such Security was registered at the close of business on such Regular Record Date. If any Security called for redemption shall not be so paid upon surrender for redemption because of the failure of the Company to comply with the preceding paragraph, interest shall be paid on the unpaid principal from the Redemption Date until such principal is paid, and to the extent lawful on any interest not paid on such unpaid principal, in each case at the rate provided in the Securities and in Section 4.01 hereof.

Section 3.06 Securities Redeemed in Part . Upon surrender of a Security that is redeemed in part, the Company shall issue and, upon the Company’s written request, the Trustee shall authenticate for the Holder at the expense of the Company a new Security equal in principal amount to the unredeemed portion of the Security surrendered.

ARTICLE IV

COVENANTS

Section 4.01 Payment of Securities . The Company shall pay or cause to be paid the principal of, premium, if any, and interest on the Securities on the dates and in the manner provided in the Securities. Principal, premium, if any, and interest shall be considered paid on the date due if the Paying Agent, if other than the Company or a Subsidiary thereof, holds as of 10:00 a.m. Eastern Standard Time on the due date money deposited by the Company in immediately available funds and designated for and sufficient to pay all principal, premium, if any, and interest then due.

Section 4.02 Maintenance of Office or Agency . The Company shall maintain in each place of payment for any series of Securities an office or agency (which may be an office of the Trustee or an


affiliate of the Trustee, Registrar or co-registrar) where Securities of a series may be surrendered for registration of transfer or for exchange and where notices and demands to or upon the Company in respect of the Securities of such series and this Indenture may be served. The Company shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee. The Company also may from time to time designate one or more other offices or agencies where the Securities of a series may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in each place of payment for Securities of any series for such purposes. The Company shall give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency.

With respect to any Global Security, and except as otherwise may be specified for such Global Security as contemplated by Section 2.03(a) hereof, the Corporate Trust Office for the Trustee shall be the place of payment where such Global Security may be presented or surrendered for payment or for registration of transfer or exchange, or where successor Securities may be delivered in exchange therefore, provided, however, that any such payment, presentation, surrender or delivery effected pursuant to the procedures of the Depositary for such Global Security shall be deemed to have been effected at the place of payment for such Global Security in accordance with the provisions of this Indenture.

The Company hereby designates the Corporate Trust Office of the Trustee as one such office or agency of the Company in accordance with Section 2.04 hereof.

Section 4.03 Reports . Whether or not required by the rules and regulations of the SEC, so long as any Securities of any series are outstanding, the Company shall furnish to the Holders of such series of Securities (i) all quarterly and annual financial information that would be required to be contained in a filing with the SEC on Forms 10-Q and 10-K if the Company were required to file such forms, including a “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and, with respect to the annual information only, a report thereon by the Company’s certified independent accountants and (ii) all current reports that would be required to be filed with the SEC on Form 8-K if the Company were required to file such reports, in each case, within the time periods specified in the SEC’s rules and regulations. In addition, whether or not required by the rules and regulations of the SEC, the Company shall file a copy of all such information and reports with the SEC for public availability within the time periods specified in the SEC’s rules and regulations (unless the SEC will not accept such a filing) and make such information available to securities analysts and prospective investors upon request. The Company shall at all times comply with TIA § 314(a).

Section 4.04 Compliance Certificate .

(a) The Company and each Guarantor, if any, (to the extent that such Guarantor is so required under the TIA) shall deliver to the Trustee, within 120 days after the end of each fiscal year, an Officers’ Certificate stating that a review of the activities of the Company and its Subsidiaries during the preceding fiscal year has been made under the supervision of the signing Officers with a view to determining whether the Company has kept, observed, performed and fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his or her knowledge the Company has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not in default in the performance or observance of any of the terms, provisions and conditions of this Indenture (or, if a Default or Event of Default shall have occurred, describing all such Defaults or Events of Default of which he or she may have knowledge and what action the Company is taking or proposes to take with respect thereto) and that to the best of his or her knowledge no event has


occurred and remains in existence by reason of which payments on account of the principal of or interest, if any, on the Securities is prohibited or if such event has occurred, a description of the event and what action the Company is taking or proposes to take with respect thereto.

ARTICLE V

SUCCESSORS

Section 5.01 Merger, Consolidation, or Sale of Assets . Unless otherwise specified as contemplated by Section 2.03(a) hereof, the Company shall not, directly or indirectly: (1) consolidate or merge with or into another Person (whether or not the Company is the surviving corporation); or (2) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the Company and its Restricted Subsidiaries taken as a whole, in one or more related transactions, to another Person; unless:

(a) either: (i) the Company is the surviving corporation; or (ii) the Person formed by or surviving any such consolidation or merger (if other than the Company) or to which such sale, assignment, transfer, conveyance or other disposition has been made is a corporation organized or existing under the laws of the United States, any state of the United States or the District of Columbia; or

(b) the Person formed by or surviving any such consolidation or merger (if other than the Company) or the Person to which such sale, assignment, transfer, conveyance or other disposition has been made assumes all the obligations of the Company under the Securities and this Indenture pursuant to a supplemental indenture reasonably satisfactory to the Trustee.

In addition, the Company may not, directly or indirectly, lease all or substantially all of the properties or assets of the Company and its Restricted Subsidiaries, taken as a whole, in one or more related transactions, to any other Person. This Section 5.01 will not apply to a sale, assignment, transfer, conveyance or other disposition of assets between or among the Company and any of the Guarantors, as applicable.

Section 5.02 Successor Corporation Substituted . Upon any consolidation or merger, or any sale, assignment, transfer, conveyance, transfer or other disposition of all or substantially all of the properties or assets of the Company and its Restricted Subsidiaries, taken as a whole in accordance with the provisions of Section 5.01 hereof, the successor Person formed by such consolidation or into which the Company is merged or to which such sale, assignment, transfer, conveyance or other disposition is made, shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor had been named as the Company therein. When a successor assumes all the obligations of its predecessor under this Indenture and the Securities following a consolidation or merger, or any sale, assignment, transfer, conveyance, transfer or other disposition of 90% or more of the assets of the predecessor in accordance with the foregoing provisions, the predecessor shall be released from those obligations.


ARTICLE VI

DEFAULTS AND REMEDIES

Section 6.01 Events of Default . Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, an “Event of Default” occurs, with respect to each series of Securities individually, if:

(a) the Company defaults in the payment when due of interest on the Securities of such series and such default continues for a period of 30 days;

(b) the Company defaults in the payment when due of principal of or premium, if any, on the Securities of such series when the same becomes due and payable at maturity, upon redemption or otherwise;

(c) the Company fails to comply with any of the provisions of Section 5.01 hereof if applicable to such series of Securities;

(d) the Company fails to observe or perform any other covenant or other agreement in this Indenture applicable to such series of Securities or the Securities of such series for 60 days after notice to the Company by the Trustee or the Holders of at least 25% in aggregate principal amount of the Securities of such series then outstanding voting as a single class;

(e) the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary pursuant to or within the meaning of Bankruptcy Law:

(i) commences a voluntary case,

(ii) consents to the entry of an order for relief against it in an involuntary case,

(iii) consents to the appointment of a custodian of it or for all or substantially all of its property,

(iv) makes a general assignment for the benefit of its creditors, or

(v) generally is not paying its debts as they become due;

(f) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:

(i) is for relief against the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary in an involuntary case;

(ii) appoints a custodian of the Company or any of its Restricted Subsidiaries or for all or substantially all of the property of the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary; or

(iii) orders the liquidation of the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary;

and the order or decree remains unstayed and in effect for 60 consecutive days;

(g) except as permitted by this Indenture, any Security Guarantee relating to such series of Securities is held in any final, non-appealable judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor relating to such series of Securities, or any Person acting on behalf of any such Guarantor, shall deny or disaffirm its obligations under such Guarantor’s Security Guarantee (unless such Guarantor could be released from its Guarantee in accordance with this Indenture and as specified pursuant to Section 2.03(a) hereof); or


(h) any other Event of Default provided with respect to the Securities of that series, which is specified in a supplemental indenture hereto or an Officers’ Certificate, in accordance with Section 2.03(a) hereof.

Section 6.02 Acceleration . If any Event of Default (other than an Event of Default specified in clause (e) or (f) of Section 6.01 hereof with respect to the Company) occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the then outstanding Securities of that series may declare all the Securities of that series to be due and payable immediately. Upon any such declaration, the Securities of that series shall become due and payable immediately. Notwithstanding the foregoing, if an Event of Default specified in clause (e) or (f) of Section 6.01 hereof occurs with respect to the Company, all outstanding Securities of that series shall be due and payable immediately without further action or notice. The Holders of a majority in aggregate principal amount of the then outstanding Securities of a series by written notice to the Trustee may on behalf of all of the Holders of such series of Securities rescind an acceleration and its consequences if all existing Events of Default (except nonpayment of principal, interest or premium that has become due solely because of the acceleration) have been cured or waived.

Section 6.03 Other Remedies . If an Event of Default with respect to a series of Securities occurs and is continuing, the Trustee may pursue any available remedy to collect the payment of principal, premium, if any, and interest on the Securities of such series or to enforce the performance of any provision of the Securities of such series or this Indenture.

The Trustee may maintain a proceeding even if it does not possess any of the Securities of a series or does not produce any of them in the proceeding. A delay or omission by the Trustee or any Holder of a Security of such series in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. All remedies are cumulative to the extent permitted by law.

Section 6.04 Waiver of Past Defaults . Holders of not less than a majority in aggregate principal amount of the then outstanding Securities of a series by notice to the Trustee may on behalf of the Holders of all of the Securities of such series waive an existing Default or Event of Default and its consequences hereunder, except a continuing Default or Event of Default in the payment of the principal of, premium, if any, or interest on, the Securities of that series (including in connection with an offer to purchase) (provided, however, that the Holders of a majority in aggregate principal amount of the then outstanding Securities of a series may rescind an acceleration and its consequences, including any related payment default that resulted from such acceleration). Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other Default or impair any right consequent thereon.

Section 6.05 Control by Majority . Holders of a majority in principal amount of the then outstanding Securities of any series may direct the time, method and place of conducting any proceeding for exercising any remedy available to the Trustee or exercising any trust or power conferred on it. However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture that the Trustee determines may be unduly prejudicial to the rights of other Holders of such Securities or that may involve the Trustee in personal liability.

Section 6.06 Limitation on Suits . A Holder of any Security of any series may pursue a remedy with respect to this Indenture or such series of Securities only if:

(a) the Holder of a Security of such series gives to the Trustee written notice of a continuing Event of Default;


(b) the Holders of at least 25% in principal amount of the then outstanding Securities of such series make a written request to the Trustee to pursue the remedy;

(c) the Holder of a Security of such series or Holders of Securities of such series offer and, if requested, provide to the Trustee indemnity satisfactory to the Trustee against any loss, liability or expense;

(d) the Trustee does not comply with the request within 60 days after receipt of the request and the offer and, if requested, the provision of indemnity; and

(e) during such 60-day period the Holders of a majority in principal amount of the then outstanding Securities of such series do not give the Trustee a direction inconsistent with the request.

A Holder of any Security may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over another Holder.

Section 6.07 Rights of Holders of Securities to Receive Payment and Convert . Notwithstanding any other provision of this Indenture, the Holder of any Security shall have the right to receive payment of principal of, premium, if any, and interest on such Security, on or after the respective due dates expressed in such Security (including in connection with an offer to purchase), or to bring suit for the enforcement of any such payment on or after such respective dates shall not be impaired or affected without the consent of such Holder.

Section 6.08 Collection Suit by Trustee . If an Event of Default specified in Section 6.01(a) or (b) hereof occurs and is continuing, the Trustee is authorized to recover judgment in its own name and as trustee of an express trust against the Company for the whole amount of principal of, premium, if any, and interest remaining unpaid on the Securities of any series and interest on overdue principal and, to the extent lawful, interest and such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel.

Section 6.09 Trustee May File Proofs of Claim . The Trustee is authorized to file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders of the Securities of any series allowed in any judicial proceedings relative to the Company (or any other obligor upon the Securities of that series), its creditors or its property and shall be entitled and empowered to collect, receive and distribute any money or other property payable or deliverable on any such claims and any custodian in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee, and in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07 hereof. To the extent that the payment of any such compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07 hereof out of the estate in any such proceeding, shall be denied for any reason, payment of the same shall be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other properties that the Holders may be entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise. Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding.


Section 6.10 Priorities . If the Trustee collects any money pursuant to this Article 6, it shall pay out the money in the following order:

First: to the Trustee, its agents and attorneys for amounts due under Section 7.07 hereof, including payment of all compensation, expense and liabilities incurred, and all advances made, by the Trustee and the costs and expenses of collection;

Second: to Holders of Securities for amounts due and unpaid on the Securities of any series for principal, premium, if any, and interest, ratably, without preference or priority of any kind, according to the amounts due and payable on the Securities of that series for principal, premium, if any and interest, respectively; and

Third: to the Company or to such party as a court of competent jurisdiction shall direct.

The Trustee may fix a record date and payment date for any payment to Holders of Securities pursuant to this Section 6.10.

Section 6.11 Undertaking for Costs . In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as a Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’ fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit by the Trustee, a suit by a Holder of a Security of any series pursuant to Section 6.07 hereof, or a suit by Holders of more than 10% in principal amount of the then outstanding Securities of any series.

ARTICLE VII

TRUSTEE

Section 7.01 Duties of Trustee .

(a) If an Event of Default with respect to the Securities of any series has occurred and is continuing, the Trustee shall exercise such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs.

(b) With respect to the Securities of any series, except during the continuance of an Event of Default with respect to Securities of such series:

(i) the duties of the Trustee shall be determined solely by the express provisions of this Indenture and the Trustee need perform only those duties that are specifically set forth in this Indenture and no others, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and

(ii) in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture. However, the Trustee shall examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture.

(c) The Trustee may not be relieved from liabilities for its own negligent action, its own negligent failure to act, or its own willful misconduct, except that:


(i) this paragraph does not limit the effect of paragraph (b) of this Section 7.01;

(ii) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; and

(iii) the Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05 hereof.

(d) Whether or not therein expressly so provided, every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b), and (c) of this Section 7.01.

(e) No provision of this Indenture shall require the Trustee to expend or risk its own funds or incur any liability. The Trustee shall be under no obligation to exercise any of its rights and powers under this Indenture at the request of any Holders, unless such Holder shall have offered to the Trustee security and indemnity satisfactory to it against any loss, liability or expense.

(f) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law.

Section 7.02 Rights of Trustee .

(a) The Trustee may conclusively rely upon any document believed by it to be genuine and to have been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document.

(b) Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel or both. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers’ Certificate or Opinion of Counsel. The Trustee may consult with counsel and the written advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection from liability in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon.

(c) The Trustee may act through its attorneys and agents and shall not be responsible for the misconduct or negligence of any agent appointed with due care.

(d) The Trustee shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within the rights or powers conferred upon it by this Indenture.

(e) Unless otherwise specifically provided in this Indenture, any demand, request, direction or notice from the Company or any Guarantor, if applicable, shall be sufficient if signed by an Officer of the Company or Guarantor, as applicable.

(f) The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or direction of any of the Holders unless such Holders shall have offered to the Trustee reasonable security or indemnity against the costs, expenses and liabilities that might be incurred by it in compliance with such request or direction.

Section 7.03 Individual Rights of Trustee . The Trustee in its individual or any other capacity may become the owner or pledgee of Securities and may otherwise deal with the Company or any Affiliate of the Company with the same rights it would have if it were not Trustee. However, in the


event that the Trustee acquires any conflicting interest, it must eliminate such conflict within 90 days, apply to the SEC for permission to continue as Trustee or resign. Any Agent may do the same with like rights and duties. The Trustee is also subject to Sections 7.10 and 7.11 hereof.

Section 7.04 Trustee’s Disclaimer . The Trustee shall not be responsible for and makes no representation as to the validity or adequacy of this Indenture or the Securities, it shall not be accountable for the Company’s use of the proceeds from the Securities or any money paid to the Company or upon the Company’s direction under any provision of this Indenture, it shall not be responsible for the use or application of any money received by any Paying Agent other than the Trustee, and it shall not be responsible for any statement or recital herein or any statement in the Securities or any other document in connection with the sale of the Securities or pursuant to this Indenture other than its certificate of authentication.

Section 7.05 Notice of Defaults . If a Default or Event of Default occurs and is continuing with respect to a series of Securities and if it is known to the Trustee, the Trustee shall mail to Holders of Securities of such series a notice of the Default or Event of Default within 90 days after it occurs. Except in the case of a Default or Event of Default in payment of principal of, premium, if any, or interest on any Security, the Trustee may withhold the notice if and so long as a committee of its Responsible Officers in good faith determines that withholding the notice is in the interests of the Holders of the Securities.

Section 7.06 Reports by Trustee to Holders of the Securities . Within 60 days after each                      beginning with the                      following the date of this Indenture, and for so long as Securities of any series remain outstanding, the Trustee shall mail to the Holders of the Securities of such series a brief report dated as of such reporting date that complies with TIA § 313(a) (but if no event described in TIA § 313(a) has occurred within the twelve months preceding the reporting date, no report need be transmitted). The Trustee also shall comply with TIA § 313(b)(2). The Trustee also shall transmit by mail all reports as required by TIA § 313(c).

A copy of each report at the time of its mailing to the Holders of Securities shall be mailed to the Company and filed with the SEC and each stock exchange on which the Securities are listed in accordance with TIA § 313(d). The Company shall promptly notify the Trustee when the Securities are listed on any stock exchange.

Section 7.07 Compensation and Indemnity . The Company shall pay to the Trustee from time to time reasonable compensation for its acceptance of this Indenture and services hereunder. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust.

The Company shall reimburse the Trustee promptly upon request for all reasonable disbursements, advances and expenses incurred or made by it in addition to the compensation for its services. Such expenses shall include the reasonable compensation, disbursements and expenses of the Trustee’s agents and counsel.

The Company shall indemnify the Trustee against any and all losses, liabilities or expenses incurred by it arising out of or in connection with the acceptance or administration of its duties under this Indenture, including the costs and expenses of enforcing this Indenture against the Company (including this Section 7.07) and defending itself against any claim (whether asserted by the Company or any Holder or any other person) or liability in connection with the exercise or performance of any of its powers or duties hereunder, except to the extent any such loss, liability or expense may be attributable to its negligence or bad faith. The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have separate counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld.


The obligations of the Company under this Section 7.07 shall survive the satisfaction and discharge of this Indenture.

To secure the Company’s payment obligations in this Section 7.07, the Trustee shall have a Lien prior to the Securities on all money or property held or collected by the Trustee, except that held in trust to pay principal and interest on particular Securities. Such Lien shall survive the satisfaction and discharge of this Indenture.

When the Trustee incurs expenses or renders services after an Event of Default specified in Section 6.01(e) or (f) hereof occurs, the expenses and the compensation for the services (including the fees and expenses of its agents and counsel) are intended to constitute expenses of administration under any Bankruptcy Law.

The Trustee shall comply with the provisions of TIA § 313(b)(2) to the extent applicable.

Section 7.08 Replacement of Trustee . A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee’s acceptance of appointment as provided in this Section 7.08.

The Trustee may resign in writing at any time and be discharged from the trust hereby created by so notifying the Company. The Holders of a majority in principal amount of the then outstanding Securities of any series may remove the Trustee by so notifying the Trustee and the Company in writing. The Company may remove the Trustee if:

(a) the Trustee fails to comply with Section 7.10 hereof;

(b) the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law;

(c) a custodian or public officer takes charge of the Trustee or its property; or

(d) the Trustee becomes incapable of acting.

If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a successor Trustee. Within one year after the successor Trustee takes office, the Holders of a majority in principal amount of the then outstanding Securities of any series may appoint a successor Trustee to replace the successor Trustee appointed by the Company.

If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company, or the Holders of at least 10% in principal amount of the then outstanding Securities of any series may petition any court of competent jurisdiction for the appointment of a successor Trustee.

If the Trustee, after written request by any Holder who has been a Holder for at least six months, fails to comply with Section 7.10 hereof, such Holder may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee.

A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Thereupon, the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, provided all sums owing to the Trustee


hereunder have been paid and subject to the Lien provided for in Section 7.07 hereof. Notwithstanding replacement of the Trustee pursuant to this Section 7.08, the Company’s obligations under Section 7.07 hereof shall continue for the benefit of the retiring Trustee.

Section 7.09 Successor Trustee by Merger, etc . If the Trustee consolidates, merges or converts into, or transfers all or substantially all of its corporate trust business to, another corporation, the successor corporation without any further act shall be the successor Trustee, provided that it is eligible under the TIA and this Article VII.

In case at the time such successor to the Trustee shall succeed to the trusts created by this Indenture any of the Securities shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor Trustee and deliver such Securities so authenticated; and, in case at that time any of the Securities shall not have been authenticated, any successor to the Trustee may authenticate such Securities either in the name of any predecessor hereunder or in the name of the successor trustee; and in all such cases such certificate shall have the full force which it is anywhere in the Securities or in this Indenture provided that the certificate of the Trustee shall have; provided that the right to adopt the certificate of authentication of any predecessor Trustee or to authenticate Securities in the name of any predecessor Trustee shall apply only to its successor or successors by merger, conversion or consolidation.

Section 7.10 Eligibility; Disqualification . There shall at all times be a Trustee hereunder that is a corporation organized and doing business under the laws of the United States of America or of any state thereof that is authorized under such laws to exercise corporate trustee power, that is subject to supervision or examination by federal or state authorities and that has a combined capital and surplus of at least $100 million as set forth in its most recent published annual report of condition.

This Indenture shall always have a Trustee who satisfies the requirements of TIA §§ 310(a)(1), (2) and (5). The Trustee is subject to TIA § 310(b).

Section 7.11 Preferential Collection of Claims Against Company . The Trustee is subject to TIA § 311(a), excluding any creditor relationship listed in TIA § 311(b). A Trustee who has resigned or been removed shall be subject to TIA § 311(a) to the extent indicated therein.

ARTICLE VIII

LEGAL DEFEASANCE AND COVENANT DEFEASANCE

Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance . Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to Securities of a particular series, the Company may elect, at its option, at any time, to have either Section 8.02 or 8.03 hereof be applied to all outstanding Securities of any series designated pursuant to Section 2.03(a) hereof as being defeasible (the “Defeased Securities”) in accordance with any additional requirements provided pursuant to Section 2.03(a) hereof and upon compliance with the conditions set forth below in this Article 8. Any such election shall be evidenced by a Board Resolution set forth in an Officers’ Certificate or in another manner specified as contemplated by Section 2.03(a) hereof for such Securities.

Section 8.02 Legal Defeasance and Discharge . Upon the Company’s exercise under Section 8.01 hereof of the option (if any) to have this Section 8.02 applied to any Securities of any series, the Company shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be deemed to have been discharged from its obligations with respect to all outstanding Defeased Securities on the date the conditions set forth below are satisfied (hereinafter, “Legal Defeasance”). For this purpose, Legal Defeasance means that the Company shall be deemed to have paid and discharged the entire Indebtedness represented by the outstanding Defeased Securities, which shall thereafter be deemed to be “outstanding”


only for the purposes of Section 8.05 hereof and the other Sections of this Indenture referred to in (a) and (b) below, and to have satisfied all its other obligations under such Defeased Securities and this Indenture (and the Trustee, on demand of and at the expense of the Company, shall execute proper instruments acknowledging the same), except for the following provisions which shall survive until otherwise terminated or discharged hereunder: (a) the rights of Holders of outstanding Defeased Securities to receive solely from the trust fund under Section 8.04 hereof, and as more fully set forth in such Section, payments in respect of the principal of, premium, if any, and interest on such Defeased Securities when such payments are due, (b) the Company’s obligations with respect to such Defeased Securities under Article 2 and Section 4.01 hereof, (c) the rights, powers, trusts, duties and immunities of the Trustee hereunder and the Company’s obligations in connection therewith and (d) this Article 8. Subject to compliance with this Article 8, the Company may exercise its option under this Section 8.02 notwithstanding the prior exercise of its option under Section 8.03 hereof.

Section 8.03 Covenant Defeasance . Upon the Company’s exercise under Section 8.01 hereof of the option (if any) to have this Section 8.03 applied to any Securities of any series the Company and, if applicable, each Guarantor shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be released from its obligations under Sections 4.03, 4.05 and 4.06 hereof and Articles 5 and 11 hereof and such other provisions as may be provided as contemplated by Section 2.03(a) hereof with respect to Securities of a particular series and with respect to the outstanding Defeased Securities on and after the date the conditions set forth in Section 8.04 hereof are satisfied (hereinafter, “Covenant Defeasance”), and the Defeased Securities shall thereafter be deemed not “outstanding” for the purposes of any direction, waiver, consent or declaration or act of Holders of such Defeased Securities (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed “outstanding” for all other purposes hereunder (it being understood that such Defeased Securities shall not be deemed outstanding for accounting purposes). For this purpose, Covenant Defeasance means that, with respect to the outstanding Defeased Securities, the Company and, if applicable, each Guarantor may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall not constitute a Default or an Event of Default under Section 6.01 hereof, but, except as specified above, the remainder of this Indenture and such Defeased Securities shall be unaffected thereby. In addition, upon the Company’s exercise under Section 8.01 hereof of the option applicable to this Section 8.03 hereof, subject to the satisfaction of the conditions set forth in Section 8.04 hereof and Sections 6.01(c), (d) and (g) hereof shall not constitute Events of Default.

Section 8.04 Conditions to Legal or Covenant Defeasance . The following shall be the conditions to the application of either Section 8.02 or 8.03 hereof to a series of outstanding Securities:

Unless otherwise specified as contemplated by Section 2.03(a) hereof with respect to any series of Securities, in order to exercise either Legal Defeasance or Covenant Defeasance:

(a) the Company must irrevocably deposit with the Trustee, in trust, for the benefit of the Holders, cash, non-callable Government Securities, or a combination thereof, in such amounts as will be sufficient, in the opinion of a nationally recognized firm of independent public accountants, to pay the principal of, premium, if any, and interest on the outstanding Securities of such series on the stated date for payment thereof or on the applicable redemption date, as the case may be;

(b) in the case of an election under Section 8.02 hereof, the Company shall have delivered to the Trustee an Opinion of Counsel confirming that (A) the Company has received from, or there has been published by, the Internal Revenue Service a ruling or (B) since the date this Indenture was first executed, there has been a change in the applicable federal income tax


law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of the outstanding Securities of such series will not recognize income, gain or loss for federal income tax purposes as a result of such Legal Defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred; and

(c) in the case of an election under Section 8.03 hereof, the Company shall have delivered to the Trustee an Opinion of Counsel confirming that the Holders of the outstanding Securities of such series will not recognize income, gain or loss for federal income tax purposes as a result of such Covenant Defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred.

Section 8.05 Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions . Subject to Section 8.06 hereof, all money and non-callable Government Securities (including the proceeds thereof) deposited with the Trustee (or other qualifying trustee, collectively for purposes of this Section 8.05, the “Trustee”) pursuant to Section 8.04 hereof in respect of the outstanding Defeased Securities shall be held in trust and applied by the Trustee, in accordance with the provisions of such Defeased Securities and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as Paying Agent) as the Trustee may determine, to the Holders of such Defeased Securities of all sums due and to become due thereon in respect of principal, premium, if any, and interest, but such money need not be segregated from other funds except to the extent required by law.

The Company shall pay and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the cash or non-callable Government Securities deposited pursuant to Section 8.04 hereof or the principal and interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of the outstanding Defeased Securities.

Anything in this Article 8 to the contrary notwithstanding, the Trustee shall deliver or pay to the Company from time to time upon the request of the Company any money or non-callable Government Securities held by it as provided in Section 8.04 hereof which in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee are in excess of the amount thereof that would then be required to be deposited to effect an equivalent Legal Defeasance or Covenant Defeasance.

Section 8.06 Repayment to Company . Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the principal of, premium, if any, or interest on any Securities of a series and remaining unclaimed for two years after such principal, and premium, if any, or interest has become due and payable shall be paid to the Company on its written request or (if then held by the Company) shall be discharged from such trust; and the Holder of such series of Securities shall thereafter look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Company cause to be published once, in The New York Times and The Wall Street Journal (national edition), notice that such money remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such notification or publication, any unclaimed balance of such money then remaining will be repaid to the Company.

Section 8.07 Reinstatement . If the Trustee or Paying Agent is unable to apply any cash or non-callable Government Securities in accordance with Section 8.02 or 8.03 hereof, as the case may be,


by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, then the Company’s obligations under this Indenture and the Defeased Securities shall be revived and reinstated as though no deposit had occurred pursuant to Section 8.02 or 8.03 hereof until such time as the Trustee or Paying Agent is permitted to apply all such money in accordance with Section 8.02 or 8.03 hereof, as the case may be; provided, however, that, if the Company makes any payment of principal of, premium, if any, or interest on any Defeased Securities following the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Defeased Securities to receive such payment from the money held by the Trustee or Paying Agent.

ARTICLE IX

AMENDMENT, SUPPLEMENT AND WAIVER

Section 9.01 Without Consent of Holders of Securities . Notwithstanding Section 9.02 hereof, the Company, the Guarantors, if any, and the Trustee at any time and from time to time may amend this Indenture or enter into one or more indentures supplemental hereto without the consent of any Holder of a Security for any of the following purposes:

(a) to cure any ambiguity, defect or inconsistency;

(b) to provide for uncertificated Securities in addition to or in place of certificated Securities in a manner that does not materially adversely affect any Holder;

(c) to provide for the assumption of the Company’s or, if applicable, a Guarantor’s obligations to the Holders of the Securities or a series by a successor pursuant to Article 5 or 11 hereof;

(d) to make any change that would provide any additional rights or benefits to the Holders or that does not adversely affect the legal rights hereunder of any Holder;

(e) to comply with requirements of the SEC in order to effect or maintain the qualification of this Indenture under the TIA;

(f) to add a Guarantor with respect to Securities of any series;

(g) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more series and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, pursuant to the requirements of Section 7.08 hereof;

(h) to mortgage, pledge, hypothecate or grant a security interest in favor of the Trustee for the benefit of the Holders of Securities of any series as additional security for the payment and performance of the Company’s or, if applicable, a Guarantor’s obligations herein in any property or assets;

(i) to add to, change or eliminate any of the provisions of this Indenture (which addition, change or elimination may apply to one or more series of Securities), provided that, any such addition, change or elimination (A) shall neither (i) apply to any Security of any series created prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor (ii) modify the rights of the Holder of any such Security with respect to such provision or (B) shall become effective only when there is no such outstanding Security; or

(j) to establish the form and terms of Securities of any series permitted by Sections 2.01 and 2.03(a) hereof, respectively.


Upon the request of the Company accompanied by a Board Resolution authorizing the execution of any such amended or supplemental Indenture, and upon receipt by the Trustee of the documents described in Section 7.02 hereof, the Trustee shall join with the Company and, if applicable, the Guarantors in the execution of any amended or supplemental Indenture authorized or permitted by the terms of this Indenture and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into such amended or supplemental Indenture that affects its own rights, duties or immunities under this Indenture or otherwise.

Section 9.02 With Consent of Holders of Securities . Except as provided below in this Section 9.02, the Company and the Trustee may amend this Indenture or the Securities of any series with the consent of the Holders of at least a majority in principal amount of the Securities of such series then outstanding voting as a single class (including consents obtained in connection with a tender offer or exchange offer for, or purchase of, such Securities), and, subject to Sections 6.04 and 6.07 hereof, any existing Default or Event of Default with respect to a particular series of Securities (other than a Default or Event of Default in the payment of the principal of, premium, if any, or interest on such Securities, except a payment default resulting from an acceleration that has been rescinded) or compliance with any provision of this Indenture or such Securities may be waived with the consent of the Holders of a majority in principal amount of the then outstanding Securities of such series voting as a single class (including consents obtained in connection with a tender offer or exchange offer for, or purchase of, such Securities).

Upon the request of the Company accompanied by a Board Resolution authorizing the execution of any such amended or supplemental Indenture, and upon the filing with the Trustee of evidence satisfactory to the Trustee of the consent of the Holders of Securities as aforesaid, and upon receipt by the Trustee of the documents described in Section 7.02 hereof, the Trustee shall join with the Company and, if applicable, the Guarantors in the execution of such amended or supplemental Indenture unless such amended or supplemental Indenture directly affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such amended or supplemental Indenture.

It shall not be necessary for the consent of the Holders of Securities under this Section 9.02 to approve the particular form of any proposed amendment or waiver, but it shall be sufficient if such consent approves the substance thereof.

After an amendment, supplement or waiver under this Section 9.02 becomes effective, the Company shall mail to the Holders of Securities affected thereby a notice briefly describing the amendment, supplement or waiver. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such amended or supplemental indenture or waiver. Subject to Sections 6.04 and 6.07 hereof and except as otherwise provided below in this Section 9.02, the Holders of a majority in aggregate principal amount of the Securities of any series then outstanding voting as a single class may waive compliance in a particular instance by the Company with any provision of this Indenture or the Securities of such series. However, without the consent of each Holder affected, an amendment or waiver under this Section 9.02 may not (with respect to any Securities of such series held by a non-consenting Holder):

(a) change the Stated Maturity of, the principal of, or any installment of principal or interest on, any such Security, or reduce the principal amount thereof or the rate of interest thereon or any premium payable upon redemption thereof or reduce the amount of principal of or premium, if any, on any such Discount Security that would be due and payable upon a declaration of acceleration of maturity thereof pursuant to Section 6.02 hereof, or change the place of


payment where, or change the coin or currency in which, any principal of, or any installment of interest on, any such Security is payable, or impair the right to institute suit for the enforcement of any such payment on or after the Stated Maturity thereof (or, in the case of redemption, on or after the Redemption Date);

(b) reduce the percentage in principal amount of the outstanding Securities of any series, the consent of whose Holders is required for any such amendment or supplemental indenture, or the consent of whose Holders is required for any waiver (of compliance with certain provisions of this Indenture or certain defaults hereunder and their consequences) with respect to the Securities of such series provided for in this Indenture;

(c) modify any of the provisions of this Section 9.02 or Section 6.04 or 6.07 hereof, except to increase the percentage of outstanding Securities of such series required for such actions to provide that certain other provisions of this Indenture cannot be modified or waived without the consent of the Holder of each outstanding Security of a series affected thereby;

(d) release any applicable Guarantor from any of its obligations under its Security Guarantee or this Indenture, except in accordance with the terms of this Indenture; or

(e) change such other matters as may be specified pursuant to Section 2.03(a) hereof.

Section 9.03 Compliance with Trust Indenture Act . Every amendment or supplement to this Indenture or the Securities of any series shall be set forth in a amended or supplemental Indenture that complies with the TIA as then in effect.

Section 9.04 Revocation and Effect of Consents . Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a Security is a continuing consent by the Holder of a Security and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder’s Security, even if notation of the consent is not made on any Security. However, any such Holder of a Security or subsequent Holder of a Security may revoke the consent as to its Securities if the Trustee receives written notice of revocation before the date the waiver, supplement or amendment becomes effective. An amendment, supplement or waiver becomes effective in accordance with its terms and thereafter binds every Holder.

Section 9.05 Notation on or Exchange of Securities . The Trustee may place an appropriate notation about an amendment, supplement or waiver on any Security of a series thereafter authenticated. The Company in exchange for all Securities of a series may issue and the Trustee shall, upon receipt of a Company Order, authenticate new Securities of such series that reflect the amendment, supplement or waiver. Failure to make the appropriate notation or issue a new Security shall not affect the validity and effect of such amendment, supplement or waiver.

Section 9.06 Trustee to Sign Amendments, etc . The Trustee shall sign any amended or supplemental Indenture authorized pursuant to this Article 9 if the amendment or supplement does not adversely affect the rights, duties, liabilities or immunities of the Trustee. The Company may not sign an amendment or supplemental Indenture until the Board of Directors approves it. In executing any amended or supplemental indenture, the Trustee shall be entitled to receive and (subject to Section 7.01 hereof) shall be fully protected in relying upon, in addition to the documents required by Section 13.04 hereof, an Officers’ Certificate and an Opinion of Counsel stating that the execution of such amended or supplemental indenture is authorized or permitted by this Indenture.

Section 9.07 Effect of Supplemental Indentures . Upon the execution of any supplemental indenture under this Article 9, this Indenture shall be modified in accordance therewith, and such supplemental indenture shall form a part of this Indenture for all purposes; and every Holder of Securities theretofore or thereafter authenticated and delivered hereunder shall be bound thereby, except to the extent otherwise set forth thereon.


ARTICLE X

SINKING FUNDS

Section 10.01 Applicability of Article . The provisions of this Article 10 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified as contemplated by Section 2.03(a) hereof for Securities of such series.

The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a “Mandatory Sinking Fund Payment,” and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as an “Optional Sinking Fund Payment.” If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided in hereof. Each sinking fund payment shall be applied to the redemption of Securities of any series as provided for by the terms of the Securities of such series.

Section 10.02 Satisfaction of Sinking Fund Payments with Securities . The Company (a) may deliver outstanding Securities of a series with the same issue date, interest rate and Stated Maturity (other than any previously called for redemption) and (b) may apply as a credit Securities of a series with the same issue date, interest rate and Stated Maturity which have been redeemed either at the election of the Company pursuant to the terms of such Securities or through the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of all or any part of any mandatory sinking fund payment with respect to the Securities of such series with the same issue date, interest rate and Stated Maturity; provided, that such Securities have not been previously so credited. Such Securities shall be received and credited for such purpose by the Trustee at the Redemption Price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly.

Section 10.03 Redemption of Securities for Sinking Fund . Not less than 60 days (or such shorter period as shall be acceptable to the Trustee) prior to each sinking fund payment date for any series of Securities, the Company will deliver to the Trustee an Officers’ Certificate specifying the amount of the next ensuing sinking fund payment for that series pursuant to the terms of that series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting Securities of that series pursuant to Section 10.02 hereof and will also deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02 hereof and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 3.03 hereof. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Sections 3.04 and 3.06 hereof.

ARTICLE XI

SECURITY GUARANTEES

Section 11.01 Applicability of this Article . Except as otherwise specified as contemplated by Section 2.03(a) hereof, the provisions of this Article 11 will be applicable to any series of Securities which is to be guaranteed by one or more Guarantors.


Section 11.02 Guarantee . Subject to this Article 11, each of the Guarantors hereby, jointly and severally, unconditionally guarantees to each Holder of Securities of a particular series as to which it is a Guarantor authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of this Indenture, the Securities of such series or the obligations of the Company hereunder or thereunder, that: (a) the principal of, premium, if any, and interest on the Securities of such series will be promptly paid in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and premium, if any, and interest on the Securities of such series, if any, if lawful, and all other obligations of the Company to the Holders or the Trustee hereunder or thereunder will be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and (b) in case of any extension of time of payment or renewal of any Securities of such series or any of such other obligations, that same will be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors shall be jointly and severally obligated to pay the same immediately. Each Guarantor agrees that this is a guarantee of payment and not a guarantee of collection.

Subject to this Article 11, the Guarantors hereby, jointly and severally, agree that their obligations hereunder shall be unconditional, irrespective of the validity, regularity or enforceability of the Securities of a series or this Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Securities of such series with respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. Each Guarantor hereby waives diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever and covenant that this Security Guarantee shall not be discharged except by complete performance of the obligations contained in the Securities of such series and this Indenture.

If any Holder or the Trustee is required by any court or otherwise to return to the Company, the Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to either the Company or the Guarantors, any amount paid by either to the Trustee or such Holder, this Security Guarantee, to the extent theretofore discharged, shall be reinstated in full force and effect.

Each Guarantor agrees that it shall not be entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. Each Guarantor further agrees that, as between the Guarantors, on the one hand, and the Holders and the Trustee, on the other hand, (x) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 hereof for the purposes of this Security Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations as provided in Article 6 hereof, such obligations (whether or not due and payable) shall forthwith become due and payable by the Guarantors for the purpose of this Security Guarantee. The Guarantors shall have the right to seek contribution from any non-paying Guarantor so long as the exercise of such right does not impair the rights of the Holders under the Security Guarantee.

Section 11.03 Limitation on Guarantor Liability . Each Guarantor, and by its acceptance of Securities of a series, each Holder, hereby confirms that it is the intention of all such parties that the Security Guarantee of such Guarantor not constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to any Security Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Guarantors hereby irrevocably agree that the obligations of


such Guarantor shall be limited to the maximum amount as will, after giving effect to all other contingent and fixed liabilities of such Guarantor that are relevant under such laws, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Guarantor in respect of the obligations of such other Guarantor under this Article 11, result in the obligations of such Guarantor under its Security Guarantee not constituting a fraudulent transfer or conveyance.

Section 11.04 Release of Guarantors . The Security Guarantee of a Guarantor with respect to any series of Securities will be released under the circumstances specified for such series of Securities pursuant to Section 2.03(a) hereof.

ARTICLE XII

SATISFACTION AND DISCHARGE

Section 12.01 Satisfaction and Discharge . Except as otherwise contemplated by 2.03(a) hereof, this Indenture will cease to be of further effect with respect to any series of Securities specified by the Company, and the Trustee, at the expense of the Company, will execute proper instruments acknowledging satisfaction and discharge of this Indenture as to such series when:

(a) either:

(i) all Securities of such series that have been authenticated (except lost, stolen or destroyed Securities of such series that have been replaced or paid and Securities of such series for whose payment money has theretofore been deposited in trust and thereafter repaid to the Company) have been delivered to the Trustee for cancellation; or

(ii) all Securities of such series that have not been delivered to the Trustee for cancellation have become due and payable by reason of the mailing of a notice of redemption or otherwise or will become due and payable within one year and the Company or, if applicable, any Guarantor has irrevocably deposited or caused to be deposited with the Trustee as trust funds in trust solely for the benefit of the Holders, cash, non-callable Government Securities, or a combination thereof, in such amounts as will be sufficient without consideration of any reinvestment of interest, to pay and discharge the entire indebtedness on the such Securities not delivered to the Trustee for cancellation for principal, premium, if any, and accrued interest to the date of maturity or redemption;

(b) the Company or, if applicable, any Guarantor has paid or caused to be paid all sums payable by it under this Indenture; and

(c) the Company or, if applicable, any Guarantor has delivered an Officers’ Certificate and an Opinion of Counsel to the Trustee stating that all conditions precedent to satisfaction and discharge have been satisfied or waived.

(d) Notwithstanding the satisfaction and discharge of this Indenture, if money shall have been deposited with the Trustee pursuant to subclause (ii) of clause (a) of this Section 12.01, the provisions of Sections 12.02 and 8.06 hereof shall survive.

Section 12.02 Application of Trust Money . Subject to the provisions of Section 8.06 hereof, all money deposited with the Trustee pursuant to Section 12.01 hereof shall be held in trust and applied by it, in accordance with the provisions of the Securities of a series and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as its own Paying Agent) as


the Trustee may determine, to the Persons entitled thereto, of the principal (and premium, if any) and interest for whose payment such money has been deposited with the Trustee; but such money need not be segregated from other funds except to the extent required by law.

If the Trustee or Paying Agent is unable to apply any money or Government Securities in accordance with Section 12.01 hereof by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s obligations and, if applicable, any Guarantor’s obligations under this Indenture and the Securities of such series shall be revived and reinstated as though no deposit had occurred pursuant to Section 11.01 hereof; provided that if the Company has made any payment of principal of, premium, if any, or interest on any Securities of such series because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of Securities of such series to receive such payment from the money or Government Securities held by the Trustee or Paying Agent.

ARTICLE XIII

MISCELLANEOUS

Section 13.01 Trust Indenture Act Controls . If any provision of this Indenture limits, qualifies or conflicts with the duties imposed by TIA Section 318(c), the imposed duties shall control. If any provision of this Indenture modifies or excludes any provision of the TIA that may be so modified or excluded, the latter provision shall be deemed to apply to this Indenture as so modified or excluded, as the case may be.

Section 13.02 Notices . Any notice or communication by the Company, any Guarantor or the Trustee to the others is duly given if in writing and delivered in Person or mailed by first class mail (registered or certified, return receipt requested), telex, telecopier or overnight air courier guaranteeing next day delivery, to the others’ address:

If to the Company and/or any Guarantor:

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

Telecopier No.: (513) 657-5042

Attention: General Counsel

With a copy to:

White & Case LLP

1155 Avenue of the Americas

New York, New York 10036

Telecopier No.: (212) 354-8113

Attention: Michelle B. Rutta, Esq.

If to the Trustee:

U.S. Bank National Association 1349 West Peachtree Street NW

Suite 1050 Atlanta, GA 30309 Telecopier No.: (404) 898-8844

Attention: Wm. Bryan Echols


The Company, any Guarantor or the Trustee, by notice to the others may designate additional or different addresses for subsequent notices or communications.

Any notice or communication to a Holder shall be mailed by first class mail, certified or registered, return receipt requested, or by overnight air courier guaranteeing next day delivery to its address shown on the register kept by the Registrar. Any notice or communication also shall be so mailed to any Person described in TIA § 313(c), to the extent required by the TIA. Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders.

If the Company mails a notice or communication to Holders, it shall mail a copy to the Trustee and each Agent at the same time.

Section 13.03 Communication by Holders of Securities with Other Holders of Securities . Holders may communicate pursuant to TIA § 312(b) with other Holders with respect to their rights under this Indenture or the Securities. The Company, the Trustee, the Registrar and anyone else shall have the protection of TIA § 312(c).

Section 13.04 Certificate and Opinion as to Conditions Precedent . Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee:

(a) an Officers’ Certificate in form and substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 13.05 hereof) stating that, in the opinion of the signers, all conditions precedent and covenants, if any, provided for in this Indenture relating to the proposed action have been satisfied or waived; and

(b) an Opinion of Counsel in form and substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 13.05 hereof) stating that, in the opinion of such counsel, all such conditions precedent and covenants have been satisfied or waived.

Section 13.05 Statements Required in Certificate or Opinion . Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than a certificate provided pursuant to TIA § 314(a)(4)) shall comply with the provisions of TIA § 314(e) and shall include:

(a) a statement that the Person making such certificate or opinion has read such covenant or condition;

(b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based;

(c) a statement that, in the opinion of such Person, he or she has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been satisfied or waived; and

(d) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been satisfied or waived.

In any case where several matters are required to be certified by, or covered by an opinion of, any specified Person, it is not necessary that all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so certified or covered by only one document, but one such Person may certify or give an opinion with respect to some matters and one or more other such Persons as to other matters, and any such Person may certify or give an opinion as to such matters in one or several documents.


Any certificate or opinion of an Officer of the Company may be based insofar as it relates to legal matters, upon a certificate or opinion of, or representations by, counsel, unless such Officer knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to the matters upon which his certificate or opinion or representations is based are erroneous. Any such certificate or opinion of counsel may be based, insofar as it relates to factual matters, upon a certificate or opinion of, or representations by, an officer or officers of the Company stating that the information with respect to such factual matters is in the possession of the Company, unless such counsel knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to such matters are erroneous.

Where any Person is required to make, give or execute two or more applications, requests, consents, certificates, statements, opinions or other instruments under this Indenture, they may, but need not, be consolidated and form one instrument.

Section 13.06 Rules by Trustee and Agents . The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar or Paying Agent may make reasonable rules and set reasonable requirements for its functions.

Section 13.07 No Personal Liability of Directors, Officers, Employees and Stockholders . No past, present or future director, officer, employee, incorporator or stockholder of the Company or any Guarantor, as such, shall have any liability for any obligations of the Company or such Guarantor under the Securities, the Security Guarantees, this Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Securities.

Section 13.08 Governing Law . THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS INDENTURE AND THE SECURITIES, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.

Section 13.09 No Adverse Interpretation of Other Agreements . This Indenture may not be used to interpret any other indenture, loan or debt agreement of the Company or its Subsidiaries or of any other Person. Any such indenture, loan or debt agreement may not be used to interpret this Indenture.

Section 13.10 Successors . All agreements of the Company in this Indenture and the Securities shall bind its successors. All agreements of the Trustee in this Indenture shall bind its successors. All agreements of each applicable Guarantor in this Indenture shall bind its successors, except as otherwise provided pursuant to Section 13.05 hereof.

Section 13.11 Severability . In case any provision in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

Section 13.12 Counterpart Originals . The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

Section 13.13 Table of Contents, Headings, etc . The Table of Contents, Cross-Reference Table and Headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part of this Indenture and shall in no way modify or restrict any of the terms or provisions hereof.

[Signatures on following page]


SIGNATURES

Dated as of [                      ]

 

OMNICARE, INC.
By:    
  Name:
  Title:

 

Attest:
 
Name:
Title:

 

[                      ]
By:    
  Name:
  Title:

 

Attest:
 
Authorized Signatory
Date:


Exhibit A

[Legend if Security is a Global Security]

THIS GLOBAL SECURITY IS HELD BY THE DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS SECURITY) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (I) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE REQUIRED PURSUANT TO THE INDENTURE, (II) THIS GLOBAL SECURITY MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.08 OF THE INDENTURE, (III) THIS GLOBAL SECURITY MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 2.13 OF THE INDENTURE AND (IV) THIS GLOBAL SECURITY MAY BE TRANFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF OMNICARE, INC.


[Face of Security]

 

     CUSIP                     
  [TITLE OF SECURITIES]   
No.           $                     

OMNICARE, INC.

promises to pay to                                                                                                                    or registered assigns, the principal sum of                                                                                                                    Interest Payment Dates [                      ] and [                      ], commencing on [                      ].

Record Dates: [                      ] and [                      ]

Dated:                      ,             

 

OMNICARE, INC.
By:    
  Name:
  Title:

 

By:    
  Name:
  Title:

 

This is one of the Securities referred to in the within-mentioned Indenture:

[                      ],

as Trustee

 

By:    
  Authorized Signatory


[Back of Security]

[TITLE OF SECURITIES]

[Insert the Global Security Legend, if applicable pursuant to the provisions of this Indenture]

[Insert any legend required by the Internal Revenue Code and the regulations thereunder]

Capitalized terms used herein shall have the meanings assigned to them in this Indenture referred to below unless otherwise indicated.

 

1. Interest.

Omnicare, Inc., a Delaware corporation (herein the “Company” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to                                  , or registered assigns, the principal sum of                      [Dollars] [if other than Dollars, substitute other currency units] on                      ,              [if the Security is to bear interest prior to Stated Maturity, insert — , and to pay interest thereon from                      or from the most recent Interest Payment Date to which interest has been paid or duly provided for], [semiannually] [if other than semi-annual interest at a fixed rate, insert frequency of payment and payment dates] on                      and                      in each year, commencing                      , and at the Stated Maturity thereof, at [if the Security is to bear interest at a fixed rate, insert — the rate of __% per annum], [if the Security is to bear interest at a rate determined with reference to one or more formula, refer to description index below] until the principal hereof is paid or made available for payment] [if applicable, insert — , and (to the extent that the payment of such interest shall be legally enforceable) at [if the Security is to bear interest at a fixed rate, insert — the rate of % per annum on any overdue principal and premium and on any overdue installment of interest from the dates such amounts are due until they are paid or made available for payment]. Interest shall be computed on the basis of [a 360-day year of twelve 30-day months] [if another basis of calculating interest is to be different, insert a description of such method.]

 

2. Method of Payment.

The Company will pay interest on the Securities on each [                      ] and [                      ] to the Persons who are registered Holders of the relevant Securities at the close of business on the [                      ] or [                      ] next preceding the Interest Payment Date, even if such Securities are canceled after such record date and on or before such Interest Payment Date, except as provided in Section 2.14 of this Indenture with respect to Defaulted Interest. The Securities will be payable as to principal, premium, if any, and interest at the office or agency of the Company maintained for such purpose in [                      ], [if applicable, insert —; provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the list provided by the Company to the Registrar and provided, further, that if this Security is a Global Security, payment may be made pursuant to the applicable procedures of the Depositary as permitted in said Indenture]. Such payment shall be in such coin or currency of [the United States of America] [insert other currency or currency unit, if applicable] as at the time of payment is legal tender for payment of public and private debts.

 

3. Paying Agent and Registrar.

Initially, the Trustee under this Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity.


4. Indenture.

This Security is one of a duly authorized issue of Securities of the Company issued and to be issued in one or more series under an Indenture, dated as of                      ,              (herein called the “Indenture”), between the Company and                      , as Trustee (herein called the “Trustee” which term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered. The terms of the Securities include those stated in this Indenture and those made part of this Indenture by reference to the Trust Indenture Act of 1939, as amended (15 U.S. Code § 77aaa-77bbbb). The Securities are subject to all such terms, and Holders are referred to this Indenture and such Act for a statement of such terms. To the extent any provision of this Security conflicts with the express provisions of this Indenture, the provisions of this Indenture shall govern and be controlling.

 

5. Redemption.

[If applicable, insert — The Securities of this series are subject to redemption upon not less than 30 days notice by mail, [if applicable, insert — (1) on                      in any year commencing with the year              and ending with the year              through operation of the sinking fund for this series at a Redemption Price equal to 100% of the principal amount, and (2)] at any time [if applicable, insert — on or after                      ,              ], as a whole or in part, at the election of the Company, at the following Redemption Prices (expressed as percentages of the principal amount): if redeemed [if applicable insert — on or before                      ,      %, and if redeemed] during the 12-month period beginning of the                      years indicated,

 

Year    Redemption Price    Year    Redemption Price

and thereafter at a Redemption Price equal to      % of the principal amount, together in the case of any such redemption [if applicable, insert — (whether through operation of the sinking fund or otherwise)] with accrued interest to the Redemption Date, but interest installments whose Stated Maturity is on or prior to such Redemption Date will be payable to the Holders of such Securities, or one or more Predecessor Securities, of record at the close of business on the relevant Record Dates referred to on the face hereof, all as provided in the Indenture.]

[If applicable, insert — The Securities of this series are subject to redemption upon not less than 30 days notice by mail, (1) on                      in any year commencing with the year              and ending with the year              through operation of the sinking fund for this series at the Redemption Prices for redemption through operation of the sinking fund (expressed as percentages of the principal amount) set forth in the table below, and (2) at any time [if applicable, insert — on or after                      ], as a whole or in part, at the election of the Company, at the Redemption Prices for redemption otherwise than through operation of the sinking fund (expressed as percentages of the principal amount) set forth in the table below: If redeemed during the 12-month period beginning                      of the years indicated,

 

Year   

Redemption Price for Redemption
Through Operation of the Sinking Fund

  

Redemption Price for Redemption

Otherwise Than Through Operation of the

Sinking Fund

 

and thereafter at a Redemption Price equal to      % of the principal amount, together in the case of any such redemption (whether through operation of the sinking fund or otherwise) with accrued interest to the


Redemption Date, but interest installments whose Stated Maturity is on or prior to such Redemption Date will be payable to the Holders of such securities, or one or more Predecessor Securities, of record at the close of business on the relevant Record Date referred to on the face hereof, all as provided in the Indenture.]

[If applicable, insert — The sinking fund for this series provides for the redemption on                      in each year beginning with the year              and ending with the year              of [if applicable, insert — not less than $                      (“mandatory sinking fund”) and not more than] $                      aggregate principal amount of Securities of this series. Securities of this series acquired or redeemed by the Company otherwise than through [mandatory] sinking fund payments may be credited against subsequent [if applicable, insert — mandatory] sinking fund payments otherwise required to be made [if applicable, insert — in the inverse order in which they become due].]

[If applicable, insert — The Securities are subject to redemption, as a whole at any time or in part from time to time, at the sole election of the Company, upon not less than 30 or more than 60 days notice by mail to the Trustee at a Redemption Price equal to $                      .]

[If applicable, insert — The Holder of this Security shall have the right to require the Company to pay this Security in full on                      ,      by giving the Company or the Registrar written notice of the exercise of such right not less than 30 or more than 60 days prior to such date.]

[If the Security is subject to redemption, insert — In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof.]

[If applicable, insert — This Security is not subject to redemption prior to maturity.]

 

6. Denominations, Transfer, Exchange.

[If applicable, insert — The Securities of this series are issuable only in registered form without coupons in denominations of $                      and any integral multiple thereof.] As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering the same. A Holder may register the transfer or exchange of the Security as provided in the Indenture and subject to certain limitations therein set forth. The Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture.

[If applicable, insert — The Securities of this series will be represented by one or more Global Securities registered in the name of                      , (the “Depositary”), or a nominee of the Depositary. So long as the Depositary, or its nominee, is the registered holder and owner of this Global Security, the Depositary or such nominee, as the case may be, will be considered the sole owner and holder of the Securities for all purposes under the Indenture. The Global Security may be transferred, in whole and not in part, only to the Depositary or another nominee of the Depositary. The Depositary will credit, on its book-entry registration and transfer system, the respective principal amounts of the Securities represented by such Global Security to the accounts of institutions that have accounts with the Depositary or its nominee (“participants”). Ownership of beneficial interests in a Global Security will be shown on, and the transfer of those ownership interests will be effected through, records maintained by the Depositary (with respect to participants’ interests) and such participants (with respect to the owners of beneficial interests in such Global Security).]

[If applicable, insert — The Securities represented by this Global Security are exchangeable for Securities in permanent form of like tenor as such Global Security in denominations of $1,000 and in any


greater amount that is an integral multiple thereof if (i) the Depositary notifies the Company that it is unwilling or unable to continue as Depositary for this Global Security or if at any time the Depositary ceases to be a clearing agency registered under the Securities Exchange Act of 1934, as amended, (ii) the Company in its discretion at any time determines not to have all of the Securities of this series represented by the Global Security and notifies the Trustee thereof, or (iii) an Event of Default has occurred and is continuing with respect to the Securities. Any Security that is exchangeable pursuant to the preceding sentence is exchangeable only for Securities of this series.]

No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith.

 

7. Persons Deemed Owners.

The registered Holder of a Security may be treated as its owner for all purposes.

 

8. Amendment, Supplement and Waiver.

Subject to certain exceptions, this Indenture and the Securities may be amended or supplemented with the consent of the Holders of at least a majority in principal amount of the then outstanding Securities of each series affected by such amendment or supplement and any existing default or compliance with any provision may be waived with the consent of the Holders of a majority in principal amount of the then outstanding Securities of each series affected by such waiver. Without the consent of any Holder of a Securities of each series affected by such amendment or supplement, this Indenture and the Securities may be amended or supplemented to, among other things, (a) cure any ambiguity, defect or inconsistency; (b) provide for uncertificated Securities in addition to or in place of certificated Securities; (c) provide for the assumption of the Company’s obligations to Holders of the Securities in case of a merger or consolidation; (d) to make any change that would provide any additional rights or benefits to the Holders of Securities or that does not adversely affect the legal rights under the Indenture of any Holder; (e) to comply with the requirements of the SEC in order to effect or maintain the qualification of this Indenture under the Trust Indenture Act; (f) to allow any Guarantor to execute a supplemental indenture to this Indenture; (g) evidence or provide for acceptance of appointment of a successor Trustee; (h) mortgage, hypothecate or grant a security interest in favor of the Trustee for the benefit of the Holders of Securities of any series as additional security for the payment and performance of the Company’s or, if applicable, the Guarantor’s obligations herein in any property or assets; or (i) add to, change or eliminate any of the provisions of this Indenture (which addition, change or elimination may apply to one or more series of Securities), provided that, any such addition, change or elimination set forth in clause (i) above (A) shall neither (x) apply to any Security of any series created prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor (y) modify the rights of the Holder of any such Security with respect to such provision or (B) shall become effective only when there is no such outstanding Security.

 

9. Defaults and Remedies.

Events of Default include: (a) default for 30 days in the payment when due of interest on the Securities; (b) default in payment when due of principal of or premium, if any, on the Securities; (c) failure by the Company to comply with Section 5.01 of the Indenture; (d) failure by the Company for 60 days to comply with certain other agreements in this Indenture or the Securities; (e) certain events of bankruptcy or insolvency with respect to the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary; and (f) except as permitted by the Indenture, any applicable Security Guarantee shall be held in any judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or any Guarantor or any Person acting on its behalf shall deny or disaffirm its obligations under such Guarantor’s Security Guarantee. If any Event of Default occurs and is continuing,


the Trustee or the Holders of at least 25% in principal amount of the then outstanding Securities may declare all the Securities to be due and payable. Notwithstanding the foregoing, in the case of an Event of Default arising from certain events of bankruptcy or insolvency involving the Company, all outstanding Securities will become due and payable without further action or notice. Holders may not enforce this Indenture or the Securities except as provided in the Indenture. Subject to certain limitations, Holders of a majority in principal amount of the then outstanding Securities may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of the Securities notice of any continuing Default or Event of Default (except a Default or Event of Default relating to the payment of principal or interest) if it determines that withholding notice is in their interest. The Holders of a majority in aggregate principal amount of the Securities then outstanding by notice to the Trustee may on behalf of the Holders of all of the Securities waive any existing Default or Event of Default and its consequences under this Indenture except a continuing Default or Event of Default in the payment of interest on, or the principal of, the Securities. The Company is required to deliver to the Trustee annually a statement regarding compliance with this Indenture, and the Company is required upon becoming aware of any Default or Event of Default, to deliver to the Trustee a statement specifying such Default or Event of Default.

 

10. Trustee Dealings with Company.

The Trustee, in its individual or any other capacity, may make loans to, accept deposits from, and perform services for the Company or its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were not the Trustee.

 

11. No Recourse Against Others.

A director, officer, employee, incorporator or stockholder, of the Company, as such, shall not have any liability for any obligations of the Company or the Guarantors under the Securities or this Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for the issuance of the Securities.

 

12. [If applicable, insert—Guarantees.

The payment by the Company of the principal of and interest on the Security is fully and unconditionally guaranteed on a joint and several basis by each of the Guarantors on the terms set forth in the Indenture.]

 

13. Authentication.

This Security shall not be valid until authenticated by the manual signature of the Trustee or an authenticating agent.

 

14. Abbreviations.

Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act).

 

15. CUSIP Numbers.

Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the Securities and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed on the Securities or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon.


The Company will furnish to any Holder upon written request and without charge a copy of this Indenture. Requests may be made to:

Omnicare, Inc.

100 East RiverCenter Boulevard

Covington, Kentucky 41011

Attention: General Counsel


ASSIGNMENT FORM

To assign this Security, fill in the form below:

 

(I) or (we) assign and transfer this Security to:    
  (Insert assignee’s legal name)
 
(Insert assignee’s soc. sec. or tax I.D. no.)
 
 
 
(Print or type assignee’s name, address and zip code)

and irrevocably appoint                                                                                                                to transfer this Security on the books of the Company. The agent may substitute another to act for him.

Date:                     

 

Your Signature:    
  (Sign exactly as your name appears on the face of this Security)

 

Signature Guarantee*:    

 

* Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee).


SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL SECURITY *

The following exchanges of a part of this Global Security for an interest in another Global Security or for a Definitive Security, or exchanges of a part of another Global Security or Definitive Security for an interest in this Global Security, have been made:

 

Principal Amount of this Global
Security following such decrease or
increase)

  

Amount of decrease in Principal
Amount of this Global Security

  

Amount of increase in Principal
Amount of this Global Security

  

Signature of authorized officer of
Trustee or Date of Exchange
Security Custodian

 

 

*   This schedule should be included only if the Security is issued in global form.

Exhibit 5.1

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

Ladies and Gentlemen:

Registration Statement on Form S-3

We have acted as counsel to Omnicare, Inc., a Delaware corporation (the “ Company ”), in connection with the preparation of a Registration Statement on Form S-3 filed on the date hereof (the “ Registration Statement ”) with the Securities and Exchange Commission (the “ Commission ”) by the Company and certain of its subsidiaries (the “ Subsidiaries ”). The Registration Statement relates to the offer and sale, from time to time, pursuant to Rule 415 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended (the “ Securities Act ”), of an indeterminate amount of the following securities: (i) common stock, par value $1.00 per share, of the Company (“ Common Stock ”); (ii) one or more classes or series of preferred stock, no par value per share, of the Company (“ Preferred Stock ”); (iii) one or more series of debt securities of the Company, consisting of debentures, notes and/or other evidences of indebtedness, which may be senior obligations (the “ Senior Debt Securities ”) or subordinated obligations (the “ Subordinated Debt Securities ”) to certain other obligations of the Company (collectively, “ Debt Securities ”); (iv) guarantees of the Debt Securities by one or more of the Subsidiaries (the “ Guarantees ”); and (v) warrants to purchase Securities (as hereinafter defined) of the Company (“ Warrants ,” and together with the Common Stock, Preferred Stock, Debt Securities and Guarantees, the “ Securities ”).

The Senior Debt Securities will be issued under a senior debt securities indenture in the form filed as an exhibit to the Registration Statement, as amended or supplemented from time to time (the “ Senior Indenture ”), proposed to be entered into between the Company and trustee (any such trustee, the “ Senior Indenture Trustee ”). The Subordinated Debt Securities will be issued pursuant to that subordinated debt securities indenture dated as of June 13, 2003 between the Company and U.S. Bank National Association (as successor to SunTrust Bank), as trustee (the “ Subordinated Indenture Trustee ”), as amended or supplemented from time to time (the “ Subordinated Indenture ”). The Senior Indenture and the Subordinated Indenture are sometimes hereinafter referred to individually as an “ Indenture ” and collectively as the “ Indentures .” The Warrants will be issued under a warrant agreement in a form that will be filed as an exhibit to a post-effective amendment to the Registration Statement or incorporated by reference therein (a “ Warrant Agreement ”).

This opinion is delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.


In connection with this opinion, we have examined (i) the Registration Statement; (ii) the form of Senior Indenture; (iii) the Subordinated Indenture; (iv) the Certificate of Incorporation of the Company, as amended and currently in effect (the “ Certificate of Incorporation ”); (v) the By-Laws of the Company, as amended and currently in effect (the “ By-laws ”); (vi) the resolutions adopted by the Board of Directors of the Company (the “ Board ”) relating to the Registration Statement and the issuance of the Securities (the “ Board Resolutions ”) and (vii) the corporate documents, records, instruments and certificates of the Subsidiaries. We have also examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials and officers and other representatives of the Company and the Subsidiaries, and such other agreements, instruments and documents as we have deemed necessary or appropriate as a basis for the opinions set forth herein.

In our examination, we have also assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed or photostatic copies, or as retrieved from the Commission’s EDGAR database, and the authenticity of the originals of such latter documents. In making our examination of documents executed by parties other than the Company or the Subsidiaries, we have assumed that such parties had the power, corporate or other, to enter into and perform all their obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and execution and delivery by such parties of such documents and the validity and binding effect thereof. As to any facts material to the opinions expressed herein which were not independently established or verified, we have, with your consent, relied upon oral or written statements and representations of officers and other representatives of the Company and others. Furthermore, we have assumed, for purposes of this opinion, that (i) at the time of issuance, sale or delivery of Common Stock or Preferred Stock, as the case may be, a sufficient number of shares of Common Stock or Preferred Stock, as the case may be, will be duly authorized and available for issuance, and (ii) each offer, issuance, sale or delivery of Common Stock, Preferred Stock, Debt Securities, Guarantees or Warrants will comply with applicable law.

In our capacity as your counsel in connection with the Registration Statement, we are familiar with the proceedings taken and proposed to be taken by the Company in connection with the Registration Statement and the authorization and issuance of the Securities. For purposes of this opinion, we have assumed that such proceedings will be timely and properly completed, in accordance with all requirements of applicable laws, in the manner presently proposed.

On the basis of the foregoing, and in reliance thereon, and subject to the additional limitations, qualifications and exceptions set forth herein, we are of the opinion that:

1. With respect to any offering of Common Stock (the “ Offered Common Stock ”), the shares of the Offered Common Stock (including any Offered Common Stock duly issued upon conversion, exchange or exercise of any other Securities) will be duly authorized, validly issued, fully paid and nonassessable, provided that the consideration therefor is not less than the par value thereof.

2. With respect to any offering of any series of Preferred Stock (the “ Offered Preferred Stock ”), when the Certificate of Designation (as hereinafter defined) has been duly filed with the Secretary of State of the State of Delaware, the shares of the Offered Preferred Stock (including any Offered Preferred Stock duly issued upon conversion, exchange or exercise of any other Securities), will be duly authorized, validly issued, fully paid and nonassessable.

3. With respect to any offering of any series of Debt Securities offered under the Senior Indenture or the Subordinated Indenture (the “ Offered Debt Securities ”), when a supplemental indenture

 

2


in respect of such Offered Debt Securities has been duly executed and delivered by the parties thereto, the Offered Debt Securities (including any Offered Debt Securities duly issued upon conversion, exchange or exercise of any other Securities) will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.

4. With respect to any offering of any series of Guarantees (the “ Offered Guarantees ”), upon (i) establishment by the Board of Directors (or equivalent thereof) of the Guarantors (the “ Guarantors ”) of the terms, conditions and provisions of any Offered Guarantees to be issued by such Guarantors; and (ii) due authorization by the Guarantors of such Offered Guarantees, the Offered Guarantees will be duly authorized by the applicable Guarantors; and when the Offered Guarantees have been duly established by the Indentures and the Debt Securities to be guaranteed by the Offered Guarantees have been duly authenticated by the Senior Indenture Trustee and the Subordinated Indenture Trustee, respectively and duly executed and delivered by the Guarantor against payment therefor in accordance with the terms and provisions of the Indentures and as contemplated by the Registration Statement, the Offered Guarantees will constitute valid and binding obligations of the applicable Guarantors, enforceable against such Guarantors in accordance with their terms.

5. With respect to any offering of any series of Warrants (the “ Offered Warrants ”), when the Warrant Agreement relating to the Offered Warrants, in the form to be filed as an exhibit to a post-effective amendment to the Registration Statement or incorporated by reference therein, has been duly executed and delivered as contemplated by the Board Resolutions or other action by the Board or a duly appointed committee thereof, the Offered Warrants will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.

The opinions set forth herein are subject to the following assumptions, qualifications, limitations and exceptions being true and correct at or prior to the time of the delivery of any Securities offered pursuant to the Registration Statement (collectively, the “ Offered Securities ”): (i) the Board, including any appropriate committee appointed thereby, and appropriate officers of the Company shall have duly established the terms of the Offered Securities and duly authorized and taken any other necessary corporate action to approve the issuance and sale of the Offered Securities and related matters (including without limitation with respect to Offered Preferred Stock, the execution, acknowledgment and filing of a Certificate of Designation (the “ Certificate of Designation ”) in accordance with the applicable provisions of the General Corporation Law of the State of Delaware) and such authorizations and actions have not been rescinded; (ii) the terms of the issuance and sale of the Offered Securities have been duly established in conformity with the Certificate of Incorporation, the By-Laws, Indenture or Warrant Agreement (collectively, the “ Applicable Agreements ”), and any other relevant agreement so as not to violate any applicable law, the Certificate of Incorporation or the By-Laws (subject to the further assumption that the Certificate of Incorporation and the By-Laws have not been amended from the date hereof in a manner that would affect the validity of any of the opinions rendered herein), or result in a default under or breach of any agreement or instrument binding upon the Company and so as to comply with any restriction imposed by any court or governmental body having jurisdiction over the Company; (iii) the Offered Securities, and any certificates or receipts representing the interests in the relevant Offered Securities, have been duly authenticated, executed, countersigned, registered and delivered upon payment of the agreed-upon consideration therefor and have been duly issued and sold in accordance with any relevant agreement (including, any Applicable Agreements), any underwriting agreement with respect to the Offered Securities or any other duly authorized, executed and delivered, applicable, valid and binding purchase agreement, or as otherwise contemplated by the Registration Statement or any post-effective amendment thereto, and any Prospectus Supplement relating thereto; (iv) the Registration Statement (including all necessary post-effective amendments) will have been declared, or otherwise have become,

 

3


effective under the Act and such effectiveness shall not have been terminated or rescinded; (v) an appropriate Prospectus Supplement will have been prepared, delivered and filed in compliance with the Securities Act and the applicable rules and regulations thereunder describing the Offered Securities offered thereby; (vi) the Offered Securities will be issued and sold in compliance with applicable Federal and state securities laws and solely in the manner stated in the Registration Statement and the applicable Prospectus Supplement and there will not have occurred any change in law affecting the validity of the opinions rendered herein; (vii) if the Offered Securities will be sold pursuant to a firm commitment underwritten offering, the underwriting agreement with respect to the Offered Securities in the form filed as an exhibit to the Registration Statement or any post-effective amendment thereto, or incorporated by reference therein, has been duly authorized, executed and delivered by the Company and the other parties thereto; and (viii) in the case of an Indenture, Warrant Agreement, Certificate of Designation or other agreement or instrument pursuant to which any Securities are to be issued, there shall be no terms or provisions contained therein which would affect the validity of any of the opinions rendered herein.

We also have assumed that (i) the Senior Indenture will be, and the Subordinated Indenture has been, duly authorized, executed and delivered by the Senior Indenture Trustee and the Subordinated Indenture Trustee, respectively, and that any Debt Securities that may be issued will be authenticated by duly authorized officers of the Senior Indenture Trustee or the Subordinated Indenture Trustee, as the case may be; and (ii) any Warrant Agreements will be duly authorized, executed, delivered and duly signed by the applicable parties thereto other than the Company. We have also assumed that the Indentures are the valid and legally binding obligations of the Senior Indenture Trustee and Subordinated Indenture Trustee.

Any opinion set forth herein as to enforceability of obligations of the Company is subject to: (i) bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or similar laws affecting the enforcement of creditors’ rights generally, and by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law) and the discretion of the court before which any proceedings therefore may be brought (such principles of equity are of general application, and in applying such principles, a court might include a covenant of good faith and fair dealing and apply concepts of reasonableness and materiality); (ii) provisions of law which may require that a judgment for money damages rendered by a court in the United States be expressed only in U.S. dollars; (iii) requirements that a claim with respect to any Debt Securities denominated other than in U.S. dollars (or a judgment denominated other than in U.S. dollars in respect of such claim) be converted into U.S. dollars at a rate of exchange prevailing on a date determined pursuant to applicable law; and (iv) governmental authority to limit, delay or prohibit the making of payments outside the United States or in foreign currency or composite currency. Rights to indemnification and contribution may also be limited by Federal and state securities laws.

We express no opinion as to the validity, legally binding effect or enforceability of any provision in any agreement or instrument that (i) requires or relates to payment of any interest at a rate or in an amount which a court would determine in the circumstances under applicable law to be commercially unreasonable or a penalty or a forfeiture or (ii) relates to governing law and submission by the parties to the jurisdiction of one or more particular courts.

This opinion is limited to the laws of the State of New York and the following statutes: the General Corporation Law of the State of Delaware; the Delaware Limited Liability Company Act; the Delaware Revised Uniform Partnership Act; the California Corporations Code; the Florida Business Corporation Act; and the Florida Revised Limited Liability Company Act. Where the laws of other jurisdictions as to the Guarantors are relevant to such opinions, we have to the extent necessary in connection with the opinions contained herein, relied upon the following opinions, dated the date hereof, that have been filed

 

4


with the Commission as exhibits to the Registration Statement: (i) Briskin, Cross & Sanford, LLC, with respect to the Georgia Guarantors; (ii) Daneker, McIntire, Schumm, Prince, Manning & Widmann, P.C., with respect to the Illinois and Maryland Guarantors; (iii) Bingham Greenebaum Doll LLP, with respect to the Indiana and Ohio Guarantors; (iv) Hancock, Daniel, Johnson & Nagle, P.C., with respect to the Kentucky, South Carolina, Virginia and West Virginia Guarantors; (v) Taylor Porter Brooks & Phillips, L.L.P., with respect to the Louisiana Guarantors; (vi) Plunkett Cooney, P.C., with respect to the Michigan Guarantors; (vii) McAfee & Taft, A Professional Corporation, with respect to the Oklahoma Guarantors; (vii) Carmody MacDonald P.C., with respect to the Missouri Guarantors; (x) Shaheen & Gordon, P.A., with respect to the New Hampshire Guarantors; (ix) Stoel Rives LLP, with respect to the Washington Guarantors; (xii) Stradley Ronon Stevens & Young, LLP, with respect to the New Jersey and Pennsylvania Guarantors; (xii) Davenport, Evans, Hurwitz & Smith, LLP, with respect to the South Dakota Guarantors; and (xii) Davis & Kuelthau, S.C., with respect to the Wisconsin Guarantors. The Securities may be issued from time to time on a delayed or continuous basis, but this opinion is limited to the laws, including the rules and regulations thereunder, as in effect on the date hereof. We disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or opinions set forth herein.

We hereby consent to the filing of this opinion with the Commission as Exhibit 5.1 to the Registration Statement. We also consent to the reference to our firm under the heading “ Legal Matters ” in the Registration Statement. In giving this consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

Very truly yours,

/s/ White & Case LLP

MR/PM/AG/JDC

 

5

Exhibit 5.2

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, OH 45202

 

  Re: Omnicare, Inc.

Medical Arts Health Care, Inc.

Pharmasource Healthcare, Inc.

Ladies and Gentlemen:

We have served as counsel to Medical Arts Health Care, Inc., a Georgia corporation ( “MAHC” ) and Pharmasource Healthcare, Inc., a Georgia corporation ( “PHI” ), both of which are wholly owned subsidiaries of Omnicare, Inc., a Delaware corporation ( “Omnicare” ), in connection with the preparation and filing of the Form S-3 Registration Statement (the “Registration Statement” ) of Omnicare. Capitalized terms used but not defined herein have the meanings ascribed to them in the Indentures (as defined below).

In connection with our representation of MAHC and PHI (each also known as a “Guarantor” and known collectively as the “Guarantors” or the “Companies” ), and as a basis for the opinions hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (hereinafter collectively referred to as the “ Documents ”):

(A) The Articles of Incorporation and Certificate of Incorporation of MAHC (the “MAHC Charter” ), dated July 29, 1986 by the Corporations Division of the Secretary of State of the State of Georgia (the “Georgia SOS” );

(B) The Bylaws of MAHC, as in effect on the date hereof (the “MAHC Bylaws” );

(C) The Certificate of Existence with respect to MAHC issued on October 20, 2014 by the Georgia SOS (the “MAHC Certificate” );

(D) The Articles of Incorporation and Certificate of Incorporation of PHI (the “PHI Charter” ), dated August 12, 1993 by the Georgia SOS;

(E) The Bylaws of PHI, as in effect on the date hereof (the “PHI Bylaws” );

(F) The Certificate of Existence with respect to PHI issued on October 20, 2014 by the Georgia SOS (the “PHI Certificate” );


Opinion Letter

Omnicare, Inc.

November 5, 2014

Page 2 of 4

 

(G) The Subordinated Debt Securities Indenture, dated June 13, 2003, between Omnicare and U.S. Bank National Association (successor trustee to SunTrust Bank), Trustee (the “Subordinated Debt Securities Indenture” );

(H) The Form of Senior Debt Securities Indenture (the “Senior Debt Securities Indenture” and, together with the Subordinated Debt Securities Indenture, the “Indentures” ) between Omnicare and the trustee party thereto; and

(I) Such other documents as we have considered necessary or appropriate to the rendering of the opinions expressed below.

In our examination of the Documents, we have assumed, without independent investigation, (a) the genuineness of all signatures, (b) the legal capacity of all individuals who have executed any of the Documents, (c) the authenticity of all documents submitted to us as originals, (d) the conformity with originals of all documents submitted to us as copies (and the authenticity of the originals of such copies), (e) the accuracy and completeness of all public records and certificates reviewed by us, and (f) the completeness of all documents submitted to us and the lack of any undisclosed modifications, waivers or amendments to any agreements or other documents examined by us.

In making our examination of documents, we have assumed that such parties had the power, corporate or other, to enter into and perform all obligations thereunder, and we have also assumed the due authorization by all requisite action, corporate or other, the valid execution by such parties and delivery by such parties of such documents and the validity, binding effect and enforceability thereof with respect to such parties. As to any facts material to this opinion, we have relied solely upon the MAHC Certificate and the PHI Certificate and have not independently verified the matters stated therein. We have made no independent investigation concerning the possible existence or state of any facts that might be relevant to any of the matters covered in this opinion.

In rendering this opinion, we have relied upon and assumed the correctness and completeness of certificates of public officials and we have not examined any court records, dockets or other public records and we have made no investigation as to the history or other transactions except as specifically set forth herein.

The phrase “our knowledge” is limited to the actual knowledge, without independent inquiry, of the lawyers at our firm who have performed legal services in connection with the issuance of this opinion letter, or the transactions described in this opinion letter. The phrase “our organizational representation” means legal services performed by lawyers at our firm with respect to and in connection with the review of the materials referenced herein and the issuance of this opinion.

Based upon the foregoing, having regard for such legal considerations as we deem relevant and subject to the assumptions, limitations and qualifications stated herein, it is our opinion that, as of the date of this letter:

1. MAHC is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Georgia;


Opinion Letter

Omnicare, Inc.

November 5, 2014

Page 3 of 4

 

2. PHI is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Georgia;

3. Each of MAHC and PHI has been incorporated under the Georgia Business Corporation Act, and the status for each is active;

4. Each of MAHC and PHI has the corporate power and capacity to guarantee the Debt Securities pursuant to the terms of the Indentures and perform its obligations under the Debt Guarantees;

5. The Debt Guarantees, upon being authorized by all necessary corporate action, executed by an authorized signatory and delivered, will be validly authorized, executed, and delivered for corporate law purposes by each Guarantor; and

6. In addition to the qualifications set forth above, the foregoing opinion is further qualified as follows:

(A) We have made no investigation as to, and we express no opinion as to, the laws of any jurisdiction other than the laws of the State of Georgia, and the federal laws of the United States of America. To the extent that any documents referred to herein are governed by and construed in accordance with the laws of a jurisdiction other than the State of Georgia, we have assumed that the laws of such jurisdiction are the same as the laws of the State of Georgia. Our opinions in Paragraph 6 are limited only to those laws, rules, or regulations of the State of Georgia or the United States of America that a lawyer in Georgia exercising customary professional diligence would reasonably recognize as being directly applicable to the Company, any of the Company’s Subsidiaries or the Company Transaction Documents.

(B) This opinion concerns only the effect of the laws (excluding the principles of conflict of laws) of the State of Georgia and the federal laws of the United States of America as currently in effect. We assume no obligation to update or supplement this opinion if any applicable laws change after the date hereof or if any facts or circumstances come to our attention after the date hereof that might change this opinion.

(C) We express no opinion as to compliance with the securities, tax, environmental, or antitrust laws of any jurisdiction.

(D) We express no opinion with respect to any matters subject to the jurisdiction of the Federal Communications Commission or any other comparable state or federal regulatory commission.

(E) The opinions set forth herein are subject to the following limitation, namely that enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, receivership, reorganization, moratorium or other laws affecting creditors’ rights generally, to general principles of equity regardless of whether considered in a proceeding in equity or at law, and to public policy principles;


Opinion Letter

Omnicare, Inc.

November 5, 2014

Page 4 of 4

 

(F) With respect to our opinion expressed in paragraph 1, we have relied solely upon the MAHC Certificate referred to above to the effect that the MAHC is duly incorporated and in good standing under the laws of the State of Georgia; and

(G) With respect to our opinion expressed in paragraph 2, we have relied solely upon the PHI Certificate referred to above to the effect that PHI is duly incorporated and in good standing under the laws of the State of Georgia.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Securities and Exchange Commissioner thereunder.

Sincerely,

B RISKIN , C ROSS  & S ANFORD , LLC

/s/ Michael D. Cross, Jr.

Exhibit 5.3

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

 

  Re: Opinion as NCS HealthCare of Illinois, LLC

Ladies and Gentlemen:

We have been retained as local counsel for Illinois law and have been requested to provide an opinion of counsel under Illinois law with reference to NCS HealthCare of Illinois, LLC , an Illinois limited liability company (the “ Subsidiary ”) in connection with the Subsidiary’s guarantees of debt securities to be issued by Omnicare, Inc. (“ Omnicare ”), pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”) , between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ” and, each an “ Indenture ”), between the Company and U.S. Bank National Association (successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Company’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014. We have not represented Omnicare, Inc. or any of its Subsidiaries generally and do not represent Omnicare or its subsidiaries on any other matter. Unless otherwise defined herein, the definitions in the Indenture apply to this letter.

We have assumed that Omnicare has duly executed and delivered all documents required of it pursuant to the Indentures and that all of its obligations thereunder are binding upon it and enforceable in accordance with all provision of applicable law.


I. Good Standing

We have first examined and have relied upon and assumed the accuracy and completeness of the records of the website of the Illinois Secretary of State where corporate, limited partnership and limited liability company registration records are maintained. As of October 21, 2014, the Subsidiary was in good standing according to the Illinois Secretary of State records. We have examined a Certificate of good standing dated October 20, 2014.

Our opinion then is as follows:

 

  1) With respect to the above Subsidiary, as of the date of this letter, but not later than November 5, 2014, the Subsidiary was duly formed as an Illinois limited liability company under Illinois law.

 

  2) The Subsidiary is in good standing in the State of Illinois and is active and authorized to do business in Illinois, and is therefore prima facie empowered to take all acts consistent with Illinois limited liability company law and the articles of organization, as amended, and operating agreement as they are in effect as of this date.

The opinion is conditioned upon no order or decree of any court having been entered appointing a receiver or trustee for the Subsidiary, no court having modified the authority of the Subsidiary, and no court or the Subsidiary having taken an action to dissolve the Subsidiary without our knowledge, and that no proceeding under the Bankruptcy Code has been filed.

II. Corporate Authority to Execute Guarantee and Enforceability of Subsidiary Guarantee

We have examined the following documents which have been represented to us as the current and complete currently applicable Articles of Organization and Operating Agreement (hereafter collectively referred to as the “Subsidiary Company Documents”).

1) Articles of Organization of NCSILL Acquisition Sub, LLC dated November 3, 2005.

2) Articles of Amendment filed January 4, 2006 evidencing the withdrawal of one sole member in favor of another sole member.

3) Articles of Merger filed July 14, 2006 of NCS HealthCare of Illinois, Inc. and NCSILL Acquisition Sub, LLC with NCS HealthCare of Illinois LLC as the surviving entity.

4) Limited Liability Company Agreement of NCS HealthCare of Illinois, LLC dated July 12, 2006

We have examined a form of the Senior Notes Indenture. We have also examined the Subordinated Notes Indenture.


We assume that the signatures on the documents of the limited liability company and any predecessor and the signatures of the member(s) of the limited liability company are the genuine signatures of the persons purporting to sign the documents. For purposes of this opinion, Omnicare and the Subsidiary may rely on a certificate of the Manager, Managing Member, President or the Secretary of the Subsidiary that to the best of the knowledge of the duly authorized officer executing the guarantee, the signatures on the Subsidiary Company Documents are genuine and were duly authorized at the time of execution.

We are relying on the required certificates for the truth of the matters contained therein.

Relying on the documents provided to us and relying on the statements in the above-stated certificates that those are the only documents which are the Articles and by-laws/operating agreement, we reach the following conclusions:

1) The Subsidiary has the corporate power and capacity under Illinois law to guarantee the Debt Securities pursuant to the terms of the Indentures and has the corporate power and capacity under Illinois law to perform the Subsidiary’s obligations with respect to the guarantee of the debt securities in the Indentures.

2) Accordingly, the guarantee by the Subsidiary under the Indentures, upon being duly authorized by all necessary limited liability company action, executed by all of the members of the Subsidiary, and delivered, will be validly authorized, executed and delivered for Illinois corporate law purposes by the Subsidiary.

Qualifications to opinion:

This letter is furnished to Omnicare, Inc. and its Subsidiary at their request, and is furnished for the benefit of the Trustee under each Indenture solely in their capacity as a Trustee, and the Holder(s) of a Security(ies), as defined in each respective Indenture. We give no opinion as to the adequacy of any securities disclosure or compliance with any securities law. The information set forth herein is limited to the period through the date of this letter except as to later dates set forth in this letter , and we undertake no obligation or responsibility to update or supplement this opinion in response to or to make you aware of subsequent changes in the status of Omnicare or any subsidiary with respect to which this opinion is being rendered, or the law or future events or information affecting the transactions contemplated by the documents relating to this transaction. We have conducted no investigation or review of the business of Omnicare, or the Guarantor referenced in this letter, except as specifically delineated in this letter. The foregoing opinion should not be construed as relating to any matter other than the specific matters discussed herein. We express no opinion with respect to compliance by Omnicare or the Subsidiary under any U.S. or state securities laws.


We express our opinion under Illinois law only without regard to choice of law or conflicts of law provisions. The rights of any Holder of Securities as defined in the Indenture, and the enforceability of the securities, the Indenture, indemnifications, and any other agreements or obligations referred to herein are subject to (i) the exercise of judicial discretion in accordance with general principles of equity (whether applied by a court of law or a court of equity), including without limitation, judicial limitations on rights to specific performance, and concepts of materiality, reasonableness, good faith and fair dealing; (ii) the valid exercise of the constitutional powers of the United States of America and of the sovereign police and taxing powers of state or other governmental units having jurisdiction; and (iii) bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws heretofore or hereafter in effect affecting creditors’ rights generally, (iv) judicially developed doctrines in these latter areas, such as substantive consolidation of entities and equitable subordination, and (v) adequacy or fairness of consideration received by a particular corporate entity, including the Subsidiary; and limitations on enforceability of rights to attorneys’ fees and expenses. Enforceability of the provisions pertaining to indemnification and our opinion herein may also be further limited by applicable securities laws and public policy. Without limiting the generality of the foregoing, under the Bankruptcy Reform Act of 1978, as amended by the Bankruptcy Amendments and Federal Judgeship Act of 1984, provisions thereof providing for acceleration of maturity in the event of insolvency or bankruptcy may be invalid, and the rights and remedies of acceleration and foreclosure, if any, under such circumstances may not be enforceable. In addition, enforcement of the securities and the Indenture may each be limited to the extent that a court of competent jurisdiction would determine that adequate consideration or value has not been received by Omnicare, Inc, or the applicable Subsidiary to which this opinion pertains to support the Subsidiary’s respective guarantee and any grant of security interests.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm of White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the


category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

DANEKER, McINTIRE, SCHUMM,

PRINCE, MANNING & WIDMANN, P.C.

/s/Brooke Schumm III

BY: Brooke Schumm III

Exhibit 5.4

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

 

  RE: Opinion as to the following entities in connection with Indentures

1. NeighborCare Repackaging, Inc. (“NeghbrCare Repkg”)

2. Professional Pharmacy Services, Inc. (“PPS, Inc.”)

3. ASCO Healthcare of New England, LLC (“ASCO HENE, LLC”)

4. NeighborCare Pharmacies, LLC

5. ASCO Healthcare, LLC

6. ASCO Healthcare of New England, Limited Partnership (“ASCO HC, LP”)

7. Main Street Pharmacy, L.L.C.

Ladies and Gentlemen:

We have been retained as local counsel in Maryland and have been requested to provide an opinion of counsel under Maryland law with reference to the above-named subsidiaries of Omnicare, LLC which are organized or incorporated under the laws of Maryland (collectively, “Subsidiaries”) in connection with the Subsidiaries’ guarantees of debt securities to be issued by Omnicare, Inc. (“ Omnicare ”), pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”) , between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ” and, each an “ Indenture ”), between the Company and U.S. Bank National Association (successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Company’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014. We have not represented Omnicare, Inc. or any of its subsidiaries generally and do not represent Omnicare or its subsidiaries on any other matter. Unless otherwise defined herein, the definitions in the Indenture apply to this letter.


We have assumed that Omnicare, Inc. has duly executed and delivered all documents required of it pursuant to the Indentures and that all of its obligations thereunder are binding upon it and enforceable in accordance with all provision of applicable law.

I. Good Standing

We have first examined and have relied upon and assumed the accuracy and completeness of the records of the website of the Maryland State Department of Assessments and Taxation where corporate, limited partnership and limited liability company registration records are maintained, referred to locally as “SDAT.”

As of October 27, 2014, all of these Subsidiaries listed below in bold letters were in good standing according to the SDAT records. We have examined a Certificate of Good Standing dated October 20, 2014 for all entities issued by SDAT transmitted to us electronically and a Certificate of Good Standing for Main Street Pharmacy, L.L.C. dated October 27, 2014 issued by SDAT transmitted to us electronically.

 

  A. Maryland corporations

 

  1. NeighborCare Repackaging, Inc. (“NeghbrCare Repkg”)

 

  2. Professional Pharmacy Services, Inc.

Our opinion then is as follows:

 

  1) With respect to the above Maryland corporations, as of the date of this letter, but not later than November 5, 2014, they were duly formed as a Maryland Corporation under the Maryland Corporations and Associations Article.

 

  2) These Maryland corporations are in good standing in the State of Maryland and are active and authorized to do business in Maryland, and are therefore prima facie empowered to take all acts consistent with Maryland corporate law and their respective articles of incorporation, as amended, and by-laws, as they are in effect as of this date.

 

  B. Maryland limited liability companies

 

  1. ASCO Healthcare of New England, LLC (“ASCO HENE, LLC”)

 

  2. NeighborCare Pharmacies, LLC

 

  3. ASCO Healthcare, LLC

 

  4. Main Street Pharmacy, L.L.C.


Our opinion then is as follows:

 

  1) With respect to these LLC Subsidiaries, as of the date of this letter, but not later than November 5, 2014, each Subsidiary was duly formed as a Maryland limited liability company under the Maryland Limited Liability Company Act.

 

  2) All of these LLC Subsidiaries are in good standing in the State of Maryland and are active and authorized to do business in Maryland, and are therefore prima facie empowered to take all acts consistent with Maryland corporate law and each Subsidiary’s Articles of Organization and Operating Agreement, as amended, as they are in effect as of this date.

 

  C. Maryland limited partnership

 

  1. ASCO Healthcare of New England, Limited Partnership (“ASCO HC, LP”)

Our opinion then is as follows:

 

  1) With respect to the above ASCO HC, LP, as of the date of this letter, but not later than November 5, 2014, the Subsidiary was duly formed as a Maryland limited partnership under the Maryland Limited Partnership Act.

 

  2) The Subsidiary is in good standing in the State of Maryland and is active and authorized to do business in Maryland, and is therefore prima facie empowered to take all acts consistent with Maryland corporate law and Subsidiary’s Certificate of Limited Partnership and Agreement of Limited Partnership, as amended, as they are in effect as of this date.

This opinion is conditioned upon no order or decree of any court having been entered appointing a receiver or trustee for the Subsidiary, no court having modified the authority of the subsidiary, and no court or the Subsidiary having taken an action to dissolve the subsidiary without our knowledge, and that no proceeding under the Bankruptcy Code has been filed.

II. Corporate Authority to Execute Guarantee and Enforceability of Subsidiary Guarantee

 

  A. Introduction

We have examined a form of the Senior Notes Indenture. We have also examined the Subordinated Notes Indenture.


  B. Maryland corporations:

 

  1. NeighborCare Repackaging, Inc. (“NeghbrCare Repkg”)

 

  2. Professional Pharmacy Services, Inc.

We have examined the following documents which have been represented to us as the current and complete currently applicable Articles of Incorporation, and we have been provided a copy of the current and complete by-laws. We assume that the signatures on the documents of the corporation and any predecessor and the signatures of the officers, or Board of Directors members, if applicable, are the genuine signatures of the persons purporting to sign the documents. For purposes of this opinion, Omnicare and the Subsidiary may rely on a certificate of the President or the Secretary of the Subsidiary that to the knowledge of the duly authorized officer executing the guarantee, the signatures on the Subsidiary Company Documents are genuine and were duly authorized at the time of execution.

We are relying on the required certificates for the truth of the matters contained therein.

Articles of Amendment dated July 8, 2005 changing the corporate name from NeighborCare Manufacturing, Inc. to NeighborCare Repackaging, Inc.

 

  1) Articles of Incorporation of NeighborCare Manufacturing, Inc. dated May 25, 2004

 

  2) Signed but undated Bylaws of NeighborCare Manufacturing, Inc.

 

  3) Articles of Merger of CareCard, Inc. and Professional Pharmacy Services, Inc. dated December 31, 2013 with PPS, Inc. as the surviving corporation

 

  4) Articles of Merger dated June 5, 1996 of Professional Pharmacy Services, Inc. into PPS Acquisition Corp. as survivor which changed its name in the Articles to Professional Pharmacy Services, Inc.

 

  5) Articles of Incorporation of PPS Acquisition Corp. dated April 19, 1996

 

  6) Amended and Restated Bylaws of Professional Pharmacy Service, Inc. dated November 20, 2006 which are undated and unsigned but will be certified to be the currently applicable bylaws.


Relying on the documents provided to us and relying on the statements in the above-stated certificates that those are the only documents which are the Articles of Incorporation and by-laws, we reach the following conclusions:

1) NeighborCare Repackaging, Inc. and PPS, Inc. have the corporate power and capacity under Maryland law to guarantee the Debt Securities pursuant to the terms of the Indenture and have the corporate power and capacity under Maryland law to perform their respective obligations with respect to the guarantee of the debt securities in the Indenture.

2) Accordingly, the guarantee by NeighborCare Repackaging, Inc. and PPS, Inc. under the Indenture, upon being duly authorized by a valid Board of Directors resolution, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for Maryland corporate law purposes by the respective Maryland corporation.

 

  C. Maryland Limited Liability Companies

We have examined the following documents which have been represented to us as the current and complete currently applicable Articles of Organization and Operating Agreement (hereafter collectively referred to as the “Subsidiary Company Documents”).

We assume that the signatures on the documents of the limited liability company and any predecessor and the signatures of the member(s) of the limited liability company are the genuine signatures of the persons purporting to sign the documents. For purposes of this opinion, Omnicare and the Subsidiary may rely on a certificate of the Manager, Managing Member, President or the Secretary of the Subsidiary that to the best of the knowledge of the duly authorized officer executing the guarantee, the signatures on the Subsidiary Company Documents are genuine and were duly authorized at the time of execution.

We are relying on the required certificates for the truth of the matters contained therein.

 

  1. ASCO Healthcare of New England, LLC (“ASCO HENE, LLC”)

We have examined the following documents which have been represented to us as the current and complete currently applicable Articles of Organization and Operating Agreement. (hereafter collectively referred to as the “Subsidiary Company Documents”).

 

  1) Articles of Organization for AHNE Acquisition Sub, LLC filed October 11, 2005.

 

  2) Articles of Merger of ASCO Healthcare of New England, Inc. and AHNE Acquisition Sub, LLC with the surviving entity being named ASCO Healthcare of New England, LLC filed July 6, 2006

 

  3) Limited Liability Company Agreement of ASCO Healthcare of New England, LLC dated July 6, 2006


Relying on the documents provided to us and relying on the statements in the above-stated certificates that those are the only documents which are the Articles and operating agreement, we reach the following conclusions:

1) ASCO HENE, LLC has the corporate power and capacity under Maryland law to guarantee the Debt Securities pursuant to the terms of the indenture and has the corporate power and capacity under Maryland law to perform the Subsidiary’s obligations with respect to the guarantee of the debt securities in the Indenture.

2) Accordingly, the guarantee by ASCO HENE, LLC under the Indenture, upon being duly authorized by all necessary limited liability company action executed by the managing member and delivered, will be validly authorized, executed and delivered for corporate law purposes by this Maryland Subsidiary.

 

  2. NeighborCare Pharmacies, LLC

We have examined the following documents which have been represented to us as the current and complete currently applicable Articles of Organization and Operating Agreement. (hereafter collectively referred to as the “Subsidiary Company Documents”).

 

  1) Articles of Organization for NeighborCare Pharmacies, LLC filed October 11, 2005.

 

  2) Articles of Merger of NCP Acquisition Sub, LLC and NeighborCare Pharmacies, Inc. with the surviving entity being named NeighborCare Pharmacies, LLC filed June 27, 2006

 

  3) Limited Liability Company Agreement of NeighborCare Pharmacies, LLC dated June 8, 2006

Relying on the documents provided to us and relying on the statements in the above-stated certificates that those are the only documents which are the Articles and operating agreement, we reach the following conclusions:

1) NeighborCare Pharmacies, LLC has the corporate power and capacity under Maryland law to guarantee the Debt Securities pursuant to the terms of the indenture and has the corporate power and capacity under Maryland law to perform the Subsidiary’s obligations with respect to the guarantee of the debt securities in the Indenture.

2) Accordingly, the guarantee by NeighborCare Pharmacies, LLC under the Indenture, upon being duly authorized by all necessary limited liability company action executed by the managing member and delivered, will be validly authorized, executed and delivered for corporate law purposes by this Maryland Subsidiary.


  3. ASCO Healthcare, LLC

We have examined the following documents which have been represented to us as the current and complete currently applicable Articles of Organization and Operating Agreement. (hereafter collectively referred to as the “Subsidiary Company Documents”).

 

  1) Articles of Organization for AH Acquisition Sub, LLC filed October 13, 2005.

 

  2) Articles of Merger of ASCO Healthcare, Inc. and AH Acquisition Sub, LLC with the surviving entity being named ASCO Healthcare, LLC filed July 1, 2006

 

  3) Limited Liability Company Agreement of ASCO Healthcare, LLC dated July 27, 2006

Relying on the documents provided to us and relying on the statements in the above-stated certificates that those are the only documents which are the Articles and operating agreement, we reach the following conclusions:

1) ASCO Healthcare, LLC has the corporate power and capacity under Maryland law to guarantee the Debt Securities pursuant to the terms of the indenture and has the corporate power and capacity under Maryland law to perform the Subsidiary’s obligations with respect to the guarantee of the debt securities in the Indenture.

2) Accordingly, the guarantee by ASCO Healthcare, LLC under the Indenture, upon being duly authorized by all necessary limited liability company action executed by the managing member and delivered, will be validly authorized, executed and delivered for corporate law purposes by this Maryland Subsidiary.

 

  4. Main Street Pharmacy, L.L.C.

We have examined the following documents which have been represented to us as the current and complete currently applicable Articles of Organization and Operating Agreement. (hereafter collectively referred to as the “Subsidiary Company Documents”).

 

  4) Articles of Organization for Main Street Pharmacy, L.L.C. dated April 25, 1995. The LLC is due to cease to exist on December 31, 2015.

 

  5) Second Amended and Restated Limited Liability Company Agreement of Main Street Pharmacy, L.L.C. dated April 21, 2008


Relying on the documents provided to us and relying on the statements in the above-stated certificates that those are the only documents which are the Articles and operating agreement, we reach the following conclusions:

1) Main Street Pharmacy, L.L.C. has the corporate power and capacity under Maryland law to guarantee the Debt Securities pursuant to the terms of the indenture and has the corporate power and capacity under Maryland law to perform the Subsidiary’s obligations with respect to the guarantee of the debt securities in the Indenture while the limited liability company exists.

2) Accordingly, the guarantee by Main Street Pharmacy, L.L.C. under the Indenture, upon being duly authorized by all necessary limited liability company action executed by the managing member and delivered, will be validly authorized, executed and delivered for corporate law purposes by this Maryland Subsidiary.

 

  D. Maryland Limited Partnership

 

  1. ASCO Healthcare of New England Limited Partnership

We have examined the following documents which have been represented to us as the current and complete currently applicable Certificate of Limited Partnership and Limited Partnership Agreement (hereafter collectively referred to as the “Subsidiary Company Documents”).

We assume that the signatures on the documents of the limited partnership and any predecessor and the signatures of the stated partners of the limited liability company are the genuine signatures of the persons purporting to sign the documents. For purposes of this opinion, Omnicare and the Subsidiary may rely on a certificate of the general partner that to the best of the knowledge of the duly authorized officer executing the guarantee, the signatures on the Subsidiary Company Documents are genuine and were duly authorized at the time of execution.

We are relying on the required certificates for the truth of the matters contained therein.

 

  1) Certificate of Limited Partnership of ASCO Healthcare of New England Limited Partnership dated May 31, 1994

 

  2) Agreement of Limited Partnership dated May 31, 1994


Relying on the documents provided to us and relying on the statements in the above-stated certificates that those are the only documents which are the Subsidiary Company Documents, we reach the following conclusions:

1) The Subsidiary has the corporate power and capacity to guarantee the Debt Securities pursuant to the terms of the indenture and has the corporate power and capacity to perform the Subsidiary’s obligations with respect to the guarantee of the debt securities in the Indenture.

2) Accordingly, the guarantee by the Subsidiary under the Indenture, upon being duly authorized by all necessary general partner action executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for corporate law purposes by this Maryland Subsidiary.

III. Qualifications to opinion:

This letter is furnished to Omnicare, Inc. and its Subsidiary at their request, and is furnished for the benefit of the Trustee under each Indenture solely in their capacity as a Trustee, and the Holder(s) of a Security(ies), as defined in each respective Indenture. We give no opinion as to the adequacy of any securities disclosure or compliance with any securities law. The information set forth herein is limited to the period through the date of this letter except as to later dates set forth in this letter , and we undertake no obligation or responsibility to update or supplement this opinion in response to or to make you aware of subsequent changes in the status of Omnicare, Inc. or any subsidiary with respect to which this opinion is being rendered, or the law or future events or information affecting the transactions contemplated by the documents relating to this transaction. We have conducted no investigation or review of the business of Omnicare, Inc. or the Guarantor referenced in this letter, except as specifically delineated in this letter. The foregoing opinion should not be construed as relating to any matter other than the specific matters discussed herein. We express no opinion with respect to compliance by Omnicare, Inc. or the Subsidiary under any U.S. or state securities laws.

We express our opinion under Maryland law only without regard to choice of law or conflicts of law provisions. The rights of any Holder of Securities as defined in the Indenture, and the enforceability of the securities, the Indenture, indemnifications, and any other agreements or obligations referred to herein are subject to (i) the exercise of judicial discretion in accordance with general principles of equity (whether applied by a court of law or a court of equity), including without limitation, judicial limitations on rights to specific performance, and concepts of materiality, reasonableness, good faith and fair dealing; (ii) the valid exercise of the constitutional powers of the United States of America and of the sovereign police and taxing powers of state or other


governmental units having jurisdiction; and (iii) bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws heretofore or hereafter in effect affecting creditors’ rights generally, (iv) judicially developed doctrines in these latter areas, such as substantive consolidation of entities and equitable subordination, and (v) adequacy or fairness of consideration received by a particular corporate entity, including the Subsidiary; and limitations on enforceability of rights to attorneys’ fees and expenses. Enforceability of the provisions pertaining to indemnification and our opinion herein may also be further limited by applicable securities laws and public policy. Without limiting the generality of the foregoing, under the Bankruptcy Reform Act of 1978, as amended by the Bankruptcy Amendments and Federal Judgeship Act of 1984, provisions thereof providing for acceleration of maturity in the event of insolvency or bankruptcy may be invalid, and the rights and remedies of acceleration and foreclosure, if any, under such circumstances may not be enforceable. In addition, enforcement of the securities and the Indenture may each be limited to the extent that a court of competent jurisdiction would determine that adequate consideration or value has not been received by Omnicare, Inc, or the applicable respective Subsidiary to which this opinion pertains to support the Subsidiary’s respective guarantee and any grant of security interests.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm of White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

DANEKER, McINTIRE, SCHUMM,

PRINCE, MANNING & WIDMANN, P.C.

/s/Brooke Schumm III

BY: Brooke Schumm III

Exhibit 5.5

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 East Fourth Street

Cincinnati OH 45202

 

  Re: Form S-3 Registration Statement of Omnicare, Inc.

Ladies and Gentlemen:

This opinion is furnished to you upon the express instruction and request of our clients, NCS Healthcare of Indiana, Inc. and NeighborCare of Indiana, LLC (together, the “ Indiana Guarantors ”) relating to the issuance, from time to time, of Senior Debt Securities and Subordinated Debt Securities (the “ Debt Securities ”) by Omnicare, Inc. pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”), between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ” and, each an “ Indenture ”), between the Company and U.S. Bank National Association (successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Company’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Indentures.

We have acted as special counsel in the State of Indiana (the “ State ”) to the Indiana Guarantors in connection with the above-captioned matter. In such capacity as special counsel to the Indiana Guarantors, we have reviewed or examined, and are familiar with, originals or copies, certified or otherwise identified to our satisfaction, of the following documents:

 

  (a) The Quality Health Care NCS, Inc. Articles of Incorporation, dated May 5, 1995;

 

  (b) The Articles of Merger of Corinthian Healthcare Systems, Inc. into Quality Health Care NCS, Inc. (with NCS Healthcare of Indiana, Inc. as the name of the surviving corporation), dated May 5, 1995;

 

  (c) The Quality Health Care NCS, Inc. Bylaws, dated May 8, 1995;

 

  (d) The NCOI Acquisition Sub, LLC Articles of Organization, dated November 2, 2005;


Indiana Guarantors

November 5, 2014

Page 2 of 5

 

  (e) The Articles of Cross-Species Merger of NeighborCare of Indiana, Inc. into NCOI Acquisition Sub, LLC (with NeighborCare of Indiana, LLC as the name of the surviving LLC), dated July 6, 2006;

 

  (f) The NeighborCare of Indiana, LLC Limited Liability Company Agreement, dated July 6, 2006;

 

  (g) Action by Unanimous Written Consent in Lieu of Meeting of the Board of Directors of NCS Healthcare of Indiana, Inc., dated October 24, 2014;

 

  (h) Action by Unanimous Written Consent in Lieu of Meeting of the Members and the Board of Managers of NeighborCare of Indiana, LLC, dated October 24, 2014; and

 

  (i) The Certificates of Existence for NCS Healthcare of Indiana, Inc. and NeighborCare of Indiana, LLC issued by the Indiana Secretary of State, each dated October 20, 2014 (collectively referred to herein as the “ Certificates of Existence ”).

The documents listed as items (a) through (i) [inclusive] above are sometimes collectively referred to herein as the “ Authority Documents .”

In rendering our opinion we have examined and relied upon the Authority Documents, and have not examined any other corporation or limited liability company documents and records or other certificates or instruments. As to various questions of fact material to our opinion, we have relied upon the Authority Documents and other certificates and written statements of the Indiana Guarantors, but we have no knowledge that any of such statements are inaccurate or incomplete.

In addition, as to certain facts material to our opinion which we did not independently establish or verify, we have relied upon written representations of the duly authorized officers or other representatives of the Indiana Guarantors, the Authority Documents, and other documents executed in connection therewith and/or referenced herein. We have not independently reviewed, established or verified the accuracy or completeness of the information set forth or certified in such documents. However, we have no reason to believe that the information contained in such documents is not complete and accurate. Except as otherwise expressly stated herein, this opinion should in no way be construed as passing upon the accuracy or completeness of any of the representations or warranties which may be or have been made to you in the Indentures (or documents referenced therein), the Authority Documents, or on any other matters, legal or otherwise, not specifically covered herein.

We further advise you that our representation of the Indiana Guarantors has been limited to this particular matter and, with respect to this particular matter, has been limited and does not involve an overall or detailed knowledge of the affairs, business operations or financial


Indiana Guarantors

November 5, 2014

Page 3 of 5

 

condition, past or present, of the Indiana Guarantors. Furthermore, we have not made any special examination of and are not expressing an opinion regarding the affairs or financial condition of the Indiana Guarantors.

We are qualified to practice law only in the State and we do not purport to be experts on, or to express an opinion herein concerning, the law of any jurisdiction other than the State and the laws of the United States of general application to transactions in the State. We express no opinion as to (i) the laws of any other jurisdiction, (ii) matters of municipal law or the laws of any local agencies within any state or (iii) state or federal tax, securities or antitrust laws. We further express no opinion with respect to the effect of any law other than the law of the State and the federal law of the United States. To the extent that the interpretation, construction or enforcement of the Indentures and the other documents referred to herein may be governed by the laws of any jurisdiction other than that of the State, we have assumed that the laws of such jurisdiction are identical to the laws of the State.

As used herein with respect to the existence or absence of facts, “to our knowledge,” “known to us,” or words or phrases of similar import shall mean, during the course of our representation of the Indiana Guarantors, no information that would give us current actual knowledge of the accuracy or inaccuracy of such statement has come within the conscious awareness of lawyers in our office who are actively involved in preparing this legal opinion or other documents in furtherance of the transaction or who we reasonably believe may have knowledge with respect to the matters addressed in this opinion. Information shall not be deemed to be within our knowledge if such information might have been revealed if there had been undertaken a canvass of all lawyers within our Firm or a general search of the Firm’s files. We have not made and accept no responsibility to make any investigation of the existence or absence of such facts and no inference as to our knowledge of the existence or absence of such facts should be drawn from our representation of the Indiana Guarantors.

In rendering the opinions herein contained, we have assumed the following with your approval:

 

  (i) the legal capacity of each natural person;

 

  (ii) the due formation of all parties to the Indentures (other than the Indiana Guarantors);

 

  (iii) the valid legal existence and good standing of all parties to the Indentures (other than the legal existence of the Indiana Guarantors; provided, however that with respect to the Indiana Guarantors, we will be relying solely upon their respective Certificates of Existence described above);

 

  (iv) the genuineness of all signatures;


Indiana Guarantors

November 5, 2014

Page 4 of 5

 

  (v) the authenticity of all documents submitted to us as originals, and the conformity to the originals of all documents submitted to us as certified, conformed, photostatic or telefacsimile copies;

 

  (vi) with respect to all documents examined by us which contained facsimile signatures, that such signatures were the original signature of the party and have the same force and effect as an original signature;

 

  (vii) that with respect to all documents described herein which have been executed by parties other than the Indiana Guarantors, all such parties had the power to enter into and perform all obligations thereunder, that all such other parties were duly authorized by all requisite action to execute, deliver and perform their respective obligations thereunder, that all signatories on all such documents were duly qualified and incumbent parties with the proper authority to execute all such documents, and the due execution and delivery of all such documents and the validity, enforceability and binding effect of all such documents on such other parties; and

 

  (viii) there have been no undisclosed modifications of any provision of any document reviewed by us in connection with the rendering of this opinion and no undisclosed prior waiver of any right or any remedy contained in any of such documents.

This opinion is given solely as of the date hereof. We express no opinion as to future amendments of the Indentures or as to the effect of any other future events.

Based on the foregoing examination, and subject to and relying on the assumptions and other matters referred to above (and subject to the limitations and qualifications contained herein), we are of the opinion that:

 

  1. D UE O RGANIZATION . Based solely upon the respective Certificates of Existence, (i) NCS Healthcare of Indiana, Inc. is a corporation incorporated and validly existing under the laws of the State and (ii) NeighborCare of Indiana, LLC is a limited liability company organized and validly existing under the laws of the State.

 

  2. D UE P OWER AND A UTHORITY . Each Indiana Guarantor has the requisite power and authority to guarantee the Debt Securities pursuant to the terms of the Indentures and perform its obligations under the Debt Guarantees.

 

  3. D UE A UTHORIZATION . The Debt Guarantees, upon being duly authorized by all necessary corporate and/or limited liability company action (as the case may be), executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for corporate law purposes by each Indiana Guarantor.


Indiana Guarantors

November 5, 2014

Page 5 of 5

 

The opinions expressed above are subject to the following qualifications:

A. The opinions expressed herein are limited to those statutes, rules and regulations that a lawyer exercising customary professional diligence in commercial transactions would reasonably recognize as being applicable to the Indiana Guarantors. We express no opinion and make no statements concerning or with respect to any statutes, ordinances, administrative decisions, rules or regulations of counties, towns, municipalities or other political subdivisions.

B. This opinion letter is based on and relies upon the current facts and the current status of the law, and is subject in all respects to, and may be limited by, after the date hereof, changes in the facts, further rules, regulations and legislation, as well as developing case law. We assume no obligation to notify any person of changes in facts or law occurring or coming to our attention after the delivery of this opinion letter, whether or not deemed material.

This opinion is limited to the matters expressly stated herein and no opinion is inferred or may be implied beyond the matters expressly stated herein.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the heading “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

 

Very truly yours,
  /s/ Bingham Greenebaum Doll LLP
 

 

B INGHAM G REENEBAUM D OLL LLP

Exhibit 5.6

November 5, 2014

Omnicare, Inc. 900

Omnicare Center

201 East Fourth Street

Cincinnati OH 45202

 

  Re: Form S-3 Registration Statement of Omnicare, Inc.

Ladies and Gentlemen:

This opinion is furnished to you upon the express instruction and request of our clients, Hytree Pharmacy, Inc., Lo-Med Prescription Services, LLC, Management & Network Services, Inc., NCS Healthcare of Iowa, LLC, NCS Healthcare of Kansas, LLC, NCS Healthcare of Kentucky, Inc., NCS Healthcare of Montana, Inc., NCS Healthcare of New Mexico, Inc., NCS Healthcare of Ohio, LLC, NCS Healthcare of South Carolina, Inc., NCS Healthcare of Tennessee, Inc., NCS Healthcare of Washington, Inc., NCS Healthcare of Wisconsin, LLC, NCS Services, Inc., and Westhaven Services Co., LLC (together, the “ Ohio Guarantors ”) relating to the issuance, from time to time, of Senior Debt Securities and Subordinated Debt Securities (the “ Debt Securities ”) by Omnicare, Inc. pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”), between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ” and, each an “ Indenture ”), between the Company and U.S. Bank National Association (successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Company’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Indentures.

We have acted as special counsel in the State of Ohio (the “ State ”) to the Ohio Guarantors in connection with the above-captioned matter. In such capacity as special counsel to the Ohio Guarantors, we have reviewed or examined, and are familiar with, originals or copies, certified or otherwise identified to our satisfaction, of the following documents:

 

  (a) The Hytree Pharmacy, Inc. Articles of Incorporation, dated September 24, 1971;

 

  (b) The Hytree Pharmacy, Inc. Bylaws;

 

  (c) The LMPS Acquisition Sub, LLC Articles of Organization, dated January 18, 2006;


Ohio Guarantors

November 5, 2014

Page 2 of 8

 

  (d) The Certificate of Merger of Lo-Med Prescription Services, Inc. into LMPS Acquisition Sub, LLC (with Lo-Med Prescription Services, LLC as the name of the surviving LLC), dated June 8, 2006;

 

  (e) The Lo-Med Prescription Services, LLC Limited Liability Company Agreement, dated June 8, 2006;

 

  (f) The Management & Network Services, Inc. Articles of Incorporation, dated January 16, 1996;

 

  (g) The Management & Network Services, Inc. Code of Regulations, dated January 16, 1996;

 

  (h) The NCSI Acquisition Sub, LLC Articles of Organization, dated November 2, 2005;

 

  (i) The Certificate of Merger of NCS Healthcare of Iowa, Inc. into NCSI Acquisition Sub, LLC (with NCS Healthcare of Iowa, LLC as the name of the surviving LLC), dated July 12, 2006;

 

  (j) The NCS Healthcare of Iowa, LLC Limited Liability Company Agreement, dated July 12, 2006;

 

  (k) The NCSK Acquisition Sub, LLC Articles of Organization, dated November 2, 2005;

 

  (l) The Certificate of Merger of NCS Healthcare of Kansas, Inc. into NCSK Acquisition Sub, LLC (with NCS Healthcare of Kansas, LLC as the name of the surviving LLC), dated July 12, 2006;

 

  (m) The NCS Healthcare of Kansas, LLC Limited Liability Company Agreement, dated July 12, 2006;

 

  (n) The NCS Healthcare of Kentucky, Inc. Articles of Incorporation, dated January 31, 1997;

 

  (o) The NCS Healthcare of Kentucky, Inc. Code of Regulations, dated January 31, 1997;

 

  (p) The NCS Healthcare of Montana, Inc. Articles of Incorporation, dated November 10, 1997;

 

  (q) The NCS Healthcare of Montana, Inc. Code of Regulations, dated November 11, 1997;


Ohio Guarantors

November 5, 2014

Page 3 of 8

 

  (r) The NCS Healthcare of New Mexico, Inc. Articles of Incorporation, dated April 23, 1998;

 

  (s) The NCS Healthcare of New Mexico, Inc. Code of Regulations, dated April 27, 1998;

 

  (t) The NCSO Acquisition Sub, LLC Articles of Organization, dated November 2, 2005;

 

  (u) The Certificate of Merger of NCS Healthcare of Ohio, Inc. into NCSO Acquisition Sub, LLC (with NCS Healthcare of Ohio, LLC as the name of the surviving LLC), dated July 12, 2006;

 

  (v) The NCS Healthcare of Ohio, LLC Limited Liability Company Agreement, dated July 12, 2006;

 

  (w) The NCS Healthcare of South Carolina, Inc. Articles of Incorporation, dated January 29, 1997;

 

  (x) The NCS Healthcare of South Carolina, Inc. Code of Regulations, dated January 29, 1997;

 

  (y) The NCS Healthcare of Tennessee, Inc. Articles of Incorporation, dated April 23, 1998;

 

  (z) The NCS Healthcare of Tennessee, Inc. Code of Regulations, dated April 27, 1998;

 

  (aa) The NCS Healthcare of Washington, Inc. Articles of Incorporation, dated October 24, 1996;

 

  (bb) The NCS Healthcare of Washington, Inc. Code of Regulations, dated October 25, 1996;

 

  (cc) The NCSW Acquisition Sub, LLC Articles of Organization, dated November 2, 2005;

 

  (dd) The Certificate of Merger of NCS Healthcare of Wisconsin, Inc. into NCSW Acquisition Sub, LLC (with NCS Healthcare of Wisconsin, LLC as the name of the surviving LLC), dated July 12, 2006;

 

  (ee) The NCS Healthcare of Wisconsin, LLC Limited Liability Company Agreement, dated July 12, 2006;


Ohio Guarantors

November 5, 2014

Page 4 of 8

 

  (ff) The NCS Services, Inc. Articles of Incorporation, dated July 8, 1996;

 

  (gg) The NCS Services, Inc. Code of Regulations, dated July 8, 1996;

 

  (hh) The WSC Acquisition Sub, LLC Articles of Organization, dated October 11, 2005;

 

  (ii) The Certificate of Merger of Westhaven Services Co. into WSC Acquisition Sub, LLC (with Westhaven Services Co., LLC as the name of the surviving LLC), dated June 9, 2006;

 

  (jj) The Westhaven Services Co., LLC Amended and Restated Limited Liability Company Agreement, dated September 15, 2009;

 

  (kk) Action by Unanimous Written Consent in Lieu of Meeting of the Board of Directors of Hytree Pharmacy, Inc., Management & Network Services, Inc., NCS Healthcare of Kentucky, Inc., NCS Healthcare of Montana, Inc., NCS Healthcare of New Mexico, Inc., NCS Healthcare of South Carolina, Inc., NCS Healthcare of Tennessee, Inc., NCS Healthcare of Washington, Inc., and NCS Services, Inc., dated October 24, 2014;

 

  (ll) Action by Unanimous Written Consent in Lieu of Meeting of the Members and the Board of Managers of Lo-Med Prescription Services, LLC, NCS Healthcare of Iowa, LLC, NCS Healthcare of Kansas, LLC, NCS Healthcare of Ohio, LLC, NCS Healthcare of Wisconsin, LLC, and Westhaven Services Co., LLC, dated October 24, 2014; and

 

  (mm) The Certificates of Good Standing for each of the Ohio Guarantors issued by the Ohio Secretary of State, each dated October 20, 2014 (collectively referred to herein as the “ Certificates of Good Standing ”).

The documents listed as items (a) through (mm) [inclusive] above are sometimes collectively referred to herein as the “ Authority Documents .”

In rendering our opinion we have examined and relied upon the Authority Documents, and have not examined any other corporation or limited liability company documents and records or other certificates or instruments. As to various questions of fact material to our opinion, we have relied upon the Authority Documents and other certificates and written statements of the Ohio Guarantors, but we have no knowledge that any of such statements are inaccurate or incomplete.

In addition, as to certain facts material to our opinion which we did not independently establish or verify, we have relied upon written representations of the duly authorized officers or other representatives of the Ohio Guarantors, the Authority Documents, and other documents


Ohio Guarantors

November 5, 2014

Page 5 of 8

 

executed in connection therewith and/or referenced herein. We have not independently reviewed, established or verified the accuracy or completeness of the information set forth or certified in such documents. However, we have no reason to believe that the information contained in such documents is not complete and accurate. Except as otherwise expressly stated herein, this opinion should in no way be construed as passing upon the accuracy or completeness of any of the representations or warranties which may be or have been made to you in the Indentures (or documents referenced therein), the Authority Documents, or on any other matters, legal or otherwise, not specifically covered herein.

We further advise you that our representation of the Ohio Guarantors has been limited to this particular matter and, with respect to this particular matter, has been limited and does not involve an overall or detailed knowledge of the affairs, business operations or financial condition, past or present, of the Ohio Guarantors. Furthermore, we have not made any special examination of and are not expressing an opinion regarding the affairs or financial condition of the Ohio Guarantors.

We are qualified to practice law only in the State and we do not purport to be experts on, or to express an opinion herein concerning, the law of any jurisdiction other than the State and the laws of the United States of general application to transactions in the State. We express no opinion as to (i) the laws of any other jurisdiction, (ii) matters of municipal law or the laws of any local agencies within any state or (iii) state or federal tax, securities or antitrust laws. We further express no opinion with respect to the effect of any law other than the law of the State and the federal law of the United States. To the extent that the interpretation, construction or enforcement of the Indentures and the other documents referred to herein may be governed by the laws of any jurisdiction other than that of the State, we have assumed that the laws of such jurisdiction are identical to the laws of the State.

As used herein with respect to the existence or absence of facts, “to our knowledge,” “known to us,” or words or phrases of similar import shall mean, during the course of our representation of the Ohio Guarantors, no information that would give us current actual knowledge of the accuracy or inaccuracy of such statement has come within the conscious awareness of lawyers in our office who are actively involved in preparing this legal opinion or other documents in furtherance of the transaction or who we reasonably believe may have knowledge with respect to the matters addressed in this opinion. Information shall not be deemed to be within our knowledge if such information might have been revealed if there had been undertaken a canvass of all lawyers within our Firm or a general search of the Firm’s files. We have not made and accept no responsibility to make any investigation of the existence or absence of such facts and no inference as to our knowledge of the existence or absence of such facts should be drawn from our representation of the Ohio Guarantors.

In rendering the opinions herein contained, we have assumed the following with your approval:

 

  (i) the legal capacity of each natural person;


Ohio Guarantors

November 5, 2014

Page 6 of 8

 

  (ii) the due formation of all parties to the Indentures (other than the Ohio Guarantors);

 

  (iii) the valid legal existence and good standing of all parties to the Indentures (other than the legal existence of the Ohio Guarantors; provided, however that with respect to the Ohio Guarantors, we will be relying solely upon their respective Certificates of Good Standing described above);

 

  (iv) the genuineness of all signatures;

 

  (v) the authenticity of all documents submitted to us as originals, and the conformity to the originals of all documents submitted to us as certified, conformed, photostatic or telefacsimile copies;

 

  (vi) with respect to all documents examined by us which contained facsimile signatures, that such signatures were the original signature of the party and have the same force and effect as an original signature;

 

  (vii) that with respect to all documents described herein which have been executed by parties other than the Ohio Guarantors, all such parties had the power to enter into and perform all obligations thereunder, that all such other parties were duly authorized by all requisite action to execute, deliver and perform their respective obligations thereunder, that all signatories on all such documents were duly qualified and incumbent parties with the proper authority to execute all such documents, and the due execution and delivery of all such documents and the validity, enforceability and binding effect of all such documents on such other parties; and

 

  (viii) there have been no undisclosed modifications of any provision of any document reviewed by us in connection with the rendering of this opinion and no undisclosed prior waiver of any right or any remedy contained in any of such documents.

This opinion is given solely as of the date hereof. We express no opinion as to future amendments of the Indentures or as to the effect of any other future events.

Based on the foregoing examination, and subject to and relying on the assumptions and other matters referred to above (and subject to the limitations and qualifications contained herein), we are of the opinion that:

 

  1.

D UE O RGANIZATION . Based solely upon the respective Certificates of Good Standing, (i) Hytree Pharmacy, Inc. is a corporation incorporated and validly existing under the laws of the State; (ii) Lo-Med Prescription Services, LLC is a


Ohio Guarantors

November 5, 2014

Page 7 of 8

 

  limited liability company organized and validly existing under the laws of the State; (iii) Management & Network Services, Inc. is a corporation incorporated and validly existing under the laws of the State; (iv) NCS Healthcare of Iowa, LLC is a limited liability company organized and validly existing under the laws of the State; (v) NCS Healthcare of Kansas, LLC is a limited liability company organized and validly existing under the laws of the State; (vi) NCS Healthcare of Kentucky, Inc. is a corporation incorporated and validly existing under the laws of the State; (vii) NCS Healthcare of Montana, Inc. is a corporation incorporated and validly existing under the laws of the State; (viii) NCS Healthcare of New Mexico, Inc. is a corporation incorporated and validly existing under the laws of the State; (ix) NCS Healthcare of Ohio, LLC is a limited liability company organized and validly existing under the laws of the State; (x) NCS Healthcare of South Carolina, Inc. is a corporation incorporated and validly existing under the laws of the State; (xi) NCS Healthcare of Tennessee, Inc. is a corporation incorporated and validly existing under the laws of the State; (xii) NCS Healthcare of Washington, Inc. is a corporation incorporated and validly existing under the laws of the State; (xiii) NCS Healthcare of Wisconsin, LLC is a limited liability company organized and validly existing under the laws of the State; (xiv) NCS Services, Inc. is a corporation incorporated and validly existing under the laws of the State; and (xv) Westhaven Services Co., LLC is a limited liability company organized and validly existing under the laws of the State.

 

  2. D UE P OWER AND A UTHORITY . Each Ohio Guarantor has the requisite power and authority to guarantee the Debt Securities pursuant to the terms of the Indentures and perform its obligations under the Debt Guarantees.

 

  3. D UE A UTHORIZATION . The Debt Guarantees, upon being duly authorized by all necessary corporate and/or limited liability company action (as the case may be), executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for corporate law purposes by each Ohio Guarantor.

The opinions expressed above are subject to the following qualifications:

A. The opinions expressed herein are limited to those statutes, rules and regulations that a lawyer exercising customary professional diligence in commercial transactions would reasonably recognize as being applicable to the Ohio Guarantors. We express no opinion and make no statements concerning or with respect to any statutes, ordinances, administrative decisions, rules or regulations of counties, towns, municipalities or other political subdivisions.

B. This opinion letter is based on and relies upon the current facts and the current status of the law, and is subject in all respects to, and may be limited by, after the date hereof, changes in the facts, further rules, regulations and legislation, as well as developing case law. We assume no obligation to notify any person of changes in facts or law occurring or coming to our attention after the delivery of this opinion letter, whether or not deemed material.


Ohio Guarantors

November 5, 2014

Page 8 of 8

 

This opinion is limited to the matters expressly stated herein and no opinion is inferred or may be implied beyond the matters expressly stated herein.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the heading “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

 

Very truly yours,
  /s/ Bingham Greenebaum Doll LLP
 

 

B INGHAM G REENEBAUM D OLL LLP

Exhibit 5.7

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

Ladies and Gentlemen:

We have acted as special counsel in the Commonwealth of Kentucky (“ State ”), to D&R Pharmaceutical Services, LLC and Three Forks Apothecary LLC (individually a “ Guarantor ” and collectively the “ Guarantors ”) in connection with the S-3 Registration Statement (the “ Registration Statement ”) relating to the senior debt securities, and subordinated debt securities (collectively the “ Debt Securities ”) to be issued, as well as the guarantees of the Securities to be issued by the Guarantors (the “ Debt Guarantees ”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the form of senior notes indenture, as amended, supplemented, waived, or otherwise modified from time to time (the “ Senior Notes Indenture ”), between Omnicare, Inc. (the “ Issuer ”) and the trustee party thereto, or the subordinated notes indenture as amended, supplemented, waived, or otherwise modified from time to time (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ”), between the Issuer and U.S. Bank National Association (as successor trustee to SunTrust Bank), as trustee, dated June 13, 2003. The Indentures were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Issuer’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014.

In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the following documents (collectively, the “ Documents ”):

 

  (a) the Senior Notes Indenture; and

 

  (b) the Subordinated Notes Indenture; and

 

  (a) the Action by Unanimous Written Consent in Lieu of Meeting of the Members and the Board of Managers of D&R Pharmaceutical Services, LLC dated October 24, 2014; and

 

  (b) the Action by Unanimous Written Consent in Lieu of Meeting of the Members and the Board of Managers of Three Forks Apothecary LLC dated October 24, 2014; and

 

  (c) the Kentucky Articles of Organization for DRPS Acquisition Sub, LLC (the “ DRPS Article s”); and


Omnicare, Inc.

November 5, 2014

Page 2 of 3

 

  (d) the Kentucky Articles of Merger of D&R Pharmaceutical Services, Inc. into DRPS Acquisition Sub, LLC, by which the surviving entity changed its name to D&R Pharmaceutical Services, LLC (the “D&R Articles of Merger”); and

 

  (e) the Limited Liability Company Agreement of D&R Pharmaceutical Services, LLC dated June 9, 2006 (the “D&R LLC Agreement”); and

 

  (f) the Kentucky Articles of Organization of Limited Liability Company for Three Forks Apothecary LLC (the “Three Forks Articles”); and

 

  (g) the Operating Agreement of Three Forks Apothecary LLC dated December 31, 2012 (the “Three Forks LLC Agreement”); and

 

  (h) a Kentucky Certificate of Existence for Three Forks Apothecary LLC dated October 20, 2014; and

 

  (i) a Kentucky Certificate of Existence for D&R Pharmaceutical Services, LLC dated October 20, 2014.

In addition, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such records, agreements, instruments and other documents, and have made such other investigations, as we have deemed necessary for the purpose of this opinion. We have also reviewed and relied upon such certificates of each applicable Guarantor as to factual matters, certificates of public officials and other instruments, documents and agreements as we have deemed necessary or appropriate to enable us to render the opinions set forth below.

For purposes of the opinions expressed below, we have assumed (a) the authenticity of all documents submitted to us as originals, (b) the conformity to the originals of all documents submitted to us as certified, electronic or photostatic copies and the authenticity of the originals, and (c) the due authorization, execution and delivery of all Documents by all appropriate parties and the validity and binding effect thereof.

We express no opinion to the extent that any Documents may be impacted by (i) applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other laws affecting the rights of creditors generally; (ii) the exercise of judicial discretion or general principles of equity, whether considered in a proceeding at law or in equity, or public policy, including applicable securities law; (iii) restrictions on the assignment of benefits payable under any governmental health care program; (iv) standards relating to privacy and confidentiality of patient information; and/or (v) standards relating to fraud and forgery.

As to factual matters, we have relied upon warranties and representations made by each applicable Guarantor that are included in the Documents and certificates of officers of each applicable Guarantor. Whenever the phrase “to our knowledge” is used herein, it refers to the actual knowledge of the attorneys of this firm involved in the representation of each applicable Guarantor in this transaction without independent investigation.


Omnicare, Inc.

November 5, 2014

Page 3 of 3

 

Subject to the foregoing assumptions, we are of the opinion that:

1. Each of D&R Pharmaceutical Services, LLC and Three Forks Apothecary LLC has been organized under the Kentucky Limited Liability Company Act and its status is active;

2. Each of D&R Pharmaceutical Services, LLC and Three Forks Apothecary LLC has the corporate power and capacity to guarantee the Debt Securities pursuant to the Indentures and perform its obligations under the Debt Guarantees; and

3. The Debt Guarantees, upon being duly authorized by all necessary limited liability company action, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for corporate law purposes by each Kentucky Guarantor.

We express no opinion as to matters under or involving the laws of any jurisdiction other than laws of the State and its political subdivisions. To the extent the laws of any other state or nation apply with respect to any of the transactions contemplated herein, we have assumed that the laws of such other state or nation are the same as the laws of the State in all applicable respects. We express no opinion concerning any matter respecting or affected by any laws other than laws that a lawyer in the State exercising customary professional diligence would reasonably recognize as being directly applicable to each applicable Guarantor and Documents or any of them.

In rendering the opinions set forth above, we have advised you only as to such knowledge as we have obtained from (a) the certificates of each applicable Guarantor; and (b) inquiries of officers and employees of each applicable Guarantor. Except to the extent otherwise expressly set forth above, for purposes of this opinion, we have not made an independent review of any agreements, instruments, writs, orders, judgments, rules or other regulations or decrees which may have been executed by or which may now be binding upon any Guarantor, nor have we undertaken to review our internal files or any files of any Grantor, relating to transactions to which any Guarantor may be a party, or to discuss their transactions or business with any other lawyers in our firm or with any other officers, partners or any employees of any Guarantor.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion of counsel as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

 

Very truly yours,
  /s/ Hancock, Daniel, Johnson & Nagle, P.C.

Exhibit 5.8

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

Ladies and Gentlemen:

We have acted as special counsel in the State of South Carolina (“ State ”) to Pharmacy Consultants, LLC (“ Guarantor ”) in connection with the S-3 Registration Statement (the “ Registration Statement ”) relating to the senior debt securities, and subordinated debt securities (collectively the “ Debt Securities ”) to be issued, as well as the guarantees of the Securities to be issued by the Guarantors (the “ Debt Guarantees ”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the form of senior notes indenture, as amended, supplemented, waived, or otherwise modified from time to time (the “ Senior Notes Indenture ”), between Omnicare, Inc. (the “ Issuer ”) and the trustee party thereto, or the subordinated notes indenture as amended, supplemented, waived, or otherwise modified from time to time (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ”), between the Issuer and U.S. Bank National Association (as successor trustee to SunTrust Bank), as trustee, dated June 13, 2003. The Indentures were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Issuer’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014.

In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the following documents (collectively, the “ Documents ”):

 

  (a) the Senior Notes Indenture; and

 

  (b) the Subordinated Notes Indenture; and

 

  (c) the Action by Unanimous Written Consent in Lieu of Meeting of the Members and the Board of Managers of Pharmacy Consultants, LLC, dated October 24, 2014; and

 

  (d) the South Carolina Articles of Incorporation of Pharmacy Consultants, Inc. (the “ SC Incorporation ”); and

 

  (e) the South Carolina Articles of Merger or Share Exchange merging PC Merger Sub, Inc. into Pharmacy Consultants, Inc. (the “ SC Articles of Merger ”); and


Omnicare, Inc.

November 5, 2014

Page 2 of 3

 

  (f) the South Carolina Conversion of a Corporation to a Limited Liability Company converting Pharmacy Consultants, Inc. into Pharmacy Consultants, LLC, and Articles of Organization for Pharmacy Consultants, LLC (the “ PC Articles ”); and

 

  (g) the Delaware Certificate of Merger of a Domestic Limited Liability Company into a Foreign Limited Liability Company merging PCI Acquisition, LLC with and into Pharmacy Consultants, LLC (the “ DE Certificate of Merger ”); and

 

  (h) the Limited Liability Company Agreement of Pharmacy Consultants, LLC dated May 2014 (the “ LLC Agreement ”); and

 

  (i) a South Carolina Certificate of Existence for Pharmacy Consultants, LLC dated October 22, 2014.

In addition, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such records, agreements, instruments and other documents, and have made such other investigations, as we have deemed necessary for the purpose of this opinion. We have also reviewed and relied upon such certificates of each applicable Guarantor as to factual matters, certificates of public officials and other instruments, documents and agreements as we have deemed necessary or appropriate to enable us to render the opinions set forth below.

For purposes of the opinions expressed below, we have assumed (a) the authenticity of all documents submitted to us as originals, (b) the conformity to the originals of all documents submitted to us as certified, electronic or photostatic copies and the authenticity of the originals, and (c) the due authorization, execution and delivery of all Documents by all appropriate parties and the validity and binding effect thereof.

We express no opinion to the extent that any Documents may be impacted by (i) applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other laws affecting the rights of creditors generally; (ii) the exercise of judicial discretion or general principles of equity, whether considered in a proceeding at law or in equity, or public policy, including applicable securities law; (iii) restrictions on the assignment of benefits payable under any governmental health care program; (iv) standards relating to privacy and confidentiality of patient information; and/or (v) standards relating to fraud and forgery.

As to factual matters, we have relied upon warranties and representations made by each applicable Guarantor, which are included in the Documents and certificates of officers of each applicable Guarantor. Whenever the phrase “to our knowledge” is used herein, it refers to the actual knowledge of the attorneys of this firm involved in the representation of each applicable Grantor in this transaction without independent investigation.


Omnicare, Inc.

November 5, 2014

Page 3 of 3

 

Subject to the foregoing assumptions, we are of the opinion that:

1. The Guarantor has been organized under the South Carolina Uniform Limited Liability Company Act of 1996 and its status is active;

2. The Guarantor has the corporate power and capacity to guarantee the Debt Securities pursuant to the Indentures and perform its obligations under the Debt Guarantees; and

3. The Debt Guarantees, upon being duly authorized by all necessary limited liability company action, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for corporate law purposes by each South Carolina Guarantor.

We express no opinion as to matters under or involving the laws of any jurisdiction other than laws of the State and its political subdivisions. To the extent the laws of any other state or nation apply with respect to any of the transactions contemplated herein, we have assumed that the laws of such other state or nation are the same as the laws of the State in all applicable respects. We express no opinion concerning any matter respecting or affected by any laws other than laws that a lawyer in the State exercising customary professional diligence would reasonably recognize as being directly applicable to each applicable Guarantor and Documents or any of them.

In rendering the opinions set forth above, we have advised you only as to such knowledge as we have obtained from (a) the certificates of each applicable Guarantor; and (b) inquiries of officers and employees of each applicable Guarantor. Except to the extent otherwise expressly set forth above, for purposes of this opinion, we have not made an independent review of any agreements, instruments, writs, orders, judgments, rules or other regulations or decrees which may have been executed by or which may now be binding upon any Guarantor, nor have we undertaken to review our internal files or any files of any Grantor, relating to transactions to which any Guarantor may be a party, or to discuss their transactions or business with any other lawyers in our firm or with any other officers, partners or any employees of any Guarantor.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion of counsel as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

Very truly yours,

/s/ Hancock, Daniel, Johnson & Nagle, P.C.

Exhibit 5.9

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

Ladies and Gentlemen:

We have acted as special counsel in the Commonwealth of Virginia (“ State ”), to Capitol Home Infusion, Inc., NeighborCare of Virginia, LLC and Williamson Drug Company, Incorporated (individually a “ Guarantor ” and collectively the “ Guarantors ”) in connection with the S-3 Registration Statement (the “ Registration Statement ”) relating to the senior debt securities, and subordinated debt securities (collectively the “ Debt Securities ”) to be issued, as well as the guarantees of the Securities to be issued by the Guarantors (the “ Debt Guarantees ”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the form of senior notes indenture, as amended, supplemented, waived, or otherwise modified from time to time (the “ Senior Notes Indenture ”), between Omnicare, Inc. (the “ Issuer ”) and the trustee party thereto, or the subordinated notes indenture as amended, supplemented, waived, or otherwise modified from time to time (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ”), between the Issuer and U.S. Bank National Association (as successor trustee to SunTrust Bank), as trustee, dated June 13, 2003. The Indentures were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Issuer’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014.

In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the following documents (collectively, the “ Documents ”):

 

  (a) the Senior Notes Indenture; and

 

  (b) the Subordinated Notes Indenture; and

 

  (c) the Action by Unanimous Written Consent in Lieu of Meeting of the Board of Directors of Capitol Home Infusion, Inc. dated October 24, 2014; and

 

  (d) the Action by Unanimous Written Consent in Lieu of Meeting of the Members and the Board of Managers of NeighborCare of Virginia, LLC dated October 24, 2014; and


Omnicare, Inc.

November 5, 2014

Page 2 of 4

 

  (e) the Action by Unanimous Written Consent in Lieu of Meeting of the Board of Directors of Williamson Drug Company, Incorporated dated October 24, 2014; and

 

  (f) the Virginia Articles and Certificate of Incorporation of Capitol Home Infusion, Inc. (the Capitol Articles ”); and

 

  (g) the Bylaws of Capitol Home Infusion, Inc. (the Capitol Bylaws ”); and

 

  (h) the Virginia Articles and Certificate of Organization of NeighborCare of Virginia, LLC; and

 

  (i) the Virginia Articles of Merger and Plan of Merger merging NeighborCare of Virginia, Inc., with and into NeighborCare of Virginia, LLC (the “ NeighborCare Merger ”); and

 

  (j) the Limited Liability Company Agreement of NeighborCare of Virginia, LLC dated May 18, 2010 (the “ NeighborCare of Virginia, LLC Agreement ”); and

 

  (k) the Virginia Articles and Certificate of Incorporation of Williamson Drug Company, Incorporated (the Williamson Articles ”); and

 

  (l) the Bylaws of Williamson Drug Company, Incorporated (the Williamson Bylaws ”); and

 

  (m) a Virginia Certificate of Good Standing for Capitol Home Infusion, Inc. dated October 23, 2014; and

 

  (n) a Virginia Certificate of Fact for NeighborCare of Virginia, LLC dated October 23, 2014; and

 

  (o) a Virginia Certificate of Good Standing for Williamson Drug Company, Incorporated dated October 23, 2014.

In addition, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such records, agreements, instruments and other documents, and have made such other investigations, as we have deemed necessary for the purpose of this opinion. We have also reviewed and relied upon such certificates of each applicable Guarantor as to factual matters, certificates of public officials and other instruments, documents and agreements as we have deemed necessary or appropriate to enable us to render the opinions set forth below.

For purposes of the opinions expressed below, we have assumed (a) the authenticity of all documents submitted to us as originals, (b) the conformity to the originals of all documents submitted to us as certified, electronic or photostatic copies and the authenticity of the originals, and (c) the due authorization, execution and delivery of all Documents by all appropriate parties and the validity and binding effect thereof.


Omnicare, Inc.

November 5, 2014

Page 3 of 4

We express no opinion to the extent that any Documents may be impacted by (i) applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other laws affecting the rights of creditors generally; (ii) the exercise of judicial discretion or general principles of equity, whether considered in a proceeding at law or in equity, or public policy, including applicable securities law; (iii) restrictions on the assignment of benefits payable under any governmental health care program; (iv) standards relating to privacy and confidentiality of patient information; and/or (v) standards relating to fraud and forgery.

As to factual matters, we have relied upon warranties and representations made by each applicable Guarantor that are included in the Documents and certificates of officers of each applicable Guarantor. Whenever the phrase “to our knowledge” is used herein, it refers to the actual knowledge of the attorneys of this firm involved in the representation of each applicable Guarantor in this transaction without independent investigation.

Subject to the foregoing assumptions, we are of the opinion that:

1. Each of Capitol Home Infusion, Inc. and Williamson Drug Company, Incorporated has been incorporated under the Virginia Stock Corporations Act, and Neighborcare of Virginia, LLC has been organized under the Virginia Limited Liability Company Act, and the status of each is active;

2. Each of Capitol Home Infusion, Inc., Williamson Drug Company, Incorporated and Neighborcare of Virginia, LLC has the corporate power and capacity to guarantee the Debt Securities pursuant to the Indentures and perform its obligations under the Debt Guarantees; and

3. The Debt Guarantees, upon being duly authorized by all necessary corporate or limited liability company action, as appropriate, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for corporate law purposes by each Virginia Guarantor.

We express no opinion as to matters under or involving the laws of any jurisdiction other than laws of the State and its political subdivisions. To the extent the laws of any other state or nation apply with respect to any of the transactions contemplated herein, we have assumed that the laws of such other state or nation are the same as the laws of the State in all applicable respects. We express no opinion concerning any matter respecting or affected by any laws other than laws that a lawyer in the State exercising customary professional diligence would reasonably recognize as being directly applicable to each applicable Guarantor and Documents or any of them.

In rendering the opinions set forth above, we have advised you only as to such knowledge as we have obtained from (a) the certificates of each applicable Guarantor; and (b) inquiries of officers and employees of each applicable Guarantor. Except to the extent otherwise expressly set forth above, for purposes of this opinion, we have not made an independent review of any agreements, instruments, writs, orders, judgments, rules or other regulations or decrees which may have been executed by or which may now be binding upon any Guarantor, nor have we undertaken to review our internal files or any files of any Grantor, relating to transactions to which any Guarantor may be a party, or to discuss their transactions or business with any other lawyers in our firm or with any other officers, partners or any employees of any Guarantor.


Omnicare, Inc.

November 5, 2014

Page 4 of 4

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion of counsel as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

Very truly yours,

/s/ Hancock, Daniel, Johnson & Nagle, P.C.

Exhibit 5.10

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

Ladies and Gentlemen:

We have acted as special counsel in the State of West Virginia (“ State ”), to Compass Health Services, LLC (“ Guarantor ”) in connection with the S-3 Registration Statement (the “ Registration Statement ”) relating to the senior debt securities, and subordinated debt securities (collectively the “ Debt Securities ”) to be issued, as well as the guarantees of the Securities to be issued by the Guarantors (the “ Debt Guarantees ”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the form of senior notes indenture, as amended, supplemented, waived, or otherwise modified from time to time (the “ Senior Notes Indenture ”), between Omnicare, Inc. (the “ Issuer ”) and the trustee party thereto, or the subordinated notes indenture as amended, supplemented, waived, or otherwise modified from time to time (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ”), between the Issuer and U.S. Bank National Association (as successor trustee to SunTrust Bank), as trustee, dated June 13, 2003. The Indentures were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Issuer’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014.

In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the following documents (collectively, the “ Documents ”):

 

  (a) the Senior Notes Indenture; and

 

  (b) the Subordinated Notes Indenture; and

 

  (c) the Action by Unanimous Written Consent in Lieu of Meeting of the Members and the Board of Managers of Compass Health Services, LLC dated October 24, 2014; and

 

  (d) the West Virginia Articles of Organization for CHS Acquisition Sub, LLC (the CHS Articles ”); and

 

  (e) the West Virginia Articles of Merger of a Domestic Corporation into a Domestic Limited Liability Company of Compass Health Services, Inc. into CHS Acquisition Sub, LLC, by which the surviving entity changed its name to Compass Health Services, LLC (the CHS Articles of Merger ”); and


Omnicare, Inc.

November 5, 2014

Page 2 of 3

 

  (f) the West Virginia Certificate of Merger for Compass Health Services, LLC (the Certificate of Merger ”); and

 

  (g) the Limited Liability Company Agreement of Compass Health Services, LLC dated June 6, 20
  06; and

 

  (h) a West Virginia Certificate of Existence of Compass Health Services, LLC dated October 20, 2014.

The Limited Liability Company Agreement of Compass Health Services, LLC (the “ LLC Agreement ”). In addition, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such records, agreements, instruments and other documents, and have made such other investigations, as we have deemed necessary for the purpose of this opinion. We have also reviewed and relied upon such certificates of each applicable Guarantor as to factual matters, certificates of public officials and other instruments, documents and agreements as we have deemed necessary or appropriate to enable us to render the opinions set forth below.

For purposes of the opinions expressed below, we have assumed (a) the authenticity of all documents submitted to us as originals, (b) the conformity to the originals of all documents submitted to us as certified, electronic or photostatic copies and the authenticity of the originals, and (c) the due authorization, execution and delivery of all Documents by all appropriate parties and the validity and binding effect thereof.

We express no opinion to the extent that any Documents may be impacted by (i) applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other laws affecting the rights of creditors generally; (ii) the exercise of judicial discretion or general principles of equity, whether considered in a proceeding at law or in equity, or public policy, including applicable securities law; (iii) restrictions on the assignment of benefits payable under any governmental health care program; (iv) standards relating to privacy and confidentiality of patient information; and/or (v) standards relating to fraud and forgery.

As to factual matters, we have relied upon warranties and representations made by each applicable Guarantor, which are included in the Documents and certificates of officers of each applicable Guarantor. Whenever the phrase “to our knowledge” is used herein, it refers to the actual knowledge of the attorneys of this firm involved in the representation of each applicable Grantor in this transaction without independent investigation.

Subject to the foregoing assumptions, we are of the opinion that:

1. The Guarantor has been organized under the West Virginia Uniform Limited Liability Company Act and its status is active;

2. The Guarantor has the corporate power and capacity to guarantee the Debt Securities pursuant to the Indentures and perform its obligations under the Debt Guarantees; and


Omnicare, Inc.

November 5, 2014

Page 3 of 3

3. The Debt Guarantees, upon being duly authorized by all necessary limited liability company action, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for corporate law purposes by each West Virginia Guarantor.

We express no opinion as to matters under or involving the laws of any jurisdiction other than laws of the State and its political subdivisions. To the extent the laws of any other state or nation apply with respect to any of the transactions contemplated herein, we have assumed that the laws of such other state or nation are the same as the laws of the State in all applicable respects. We express no opinion concerning any matter respecting or affected by any laws other than laws that a lawyer in the State exercising customary professional diligence would reasonably recognize as being directly applicable to each applicable Guarantor and Documents or any of them.

In rendering the opinions set forth above, we have advised you only as to such knowledge as we have obtained from (a) the certificates of each applicable Guarantor; and (b) inquiries of officers and employees of each applicable Guarantor. Except to the extent otherwise expressly set forth above, for purposes of this opinion, we have not made an independent review of any agreements, instruments, writs, orders, judgments, rules or other regulations or decrees which may have been executed by or which may now be binding upon any Guarantor, nor have we undertaken to review our internal files or any files of any Grantor, relating to transactions to which any Guarantor may be a party, or to discuss their transactions or business with any other lawyers in our firm or with any other officers, partners or any employees of any Guarantor.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion of counsel as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

Very truly yours,

/s/ Hancock, Daniel, Johnson & Nagle, P.C.

Exhibit 5.11

Effective Date:

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

Re: Form S-3 Registration Statement of Omnicare, Inc.

Ladies and Gentlemen:

We have acted as special Louisiana counsel to Campo’s Medical Pharmacy, Inc., a Louisiana corporation ( “Campo’s” ) in connection with Campo’s guarantee of the Debt Securities ( “Debt Securities” ) to be issued by Omnicare, Inc. ( “Omnicare” ), pursuant to (i) a form of senior notes indenture (the “Senior Notes Indenture” ), between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “Subordinated Notes Indenture” and, together with the Senior Notes Indenture, the “Indentures” and, each an “Indenture” ), between the Company and U.S. Bank National Association (successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which were filed with the Securities and Exchange Commission (the “Commission” ) as exhibits to the Company’s registration statement on Form S-3 (the “Registration Statement” ) on November 5, 2014.

This opinion is being furnished to you in connection with the proposed Debt Securities to be issued by under an Indenture, which Debt Securities are to be registered under the Securities Act of 1933, pursuant to the Registration Statement.

In rendering this opinion, we have examined the following documents:

(1) Copies of the Articles of Incorporation of Campo’s;

(2) Copies of the Bylaws of Campo’s;

(3) Action by Unanimous Written Consent of the Board of Directors of Campo’s various entities; dated October 24, 2014, (the “Corporate Resolutions” ), authorizing the guarantee of the Debt Securities by Campo’s (the “Debt Guarantees” );

(4) Certificate of Good Standing from the Louisiana Secretary of State dated October 20, 2014 reflecting that Campo’s is duly incorporated and is in good standing in the State of Louisiana.


Omnicare, Inc.

Page 2

 

We have also reviewed the Secretary’s Certificate of Campo’s to which were attached Items 1-3 above.

The documents listed in clauses (1) through (3) above are referred to herein as the “Organizational Documents”.

We are of the opinion that:

(A) Campo’s has been incorporated under the Louisiana Business Corporation Act and its status is active.

(B) Campo’s has the corporate power and capacity to guarantee the Debt Securities pursuant to the terms of each Indenture and perform its obligations under the Debt Guarantees.

(C) The Debt Guarantees, upon being duly authorized by all necessary corporate action, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for corporate law purposes by Campo’s.

These opinions are rendered subject to the following qualifications, assumptions, exceptions, and limitations:

In rendering the opinions set forth herein, we have relied upon certificates of public officials and upon certificates of officers and other representatives of Omnicare and of Campo’s, including the Resolutions, and such other documents, records and information as we have deemed necessary or appropriate, including the Louisiana Secretary of State’s Certificate of Good Standing dated October 20, 2014 for Campo’s. We have assumed that all signatures are genuine; that all documents submitted to us as originals are authentic; that all documents submitted to us as copies conform to the originals; that each Indenture, Debt Securities and Debt Guarantees have been duly executed and delivered by all parties thereto, other than Campo’s, and that the facts stated in all such documents are true and correct. In rendering this opinion, with your permission, we have not made any independent investigation as to the accuracy or completeness of any facts or representations, warranties, data or other information, whether written or oral, that may have been made by or on behalf of the parties, except as may otherwise be specifically set forth herein, if any. We are also assuming the Debt Guarantees have been, or will be, duly executed and delivered by Campo’s.

We have limited our opinion to matters of the laws of the State of Louisiana, however, even as to Louisiana law, we express no opinion with respect to (1) any state or local taxes or tax statutes, (2) any securities laws, (3) any health care laws or (4) any environmental laws, nor do we render any opinion as to any federal laws, to which Campo’s may be subject.


Omnicare, Inc.

Page 3

 

Our opinions are subject to the following additional assumptions, limitations, qualification, and exceptions:

A. All opinions are subject to (i) the effect of any applicable bankruptcy, insolvency, reorganization, or similar laws affecting creditors’ rights generally; and (ii) the discretionary powers of the courts to make available remedies of specific performance, injunctive relief or other equitable remedies.

B. We have assumed that you and all other parties to the Indentures, Debt Securities and Debt Guarantees, excluding Campo’s, are duly organized and authorized to enter into the various transactions and to execute and deliver all of the various documents to which each is a party, and that those documents have been duly executed and delivered, and are legally binding on all such parties.

C. We have assumed the legal capacity of all natural persons who have signed and/or will sign the various documents, whether in their individual and/or representative capacities.

D. We have assumed that Campo’s is a wholly owned subsidiary of Omnicare and that entering into the Debt Guarantees and the guaranty of the obligations serves a legitimate business purpose of Campo’s and Campo’s has received value for entering into said transactions.

E. We have assumed there are no other agreements or understandings among the parties to each of the Indentures, Debt Securities and Debt Guarantees, or related documents, written or oral, and there is no usage of trade or course of conduct among the parties that would in any case, define, supplement, expand or limit or qualify the terms of such documents.

F. Specific performance of the provisions of any agreement is an equitable remedy which may or may not be ordered by a court in its discretion. No opinion is rendered as to the effectiveness of any provisions which authorize or purport to authorize the extra judicial enforcement of any rights or obligations or the waiver of any rights. We point out that generally extra-judicial enforcement is not allowed under Louisiana law.

G. Our opinion also assumes that all parties will enforce their rights under the various documents, in good faith and its conformity to law and in a commercially reasonable manner.

H. While Louisiana law does not purport to govern the Debt Guarantees, to the extent Louisiana law applies, the ability to collect any attorney fees as to enforcement of the Debt Guarantees against Campo’s is limited by the Louisiana Rules of Professional Conduct and other principles of Louisiana law.

These opinions are rendered as of the date hereof and we have no duty to advise you of any changes in law or judicial decisions which may affect or limit the opinions set forth above. The opinions set forth herein are opinions based upon our professional judgment and are not, and shall not be construed, as a warranty or guaranty.


Omnicare, Inc.

Page 4

 

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder.

This opinion is specifically limited to the presently effective laws of the State of Louisiana. No opinions are or may be inferred, and we do not, render any opinion as to any matter, except as specifically, and expressly set forth herein.

 

Very truly yours,
/s/ Taylor, Porter, Brooks & Phillips, L.L.P.

Exhibit 5.12

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

 

Re: Guaranty of Indentures of Omnicare, Inc. (“Parent”) by Specialized Pharmacy Services, LLC

Dear Sir/Madam:

We have acted as counsel to Specialized Pharmacy Services, LLC, a Michigan limited liability company (the “ Guarantor ”) with respect to the above-referenced matter. This opinion is being rendered pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”), between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ”), between the Company and U.S. Bank National Association (as successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Company’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014, regarding the issuance of certain Securities (as defined in each of the Indentures), from time to time, which Securities are guaranteed by the Guarantor and certain other subsidiaries of the Parent.

In connection with this opinion, we have examined the original or a copy certified or otherwise identified to our satisfaction as a true copy of each of the following documents:

 

  (a) The Articles of Incorporation of Specialized Pharmacy Services, Inc. (“ SPS Corp. ”) dated March 3, 1977;

 

  (b) The Articles of Organization of SPS Acquisition Sub, LLC (“ Acquisition ”) dated October 11, 2005;

 

  (c) A Certificate of Merger dated June 9, 2006 between SPS Corp. and Acquisition wherein (i) SPS Corp. was merged into Acquisition and (ii) the name of Acquisition was changed to “Specialized Pharmacy Services, LLC”;

 

  (d) A Certificate of Good Standing of Guarantor dated October 20, 2014;


Omnicare, Inc.

November 5, 2014

Page 2

 

  (e) The Limited Liability Company Agreement of Guarantor dated June 9, 2006;

 

  (f) The Unanimous Written Consent in Lieu of Meeting of the Member of Guarantor dated October 24, 2014;

 

  (g) The Indentures; and

 

  (h) A Secretary’s Certificate dated November 5, 2014.

The documents referenced in subparagraphs (a) – (h) above are hereinafter collectively, the “Documents.”

We have assumed the genuineness of all signatures other than those persons signing on behalf of the Guarantor, the legal capacity of natural persons executing the Documents, and the authenticity of all items submitted to us as originals and the conformity with originals of all items submitted to us as copies. In making our examination of the Documents executed by entities other than the Guarantor we have assumed that each such other entity has the power, authority and capacity to enter into and perform all of its obligations thereunder and also have assumed the due authorization by each such other entity of all requisite action and the due execution and delivery of such Documents by each such other entity and the validity and binding effect thereof as to each such entity. Without limiting the legal conclusions reached in this opinion, we have assumed the truth and accuracy of the representations and warranties of the Guarantor in the Documents. We have not undertaken any independent investigation or verification as to such matters.

Whenever our opinion herein with respect to the existence or absence of facts is indicated to be based on our actual knowledge, it is intended to signify that during the course of our representation of the Guarantor as herein described, no information has come to our attention which would give us actual knowledge of the existence or absence of such facts, or suggest that further inquiry is required to confirm or refute the existence of such facts. However, except to the extent expressly set forth herein, we have not undertaken any independent investigation to determine the existence or absence of such facts, and no inference as to our knowledge of the existence or absence of such facts should be drawn from our representation of the Guarantor.

These opinions are based solely on the laws of Michigan and, where applicable, the laws of the United States of America; and no opinion is given with respect to the laws of any other jurisdiction nor the application of conflict or choice of law principles.


Omnicare, Inc.

November 5, 2014

Page 3

 

We understand that all of the foregoing assumptions and limitations are acceptable to you. The opinions hereinafter expressed are subject to the further qualifications:

 

  (a) Our opinion is subject to the effect of bankruptcy, insolvency, reorganization, arrangement, moratorium or other similar laws relating to or affecting the rights of creditors generally, and to the discretionary nature of specific performance and other equitable remedies.

 

  (b) Our opinion is subject to limitations imposed by general principles of equity and public policy upon the specific enforceability of any of the remedies, covenants or other provisions of the Indentures and upon the availability of injunctive relief or other equitable remedies, and the application of principles of equity (regardless of whether enforcement is considered in proceedings in law or in equity) in regard to certain covenants and provisions of agreements where (i) the breach of such covenants or provisions imposes restrictions or burdens upon the Parent, including the acceleration of indebtedness due under the Indentures, and it cannot be demonstrated that the enforcement of such restrictions or burdens is reasonably necessary for the protection of the creditor, or (ii) the creditor’s enforcement of such covenants or provisions would violate principles of good faith and fair dealing, or would be commercially unreasonable.

 

  (c) Certain rights and remedies contained in the Indentures may be rendered ineffective, or limited, by applicable laws and judicial decisions governing such provisions, but such laws and judicial decisions do not, in our opinion, make the Indentures inadequate for the practical realization of the benefits intended to be provided by the Indentures except for the economic consequences of any procedural delay which may result from such laws and decisions.

 

  (d) We express no opinion as to the enforceability of the indemnification provisions of the Indentures, or any provisions exculpating a holder of the Securities or any of its representatives from any liability, in each case insofar as such provisions might require indemnification or exculpation with respect to any violations of securities laws or relating to any litigation by any party determined adversely to any party other than the Parent or the Guarantor. We express no opinion as to the enforceability of any provision exculpating any holder of the Securities or any of its representatives relating to any loss, cost or expense arising out of any violation by any party other than the Guarantor of any of that party’s duties, the Indentures, general principles of equity or public policy.


Omnicare, Inc.

November 5, 2014

Page 4

 

  (e) Notwithstanding anything contained in the Indentures, a holder of the Securities may be limited to recovering only reasonable expenses with respect to enforcement or collection of the obligations under the Indentures.

Based upon and subject to the following, it is our opinion that:

 

  1. The Guarantor is validly existing and in good standing under the laws of the State of Michigan;

 

  2. The Guarantor has the requisite corporate power and authority to execute and deliver and to perform its obligations under the Indentures and to guarantee the guaranteed obligations under the Indentures; and

 

  3. The Guarantor has taken all necessary corporate actions to duly authorize the execution, delivery and performance of the Indentures and to guarantee the guaranteed obligations under the Indentures.

These opinions are given only as of the date hereof and do not contemplate, and no opinion is given with respect to, future events or subsequent changes in law or fact and we do not undertake to update these opinions or to give any other notice concerning any such changes which may come to our attention. This opinion is given as of the date hereof and we assume no obligation to advise the Parent of changes that may hereafter be brought to our attention even if such changes would affect our opinion.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by the law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission hereunder.

 

PLUNKETT COONEY, P.C.
/s/ Scott K. Lites
By:   Scott K. Lites
Its:   Vice President

Exhibit 5.13

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

 

  Re: Interlock Pharmacy Systems, LLC and
Home Pharmacy Services, LLC

Ladies and Gentlemen:

We have acted as special Missouri counsel for Interlock Pharmacy Systems, LLC (formerly known as IP Acquisition Sub, LLC), a Missouri limited liability company (“ Interlock ”), and Home Pharmacy Services, LLC (formerly known as Home Pharmacy Merger Sub LLC), a Missouri limited liability company (“ HPS ”), in connection with the matters set forth herein. At your request, this opinion is being furnished to you.

For purposes of giving the opinions hereinafter set forth, our examination of documents has been limited to the examination of executed or conformed counterparts, or copies otherwise proved to our satisfaction, of the following:

(a) The Articles of Organization of Interlock dated October 11, 2005, as filed in the office of the Secretary of State of the State of Missouri (the “ Secretary of State ”) on October 11, 2005, as amended by the Articles of Merger and Agreement and Plan of Merger, dated as of June 9, 2006, as filed in the office of the Secretary of State on July 18, 2006;

(b) The Certificate of Organization issued to Interlock by the Secretary of State on October 11, 2005 (the “ Interlock Certificate of Organization ”);

(c) The Certificate of Merger issued to Interlock by the Secretary of State on July 18, 2006, and corrected as of August 9, 2006 (the “ Interlock Certificate of Merger ”);

(d) The Limited Liability Company Agreement of Interlock, dated as of June 9, 2006 (the “ Interlock LLC Agreement ”);

(e) A Secretary’s Certificate dated as of November 5, 2014 from the Secretary of Interlock;


Omnicare, Inc.

November 5, 2014

Page 2

 

(f) Written Consent of the Sole Member of Interlock dated as of October 24, 2014 (the “ Interlock Resolutions ”), as to certain matters;

(g) A Certificate of Good Standing for Interlock, dated as of October 20, 2014, obtained from the Secretary of State (“ Interlock Certificate of Good Standing ”);

(h) The Articles of Organization of HPS dated December 10, 2001, as filed in the office of the Secretary of State on December 12, 2001, as amended by the Articles of Merger, dated as of December 19, 2001, as filed in the office of the Secretary of State on December 28, 2001 with an effective date of December 31, 2001;

(i) The Certificate of Organization issued to HPS by the Secretary of State on December 12, 2001 (the “ HPS Certificate of Organization ”);

(j) The Corrected Certificate of Merger issued to HPS by the Secretary of State on December 28, 2001 with an effective date of December 31, 2001 (“ HPS Certificate of Merger ”);

(k) The Limited Liability Company Declaration of HPS, dated as of December 31, 2001 (the “ HPS LLC Agreement ”);

(l) A Secretary’s Certificate dated as of November 5, 2014 from the Secretary of HPS;

(m) Written Consent of the Board of Managers and Sole Member of HPS dated as of October 24, 2014 (the “ HPS Resolutions ”), as to certain matters;

(n) A Certificate of Good Standing for HPS, dated as of October 22, 2014, obtained from the Secretary of State (“ HPS Certificate of Good Standing ”);

(o) The documents listed on Schedule A attached (collectively, the “ Indentures ”).

Capitalized terms used and not defined herein are used as defined in each of the Indentures.

For purposes of this opinion, we have not reviewed any documents other than the documents listed in paragraphs (a) through (o) above. In particular, we have not reviewed any document (other than the documents listed in paragraphs (a) through (o) above) that is referred to in or incorporated by reference into any document reviewed by us. We have assumed that there exists no provision in any document that we have not reviewed that is inconsistent with the opinions stated herein. We have conducted no independent factual investigation of our own but rather have relied solely upon the foregoing documents, the statements and information set forth therein and the additional matters recited or assumed herein, all of which we have assumed to be true, complete and accurate in all material respects.


Omnicare, Inc.

November 5, 2014

Page 3

 

With respect to all documents examined by us, we have assumed that (i) all signatures on documents examined by us are genuine, (ii) all documents submitted to us as originals are authentic, (iii) all documents submitted to us as copies conform with the original copies of those documents, and (iv) the documents, in the forms submitted to us for our review, have not been and will not be altered or amended in any respect material to our opinions expressed herein.

For purposes of this opinion, we have assumed (i) except to the extent provided in paragraphs 1 and 4 below, that each party to the documents examined by us has been duly created, organized or formed, as the case may be, and is validly existing in good standing under the laws of the jurisdiction governing its creation, organization or formation, (ii) that each natural person who is a signatory to any of the documents examined by us has the requisite legal capacity, (iii) except to the extent provided in paragraphs 2 and 5 below, that each of the parties to the documents examined by us has the power and authority to execute and deliver, and to perform its obligations under, such documents, (iv) except to the extent provided in paragraphs 3 and 6 below, that each of the parties to the documents examined by us has duly authorized, executed and delivered such documents, and (v) that each of the documents examined by us constitutes a valid and binding agreement of the parties thereto, and is enforceable against the parties thereto, in accordance with its terms. Other than this letter, we have not participated in the preparation of any material relating to Interlock or HPS and assume no responsibility for the contents of any such material.

This opinion is limited to the laws of the State of Missouri (excluding the securities and blue sky laws of the State of Missouri), and we have not considered and express no opinion on the laws of any other jurisdiction, including federal laws and rules and regulations relating thereto. Our opinions are rendered only with respect to Missouri laws and rules, regulations and orders thereunder that are currently in effect. In rendering the opinions set forth herein, we express no opinion concerning (i) the creation, attachment, perfection or priority of any security interest, lien or other encumbrance, or (ii) the nature or validity of title to any property.

Based upon the foregoing, and upon our examination of such questions of law and statutes of the State of Missouri as we have considered necessary or appropriate, and subject to the assumptions, qualifications, limitations and exceptions set forth herein, we are of the opinion that:

1. Based solely on the Interlock Certificate of Organization and the Interlock Certificate of Merger, Interlock has been duly formed and, based solely on the Interlock Certificate of Good Standing, is validly existing in good standing as a limited liability company under the Missouri Limited Liability Company Act (RSMo. § 347.010, et seq. ) (the “ LLC Act ”).

2. Interlock has all necessary limited liability company power, capacity and authority under the LLC Act, the Interlock LLC Agreement and the Interlock Resolutions (a) to guarantee the Securities pursuant to the terms of the Indentures, (b) to execute and deliver the Security Guarantees pursuant to the terms of the Indentures, and (c) to perform its obligations under the Security Guarantees, as described in the Indentures.


Omnicare, Inc.

November 5, 2014

Page 4

 

3. The Security Guarantees to be executed by Interlock, upon being duly authorized by all necessary limited liability company action, and executed by an authorized signatory and delivered, will be validly authorized, executed and delivered by Interlock under the LLC Act, the Interlock LLC Agreement and the Interlock Resolutions.

4. Based solely on the HPS Certificate of Organization and the HPS Certificate of Merger, HPS has been duly formed and, based solely on the HPS Certificate of Good Standing, is validly existing in good standing as a limited liability company under the LLC Act.

5. HPS has all necessary limited liability company power, capacity and authority under the LLC Act, the HPS LLC Agreement and the HPS Resolutions (a) to guarantee the Securities pursuant to the terms of the Indentures, (b) to execute and deliver the Security Guarantees pursuant to the terms of the Indentures, and (c) to perform its obligations under the Security Guarantees, as described in the Indentures.

6. The Security Guarantees to be executed by HPS, upon being duly authorized by all necessary limited liability company action, and executed by an authorized signatory and delivered, will be validly authorized, executed and delivered by HPS under the LLC Act, the HPS LLC Agreement and the HPS Resolutions.

The opinions expressed above are subject to the following additional assumptions, qualifications, limitations and exceptions:

In connection with the foregoing, we hereby consent to you and your successors and assigns relying as to matters of Missouri law upon this opinion, subject to the understanding that the opinions herein are given on the date hereof and such opinions are rendered only with respect to facts existing on the date hereof and laws and rules, regulations and orders thereunder in effect as of such date. We assume no, and hereby disclaim any, responsibility to supplement this opinion with respect to matters occurring after the date hereof.

In addition, we hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement to be filed by Omnicare Inc. on the date hereof with the Securities and Exchange Commission (the “ Registration Statement ”). Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the United States Securities and Exchange Commission thereunder.

 

Very truly yours,
/s/ Carmody MacDonald P.C.

GJM/MBH


Schedule A

 

1. The Form of Senior Debt Securities Indenture, by and between Omnicare, Inc., a Delaware Corporation, as Company (as defined therein) and the trustee party thereto (as defined therein).

 

2. The Subordinated Debt Securities Indenture, dated as of June 13, 2003, by and between Omnicare, Inc., a Delaware Corporation, as Company (as defined therein), and U.S. Bank National Association (as successor trustee to SunTrust Bank), as Trustee (as defined therein).

Exhibit 5.14

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

 

RE: NCS Healthcare of New Hampshire, Inc. and Uni-Care Health Services of Maine, Inc.

Ladies and Gentlemen:

We have acted as counsel to NCS Healthcare of New Hampshire, Inc. (“ NCS ”) and Uni-Care Health Services of Maine, Inc. (“ Uni-Care ”) in connection with the guarantee (the “ Debt Guarantee ”) of debt securities to be issued pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”), between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ”), between the Company and U.S. Bank National Association (as successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Company’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014.

In our capacity as counsel to NCS and Uni-Care, we have examined the corporate filings and By-Laws of both companies. We have examined original, certified copies, or copies otherwise authenticated to our satisfaction, of such documents as we have deemed necessary or advisable to examine in order to furnish the opinion herein expressed, and we have made other examination as to matters of fact and law as we have deemed necessary in order to enable us to give this opinion.

In such examination, we have assumed the genuineness of all signatures, the legal capacity and competence of all individuals, the completeness and accuracy of all corporate records provided to us, the authenticity of all documents submitted to us as originals, the conformity to original documents of all copies of documents submitted to us as copies, and the authenticity of the originals of such latter documents. In rendering this opinion, we have relied upon and are assuming the correctness of certificates of public officials and the officers of the Company. We have not conducted any independent investigation of, or attempted to verify independently, such factual matters.


Based upon and subject to the foregoing, we are of the opinion that:

 

  1. Uni-Care has been incorporated under the New Hampshire Business Corporation Act since November 19, 1993, is active and in good standing under the laws of the State of New Hampshire.

 

  2. Uni-Care has the corporate power and capacity to guarantee the Debt Securities pursuant to the terms of the Indentures and perform its obligations under the Debt Guarantees.

 

  3. NCS has been incorporated under the New Hampshire Business Corporation Act since November 15, 1993, is active and in good standing under the laws of the State of New Hampshire.

 

  4. NCS has the corporate power and capacity to guarantee the Debt Securities pursuant to the terms of the Indentures and perform its obligations under the Debt Guarantees.

 

  5. The Debt Guarantees, upon being duly authorized by all necessary corporate action, executed by an authorized signature and delivered, will be validly authorized, executed and delivered for corporate law purposes by each New Hampshire Guarantor.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

 

Respectfully submitted,
/s/ Sean T. O’Connell
Sean T. O’Connell

Exhibit 5.15

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

Ladies and Gentlemen:

We have acted as New Jersey counsel for Institutional Health Care Services, LLC, a New Jersey limited liability company (the “ Guarantor ”), in connection with the guarantee (the “ Debt Guarantee ”) of debt securities (the “ Debt Securities ”) to be issued pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”), between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ” and, each an “ Indenture ”), between the Company and U.S. Bank National Association (successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which are filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Company’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014.

Terms used (but not defined) herein have the meanings assigned to them in each of the Indentures.

We have reviewed an electronic copy of the Indentures.

We have also examined originals or copies, certified or otherwise identified to our satisfaction, of the documents, limited liability company records and certificates of public officials and officers of the Guarantor described in Exhibit A and have conducted such investigation of law as we have deemed appropriate to give the opinions set forth below. In addition, we have relied as to certain matters of fact upon the representations of the Guarantor contained in the Indentures and in the Secretary’s Certificate of the Guarantor dated November 5, 2014.


Omnicare, Inc.

November 5, 2014

Page 2

 

We have assumed without independent investigation and without opining thereon that the following facts and conclusions are accurate:

 

  a) All signatures on all instruments and documents submitted to us are genuine; all documents and other records submitted to us as originals are authentic and complete; and all documents and other records submitted to us as copies are accurate and complete copies of the originals thereof. No modifications or amendments have been made to the Indentures since the date of execution or to the Certificate of Limited Liability Company or Limited Liability Company Agreement since the dates referenced on Exhibit A.

 

  b) The sole member of the Guarantor duly authorized, executed and delivered the Limited Liability Company Agreement of the Guarantor and such agreement remains in full force and effect and has not been amended, orally or in writing.

 

  c) The sole member of the Guarantor has not agreed to take or taken any action to dissolve the Guarantor.

 

  d) The sole member named in the Limited Liability Company Agreement is and has been continuously since July 6, 2006, the sole member of the Guarantor.

 

  e) Each provision of the Indentures is enforceable under New York law.

 

  f) None of the representations or warranties in the Indentures or the Registration Statement contains any untrue statement of material fact or omits to state any material fact necessary to make such statements not misleading.

Based on the foregoing, and subject to the assumptions, exceptions, limitations and qualifications set forth herein, we are of the opinion that:

1. The Guarantor is a limited liability company formed under the New Jersey Limited Liability Company Act and its status is active.

2. The Guarantor has the limited liability company power to guarantee the Debt Securities pursuant to the terms of the Indentures and perform its obligations under the Debt Guarantees.

3. The Debt Guarantees, upon being duly authorized by all necessary limited liability company action, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for limited liability company law purposes by the Guarantor.

The foregoing opinions are subject to the following exceptions, limitations and qualifications:

 

  a) We express no opinion as to the law of any jurisdiction other than the law of the State of New Jersey.


Omnicare, Inc.

November 5, 2014

Page 3

 

  b) In expressing the opinion set forth in paragraph 1, we have relied solely on the Certificate dated October 20, 2014 of the Division of Revenue and Enterprise Services of the Department of Treasury of the State of New Jersey as to the active status of the Guarantor in the State of New Jersey.

 

  c) The opinions expressed herein are based upon facts and applicable laws covered by our opinions, each as in existence on this date. We assume no obligation to update or supplement such opinions to reflect any fact or circumstance that may come to our attention or any change in law that may occur. The opinions contained herein are legal opinions only and do not constitute a guarantee or warranty of the matters stated. The opinions are limited to the matters stated, and no opinion is implied or may be inferred beyond the matters expressly stated.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use to our name under the caption—“Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

 

Very truly yours,
STRADLEY RONON STEVENS & YOUNG, LLP
By:   /s/ E. Carolan Berkley
  E. Carolan Berkley,
  A Partner


EXHIBIT A

Secretary’s Certificate of the Guarantor dated November 5, 2014.

Certificate of Formation, Limited Liability Company filed with the Division of Revenue in the Department of the Treasury of New Jersey (the “Filing Office”) on October 11, 2005 and Certificate of Merger/Consolidation filed with the Filing Office on July 10, 2006.

Certificate dated October 20, 2014, issued by the Filing Office as to the valid existence of the Guarantor in the State of New Jersey.

Limited Liability Company Agreement dated July 6, 2006.

Exhibit 5.16

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

Ladies and Gentlemen:

We have acted as Pennsylvania counsel for Continuing Care Rx, LLC, Omnicare Pharmacies of Pennsylvania West, LLC and Suburban Medical Services, LLC, each a Pennsylvania limited liability company (each an “ LLC Guarantor” and collectively, the “ LLC Guarantors ”) and for NeighborCare, Inc. and Delco Apothecary, Inc., each a Pennsylvania corporation (each a “ Corporate Guarantor ” and collectively, the “ Corporate Guarantors” and together with the LLC Guarantors, the “ Guarantors ”), in connection with the guarantee (the “ Debt Guarantee ”) of debt securities (the “ Debt Securities ”) to be issued pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”), between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ” and, each an “ Indenture ”), between the Company and U.S. Bank National Association (successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which are filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Company’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014.

Terms used (but not defined) herein have the meanings assigned to them in each of the Indentures.

We have reviewed an electronic copy of the Indentures.

We have also examined originals or copies, certified or otherwise identified to our satisfaction, of the documents, corporation and limited liability company records and certificates of public officials and officers of the Guarantors described in Exhibit A and have conducted such investigation of law as we have deemed appropriate to give the opinions set forth below. In addition, we have relied as to certain matters of fact upon the representations of the Guarantors contained in the Indentures and in the Secretary’s Certificate of the Guarantors dated November 5, 2014.


Omnicare, Inc.

November 5, 2014

Page 2

 

We have assumed without independent investigation and without opining thereon that the following facts and conclusions are accurate:

 

  a) All signatures on all instruments and documents submitted to us are genuine; all documents and other records submitted to us as originals are authentic and complete; and all documents and other records submitted to us as copies are accurate and complete copies of the originals thereof. No modifications or amendments have been made to the Indentures since the date of execution or to the Certificates of Organization of Domestic Limited Liability Company or Limited Liability Company Agreements of the LLC Guarantors or Articles of Incorporation or Bylaws of the Corporate Guarantors since the dates referenced on Exhibit A.

 

  b) The sole member of each LLC Guarantor duly authorized, executed and delivered the Limited Liability Company Agreement of the respective LLC Guarantor and each such agreement remains in full force and effect and has not been amended, orally or in writing.

 

  c) The sole member of each LLC Guarantor has not agreed to take or taken any action to dissolve the LLC Guarantor of which it is a member.

 

  d) The sole member named in the Limited Liability Company Agreement of each LLC Guarantor is and has been continuously the sole member of the respective LLC Guarantor.

 

  e) Each provision of the Indentures is enforceable under New York law.

 

  f) None of the representations or warranties in the Indentures or the Registration Statement contains any untrue statement of material fact or omits to state any material fact necessary to make such statements not misleading.

Based on the foregoing, and subject to the assumptions, exceptions, limitations and qualifications set forth herein, we are of the opinion that:

1. Each LLC Guarantor is a limited liability company formed and presently subsisting under the Pennsylvania Limited Liability Company Act.

2. Each LLC Guarantor has the limited liability company power to guarantee the Debt Securities pursuant to the terms of the Indentures and perform its obligations under the Debt Guarantees.

3. The Debt Guarantees, upon being duly authorized by all necessary limited liability company action, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for limited liability company law purposes by each LLC Guarantor.


Omnicare, Inc.

November 5, 2014

Page 3

 

4. Each Corporate Guarantor is a corporation formed and presently subsisting under the laws of the Commonwealth of Pennsylvania.

5. Each Corporate Guarantor has the corporate power to guarantee the Debt Securities pursuant to the terms of the Indentures and perform its obligations under the Debt Guarantees.

6. The Debt Guarantees, upon being duly authorized by all necessary corporate action, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for corporate law purposes by each Corporate Guarantor.

The foregoing opinions are subject to the following exceptions, limitations and qualifications:

 

  a) We express no opinion as to the law of any jurisdiction other than the law of the Commonwealth of Pennsylvania.

 

  b) In expressing the opinions set forth in paragraphs 1 and 4, we have relied solely on the Subsistence Certificates dated October 20, 2014 of the Secretary of the Commonwealth of the Department of State of the Commonwealth of Pennsylvania as to the subsistence of the Guarantors in the Commonwealth of Pennsylvania.

 

  c) The opinions expressed herein are based upon facts and applicable laws covered by our opinions, each as in existence on this date. We assume no obligation to update or supplement such opinions to reflect any fact or circumstance that may come to our attention or any change in law that may occur. The opinions contained herein are legal opinions only and do not constitute a guarantee or warranty of the matters stated. The opinions are limited to the matters stated, and no opinion is implied or may be inferred beyond the matters expressly stated.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use to our name under the caption—“Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

 

Very truly yours,
STRADLEY RONON STEVENS & YOUNG, LLP
By:   /s/ E. Carolan Berkley
  E. Carolan Berkley,
  A Partner


EXHIBIT A

Secretary’s Certificate of the Guarantors dated November 5, 2014.

Subsistence Certificates dated October 20, 2014 of the Secretary of the Commonwealth of the Department of State of the Commonwealth of Pennsylvania as to the subsistence of the Guarantors in the Commonwealth of Pennsylvania.

Certificate of Organization, Domestic Limited Liability Company of Continuing Care Rx, LLC filed with the Secretary of the Commonwealth, Pennsylvania Department of State, Corporation Bureau on March 30, 2011, effective March 31, 2011; Certificate of Merger or Consolidation, Limited Liability Company filed with the Secretary of the Commonwealth, Pennsylvania Department of State, Corporation Bureau on March 30, 2011, effective March 31, 2011.

Limited Liability Company Agreement of Continuing Care Rx, LLC effective as of March 31, 2011 by CCRx Holdings, Inc., as sole member.

Certificate of Organization, Domestic Limited Liability Company of OPPW Acquisition Sub, LLC filed with the Secretary of the Commonwealth, Pennsylvania Department of State, Corporation Bureau on October 12, 2005; Certificate of Merger or Consolidation, Limited Liability Company filed with the Secretary of the Commonwealth, Pennsylvania Department of State, Corporation Bureau on June 9, 2006 and Agreement and Plan of Merger between OmniCare Pharmacies of Pennsylvania West, Inc. and OPPW Acquisition Sub, LLC, as the survivor, which was renamed as OmniCare Pharmacies of Pennsylvania West, LLC, as part of the Agreement.

Limited Liability Company Agreement of OmniCare Pharmacies of Pennsylvania West, LLC dated June 9, 2006 by NeighborCare, Inc., as sole member.

Certificate of Organization, Domestic Limited Liability Company of Suburban Medical Services, LLC filed with the Secretary of the Commonwealth, Pennsylvania Department of State, Corporation Bureau on December 26, 2008; Certificate of Merger or Consolidation, Limited Liability Company filed with the Secretary of the Commonwealth, Pennsylvania Department of State, Corporation Bureau on December 26, 2008, effective December 31, 2008.

Limited Liability Company Operating Agreement of Suburban Medical Services, LLC dated December 31, 2008 by ASCO Healthcare LLC, as sole member.


Articles of Incorporation of Delco Apothecary, Inc. filed with the Secretary of the Commonwealth of the Commonwealth of Pennsylvania on April 19, 1965; Amended and Restated Bylaws of Delco Apothecary, Inc.

Amended and Restated Articles of Incorporation of NeighborCare, Inc. filed with the Secretary of the Commonwealth, Pennsylvania Department of State as part of the Articles of Merger of Nectarine Acquisition Corp. with NeighborCare, Inc. on July 28, 2005.

Exhibit 5.17

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

 

  Re: CP Acquisition Corp.

Ladies and Gentlemen:

We have acted as Oklahoma counsel to CP Acquisition Corp., an Oklahoma corporation (the “ Company ”), in connection with the Registration Statement (the “ Registration Statement ”) on Form S-3 filed by Omnicare, Inc., a Delaware corporation (“ Omnicare ”), with the Securities and Exchange Commission on the date of this letter.

In connection with the opinions expressed in this letter, we have examined copies of the following documents, each dated the date of this letter unless otherwise noted:

 

  (1) the Indenture, dated June 13, 2003, between Omnicare and U.S. Bank National Association (as successor trustee to SunTrust Bank) relating to subordinated notes;

 

  (2) the form of Indenture attached as an exhibit to the Registration Statement relating to senior notes;

 

  (3) a copy of a Certificate of Good Standing, dated October 20, 2014, issued by the Secretary of State of the State of Oklahoma (the “ Good Standing Certificate ”); and

 

  (4) a copy of a certificate of an officer of the Company (the “ Officer’s Certificate ”) dated November 5, 2014, certifying to us certain matters of fact relevant to our opinions in this letter, including (i) a copy of the certificate of incorporation of the Company (the “ Certificate of Incorporation ”), (ii) a copy of the bylaws of the Company (the “ Bylaws ”), and (iii) a written consent of the directors of the Company.

The documents identified in (1) and (2) are the “ Indentures ” and each is an “ Indenture .” “ Security Guaranty ” has the meaning given to it in the Indentures.


OPINIONS

Based upon the foregoing, and subject to the assumptions, qualifications and limitations set forth in this letter, we are of the opinion that:

 

  (a) The Company is a corporation existing in good standing under the laws of the State of Oklahoma.

 

  (b) The Company has the corporate power and authority to make the Security Guaranties.

 

  (c) A Security Guaranty under an Indenture will be duly authorized upon the authorization of the Security Guaranty by all corporate action required by the Certificate of Incorporation, the Bylaws and the Oklahoma General Corporation Act. A supplemental indenture in respect of any Securities (as defined in an Indenture) that are to be subject to a Security Guaranty by the Company will be duly executed and delivered by the Company upon (i) the due execution by a duly qualified and elected officer that has been authorized to execute the supplemental indenture by all corporate action required by the Certificate of Incorporation, the Bylaws and the Oklahoma General Corporation Act and (ii) the physical delivery of the supplemental indenture without condition and with the intention to be immediately bound by it.

ASSUMPTIONS, QUALIFICATIONS AND LIMITATIONS

The opinions set forth above are subject to the following assumptions, qualifications and limitations:

 

  (A) We have assumed the legal capacity of all natural persons executing documents, the genuineness of all signatures, the authenticity of original and certified documents and the conformity to original of documents submitted to us as copies.

 

  (B) We have assumed that each Indenture and each supplement indenture issued pursuant to an Indenture are enforceable against the parties.

 

  (C) In connection with the opinions expressed in paragraph (a), we have relied solely upon the Good Standing Certificate and the Certificate of Incorporation.

 

  (D) With respect to certain matters of fact relevant to our opinions set forth in this letter, we have relied on the Officer’s Certificate.

 

  (E) We have assumed that the Security Guaranties are necessary to the conduct, promotion or attainment of the business of the Company.

 

  (F) The opinions in this opinion letter are limited to the laws of the State of Oklahoma.


All assumptions and statements of reliance herein have been made without any independent investigation or verification on our part except to the extent, if any, otherwise expressly stated herein. We express no opinion with respect to the subject matter or accuracy of the assumptions or items upon which we have relied. The qualifications, limitations, assumptions, and exceptions in this letter are material to the opinions expressed in this letter, and the inaccuracy of any assumptions could render these opinions inaccurate.

We have prepared this opinion letter in accordance with customary practice for the preparation and interpretation of closing opinions of this type. We have assumed, and your acceptance of this letter shall confirm, that you (alone or with your counsel) are familiar with this customary practice.

The opinions expressed in this letter are as of the date of this letter. We have no obligation to update or supplement the opinions in response to changes in the law or future events.

We consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with their opinion attached as an exhibit to the Registration Statement. Additionally, we consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder.

Very truly yours,

/s/ McAfee & Taft, A Professional Corporation

Exhibit 5.18

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 East Fourth Street

Cincinnati, OH 45202

 

  Re: Form S-3 Registration Statement

Ladies and Gentlemen:

We have acted as special South Dakota counsel to Omnicare Pharmacy and Supply Services, LLC, a South Dakota Limited Liability Company (the “ SD Guarantor ”), in connection with the preparation and filing by the SD Guarantor, and its ultimate parent corporation, Omnicare, Inc. (“ Omnicare ”), and certain other subsidiaries of Omnicare (collectively the “ Registrants ”), of a Registration Statement on Form S-3 (the “ Registration Statement ”), which was filed by Omnicare on November 5, 2014 with the Securities Exchange Commission (the “ Commission ”).

The Registration Statement relates to the issuance, from time to time, of certain debt securities of Omnicare (the “ Debt Securities ”), and guarantees of the Debt Securities (the “ Guarantees ”) by one or more of the Registrants (each a “ Guarantor ,” and, collectively, the “ Guarantors ”), including, without limitation, the Guarantees pursuant to which the SD Guarantor will be a Guarantor (the “ SD Guarantee ”). Pursuant to the prospectus forming a part of the Registration Statement (the “ Prospectus ”), Omnicare proposes to register the Debt Securities under the Securities Act of 1933 (as amended) (the “ Act ”), as set forth in the Registration Statement, to be issued pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”), between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ” and, each an “ Indenture ”), between the Company and U.S. Bank National Association (successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which were filed as exhibits to the Registration Statement on November 5, 2014.


November 5, 2014

Page 2

I. DOCUMENTS EXAMINED:

In our capacity as counsel to the SD Guarantor, we have reviewed the following documents:

 

  1. the Registration Statement and the Prospectus;

 

  2. the Indentures;

 

  3. the Limited Liability Company Agreement of Omnicare Pharmacy and Supply Services, LLC, dated June 9, 2006;

 

  4. the original Articles of Organization of OPSS Acquisition Sub, LLC (n/k/a Omnicare Pharmacy and Supply Services, LLC), dated November 30, 2005;

 

  5. the Articles of Merger of Omnicare Pharmacy and Supply Services, Inc. with and into OPSS Acquisition Sub, LLC, dated June 9, 2006, which Articles of Merger changed the name of OPSS Acquisition Sub, LLC to Omnicare Pharmacy and Supply Services, LLC;

 

  6. the Certificate of Existence issued for Omnicare Pharmacy and Supply Services, LLC, by the Secretary of State of the State of South Dakota on October 20, 2014; and

 

  7. certain resolutions adopted by the sole member and the managers (if any) of the SD Guarantor relating to the Registration Statement, the SD Guarantee, and related matters;

II. ASSUMPTIONS:

In reaching the opinions set forth below, we have assumed the following:

 

  1. Each of the parties to the Registration Statement and the Indentures, including the SD Guarantor, has duly and validly executed and delivered each such instrument, document, and agreement to be executed in connection therewith and to which such party is a signatory.

 

  2. Each natural person executing any instrument, document, or agreement on behalf of the SD Guarantor or any other entity is legally competent to do so.

 

  3. The genuineness of all signatures and the authenticity of all items submitted to us as originals and the conformity to originals of all items submitted to us as copies, and that all public records reviewed are accurate and complete.


November 5, 2014

Page 3

III. OPINION:

Based upon the foregoing, we are of the opinion that:

 

  1. SD Guarantor has been organized under the South Dakota Limited liability Company Act and remains in existence.

 

  2. SD Guarantor has the company power and capacity to guarantee the Debt Securities pursuant to the terms of the Indentures and to perform its obligations under the SD Guarantee.

 

  3. The SD Guarantee, upon being duly authorized by all necessary limited liability company action and executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for limited liability company law purposes by the SD Guarantor.

IV. QUALIFICATIONS:

In addition to the assumptions set forth above, the opinions set forth above are also subject to the following qualifications:

 

  (A) We express no opinion as to the laws of any jurisdiction other than the laws of the State of South Dakota. We assume no obligation to supplement this opinion if any applicable laws change after the date of this opinion, or if we become aware of any facts that might change the opinions expressed above after the date of this opinion.

 

  (B) Our opinion in paragraph 1 above as to the organization of the SD Guarantor as a South Dakota limited liability company currently in existence is based solely on our review of the Certificate of Existence issued by the South Dakota Secretary of State on October 20, 2014.

 

  (C) No opinion is expressed herein with respect to the enforceability of any term, agreement or other provision contained in the Indentures or any guaranty or other agreement, document or instrument to which SD Guarantor may be a party or by which it is intended to be bound.

 

  (D) As to various questions of fact material to our opinion, we have relied upon the truthfulness of the representations made in the Indentures, Registration Statement and Prospectus and in the certificates of public officials and in the resolutions and certificates of the purported members, officers and managers of the SD Guarantor.


November 5, 2014

Page 4

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Act, or the rules and regulations of the Commission thereunder.

Sincerely,

/s/ DAVENPORT, EVANS, HURWITZ & SMITH, L.L.P.

Exhibit 5.19

November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

 

  Re: Washington Guarantor of Omnicare, Inc.

Ladies and Gentlemen:

We have acted as special Washington counsel to Evergreen Pharmaceutical, LLC, a Washington limited liability company (the “ Washington Guarantor ”), in connection with the debt securities (the “ Notes ”) to be issued pursuant (i) a form of senior notes indenture (the “ Senior Notes Indenture ”), between the Company and the trustee party thereto or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ” and, each an “ Indenture ”), between the Company and U.S. Bank National Association (as successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, which were filed with the Securities and Exchange Commission (the “ Commission ”) as exhibits to the Company’s registration statement on Form S-3 (the “ Registration Statement ”) on November 5, 2014.

The law covered by the opinions expressed herein is limited to the laws of the State of Washington.

 

A. Documents and Matters Examined

For purposes of rendering this opinion letter, we have examined originals or copies of the following documents, instruments and agreements dated on or as of the date hereof, except as otherwise indicated:

A-1. the Indentures; and

A-2. the documents listed or otherwise described on Schedule A (“ Schedule A ”) attached to this opinion letter.


Omnicare, Inc.

November 5, 2014

Page 2

 

As to certain matters of fact bearing on the opinions expressed herein, we have relied, without investigation, on:

 

  (a) Certificate of Existence for Evergreen Pharmaceutical, LLC issued by the Secretary of State for the State of Washington on October 20, 2014 (the “ Certificate of Existence ”); and

 

  (b) Information provided in the Certificate of Secretary of Guarantors effective as of November 5, 2014.

 

B. Assumptions

For purposes of this opinion letter, we have relied on customary assumptions, including the following assumption:

B-1. The issuance of the Notes may reasonably be expected to benefit, directly or indirectly, the Washington Guarantor and the Washington Guarantor has received adequate and sufficient consideration and will derive adequate and sufficient benefit in respect of its obligations under each of the Indentures.

We have not undertaken an independent investigation to determine the accuracy of our assumptions made in this opinion letter, and any inquiry undertaken by us during the preparation of this opinion letter should not be regarded as such an investigation. No inference as to our knowledge of any matters bearing on the accuracy of our assumptions in this opinion letter should be drawn from the fact of our representation of the Washington Guarantor.

 

C. Opinions

Based on the foregoing examinations and assumptions and subject to the qualifications and exclusions stated below, we are of the opinion that:

C-1. Based solely on the Certificate of Existence, the Washington Guarantor is validly existing under the laws of the State of Washington.

C-2. The Washington Guarantor has all necessary limited liability company power and limited liability company authority to execute, deliver, and perform its obligations under the Indentures.

C-3. The Washington Guarantor has taken all limited liability company action necessary to authorize the execution, delivery and performance of the Indentures.


Omnicare, Inc.

November 5, 2014

Page 3

 

D. Qualifications, Limitations and Exclusions

The opinions set forth herein are subject to the following qualifications, limitations, and exclusions.

D-1. We express no opinion as to the enforceability of the Indentures.

D-2. We express no opinion as to any law other than the law of the State of Washington. In addition, our opinions herein are based upon our consideration of only those statutes, rules and regulations which in our experience, are normally applicable to transactions of the type provided for in the Indentures. Without limiting the foregoing, we have not examined and we express no opinion as to any matters governed by (i) any banking or insurance company law, rule or regulation, (ii) any law, rule or regulation relating to taxation, (iii) the statutes and ordinances, administrative decisions and rules and regulations of countries, towns, agencies, counties, municipalities and special political subdivisions, (iv) state securities or “Blue Sky” laws, rules and regulations, (v) equitable principles or by any applicable bankruptcy, reorganization, winding-up, insolvency, moratorium, fraudulent conveyance, fraudulent transfer, or other laws of general application affecting the enforcement of creditors’ rights generally (including, without limitation, the effectiveness of waivers of defenses and legal rights) and (vi) antitrust and unfair competition laws and regulations.

This opinion letter is to be interpreted in accordance with the report by the TriBar Opinion Committee, Third Party “Closing” Opinions, 53 B US . L AW . 592 (Feb. 1998) and the report by the Ad Hoc Committee on Third-Party Legal Opinions of the Business Law Section of the Washington State Bar Association, Supplemental Report Covering Secured Lending Transactions (Oct. 2000). This opinion letter is delivered as of its date and without any undertaking to advise you of any changes of law or fact that occur after the date of this opinion letter even though the changes may affect the legal analysis, a legal conclusion or information confirmed in this opinion letter.

This opinion letter is delivered as of its date and without any undertaking to advise you of any changes of law or fact that occur after the date of this opinion letter even though the changes may affect the legal analysis, a legal conclusion or information confirmed in this opinion letter.


Omnicare, Inc.

November 5, 2014

Page 4

 

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use to our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.

Very truly yours,

/s/ Stoel Rives LLP


SCHEDULE A

 

1. Evergreen Pharmaceutical, LLC , a Washington limited liability company.

 

  a. The following documents certified by the secretary of Evergreen Pharmaceutical, LLC on November 5, 2014:

i. Certificate of Incorporation of EP Acquisition Sub, LLC issued by the Secretary of State for the State of Washington on October 11, 2005.

ii. Certificate of Merger merging Brim Outpatient Services, Inc. into EP Acquisition Sub, LLC issued by the Secretary of State for the State of Washington on June 12, 2006.

iii. Articles of Merger merging Evergreen Pharmaceutical, Inc. into EP Acquisition Sub, LLC filed with the Secretary of State for the State of Washington on June 12, 2006.

 

  b. The following documents certified by the secretary of Evergreen Pharmaceutical, LLC on November 5, 2014:

i. Limited Liability Company Agreement of Evergreen Pharmaceutical, LLC, dated June 9, 2006.

Exhibit 5.20

Dated as of November 5, 2014

Omnicare, Inc.

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio 45202

 

  Re: Omnicare, Inc. – Local Counsel Opinion for Roeschen’s Healthcare, LLC

Ladies and Gentlemen:

We have acted as special local counsel to Roeschen’s Healthcare, LLC, a Wisconsin limited liability company (“Wisconsin Guarantor”), and a subsidiary of Omnicare, Inc., a Delaware corporation (“Company”), in connection with the preparation and filing by the Company, certain subsidiaries of the Company, and Wisconsin Guarantor (collectively, the “ Registrants ”) of an automatic shelf registration statement on Form S-3 (the “ Registration Statement ”) to be filed with the Securities and Exchange Commission (the “ Commission ”) under the Securities Act of 1933, as amended (the “ Securities Act ”) relating to the issuance and offering, from time to time, of, among other things, certain Debt Securities (as defined below) and guarantees of the Debt Securities by one or more Registrants, including, without limitation the Wisconsin Guarantor. In accordance with the prospectus forming a part of the Registration Statement (the “ Prospectus ”), the Company proposes to issue the Debt Securities pursuant to (i) a form of senior notes indenture (the “ Senior Notes Indenture ”) between the Company and the trustee party thereto, relating to the senior secured notes (the “ Senior Debt Securities ”) or (ii) a subordinated notes indenture (the “ Subordinated Notes Indenture ” and, together with the Senior Notes Indenture, the “ Indentures ” and, each an “ Indenture ”), between the Company and U.S. Bank National Association (successor trustee to SunTrust Bank), as trustee, dated June 13, 2003, relating to the subordinated notes, (the “ Subordinated Debt Securities ” and, together with the Senior Debt Securities, the “ Debt Securities ”) which are exhibits to the Registration Statement and will be filed therewith. Capitalized terms used but not defined herein shall have the meaning assigned thereto in the Indentures. This opinion letter has been prepared and should be understood in accordance with the Legal Opinion Principles, 53 Bus. Law 831 (1998) (the “ABA Report”) and Third Party “Closing” Opinions: A Report of the TriBar Opinion Committee, 53 Bus. Law 592 (1998).

In connection with rendering our opinion, we have examined the Registration Statement and the following:

1. the Senior Indenture;

2. the Subordinated Indenture;

3. Articles of Organization of Guarantor, certified as in effect on the date hereof by the Wisconsin Department of Financial Institutions (the “Filing Office”);


Omnicare, Inc.

Dated as of November 5, 2014

Page 2

 

4. Limited Liability Company Agreement of Guarantor (the “LLC Agreement”), certified as in effect on the date hereof by an officer of the Guarantor;

5. Certificate of Status for Guarantor issued by the Filing Office dated as of November 3, 2014; and

6. A Certificate of the Company’s Secretary dated of even date herewith with authorizing resolutions attached thereto effective as of October 24, 2014 (the “Secretary Certificate”).

The documents referenced in paragraphs 3, 4 and 6 above are hereinafter referred to as the “ Organizational Documents ”. We have also examined such other instruments, corporate records, certificates of officers or other representatives of the Guarantor and other documents as we have deemed necessary or appropriate as a basis for the opinions set forth herein.

As to matters of fact, we have relied on the representations and warranties made by the parties in the Indentures, and on certificates of public officials and the Secretary’s Certificate and other documents we have reviewed as a basis for the opinions set forth herein. We have made no independent investigation of the accuracy or completeness of such matters of fact.

We have not undertaken an independent audit, examination, investigation or inspection of the matters described or contained in the Opinion Documents, and have relied solely on the facts and circumstances described and set forth therein.

In rendering this opinion we have, with your permission, assumed or relied, without investigation, verification or inquiry that:

a. The genuineness of all signatures;

b. The authenticity of all documents submitted to us as originals;

c. As to matters of fact, the truth, accuracy and completeness of the information, factual matters, and representations and warranties contained in the records, documents, instruments and certificates we have reviewed as of their stated dates and as of the date hereof;

d. The representations and warranties and other statements contained in the Registration Statement, Prospectus and the Organizational Documents are true, correct and complete as to all matters of fact;

e. The Registration Statement and Prospectus contain all disclosures of fact in a true and accurate manner;

f. The Registration Statement has been duly authorized and accepted by the parties thereto;

g. There are no oral or written statements or agreements that modify, amend or vary, or purport to modify, amend or vary, any of the terms of the Registration Statement or Prospectus;

h. The Debt Securities will be duly authenticated by the Trustees;


Omnicare, Inc.

Dated as of November 5, 2014

Page 3

 

i. Each party to the Registration Statement and Indentures (other than Guarantor) will be duly organized and validly existing and in good standing in its jurisdiction of organization;

j. Each party to the Indentures (other than Guarantor) has full power and authority to execute, deliver, and perform its obligations under the Indentures to which it is a party, and the Indentures to which it is a party have been duly authorized by all necessary action on its part and have been duly executed and duly delivered by it;

k. Each natural person executing the Registration Statement, Indentures and any other document referred to herein is legally competent to do so;

l. Each document submitted to us for review is accurate and complete, each such document that is an original is authentic, each such document that is a copy or a draft conforms to an authentic original, and all signatures on each such document are genuine;

m. The constitutionality and validity of all relevant laws, regulations, agency actions unless a reported case has otherwise held or widespread concern has been expressed by commentators as reflected in materials which lawyers routinely consult; and

n. Legally sufficient consideration has been given to support the enforceability of the Guarantor’s obligations under the Indentures.

Based upon an subject to the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, we are of the opinion that:

1. Guarantor is a limited liability company, validly existing under the laws of the State of Wisconsin (the “State”) and, based solely on certificates of the Filing Office, has filed its most recent required annual report, and has not filed Articles of Dissolution, with the Filing Office.

2. Guarantor has the limited liability company power and capacity to guarantee the Debt Securities pursuant to the terms of the Indentures and perform its obligations under the guarantees within the Indentures.

3. The Security Guarantees, upon being duly authorized by all necessary limited liability company action, in accordance with Wisconsin limited liability company law and the Guarantors Organizational Documents, executed by an authorized signatory and delivered, will be validly authorized, executed and delivered for Wisconsin limited liability company law purposes by the Guarantor.

The foregoing opinions are subject to bankruptcy, receivership, reorganization, insolvency, arrangement, moratorium, fraudulent conveyance or transfer, and other laws and judicially developed doctrines relating to or affecting the rights and remedies of creditors generally, including limitations imposed by judicial decisions relating thereto, and to general principles of equity, regardless of whether considered in a proceeding in equity or at law, including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing, and including principles under which a court has discretion granting specific performance or injunctive or other equitable relief. We express no opinion as to the accuracy, correctness or completeness of any statement in the Registration Statement.


Omnicare, Inc.

Dated as of November 5, 2014

Page 4

 

The opinions expressed herein are limited to the laws of the State in effect on the date hereof as they presently apply, and we express no opinion herein as to the laws of any other jurisdiction, or any securities laws or anti-fraud provisions of applicable securities laws. These opinions are given as of the date hereof, they are intended to apply only to those facts and circumstances that exist as of the date hereof, and we assume no obligation or responsibility to update or supplement these opinions to reflect any facts or circumstances that may hereafter come to our attention or any changes in laws that may hereafter occur, or to inform the addressees of any change in circumstances occurring after the date hereof that would alter the opinions rendered herein.

This opinion is limited to the matters set forth herein, and no opinion may be inferred or implied beyond the matters expressly contained herein. This opinion letter may not be used or relied on for any other purpose without our prior written consent. Except as provided below, no portion of this letter may be quoted, circulated or referred to in any other document for any other purpose without our prior written consent.

We hereby consent to reliance on this opinion letter and the opinions provided herein by the law firm White & Case LLP in connection with the legal opinion provided by that law firm that is included as an exhibit to the Registration Statement. Additionally, we hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under the Section 7 of the Securities Act, or the rules and regulations of the Commission thereunder.

Very truly yours,

/s/ DAVIS & KUELTHAU, S.C.

Exhibit 23.21

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated February 19, 2014, except with respect to our opinion on the consolidated financial statements insofar as it relates to the effects of the changes in guarantors discussed in Note 21, as to which the date is November 5, 2014, relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in Omnicare, Inc.’s Current Report on Form 8-K dated November 5, 2014. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Cincinnati, OH

November 5, 2014

Exhibit 25.1

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM T-1

 

 

STATEMENT OF ELIGIBILITY

UNDER THE TRUST INDENTURE ACT OF 1939

OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE

 

¨ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2)

 

 

U.S. BANK NATIONAL ASSOCIATION

(Exact name of Trustee as specified in its charter)

 

 

31-0841368

I.R.S. Employer Identification No.

 

800 Nicollet Mall

Minneapolis, Minnesota

  55402
(Address of principal executive offices)   (Zip Code)

William Bryan Echols

U.S. Bank National Association

1349 West Peachtree St, Suite 1050

Atlanta, GA 30309

(404) 898-8838

(Name, address and telephone number of agent for service)

 

 

OMNICARE, INC.

(Issuer with respect to the Securities)

 

 

 

Delaware   31-1001351
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

900 Omnicare Center

201 E. Fourth Street

Cincinnati, Ohio

  45202
(Address of Principal Executive Offices)   (Zip Code)

 

 

Senior Debt Securities

Subordinated Debt Securities

(Title of the Indenture Securities)

 

 

 


FORM T-1

 

Item 1.    GENERAL INFORMATION . Furnish the following information as to the Trustee.
   a)    Name and address of each examining or supervising authority to which it is subject.
         Comptroller of the Currency
         Washington, D.C.
   b)    Whether it is authorized to exercise corporate trust powers.
         Yes
Item 2.    AFFILIATIONS WITH OBLIGOR. If the obligor is an affiliate of the Trustee, describe each such affiliation.
      None   
Items 3-15       Items 3-15 are not applicable because to the best of the Trustee’s knowledge, the obligor is not in default under any Indenture for which the Trustee acts as Trustee.
Item 16.    LIST OF EXHIBITS: List below all exhibits filed as a part of this statement of eligibility and qualification.
   1.    A copy of the Articles of Association of the Trustee.*
   2.    A copy of the certificate of authority of the Trustee to commence business, attached as Exhibit 2.
   3.    A copy of the certificate of authority of the Trustee to exercise corporate trust powers, attached as Exhibit 3.
   4.    A copy of the existing bylaws of the Trustee, attached as Exhibit 4.
   5.    A copy of each Indenture referred to in Item 4, if the obligor is in default. Not applicable.
   6.    The consent of the Trustee required by Section 321(b) of the Trust Indenture Act of 1939, as amended (the “Act”), attached as Exhibit 6.
   7.    Report of Condition of the Trustee as of September 30, 2014 published pursuant to law or the requirements of its supervising or examining authority, attached as Exhibit 7.
   8.    A copy of any order pursuant to which the foreign trustee is authorized to act as sole trustee under indentures qualified or to be qualified under the Act. Not applicable.

 

2


   9.   

Consentto service of process. Not applicable.

 

* Incorporated by reference to Exhibit 25.1 to Amendment No. 2 to registration statement on Form S-4, Registration Number 333-128217 filed on November 15, 2005.

 

3


SIGNATURE

Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the Trustee, U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility and qualification to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Atlanta, State of Georgia on the 5 th of November, 2014.

 

By:   /s/ William Bryan Echols
  William Bryan Echols
  Vice President

 

4


Exhibit 2

 

LOGO

Office of the Comptroller of the Currency Washington, DC 20219 CERTIFICATE OF CORPORATE EXISTENCE I, Thomas J. Curry, Comptroller of the Currency, do hereby certify that: 1. The Comptroller of the Currency, pursuant to Revised Statutes 324, et seq, as amended, and 12 USC 1, et seq, as amended, has possession, custody, and control of all records pertaining to the chartering, regulation, and supervision of all national banking associations. 2. “U.S. Bank National Association,” Cincinnati, Ohio (Charter No. 24), is a national banking association formed under the laws of the United States and is authorized thereunder to transact the business of banking on the date of this certificate. IN TESTIMONY WHEREOF, today, September 2, 2014, I have hereunto subscribed my name and caused my seal of office to be affixed to these presents at the U.S. Department of the Treasury, in the City of Washington, District of Columbia.

 

5


Exhibit 3

 

LOGO

Office of the Comptroller of the Currency Washington, DC 20219 CERTIFICATION OF FIDUCIARY POWERS I, Thomas J. Curry, Comptroller of the Currency, do hereby certify that: 1. The Office of the Comptroller of the Currency, pursuant to Revised Statutes 324, et seq, as amended, and 12 USC 1, et seq, as amended, has possession, custody, and control of all records pertaining to the chartering, regulation, and supervision of all national banking associations. 2. “U.S. Bank National Association,” Cincinnati, Ohio (Charter No. 24), was granted, under the hand and seal of the Comptroller, the right to act in all fiduciary capacities authorized under the provisions of the Act of Congress approved September 28, 1962, 76 Stat. 668, 12 USC 92a, and that the authority so granted remains in full force and effect on the date of this certificate. IN TESTIMONY WHEREOF, today, September 2, 2014, I have hereunto subscribed my name and caused my seal of office to be affixed to these presents at the U.S. Department of the Treasury, in the City of Washington, District of Columbia.

 

6


Exhibit 4

AMENDED AND RESTATED

BYLAWS

OF

U.S. BANK NATIONAL ASSOCIATION

ARTICLE I.

MEETINGS OF SHAREHOLDERS

Section 1. Annual Meeting

The annual meeting of shareholders shall be held at the main banking house of the Association or other convenient place duly authorized by the Board of Directors (the “Board”) at 11:00 a.m. on the second Tuesday in March of each year, or such other date or time which the Board may designate at any Board meeting held prior to the required date for sending notice of the annual meeting to the shareholders. Notice of such meeting shall be mailed to shareholders not less than ten (10) or more than sixty (60) days prior to the meeting date.

Section 2. Special Meetings

Special meetings of shareholders may be called and held at such times and upon such notice as is specified in the Articles of Association.

Section 3. Quorum

A majority of the outstanding capital stock represented in person or by proxy shall constitute a quorum of any meeting of the shareholders, unless otherwise provided by law, but less than a quorum may adjourn any meeting, from time to time, and the meeting may be held as adjourned without further notice.

Section 4. Inspectors

The Board of Directors may, and in the event of its failure so to do, the Chairman of the Board may appoint Inspectors of Election who shall determine the presence of quorum, the validity of proxies, and the results of all elections and all other matters voted upon by shareholders at all annual and special meetings of shareholders.

Section 5. Voting

In deciding on questions at meetings of shareholders, except in the election of directors, each shareholder shall be entitled to one vote for each share of stock held. A majority of votes cast shall decide each matter submitted to the shareholders, except where by law a larger vote is required. In all elections of directors, each shareholder shall have the right to vote the number of shares owned by him for as many persons as there are directors to be elected, or to cumulate such shares and give one candidate as many votes as the number of directors multiplied by the number of his shares equal, or to distribute them on the same principle among as many candidates as he shall think fit.

 

7


Section 6. Waiver and Consent

The shareholders may act without notice or a meeting by a unanimous written consent by all shareholders.

ARTICLE II.

BOARD OF DIRECTORS

Section 1. Term of Office

The directors of this Association shall hold office for one year and until their successors are duly elected and qualified.

Section 2. Number

As provided in the Articles of Association, the Board of this Association shall consist of not less than five nor more than twenty-five members. At any meeting of the shareholders held for the purpose of electing directors, or changing the number thereof, the number of directors may be determined by a majority of the votes cast by the shareholders in person or by proxy.

Any vacancy occurring in the Board shall be filled by the remaining directors. Between meetings of the shareholders held for the purpose of electing directors, the Board by a majority vote of the full Board may increase the size of the Board by not more than four directors in any one but not to more than a total of twenty-five directors, and fill any vacancy so created in the Board. All directors shall hold office until their successors are elected and qualified.

Section 3. Regular Meetings

The organizational meeting of the Board of Directors shall be held as soon as practicable following the annual meeting of shareholders at such time and place as the Chairman or President may designate. Other regular meetings of the Board of Directors shall be held quarterly at such time and place as may be designated in the notice of the meeting. When any regular meeting of the Board falls on a holiday, the meeting shall be held on the next banking business day, unless the Board shall designate some other day.

Section 4. Special Meetings

Special meetings of the Board of Directors may be called by the Chairman of the Board of the Association, or at the request of three or more Directors. Notice of the time, place and purposes of such meetings shall be given by letter, by telephone, in person, by facsimile, by electronic mail or other reasonable manner to every Director.

 

8


Section 5. Quorum

A majority of the entire membership of the Board shall constitute a quorum of any meeting of the Board.

Section 6. Necessary Vote

A majority of those Directors present and voting at any meeting of the Board of Directors shall decide each matter considered, except where otherwise required by law or the Articles or Bylaws of this Association.

Section 7. Compensation

Directors, excluding full-time employees of the Bank, shall receive such reasonable compensation as may be fixed from time to time by the Board of Directors.

ARTICLE III.

OFFICERS

Section 1. Who Shall Constitute

The Officers of the Association shall be a Chairman of the Board, Chief Executive Officer, a President, a Secretary, and other officers such as Vice Chairman of the Board, Executive Vice Presidents, Senior Vice Presidents, Vice Presidents, Assistant Vice Presidents, Assistant Secretaries, Trust Officers, Assistant Trust Officers, Controller, and Assistant Controller, as the Board may appoint from time to time. The Board may choose to delegate authority to elect officers other than the Chairman, Chief Executive Officer, President, Secretary, Vice Chairman and Executive Vice Presidents, to the Chief Executive Officer or President. Any person may hold two offices. The Chief Executive Officer and the President shall at all times be members of the Board of Directors.

Section 2. Term of Office

All officers shall be elected for and shall hold office until their respective successors are elected and qualified or until their earlier death, resignation, retirement, disqualification or removal from office, subject to the right of the Board of Directors in its sole discretion to discharge any officer at any time.

Section 3. Chairman of the Board

The Chairman of the Board shall have general executive powers and duties and shall perform such other duties as may be assigned from time to time by the Board of Directors. He shall, when present, preside at all meetings of the shareholders and directors and shall be ex officio a member of all committees of the Board.

Section 4. Chief Executive Officer

The Chief Executive Officer, who may also be the Chairman or the President, shall have general executive powers and duties and shall perform such other duties as may be assigned from time to time by the Board of Directors.

 

9


Section 5. President

The President shall have general executive powers and duties and shall perform such other duties as may be assigned from time to time by the board of Directors. In addition, if designated by the Board of Directors, the President shall be the Chief Executive Officer and shall have all the powers and duties of the Chief Executive Officer, including the same power to name temporarily a Chief Executive Officer to serve in the absence of the President if there is a vacancy in the position of the chairman or in the event of the absence or incapacity of the Chairman.

Section 6. Vice Chairmen of the Board

The Board of Directors shall have the power to elect one or more Vice Chairmen of the Board of Directors. Any such Vice Chairman of the Board shall participate in the formation of the policies of the Association and shall have such other duties as may be assigned to him from time to time by the Chairman of the Board or by the Board of Directors.

Section 7. Other Officers

The Secretary and all other officers appointed by the Board of Directors shall have such duties as defined by law and as may from time to time be assigned to them by the Chief Executive Officer or the Board of Directors.

ARTICLE IV.

COMMITTEES

Section 1. Compensation Committee

The duties of the Compensation Committee of the Association shall be carried out by the Compensation Committee of the financial holding company that is the parent of this Association.

Section 2. Committee on Audit

The duties of the Audit Committee of the Association shall be carried out by the Audit Committee of the financial holding company that is the parent of this Association.

Section 3. Trust Management Committee

The Board of Directors of this Association shall appoint a Trust Management Committee to provide oversight of the fiduciary activities of the Association. The Trust Management Committee shall determine policies governing fiduciary activities. The Trust Management Committee or such sub-committees, officers or others as may be duly designated by the Trust Management Committee shall oversee the processes related to fiduciary activities to assure conformity with fiduciary policies it establishes, including ratifying the acceptance and the closing out or relinquishment of all trusts. All actions of the Trust Committee shall be reported to the Board of Directors.

 

10


Section 4. Other Committees

The Board of Directors may appoint, from time to time, other committees for such purposes and with such powers as the Board may direct.

ARTICLE V.

MINUTE BOOK

The organization papers of this Association, the Bylaws as revised or amended from time to time and the proceedings of all regular and special meetings of the shareholders and the directors shall be recorded in a minute book or books. All reports of committees required to be made to the Board shall be recorded in a minute book or shall be filed by the recording officer. The minutes of each meeting of the shareholders and the Board shall be signed by the recording officer.

ARTICLE VI.

CONVEYANCES, CONTRACTS, ETC.

All transfers and conveyances of real estate, mortgages, and transfers, endorsements or assignments of stock, bonds, notes, debentures or other negotiable instruments, securities or personal property shall be signed by any elected or appointed officer.

All checks, drafts, certificates of deposit and all funds of the Association held in its own or in a fiduciary capacity may be paid out by an order, draft or check bearing the manual or facsimile signature of any elected or appointed officer of the Association.

All mortgage satisfactions, releases, all types of loan agreements, all routine transactional documents of the Association, and all other instruments not specifically provided for, whether to be executed in a fiduciary capacity or otherwise, may be signed on behalf of the Association by any elected or appointed officer thereof.

The Secretary or any Assistant Secretary of the Association or other proper officer may execute and certify that required action or authority has been given or has taken place by resolution of the Board under this Bylaw without the necessity of further action by the Board.

ARTICLE VII.

SEAL

The Association shall have no corporate seal.

 

11


ARTICLE VIII.

INDEMNIFICATION OF DIRECTORS,

OFFICERS, AND EMPLOYEES

Section 1. General.

The Association shall indemnify to the full extent permitted by and in the manner permissible under the Delaware General Corporation Law, as amended from time to time (but, in the case of any such amendment, only to the extent that such amendment permits the Association to provide broader indemnification rights than said law permitted the Association to provide prior to such amendment), any person made, or threatened to be made, a party to any action, suit, or proceeding, whether criminal, civil, administrative, or investigative, by reason of the fact that such person (i) is or was a director, advisory director, or officer of the Association or any predecessor of the Association, or (ii) is or was a director, advisory director or officer of the Association or any predecessor of the Association and served any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise as a director, advisory director, officer, partner, trustee, employee or agent at the request of the Association or any predecessor of the Association; provided , however , that the Association shall indemnify any such person seeking indemnification in connection with a proceeding (or part thereof) initiated by such person, except for a proceeding contemplated by Section 4 of this Article VIII, only if such proceeding (or part thereof) was authorized by the Board of Directors.

Section 2. Advancement of Expenses.

The right to indemnification conferred in this Article VIII shall be a contract right and shall include the right to be paid by the Association the expenses incurred in defending any such proceeding or threatened proceeding in advance of its final disposition, such advances to be paid by the Association within 20 days after the receipt by the Association of a statement or statements from the claimant requesting such advance or advances from time to time; provided , however , that if the General Corporation Law of the State of Delaware requires, the payment of such expenses incurred by a director, advisory director or officer in his or her capacity as a director, advisory director or officer (and not in any other capacity in which service was or is rendered by such person while a director, advisory director or officer, including, without limitation, service to an employee benefit plan) in advance of the final disposition of a proceeding, shall be made only upon delivery to the Association of an undertaking by or on behalf of such director, advisory director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director, advisory director or officer is not entitled to be indemnified under this Article VIII or otherwise.

Section 3. Procedure for Indemnification.

To obtain indemnification under this Article VIII, a claimant shall submit to the Association a written request, including therein or therewith such documentation and information as is reasonably available to the claimant and is reasonably necessary to determine whether and to what extent the claimant is entitled to indemnification. Upon written request by a claimant for indemnification pursuant to the first sentence of this Section 3, a determination, if required by applicable law, with respect to the claimant’s entitlement thereto shall be made as follows: (1) if requested by the claimant, by Independent Counsel (as hereinafter defined), or (2) if no request is made by the claimant for a determination by Independent Counsel, (i) by a majority vote of the Disinterested Directors (as hereinafter defined), even though less than a quorum, or by a

 

12


majority vote of a committee of Disinterested Directors designated by a majority vote of Disinterested Directors, even though less than a quorum, or (ii) if there are no Disinterested Directors or if the Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board of Directors, a copy of which shall be delivered to the claimant. In the event the determination of entitlement to indemnification is to be made by Independent Counsel at the request of the claimant, the Independent Counsel shall be selected by the Board of Directors. If it is so determined that the claimant is entitled to indemnification, payment to the claimant shall be made within 10 days after such determination.

Section 4. Certain Remedies.

If a claim under Section 1 of this Article VIII is not paid in full by the Association within thirty days after a written claim pursuant to Section 3 of this Article VIII has been received by the Association, or if a claim under Section 2 of this Article VIII is not paid in full by the Association within twenty days after a written claim pursuant to Section 2 of this Article VIII has been received by the Association, the claimant may at any time thereafter bring suit against the Association to recover the unpaid amount of the claim and, if successful in whole or in part, the claimant shall be entitled to be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where the required undertaking, if any is required, has been tendered to the Association) that the claimant has not met the standard of conduct which makes it permissible under the General Corporation Law of the State of Delaware for the Association to indemnify the claimant for the amount claimed, but the burden of proving such defense shall be on the Association. Neither the failure of the Association (including its Board of Directors or Independent Counsel) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct set forth in the General Corporation Law of the State of Delaware, nor an actual determination by the Association (including its Board of Directors or Independent Counsel) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard of conduct.

Section 5. Binding Effect.

If a determination shall have been made pursuant to Section 3 of this Article VIII that the claimant is entitled to indemnification, the Association shall be bound by such determination in any judicial proceeding commenced pursuant to Section 4 of this Article VIII.

Section 6. Validity of this Article VIII.

The Association shall be precluded from asserting in any judicial proceeding commenced pursuant to Section 4 of this Article VIII that the procedures and presumptions of this Article VIII are not valid, binding and enforceable and shall stipulate in such proceeding that the Association is bound by all the provisions of this Article VIII.

 

13


Section 7. Nonexclusivity, etc .

The right to indemnification and the payment of expenses incurred in defending a proceeding or threatened proceeding in advance of its final disposition conferred in this Article VIII shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, provision of the Articles of Association, Bylaws, agreement, vote of shareholders or Disinterested Directors or otherwise. No repeal or modification of this Article VIII, or adoption of any provision inconsistent herewith shall in any way diminish or adversely affect the rights of any present or former director, advisory director, officer, employee or agent of the Association or any predecessor thereof hereunder in respect of any occurrence or matter arising, or of any claim involving allegations of acts or omissions occurring or arising, prior to any such repeal or modification.

Section 8. Insurance.

The Association may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Association or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Association would have the power to indemnify such person against such expense, liability or loss under the General Corporation Law of the State of Delaware. To the extent that the Association maintains any policy or policies providing such insurance, each such director or officer, and each such agent or employee to whom rights to indemnification have been granted as provided in Section 9 of this Article VIII, shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage thereunder for any such director, officer, employee or agent.

Section 9. Indemnification of Other Persons.

The Association may grant rights to indemnification, and rights to be paid by the Association the expenses incurred in defending any proceeding in advance of its final disposition, to any present or former employee or agent of the Association or any predecessor of the Association to the fullest extent of the provisions of this Article VIII with respect to the indemnification and advancement of expenses of directors, advisory directors and officers of the Association.

Section 10. Severability.

If any provision or provisions of this Article VIII shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (1) the validity, legality and enforceability of the remaining provisions of this Article VIII (including, without limitation, each portion of any paragraph of this Article VIII containing any such provision held to be invalid, illegal or unenforceable, that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby; and (2) to the fullest extent possible, the provisions of this Article VIII (including, without limitation, each such portion of any paragraph of this Article VIII containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable.

 

14


Section 11. Certain Definitions.

For purposes of this Article VI:

(1) “Disinterested Director” means a director of the Association who is not and was not a party to the matter in respect of which indemnification is sought by the claimant.

(2) “Independent Counsel” means a law firm, a member of a law firm, or an independent practitioner that is experienced in matters of corporation law and shall include any such person who, under the applicable standards of professional conduct then prevailing, would not have a conflict of interest in representing either the Association or the claimant in an action to determine the claimant’s rights under this Article VIII.

Section 12. Notices.

Any notice, request or other communication required or permitted to be given to the Association under this Article VIII shall be in writing and either delivered in person or sent by telecopy, telex, telegram, overnight mail or courier service, or certified or registered mail, postage prepaid, return receipt requested, to the Secretary of the Association and shall be effective only upon receipt by the Secretary.

Section 13. Payments

Notwithstanding any other provision of this Article VIII, however, (a) any indemnification payments to an institution-affiliated party, as defined at 12 USC 1813(u), for an administrative proceeding or civil action initiated by a federal banking agency, shall be reasonable and consistent with the requirements of 12 USC 1828(k) and the associated regulations; and (b) any indemnification payments and advancement of costs and expenses to an institution-affiliated party, as defined at 12 USC 1813(u), in cases involving an administrative proceeding or civil action not initiated by a federal banking agency, shall be consistent with safe and sound banking practices.

ARTICLE IX.

AMENDMENTS

These Bylaws, or any of them, may be added to, altered, amended or repealed by the Board at any regular or special meeting of the Board.

ARTICLE X.

GOVERNING

LAW

This Association designates the Delaware General Corporation Law, as amended from time to time, as the governing law for its corporate governance procedures, to the extent not inconsistent with Federal banking statutes and regulations.

October 20, 2014

 

15


Exhibit 6

CONSENT

In accordance with Section 321(b) of the Trust Indenture Act of 1939, the undersigned, U.S. BANK NATIONAL ASSOCIATION hereby consents that reports of examination of the undersigned by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and Exchange Commission upon its request therefor.

Dated: November 5, 2014

 

By:   /s/ William Bryan Echols
 

William Bryan Echols

Vice President

 

16


Exhibit 7

U.S. Bank National Association

Statement of Financial Condition

As of 9/30/2014

($000’s)

 

     9/30/2014  

Assets

  

Cash and Balances Due From Depository Institutions

   $ 6,169,498   

Securities

     96,412,984   

Federal Funds

     61,856   

Loans & Lease Financing Receivables

     244,220,646   

Fixed Assets

     4,101,858   

Intangible Assets

     13,291,012   

Other Assets

     22,775,893   
  

 

 

 

Total Assets

   $ 387,033,747   

Liabilities

  

Deposits

   $ 284,226,575   

Fed Funds

     1,282,645   

Treasury Demand Notes

     0   

Trading Liabilities

     565,781   

Other Borrowed Money

     42,642,374   

Acceptances

     0   

Subordinated Notes and Debentures

     5,023,000   

Other Liabilities

     12,043,509   
  

 

 

 

Total Liabilities

   $ 345,783,884   

Equity

  

Common and Preferred Stock

   $ 18,200   

Surplus

     14,266,407   

Undivided Profits

     26,110,078   

Minority Interest in Subsidiaries

   $ 855,178   
  

 

 

 

Total Equity Capital

   $ 41,249,863   

Total Liabilities and Equity Capital

   $ 387,033,747   

 

17